<SEC-DOCUMENT>0001683168-20-003785.txt : 20201109
<SEC-HEADER>0001683168-20-003785.hdr.sgml : 20201109
<ACCEPTANCE-DATETIME>20201109163034
ACCESSION NUMBER:		0001683168-20-003785
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		69
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201109
DATE AS OF CHANGE:		20201109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACACIA RESEARCH CORP
		CENTRAL INDEX KEY:			0000934549
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		IRS NUMBER:				954405754
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37721
		FILM NUMBER:		201298140

	BUSINESS ADDRESS:	
		STREET 1:		4 PARK PLAZA
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9494808300

	MAIL ADDRESS:	
		STREET 1:		4 PARK PLAZA
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>acacia_i10q-093020.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ACTG="http://acaciaresearch.com/20200930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2020_currency -->
<!-- Field: Set; Name: xdx; ID: xdx_037_ACTG_acaciaresearch.com_20200930 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20200101_20200930 -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0000934549 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DDocumentFiscalYearFocus_2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DDocumentFiscalPeriodFocus_Q3 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<!-- Field: Set; Name: xdx; ID: xdx_079_SO_C%2D%2D\Users\Fran\Dropbox (GlobalOne)\GlobalOne Team Folder\edgar\Acacia 10%2DQ 09%2D30%2D20\acacia__10q%2Dtagged.xdxs -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityCentralIndexKey">0000934549</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:DocumentFiscalYearFocus">2020</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonNumeric>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0453" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0460" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0464" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0468" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0469" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0474" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0502" unitRef="Shares" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0506" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0507" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-07-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0514" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-07-012019-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-07-012019-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-07-012019-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0518" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-07-012019-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0524" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0532" unitRef="Shares" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0548" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0549" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0550" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0551" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0553" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0557" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0558" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0560" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0561" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0564" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0566" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0568" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0569" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0573" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0576" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0577" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0579" unitRef="Shares" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0581" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0582" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0583" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0586" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0594" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0595" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0596" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0613" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0621" unitRef="Shares" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0625" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0626" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0627" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0628" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0630" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0634" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-01-012019-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0635" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0637" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0638" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0643" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0644" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0645" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0647" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0648" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0653" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0654" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0655" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0656" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0657" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0661" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" id="xdx2ixbrl0669" unitRef="Shares" xs:nil="true"></ix:nonFraction>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="actg-20200930.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-01-01to2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_NonCashStockCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:NonCashStockCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_NonCashStockCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:NonCashStockCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_NonCashStockCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:NonCashStockCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_NonCashStockCompensationExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:NonCashStockCompensationExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_PaidUpRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_RecurringRevenueAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_OneLicenseeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_OneLicensee2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_TradingSecuritesrEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesrEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_TradingSecuritesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_TradingSecuritesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TradingSecuritesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TradingSecuritesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TradingSecuritesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_TradingSecuritesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesDerivativetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputDiscountRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputDiscountRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_EmbeddedDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_EmbeddedDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputCreditSpreadMember_custom_EmbeddedDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_EmbeddedDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_VeritoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_RestrictedStockUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_EmployeeStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquityBasedIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_EquityBasedIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquityBasedIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_EquityBasedIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesAWarrantsMember132390937">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_SeriesAWarrantsMember132390953">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesAWarrantsMember132390968">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_SeriesAWarrantsMember132390984">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember132391000">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_SeriesBWarrantsMember132391000">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132391015">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_SeriesBWarrantsMember132391031">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-012018-12-31_custom_VeritoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_VeritoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-03-31_custom_VeritoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_WarrantInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_CommonStockInvestmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-05_custom_StockRepurchaseProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ACTG:StockRepurchaseProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-202020-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-20</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-012020-04-23_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-01</xbrli:startDate>
        <xbrli:endDate>2020-04-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_us-gaap_CommonStockMember132393281">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-11-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-11-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-02-25_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-25_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132394531">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:ExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:ExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotes1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:ExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotes1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesARedeemableConvertibleStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember132395046">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-06-04_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-06-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-04-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquitySecuritiesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_EquitySecuritiesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquitySecuritiesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_EquitySecuritiesDerivativeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesLFFundPrivateSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesLFFundPrivateSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesLFFundPrivateSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesLFFundPrivateSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_EquitySecuritiesForwardContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesForwardContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_EquitySecuritiesForwardContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesForwardContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_EquitySecuritiesForwardContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesForwardContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_EquitySecuritiesForwardContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesForwardContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritiesLFFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritiesLFFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritiesLFFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritiesLFFundPublicSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-012020-09-30_custom_TradingSecuritesLfFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-012019-09-30_custom_TradingSecuritesLfFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-09-30_custom_TradingSecuritesLfFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-09-30_custom_TradingSecuritesLfFundSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000934549</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>ACTG:Integer</xbrli:measure>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><a href="#a1"><span style="font-size: 7pt">Table of Contents</span></a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>________________________________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_906_edei--DocumentType_c20200101__20200930_zq09qRur9ZIj"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>________________________________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_902_edei--DocumentQuarterlyReport_c20200101__20200930_zXpasv6bTYMi"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">&#9746;</ix:nonNumeric></span> <b>QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR THE QUARTERLY PERIOD ENDED <b><span id="xdx_903_edei--DocumentPeriodEndDate_c20200101__20200930_zBNGYFF9Vza3"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">SEPTEMBER
30, 2020</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_906_edei--DocumentTransitionReport_c20200101__20200930_zb2er0JNCQn6"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span> <b>TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR THE TRANSITION PERIOD FROM <span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>
TO <span style="text-decoration: underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number: <span id="xdx_901_edei--EntityFileNumber_c20200101__20200930_zr6H50fMD8Hb"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityFileNumber">1-37721</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>________________________________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityRegistrantName_c20200101__20200930_z4r07jagJZS5"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityRegistrantName">Acacia Research Corporation</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified
in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>________________________________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="width: 1%">&#160;</td>
    <td style="width: 51%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20200101__20200930_zMfkC7neO0u5" style="text-transform: uppercase"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 46%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20200101__20200930_zxfUTsAaaP12"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityTaxIdentificationNumber">95-4405754</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>incorporation or organization)</b></p></td>
    <td>&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(I.R.S. Employer</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20200101__20200930_zycm7KtKdZ4g"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityAddressAddressLine1">4 Park Plaza</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressAddressLine2_c20200101__20200930_zp6mdK7yX3ti"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityAddressAddressLine2">Suite 550</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressCityOrTown_c20200101__20200930_zXFhP3aidFz6"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityAddressCityOrTown">Irvine</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20200101__20200930_z9X5XxW9HR5"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span>
<span id="xdx_907_edei--EntityAddressPostalZipCode_c20200101__20200930_z1nW3FrTgg48"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityAddressPostalZipCode">92614</ix:nonNumeric></span> </b>&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of principal executive offices,
Zip Code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--CityAreaCode_c20200101__20200930_zPYer3ElMJFh"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:CityAreaCode">(949)</ix:nonNumeric></span> <span id="xdx_907_edei--LocalPhoneNumber_c20200101__20200930_zpkuACLkxw1g"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:LocalPhoneNumber">480-8300</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant&#8217;s telephone number,
including area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>________________________________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Trading Symbol(s)</span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--Security12bTitle_c20200101__20200930_zYzGqc75Nbj6"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_edei--TradingSymbol_c20200101__20200930_zdZKUzdG17U5"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:TradingSymbol">ACTG</ix:nonNumeric></span></span></td>
    <td style="text-align: center">The <span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--SecurityExchangeName_c20200101__20200930_zO4BISj9cupi"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Stock Market, LLC</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. &#9746; <span id="xdx_904_edei--EntityCurrentReportingStatus_c20200101__20200930_zc5poZee0SHc"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9744; No</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#9746;
<span id="xdx_90E_edei--EntityInteractiveDataCurrent_c20200101__20200930_zfqWE7Z4Nef3"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9744; No</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging
growth company&#8221; in Rule 12b-2 of the Exchange Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="width: 59%"><span style="font: 10pt Times New Roman, Times, Serif">Large accelerated filer &#9744;</span></td>
    <td style="width: 10%">&#160;</td>
    <td style="width: 30%"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--EntityFilerCategory_c20200101__20200930_zuKn5Hinn8I6"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" name="dei:EntityFilerCategory">Accelerated Filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Non-accelerated filer &#9744;</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Smaller reporting company <span id="xdx_90F_edei--EntitySmallBusiness_c20200101__20200930_zK1Pauk9xi68"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Emerging growth company <span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20200101__20200930_zCBGVF3Va352"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; <span id="xdx_907_edei--EntityShellCompany_c20200101__20200930_z5RASWF8KDml"><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> &#9746;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of November 2, 2020, <span id="xdx_900_edei--EntityCommonStockSharesOutstanding_iI_c20201102_zzG8FPNgmsI6"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2020-11-02" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">49,279,453</ix:nonFraction></span> shares of the registrant&#8217;s
common stock, $0.001 par value, were issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">&#160;</td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM 10-Q</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE QUARTERLY PERIOD ENDED</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>September 30, 2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a1"></span>INDEX</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="width: 10%">&#160;</td>
    <td style="width: 80%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Page</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td><a href="#a19"><span style="font: 10pt Times New Roman, Times, Serif"><b>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">3</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>PART I.</b></span></td>
    <td><a href="#a2"><span style="font: 10pt Times New Roman, Times, Serif"><b>FINANCIAL INFORMATION</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 1.</span></td>
    <td><a href="#a3"><span style="font: 10pt Times New Roman, Times, Serif">Financial Statements</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-indent: -10pt; padding-left: 10pt"><a href="#a21"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-indent: -10pt; padding-left: 10pt"><a href="#a20"><span style="font: 10pt Times New Roman, Times, Serif">Unaudited Condensed Consolidated Statements of Operations for the Three and Nine months Ended September 30, 2020 and 2019</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">5</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a5">Unaudited Condensed Consolidated Statements of Series A Redeemable Convertible Preferred Stock and Stockholders' Equity for the Three and Nine months Ended September 30, 2020 and 2019</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">6</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a6">Unaudited Condensed Consolidated Statements of Cash Flows for the Nine months Ended September 30, 2020 and 2019</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td><a href="#a7"><span style="font: 10pt Times New Roman, Times, Serif">Notes to Unaudited Condensed Consolidated Financial Statements</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">9</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 2.</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a8">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">30</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 3.</span></td>
    <td><a href="#a9"><span style="font: 10pt Times New Roman, Times, Serif">Quantitative and Qualitative Disclosures about Market Risk</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">43</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 4.</span></td>
    <td><a href="#a10"><span style="font: 10pt Times New Roman, Times, Serif">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">44</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>Part II.</b></span></td>
    <td><a href="#a11"><span style="font: 10pt Times New Roman, Times, Serif"><b>OTHER INFORMATION</b></span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">45</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 1.</span></td>
    <td><a href="#a12"><span style="font: 10pt Times New Roman, Times, Serif">Legal Proceedings</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">45</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 1A.</span></td>
    <td><a href="#a13"><span style="font: 10pt Times New Roman, Times, Serif">Risk Factors</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">45</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 2.&#160;</span></td>
    <td><a href="#a14"><span style="font: 10pt Times New Roman, Times, Serif">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">45</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 3.&#160;</span></td>
    <td><a href="#a15"><span style="font: 10pt Times New Roman, Times, Serif">Defaults Upon Senior Securities</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">45</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 4.&#160;</span></td>
    <td><a href="#a16"><span style="font: 10pt Times New Roman, Times, Serif">Mine Safety Disclosures</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">46</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 5.&#160;</span></td>
    <td><a href="#a17"><span style="font: 10pt Times New Roman, Times, Serif">Other Information</span></a></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">46</span></td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
<tr>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Item 6.</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a18">Exhibits</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">46</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a19"></span><b>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Quarterly Report on Form 10-Q for the three months ended
September 30, 2020, or this Report, contains forward-looking statements within the meaning of the federal securities laws, which
statements are subject to substantial risks and uncertainties. These forward-looking statements are intended to qualify for the
safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements
of historical fact included in this Report, or incorporated by reference into this Report, are forward-looking statements. Throughout
this Report, we have attempted to identify forward-looking statements by using words such as &#8220;may,&#8221; &#8220;believe,&#8221;
&#8220;will,&#8221; &#8220;could,&#8221; &#8220;project,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221;
&#8220;should,&#8221; &#8220;continue,&#8221; &#8220;potential,&#8221; &#8220;plan,&#8221; &#8220;forecasts,&#8221; &#8220;goal,&#8221;
&#8220;seek,&#8221; &#8220;intend,&#8221; &#8220;predict,&#8221; other forms of these words or similar words or expressions or
the negative thereof, although not all forward-looking statements contain these terms. Such statements address future events and
conditions concerning, among other things, intellectual property, or IP, acquisition and development, licensing and enforcement
activities, other related business activities, the impact of the COVID-19 pandemic, capital expenditures, earnings, litigation,
regulatory matters, markets for our services, liquidity and capital resources and accounting matters. Actual results in each case
could differ materially from those anticipated in such statements by reason of factors such as our ability to invest in new technologies
and patents, future global economic conditions, changes in demand for our services, legislative, regulatory and competitive developments
in markets in which we and our subsidiaries operate, results of litigation and other circumstances affecting anticipated revenues
and costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have based our forward-looking statements on management&#8217;s
current expectations and projections about trends affecting our business and industry and other future events. Although we do not
make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy.
Forward-looking statements are subject to substantial risks and uncertainties that could cause our future business, financial condition,
results of operations or performance to differ materially from our historical results or those expressed or implied in any forward-looking
statement contained in this Report. Some of the risks and uncertainties that may cause actual results to differ from those expressed
or implied in the forward-looking statements are described in &#8220;Risk Factors&#8221; included in Part II, Item1A of this Report
on Form 10-Q, and in &#8220;Risk Factors&#8221; included in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year
ended December 31, 2019, filed with the Securities and Exchange Commission, or the SEC, on March 16, 2020, or our Annual Report,
as well as in our other public filings with the SEC. In addition, actual results may differ as a result of additional risks and
uncertainties of which we are currently unaware or which we do not currently view as material to our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The information contained in this Quarterly Report on Form 10-Q
is not a complete description of our business or the risks associated with an investment in our common stock. We urge you to carefully
review and consider the various disclosures made by us in this report and in our other reports filed with the SEC. You should read
this Report in its entirety, together with the documents that we file as exhibits to this Report and the documents that we incorporate
by reference into this Report, with the understanding that our future results may be materially different from what we currently
expect. The forward-looking statements we make speak only as of the date on which they are made. We expressly disclaim any intent
or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to
changes in our opinions or expectations, except as required by applicable law or the rules of The NASDAQ Stock Market, LLC. If
we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We qualify all of our forward-looking statements by these cautionary
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a2"></span>PART I--FINANCIAL INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a3"></span><b>Item 1. Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a21"></span><b>UNAUDITED CONDENSED CONSOLIDATED BALANCE
SHEETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands, except share and per share
data)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_111_pn3n3_zGgehmBTGbH7" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_491_20200930_zziOayNfw4Vj" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49F_20191231_zywaKGXMqdw4" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom">
    <td colspan="8" style="font-size: 10pt; font-weight: bold; text-align: center">ASSETS</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AssetsCurrentAbstract_i01B" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Current assets:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pn3n3_maACzcFR_zVi0LkvR1Cp" style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; font-size: 10pt; text-align: left; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">162,564</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57,359</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AvailableForSaleSecuritiesDebtSecuritiesCurrent_i02I_pn3n3_d0_maACzcFR_z6hQglAm7ZN7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Trading securities - debt</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93,843</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--AvailableForSaleSecuritiesEquitySecuritiesCurrent_i02I_pn3n3_maACzcFR_zzY1YSTiuFuh" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Trading securities - equity</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,471</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,140</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--EquitySecuritiesFvNi_i02I_pn3n3_d0_maACzcFR_z2p01rBRsIK5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Equity securities - private</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNi" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">116,009</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNi" contextRef="AsOf2019-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DerivativeAssetsCurrent_i02I_pn3n3_d0_maACzcFR_z6v9HngNgEIf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Equity securities derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeAssetsCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,818</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeAssetsCurrent" contextRef="AsOf2019-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EquitySecuritiesFvNiCost_i02I_pn3n3_d0_maACzcFR_zAYb0xMzT601" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Equity securities forward contract</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiCost" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">340</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiCost" contextRef="AsOf2019-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--PrepaidInvestment_i02I_pn3n3_d0_maACzcFR_zmMCgLVFQ7if" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Prepaid investment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PrepaidInvestment" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,900</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:PrepaidInvestment" contextRef="AsOf2019-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_i02I_pn3n3_maACzcFR_zvPUSwzYQn1e" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Accounts receivable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">511</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pn3n3_maACzcFR_z6Z3pWwzUAS5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid expenses and other current assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,685</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,912</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AssetsCurrent_i02TI_pn3n3_mtACzcFR_maAza5M_zcPKnSYOvrk1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total current assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">366,050</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">171,765</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--RestrictedCashAndInvestmentsNoncurrent_i01I_pn3n3_maAza5M_zC4Q9ehVP7E6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Long-term restricted cash</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--InvestmentsFairValueDisclosure_i01I_pn3n3_maAza5M_zYbqc3dv1DZ4" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Investment at fair value (Note 5)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">982</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_i01I_pn3n3_maAza5M_zLzPwUwsIvX1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Patents, net of accumulated amortization</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,071</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,814</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_pn3n3_maAza5M_zky5Ck1rgwZ3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Leased right-of-use assets</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,101</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,264</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--OtherAssetsNoncurrent_i01I_pn3n3_maAza5M_zWOUob8SGwPe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Other non-current assets</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,311</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">818</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--Assets_i01TI_pn3n3_mtAza5M_zrNCqTd2MKW3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">426,515</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">218,161</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td colspan="8" style="font-size: 10pt; font-weight: bold; text-align: center">LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY</td><td style="font-size: 10pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Current liabilities:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--AccountsPayableCurrent_i02I_pn3n3_maLCzYXG_zXvCefMcMhl9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Accounts payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,707</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,765</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pn3n3_maLCzYXG_zhTyE3e4t43" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Accrued expenses and other current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,849</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,265</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_i02I_pn3n3_maLCzYXG_zp9VBt0Yq58l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Accrued compensation</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,595</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">507</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--RoyaltiesAndContingentLegalFeesPayable_i02I_pn3n3_maLCzYXG_zTMFt6bjNHdf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Royalties and contingent legal fees payable</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:RoyaltiesAndContingentLegalFeesPayable" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,230</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:RoyaltiesAndContingentLegalFeesPayable" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,178</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--SecuredDebtCurrent_i02I_pn3n3_d0_maLCzYXG_zzx8IcJmywBf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Senior Secured Notes Payable - short-term</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113,933</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="AsOf2019-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LiabilitiesCurrent_i02TI_pn3n3_mtLCzYXG_maLz5Y2_zxxSFvQrkimk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total current liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138,314</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,715</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DerivativeLiabilitiesNoncurrent_i01I_pn3n3_maLz5Y2_z7SXdB9Vm5D4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Series A warrant liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeLiabilitiesNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,568</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_i01I_pn3n3_maLz5Y2_zPiRILke9CNj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Series A embedded derivative liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,682</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,974</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DerivativeLiabilitiesNoncurrent1_i01I_pn3n3_d0_maLz5Y2_zG7zsxiMGsR9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Series B warrant liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:DerivativeLiabilitiesNoncurrent1" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,796</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:DerivativeLiabilitiesNoncurrent1" contextRef="AsOf2019-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_pn3n3_maLz5Y2_zVBgNeBAQLff" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Long-term lease liabilities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,101</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,264</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherLiabilitiesNoncurrent_i01I_pn3n3_maLz5Y2_zBKZVlK5MYy8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">593</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">593</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--Liabilities_i01TI_pn3n3_mtLz5Y2_maLASEzuFz_zUSLRoj0k0Gj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214,090</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,114</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CommitmentsAndContingencies_i01I_pn3n3_d0_zKNaD5Qceat5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Commitments and contingencies (Note 6)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--PreferredStockRedemptionAmount_i01I_pn3n3_maLASEzuFz_zJjzUulh9lgc" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Series A redeemable convertible preferred stock, par value $<span id="xdx_905_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pip0_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zSSDeh2gpM0h" title="Series A redeemable convertible preferred stock, par value"><span id="xdx_90E_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pip0_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zx0VK0QFF0fi" title="Series A redeemable convertible preferred stock, par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share; stated value $<span id="xdx_904_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_pip0_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_z76AIAULFj9c" title="Series A redeemable convertible preferred stock, value per share"><span id="xdx_905_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_pip0_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zNQiExgc98D7" title="Series A redeemable convertible preferred stock, value per share"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">100</ix:nonFraction></ix:nonFraction></span></span> per share; <span id="xdx_90D_eus-gaap--TemporaryEquitySharesAuthorized_iI_pip0_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zdDkjTaY9j1k" title="Series A redeemable convertible preferred stock, shares authorized"><span id="xdx_906_eus-gaap--TemporaryEquitySharesAuthorized_iI_pip0_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zM6R8L2XVaR9" title="Series A redeemable convertible preferred stock, shares authorized"><span id="xdx_90D_eus-gaap--TemporaryEquitySharesIssued_iI_pip0_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zmoiOjSpxLod" title="Series A redeemable convertible preferred stock, shares issued"><span id="xdx_90C_eus-gaap--TemporaryEquitySharesIssued_iI_pip0_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zck1qjy0y1Rd" title="Series A redeemable convertible preferred stock, shares issued"><span id="xdx_909_eus-gaap--TemporaryEquitySharesOutstanding_iI_pip0_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zIqyVId0JVkc" title="Series A redeemable convertible preferred stock, shares outstanding"><span id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pip0_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zwSMpyeTf335" title="Series A redeemable convertible preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">350,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span></span> shares authorized, issued and outstanding as of September 30, 2020 and December 31, 2019, respectively; aggregate liquidation preference of $<span id="xdx_90A_eus-gaap--TemporaryEquityLiquidationPreference_iI_pn3n3_c20200930__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_zz8728drSr45" title="Series A redeemable convertible preferred stock, liquidation preference"><span id="xdx_90F_eus-gaap--TemporaryEquityLiquidationPreference_iI_pn3n3_c20191231__us-gaap--StatementClassOfStockAxis__us-gaap--RedeemablePreferredStockMember_z3wD7qrc0TOh" title="Series A redeemable convertible preferred stock, liquidation preference"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreference" contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,000</ix:nonFraction></ix:nonFraction></span></span> as of September 30, 2020 and December 31, 2019, respectively</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockRedemptionAmount" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,134</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockRedemptionAmount" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,089</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Stockholders' equity:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--PreferredStockValue_i01I_pn3n3_d0_maSEzZCw_zlFbcNDwIWf2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Preferred stock, par value $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20200930_zq9rZCHSXF2d" title="Preferred stock, par value"><span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20191231_zCtT5eIIhpm" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share; <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_pip0_c20200930_zDodzXArQ0U9" title="Preferred stock, shares authorized"><span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pip0_c20191231_zXQ5nKQzG7w6" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pip0_do_c20200930_zQzboKjcdKs7" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pip0_do_c20191231_z0r8bBUzRCug" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_pip0_do_c20191231_zhTFbADSO0d5" title="Preferred stock, shares outstanding"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pip0_do_c20200930_zBXBwxKKTZif" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-09-30" format="ixt-sec:numwordsen" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2019-12-31" format="ixt-sec:numwordsen" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2019-12-31" format="ixt-sec:numwordsen" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-09-30" format="ixt-sec:numwordsen" decimals="INF" scale="0" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued or outstanding</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2019-12-31" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CommonStockValue_i01I_pn3n3_maSEzZCw_zS5GCrOlMWh9" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Common stock, par value $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20200930_z5hdSkNuaBIi" title="Common stock, par value"><span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20191231_zQOyGSJ1G8L2" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> per share; <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pip0_c20200930_z40lxwgQWE0a" title="Common stock, shares authorized"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_pip0_c20191231_zZQ8KsmzJg6" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">300,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pip0_c20200930_zmj5ub0DU9Kc" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_pip0_c20200930_znrwnYl75by1" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,279,453</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pip0_c20191231_zyDIrfmjD1F2" title="Common stock, shares outstanding"><span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pip0_c20191231_zmbxIVbfwQEa" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">50,370,987</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--TreasuryStockValue_i01NI_pn3n3_di_msSEzZCw_zKKw1ToLmr9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Treasury stock, at cost, <span id="xdx_902_eus-gaap--TreasuryStockShares_iI_pip0_c20200930_zLQoLGwLb9qi" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">4,604,365</ix:nonFraction></span> and <span id="xdx_909_eus-gaap--TreasuryStockShares_iI_pip0_c20191231_zj0BySv0Hcyj"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">2,919,828</ix:nonFraction></span> shares as of September 30, 2020 and December 31, 2019, respectively</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,270</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39,272</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--AdditionalPaidInCapital_i01I_pn3n3_maSEzZCw_zuVRRZdo6Rdk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Additional paid-in capital</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650,130</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">652,003</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_pn3n3_maSEzZCw_zWi8w4KtuQG2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">406,451</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">439,656</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--StockholdersEquity_i01TI_pn3n3_mtSEzZCw_maSEIPAzQLH_zW1a0XB0afmf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Total Acacia Research Corporation stockholders' equity</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200,458</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">173,125</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--MinorityInterest_i01I_pn3n3_maSEIPAzQLH_zfPHVnJ9Eehb" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Noncontrolling interests</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_pn3n3_mtSEIPAzQLH_maLASEzuFz_zEeo9P7LL3z5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total stockholders' equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202,291</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174,958</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzuFz_zRR7KzHFEjh5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total liabilities, redeemable convertible preferred stock, and stockholders' equity</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">426,515</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">218,161</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral
part of these condensed consolidated financial statements.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="text-align: center; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">ACACIA RESEARCH CORPORATION</p>

<p style="text-align: center; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt"><span id="a20"></span>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</p>

<p style="text-align: center; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt">(In thousands, except share and per share data)</p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_113_pn3n3_zVw0pQZFyEqa" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49C_20200701__20200930_zCX6maGeZOeg" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_490_20190701__20190930_zeKgKBhy7YFh" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49A_20200101__20200930_zPjoDGh6DXf4" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49C_20190101__20190930_z4v34ChhnPu2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt"><b>&#160;</b></td><td style="text-align: center; font-size: 10pt"><b>&#160;</b></td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><b>Three Months Ended</b></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-size: 10pt"><b>&#160;</b></td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><b>Nine Months Ended</b></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt"><b>&#160;</b></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><b>September 30,</b></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><b>September 30,</b></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; font-size: 10pt"><b>&#160;</b></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><b>2020</b></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><b>2019</b></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><b>2020</b></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><b>&#160;</b></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><b>2019</b></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><b>&#160;</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maNPILzXPk_zXch6BZRc5Hc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 48%; font-size: 10pt; text-align: left; padding-bottom: 1pt">Revenues</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,466</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,711</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,399</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,558</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--CostOfRevenueAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Portfolio operations:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--RoyaltyExpense_i01_pn3n3_maCOGASz8ug_z2A1ADhmmBkc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Inventor royalties</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,772</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">776</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,843</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RoyaltyExpense" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,752</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--ContingentLegalFees_i01_pn3n3_maCOGASz8ug_zg8SZSbleaYc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Contingent legal fees</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ContingentLegalFees" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,609</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ContingentLegalFees" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ContingentLegalFees" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,855</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ContingentLegalFees" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">587</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--LitigationAndLicensingExpensesPatents_i01_pn3n3_maCOGASz8ug_z7Ev5VMfGB9k" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Litigation and licensing expenses - patents</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:LitigationAndLicensingExpensesPatents" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,001</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:LitigationAndLicensingExpensesPatents" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">987</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:LitigationAndLicensingExpensesPatents" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,497</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:LitigationAndLicensingExpensesPatents" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,643</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--AmortizationOfIntangibleAssets_i01_pn3n3_maCOGASz8ug_zDbJcDgEDcV2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Amortization of patents</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,174</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">863</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,522</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,337</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherOperatingIncomeExpenseNet_i01N_pn3n3_di0_msCOGASz8ug_zXfBfCUIq332" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other portfolio expenses (income)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">475</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">308</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OtherOperatingIncomeExpenseNet" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">175</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CostOfGoodsAndServicesSold_i01T_pn3n3_mtCOGASz8ug_msNPILzXPk_zLAScPVrRkg2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total portfolio operations</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,556</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,186</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,409</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,494</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_ecustom--NetPortfolioIncomeLoss_i01_pn3n3_mtNPILzXPk_maOILzRtL_zvd4688ne25e" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 20pt">Net portfolio income (loss)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:NetPortfolioIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,910</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:NetPortfolioIncomeLoss" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">475</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:NetPortfolioIncomeLoss" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,990</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:NetPortfolioIncomeLoss" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,936</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--GeneralAndAdministrativeExpense_i01_pn3n3_msOILzRtL_z8CmlVO62dZg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left; padding-bottom: 1pt; padding-left: 10pt">General and administrative expenses<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,692</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,630</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,089</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,048</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingIncomeLoss_i01T_pn3n3_mtOILzRtL_maILFCOzajm_zFfyZcB8QUH5" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Operating loss</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,782</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,105</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,099</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,984</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OtherNonoperatingIncomeExpenseAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Other income (expense):</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--UnrealizedGainLossOnInvestments_i01_pn3n3_maNIEzVoR_zhjzQr14O6lj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of investment, net (Note 5)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,081</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,266</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,704</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,622</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--GainLossOnSaleOfInvestments_i01_pn3n3_d0_maNIEzVoR_z9yGdXNXuGz8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Loss on sale of investment (Note 5)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">915</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,762</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,147</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--ImpairmentOfInvestments_i01N_pn3n3_di0_msNIEzVoR_z2j2ZL2JzXm" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Impairment of other investment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,195</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_i01_pn3n3_d0_maNIEzVoR_z0yINFNAU2zk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Gain on disposal of other investment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DerivativeGainLossOnDerivativeNet_i01_pn3n3_d0_maNIEzVoR_zTvh2H96l5N9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Change in fair value of the Series A and B warrants and embedded derivatives</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,672</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">46,612</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DerivativeGainLossOnDerivativeNet" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--IncreaseDecreaseInEquitySecuritiesFvNi_i01_pn3n3_d0_maNIEzVoR_zyjW8FWbPkm3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Change in fair value of equity securities derivative and forward contract</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">64,011</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,542</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--GainLossOnSaleOfDerivatives_i01_pn3n3_d0_maNIEzVoR_zkClKkOWO3ti" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Gain on sale of prepaid investment and derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DebtSecuritiesTradingUnrealizedGainLoss_i01_pn3n3_maNIEzVoR_zSXKKMfEH2Ic" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; font-size: 10pt; text-align: left; padding-left: 20pt">Change in fair value of trading securities and equity securities - private</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">84,499</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">482</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81,907</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DebtSecuritiesTradingUnrealizedGainLoss" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">132</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AvailableForSaleSecuritiesGrossRealizedGainLossNet_i01_pn3n3_maNIEzVoR_za8rMe4bzyMg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Gain (loss) on sale of trading securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,737</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">238</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,272</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">226</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i01_pn3n3_maNIEzVoR_zMPu8Q0Ez8Ih" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Loss on foreign currency exchange</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">48</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">106</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,938</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">106</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--InterestExpenseDebt_i01N_pn3n3_di0_msNIEzVoR_zgW0sjx6WVf1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-left: 10pt">Interest expense on Senior Secured Notes</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,410</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,178</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--InterestAndOtherIncome_i01_pn3n3_maNIEzVoR_z0I6OFhYuZVk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Interest income and other</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,028</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">811</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestAndOtherIncome" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,012</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_i01T_pn3n3_mtNIEzVoR_maILFCOzajm_zyJbb9c28I01" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total other income (expense)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,213</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,503</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,047</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,456</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_mtILFCOzajm_maILFCOzfzp_zj9kv4FV78r6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Income (loss) before income taxes</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,431</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31,948</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,440</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iN_pn3n3_di0_msILFCOzfzp_z57x3ANhHu75" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Income tax benefit (expense)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,257</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">323</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iT_pn3n3_mtILFCOzfzp_maNILzec9_ztVNEeo1tPzh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Net income (loss) including noncontrolling interests in subsidiaries</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,763</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_pn3n3_di0_msNILzec9_zmmAQzdKGIAf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net loss attributable to noncontrolling interests in subsidiaries</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-07-012020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzec9_zrtToL7hPYW2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) attributable to Acacia Research Corporation</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,749</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i_pn3n3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) attributable to common stockholders - basic</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,529</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,749</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--EarningsPerShareBasic_pip0_zgD6TlxFIU04" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Basic net income (loss) per common share</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.63</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="USDPShares">0.15</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.51</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="USDPShares">0.36</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pip0_zIcGhyRxfQml" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Weighted average number of shares outstanding - basic</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">48,467,885</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,828,361</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">48,949,706</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,727,385</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_zv3eMj9MlcR1" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) attributable to common stockholders - diluted</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,204</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,380</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,749</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--EarningsPerShareDiluted_pip0_zixRXSNg7SM9" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net income (loss) per common share</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.32</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="USDPShares">0.15</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.36</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="USDPShares">0.36</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pip0_zVoBQqWxXrq4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Weighted average number of shares outstanding - diluted</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">90,624,702</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,828,361</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">60,153,773</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,727,385</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="margin: 0">&#160;</p>

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">(1) General and administrative expenses were comprised of the following:</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_113_pn3n3_zkD0hMpiqDg7" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; text-align: center"></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Three Months
    Ended</b></span></td><td><span style="font-size: 10pt"><b>&#160;</b></span></td><td><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="6" style="text-align: center"><span style="font-size: 10pt"><b>Nine Months Ended</b></span></td><td><span style="font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt"><b>September
    30,</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"><b>&#160;</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>September 30,</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2019</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2019</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 48%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">General and administrative expenses</span></td><td style="width: 2%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--GeneralAndAdministrativeExpense_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_pn3n3" title="General and administrative expenses" style="width: 9%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-07-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,204</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--GeneralAndAdministrativeExpense_c20190701__20190930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_pn3n3" title="General and administrative expenses" style="width: 9%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-07-012019-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,330</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--GeneralAndAdministrativeExpense_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_pn3n3" title="General and administrative expenses" style="width: 9%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,846</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--GeneralAndAdministrativeExpense_c20190101__20190930__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_pn3n3" title="General and administrative expenses" style="width: 9%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-01-012019-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,295</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Non-cash stock compensation
    expense - G&amp;A</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_988_ecustom--NoncashStockBasedCompensationCredit_c20200701__20200930__us-gaap--IncomeStatementLocationAxis__custom--NonCashStockCompensationExpenseMember_pn3n3" title="Non-cash stock based compensation credit" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:NoncashStockBasedCompensationCredit" contextRef="From2020-07-012020-09-30_custom_NonCashStockCompensationExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">488</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_989_ecustom--NoncashStockBasedCompensationCredit_c20190701__20190930__us-gaap--IncomeStatementLocationAxis__custom--NonCashStockCompensationExpenseMember_pn3n3" title="Non-cash stock based compensation credit" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:NoncashStockBasedCompensationCredit" contextRef="From2019-07-012019-09-30_custom_NonCashStockCompensationExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_981_ecustom--NoncashStockBasedCompensationCredit_c20200101__20200930__us-gaap--IncomeStatementLocationAxis__custom--NonCashStockCompensationExpenseMember_pn3n3" title="Non-cash stock based compensation credit" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:NoncashStockBasedCompensationCredit" contextRef="From2020-01-012020-09-30_custom_NonCashStockCompensationExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,243</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td id="xdx_982_ecustom--NoncashStockBasedCompensationCredit_c20190101__20190930__us-gaap--IncomeStatementLocationAxis__custom--NonCashStockCompensationExpenseMember_pn3n3" title="Non-cash stock based compensation credit" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:NoncashStockBasedCompensationCredit" contextRef="From2019-01-012019-09-30_custom_NonCashStockCompensationExpenseMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">753</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Total
    general and administrative expenses</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--GeneralAndAdministrativeExpense_c20200701__20200930_pn3n3" title="General and administrative expenses" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,692</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--GeneralAndAdministrativeExpense_c20190701__20190930_pn3n3" title="General and administrative expenses" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,630</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--GeneralAndAdministrativeExpense_c20200101__20200930_pn3n3" title="General and administrative expenses" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,089</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--GeneralAndAdministrativeExpense_c20190101__20190930_pn3n3" title="General and administrative expenses" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,048</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="margin: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of these condensed consolidated financial statements. &#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a5"></span>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands, except share data)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_114_pn3n3_zDWXvtyVV1n8" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&apos; EQUITY" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_custom--SeriesARedeemableConvertiblePreferredStockMember_zzCtRfkk7SPj" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zH3MEf77H4vl" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_zkTsyWHD9Oqk" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z6fZc6ycYecc" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zCZCBzoqChu7" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zAtmfRH0aNn5" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_4BA_z9c7UAZmNARb" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"></td>
    <td colspan="27" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>For the Three
    Months Ended September 30, 2020</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; padding-bottom: 1pt; text-indent: -5pt"></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>&#160;</b></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>Series A Redeemable Convertible
Preferred Stock</b></span></p>

 </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-left: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>&#160;Common Stock</b></span></p>

 </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Treasury </b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Additional<br />
    Paid-in<br /> </b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Accumulated </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Noncontrolling<br />
    Interests in<br /> Operating<br /> </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Total<br /> Stockholders'<br /> </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Amount</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-left: Black 1pt solid; padding-bottom: 1pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Amount&#160;</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Stock</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Capital</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Deficit</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Subsidiaries</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Equity</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>
<tr id="xdx_430_c20200701__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pn3n3_zZ81ttxC8bJ2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 18%; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font-size: 8pt">Balance at June 30, 2020</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pip0_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_z4xf5ooadRTc" title="Beginning balance, shares" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,400</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pip0_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFdq8sZVzCB7" title="Beginning balance, shares" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,306,137</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650,843</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">444,799</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">164,656</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--NetIncomeLoss_zSo2ai1iV6Tc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net income
     (loss) attributable to Acacia Research Corporation</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0448">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid">&#160;</td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0449">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0450">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0451">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0453">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue_zLGQ8IURWDU2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Accretion of Series A Redeemable Convertible Preferred
    Stock to redemption value</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">734</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid">&#160;</td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0457">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0458">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">734</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0460">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0461">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">734</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--DividendsPreferredStockStock_iN_pn3n3_di_znjgGT43PVX7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Dividend on Series A Redeemable Convertible Preferred
    Stock</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0464">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid">&#160;</td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0465">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0466">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0468">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0469">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zwNMleL6Wnwg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Compensation expense for share-based
    awards, net of forfeitures</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0472">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pip0_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9RiXlcKEOU1" title="Compensation expense for share-based awards, net of forfeitures, shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="Shares">26,684</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0473">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0474">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">488</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0476">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0477">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">488</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_432_c20200701__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pn3n3_zf6DqEbb1j2e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">Balance at September 30,
    2020</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_pip0_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zy57d9fU4Kf7" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,134</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_pip0_c20200701__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMSUeZcPzoKf" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,279,453</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650,130</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">406,451</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202,291</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"></td>
    <td colspan="27" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>For the Three
    Months Ended September 30, 2019</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; padding-bottom: 1pt; text-indent: -5pt"></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>&#160;</b></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>Series A Redeemable Convertible
Preferred Stock</b></span></p>

 </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-left: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>&#160;Common Stock</b></span></p>

 </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Treasury </b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Additional<br />
    Paid-in<br /> </b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Accumulated </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Noncontrolling<br />
    Interests in<br /> Operating<br /> </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Total<br /> Stockholders'<br /> </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Amount</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-left: Black 1pt solid; padding-bottom: 1pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Amount&#160;</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Stock</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Capital</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Deficit</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Subsidiaries</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Equity</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>

<tr id="xdx_439_c20190701__20190930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pn3n3_zEGf34roVqIe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; width: 18%; font-size: 10pt; font-weight: bold; text-indent: -5pt"><span style="font-size: 8pt">Balance at June 30, 2019</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pip0_c20190701__20190930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zPzRxv8xpCzc" title="Beginning balance, shares" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0502">&#8211;</span></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0494">&#8211;</span></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pip0_c20190701__20190930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zz0zfzoV5wej" title="Beginning balance, shares" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">50,132,871</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,272</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">651,688</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">432,682</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">181,617</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_znxRO6eH55bi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net income
    (loss) attributable to Acacia Research Corporation</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0506">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid">&#160;</td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0507">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0508">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0509">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0511">&#8211;</span></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_z1PKr7HC23Yg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Compensation expense for share-based
    awards, net of forfeitures</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0514">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pip0_c20190701__20190930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpyBnukDql24" title="Compensation expense for share-based awards, net of forfeitures, shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2019-07-012019-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">210,434</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0515">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0516">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-07-012019-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0518">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0519">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_43D_c20190701__20190930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pn3n3_zHfdr6nMgV23" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">Balance at September 30,
    2019</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pip0_c20190701__20190930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zNxOWZ64D5Y3" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0532">&#8211;</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0524">&#8211;</span></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pip0_c20190701__20190930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze1gQ43ECSo4" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">50,343,305</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,272</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">651,988</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">440,290</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174,309</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>The accompanying notes are an integral
part of these condensed consolidated financial statements.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands, except share data)</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"></td>
    <td colspan="27" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>For the Nine Months
    Ended September 30, 2020</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; padding-bottom: 1pt; text-indent: -5pt"></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>&#160;</b></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>Series A Redeemable Convertible
Preferred Stock</b></span></p>

 </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-left: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>&#160;Common Stock</b></span></p>

 </td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Treasury </b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Additional<br />
    Paid-in<br /> </b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Accumulated </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Noncontrolling<br />
    Interests in<br /> Operating<br /> </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 8pt"><b>Total<br /> Stockholders'<br /> </b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Amount</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-left: Black 1pt solid; padding-bottom: 1pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Shares</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt"><b>Amount&#160;</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Stock</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Capital</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Deficit</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Subsidiaries</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>Equity</b></span></td><td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>

<tr id="xdx_437_c20200101__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pn3n3_z3JvfcxRweT" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; width: 18%; font-size: 8pt; font-weight: bold; text-indent: -5pt"><span style="font-size: 8pt">Balance at December 31, 2019</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pip0_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zJW18qFVfAk3" title="Beginning balance, shares" style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,089</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pip0_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpE5UHbDCTgk" title="Beginning balance, shares" style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">50,370,987</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,272</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">652,003</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">439,656</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174,958</ix:nonFraction></span></td><td style="width: 1%; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_zAwAErCjCKc3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net income
    (loss) attributable to Acacia Research Corporation</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0548">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0549">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0550">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0551">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0553">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_40E_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue_zcXCaoxLexai" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Accretion of Series A Redeemable Convertible Preferred
    Stock to redemption value</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,045</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0557">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0558">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,045</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0560">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0561">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,045</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr id="xdx_408_eus-gaap--DividendsPreferredStockStock_iN_pn3n3_di_zOmaDmBKpa8h" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Dividend on Series A Redeemable Convertible Preferred
    Stock</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0564">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0565">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0566">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,119</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0568">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0569">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:DividendsPreferredStockStock" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,119</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_iP2us-gaap--DividendsPreferredStockStock_z6ifLeTOMjwe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Stock options exercised</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iP3us-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pip0_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfXFv6qLRl38" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0579">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0573">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0574">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0576">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0577">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zPrmXzdniMW8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Compensation expense for share-based awards, net
    of forfeitures</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0581">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pip0_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDyW6fdKJMVb" title="Compensation expense for share-based awards, net of forfeitures, shares" style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">593,003</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0582">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0583">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,243</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0585">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0586">&#8211;</span></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 8pt; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1243</ix:nonFraction></span></td><td style="font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--StockRepurchasedDuringPeriodValue_iNP3us-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pn3n3_di_zOhcHhURkSk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Repurchase of common stock</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td id="xdx_987_eus-gaap--StockRepurchasedDuringPeriodShares_iP3us-gaap--StockRepurchasedDuringPeriodValue_pip0_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z0i6h4Yr6uVd" title="Repurchase of common stock, shares" style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="Shares">1,684,537</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,998</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0594">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0595">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0596">&#8211;</span></span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 8pt; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,999</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 8pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr id="xdx_43D_c20200101__20200930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pn3n3_zcGXvaG9glmi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt"><span style="font-size: 8pt">Balance at September 30,
    2020</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_pip0_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zJAfcDLfksGk" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">350,000</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,134</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-left: Black 1pt solid; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pip0_c20200101__20200930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zojUvXvYCy7j" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,279,453</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,270</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">650,130</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">406,451</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 8pt; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">202,291</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>


<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"></td>
    <td colspan="27" style="border-bottom: Black 1pt solid; padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>For the Nine Months
    Ended September 30, 2019</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; padding-bottom: 1pt; text-indent: -5pt"></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>&#160;</b></span></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>Series A Redeemable Convertible
Preferred Stock</b></span></p>

 </td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-left: Black 1pt solid; padding-left: 5pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt"><b>&#160;Common Stock</b></span></p>

 </td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Treasury </b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Additional<br />
    Paid-in<br /> </b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Accumulated </b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Noncontrolling<br />
    Interests in<br /> Operating<br /> </b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Total<br /> Stockholders'<br /> </b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Shares</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Amount</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td style="border-left: Black 1pt solid; padding-left: 5pt; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Shares</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Amount&#160;</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Stock</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Capital</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Deficit</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Subsidiaries</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-left: 5pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>Equity</b></span></td><td style="padding-left: 5pt; padding-bottom: 1pt; text-align: center; text-indent: -5pt"><span style="font-size: 8pt"><b>&#160;</b></span></td></tr>

<tr id="xdx_433_c20190101__20190930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_pn3n3_zkz0sGY6LxI7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; width: 18%; font-size: 8pt; font-weight: bold; text-indent: -5pt">Balance at December 31, 2018</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pip0_c20190101__20190930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zltKzbi0cbv2" title="Beginning balance, shares" style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0621">&#8211;</span></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">&#8211;</span></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-left: Black 1pt solid; padding-left: 5pt; width: 1%; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pip0_c20190101__20190930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGhgBoxd2M12" title="Beginning balance, shares" style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,639,319</ix:nonFraction></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,272</ix:nonFraction></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">)</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">651,156</ix:nonFraction></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">422,541</ix:nonFraction></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">)</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,847</ix:nonFraction></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="padding-left: 5pt; width: 7%; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">191,240</ix:nonFraction></td><td style="padding-left: 5pt; width: 1%; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_zvZo194hXUQf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Net income (loss) attributable to Acacia
    Research Corporation</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">&#8211;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0625">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-left: Black 1pt solid; padding-left: 5pt; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">&#8211;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0626">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0627">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0628">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,749</ix:nonFraction></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">)</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0630">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,749</ix:nonFraction></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">)</td></tr>
<tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zi8zYV1VcBob" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Stock options exercised</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-left: Black 1pt solid; padding-left: 5pt; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pip0_c20190101__20190930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaNr5eLCZiMa" title="Stock options exercised, shares" style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">25,136</ix:nonFraction></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0634">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0635">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0637">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0638">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zjzbILCcyAdf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">Compensation expense for share-based awards, net of forfeitures</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">&#8211;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0643">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-left: Black 1pt solid; padding-left: 5pt; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pip0_c20190101__20190930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zERJpEXWA63" title="Compensation expense for share-based awards, net of forfeitures, shares" style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">678,850</ix:nonFraction></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0644">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0645">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">753</ix:nonFraction></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0647">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0648">&#8211;</span></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">753</ix:nonFraction></td><td style="padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iP3us-gaap--StockRepurchasedDuringPeriodShares_zXdqfUPyxFxl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 8pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt">Net income attributable to noncontrolling interests in subsidiaries</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">&#8211;</td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0653">&#8211;</span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-left: Black 1pt solid; padding-left: 5pt; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">&#8211;</td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0654">&#8211;</span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0655">&#8211;</span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0656">&#8211;</span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0657">&#8211;</span></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">)</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: left; text-indent: -5pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-left: 5pt; font-size: 8pt; text-align: right; text-indent: -5pt">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 8pt; text-align: left; text-indent: -5pt">)</td></tr>
<tr id="xdx_43B_c20190101__20190930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_pn3n3_zpCwCvbRFB74" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 8pt; font-weight: bold; padding-bottom: 2.5pt; text-indent: -5pt">Balance at September 30, 2019</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pip0_c20190101__20190930__us-gaap--StatementEquityComponentsAxis__custom--SeriesARedeemableConvertiblePreferredStockMember_zjJmwUdI83i3" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0669">&#8211;</span></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><span style="-sec-ix-hidden: xdx2ixbrl0661">&#8211;</span></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-left: Black 1pt solid; padding-left: 5pt; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pip0_c20190101__20190930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsrFljPEBiwl" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">50,343,305</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,272</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">)</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">651,988</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">440,290</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">)</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,833</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">$</td><td style="border-bottom: Black 2.5pt double; padding-left: 5pt; font-size: 8pt; font-weight: bold; text-align: right; text-indent: -5pt"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174,309</ix:nonFraction></td><td style="padding-left: 5pt; padding-bottom: 2.5pt; font-size: 8pt; font-weight: bold; text-align: left; text-indent: -5pt">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><i>The accompanying
notes are an integral part of these condensed consolidated financial statements.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a6"></span>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF CASH FLOWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(In thousands)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_112_pn3n3_zl9fJuJmw0xd" summary="xdx: Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49B_20200101__20200930_zhOzV1pyrkO3" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190101__20190930_zWz0OHkDPdqd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b>Nine Months Ended</b></span></td><td><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><span style="font-size: 10pt"><b>September 30,</b></span></td><td><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2020</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt">2019</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zGiDx1t8uzM" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">Cash flows from operating activities:</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_i01_maCzvND_zifECSzXWfp1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; width: 66%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Net income (loss) including noncontrolling
    interests in subsidiaries</span></td><td style="width: 2%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 13%; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="width: 2%; font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 13%; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,763</ix:nonFraction></span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_40B_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zwx1CDGvraac" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Adjustments
    to reconcile net income (loss) including noncontrolling interests in subsidiaries to net cash provided by (used in) operating
    activities:</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--UnrealizedGainLossOnInvestments_i01N_di_msCzvND_ze9c8uxsW03k" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Change in fair value of investment, net (Note
    5)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,704</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,622</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_401_eus-gaap--LossOnSaleOfInvestments_i01_maCzvND_zPH4wRkdzwgj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Loss on sale of investment (Note 5)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,762</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,147</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40D_eus-gaap--ImpairmentOfInvestments_i01_d0_maCzvND_z3d5v6DzQaec" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Impairment of other investment</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ImpairmentOfInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,195</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--EquityMethodInvestmentRealizedGainLossOnDisposal_i01N_di0_msCzvND_zwaH7BqBVC4d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Gain on disposal of other investment (Note 5)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_400_eus-gaap--DepreciationAndAmortization_i01_maCzvND_zX3Q88D2VTsa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Depreciation and amortization</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,609</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,344</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_i01_d0_maCzvND_zyfHqhIykUpf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Amortization of debt discount and issuance costs</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">955</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_i01N_di0_msCzvND_z3rVOZTc0bT9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Change in fair value of Series A redeemable convertible
    preferred stock embedded derivative</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,708</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40C_eus-gaap--UnrealizedGainLossOnDerivatives_i01N_di0_msCzvND_zR4Apjvo2wFj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Change in fair value of Series A warrants</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,036</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnDerivatives" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_407_ecustom--UnrealizedGainLossOnDerivatives1_i01N_di0_msCzvND_zMl2aCx7y4u3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Change in fair value of Series B warrants</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:UnrealizedGainLossOnDerivatives1" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">36,867</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:UnrealizedGainLossOnDerivatives1" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--ShareBasedCompensation_i01_maCzvND_zzVl3JhE22Rb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Non-cash stock compensation</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,243</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">753</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_i01N_di0_msCzvND_zvpBr8ICAp0i" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Loss on foreign currency exchange</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,938</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_406_eus-gaap--TradingSecuritiesUnrealizedHoldingGainLoss_i01N_di_msCzvND_zpGSG7RQM7h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Change in fair value of trading securities and
    equity securities - private</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81,907</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">914</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_40F_eus-gaap--DebtSecuritiesRealizedGainLoss_i01N_di0_msCzvND_z3EABs9Hneq1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Loss on sale of trading securities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DebtSecuritiesRealizedGainLoss" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,272</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:DebtSecuritiesRealizedGainLoss" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInEquitySecuritiesFvNi_i01N_di0_msCzvND_zW3r9LHajcjg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Change in fair value of equity securities derivative
    and forward contract</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,542</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--GainLossOnSaleOfDerivatives_i01N_di0_msCzvND_zHVs0sSgPvn" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Gain on sale of prepaid investment and derivative</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zljWjqpudC8a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Changes in assets and liabilities:</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzvND_zqOHNbFDnM6g" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Accounts receivable</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">248</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,085</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i01N_di_msCzvND_zjOyqPuXUdJj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Prepaid expenses and other assets</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,038</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">983</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_40A_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i01_maCzvND_z0Sbrd8O2Sd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Accounts payable and accrued
    expenses</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">614</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt"></span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">326</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40F_ecustom--IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_i01_maCzvND_z811Wm3G0o07" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Royalties and contingent
    legal fees payable</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,052</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">20,414</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzvND_maCz16b_zM7ZMv9e8lUk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Net cash provided by (used
    in) operating activities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,549</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">846</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zMQf7c8trHK4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">Cash flows from investing
    activities:</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msCzQ1z_z6l9QOAoCeEg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Patent acquisition costs</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,780</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,420</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_40E_eus-gaap--ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment_i01_maCzQ1z_zJdcsX9h1gB1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Sale of investment at fair value (Note 5)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,460</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,260</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_408_eus-gaap--ProceedsFromSaleAndMaturityOfOtherInvestments_i01_d0_maCzQ1z_zk3btX29haSb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">(Purchase) Sale of other investments (Note 5)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_401_eus-gaap--PaymentsToAcquireShortTermInvestments_i01N_di_msCzQ1z_zAi1SNbSWLBg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Purchases of trading securities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,800</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103,718</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_40C_eus-gaap--ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_i01_maCzQ1z_zBncwlkzSrse" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Maturities and sales of trading securities</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">316,746</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,816</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToAcquireInvestments_i01N_di0_msCzQ1z_zGJ2QWsadx2j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Purchases of prepaid investment</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">276,275</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PaymentsToAcquireInvestments" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_eus-gaap--PaymentsForHedgeInvestingActivities_i01N_di0_msCzQ1z_zB54JmELV1Ag" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 30pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Equity securities derivative and forward contract
    acquisition cost</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsForHedgeInvestingActivities" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,989</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PaymentsForHedgeInvestingActivities" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_409_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzQ1z_zsZ1XKArJISf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Purchases of property and
    equipment</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">177</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzQ1z_maCz16b_zP3f0IuJcgue" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Net cash used in investing
    activities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,815</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">61,181</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zNsVdO1GZN8d" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: bold; text-align: left"><span style="font-size: 10pt">Cash flows from financing
    activities:</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--PaymentsForRepurchaseOfCommonStock_i01N_di0_msCzxWY_zBwmIvjNEKx8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Repurchase of common stock</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,998</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--ProceedsFromIssuanceOfDebt_i01_d0_maCzxWY_zXGl0ucni0hk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Issuance of Senior Secured Notes, net of lender
    fee</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,437</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--RepaymentsOfSecuredDebt_i01N_di0_msCzxWY_zyjJAHdnvfDc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Senior Secured Notes issuance costs paid to other
    parties</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">496</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_405_eus-gaap--PaymentsOfDividends_i01N_di0_msCzxWY_zx6CWSPJICj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Dividend on Series A Redeemable Convertible Preferred
    Stock</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,120</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOfWarrants_i01_d0_maCzxWY_zgmaK9FXtis4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Issuance of Series B warrants</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,600</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_407_eus-gaap--ProceedsFromStockOptionsExercised_i01_maCzxWY_zDbL2IfKjbdj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Proceeds from exercise of
    stock options</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzxWY_maCz16b_zhnbLePmYJM8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Net cash provided by financing
    activities</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109,471</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_iT_mtCz16b_zazO6ULvlx58" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">Increase (decrease) in cash and cash equivalents
    and restricted cash</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105,205</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">61,948</ix:nonFraction></span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_ziPUq3xfrjs9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Cash and cash equivalents
    and restricted cash, beginning</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92,359</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">128,809</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_40A_eus-gaap--RestrictedCashAndCashEquivalentsAtCarryingValue_iE_zmhxVw7cxim1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Cash and cash equivalents
    and restricted cash, ending</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">197,564</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66,861</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_400_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_z4zJvw3FtLk3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Supplemental schedule of noncash investing activities:</span></td><td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_403_ecustom--AcquisitionOfPrepaidInvestmentSecurities_i01_d0_zrDgxiqK1W61" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Acquisition of prepaid
    investment securities</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:AcquisitionOfPrepaidInvestmentSecurities" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">231,480</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 10pt"><ix:nonFraction name="ACTG:AcquisitionOfPrepaidInvestmentSecurities" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>



<p style="margin: 0">&#160;</p>

<p style="text-align: center; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of these condensed consolidated financial statements. </p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ACACIA RESEARCH CORPORATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a7"></span>NOTES TO UNAUDITED CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_804_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zcOvkbxxmSQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. <span>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="ACTG:DescriptionOfBusinessPolicyTextBlock"><p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_z32GuCyYITk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
&#8220;Acacia&#8221; and the &#8220;Company&#8221; refer to Acacia Research Corporation and/or its wholly and majority-owned and
controlled operating subsidiaries, and/or where applicable, its management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia was incorporated on January 25, 1993 under the laws of
the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries invest in, license and
enforce patented technologies. Acacia&#8217;s operating subsidiaries partner with inventors and patent owners, applying their legal
and technology expertise to patent assets to unlock the financial value in their patented inventions. In recent years, Acacia has
also invested in technology companies. Acacia leverages its experience, expertise, data and relationships developed as a leader
in the intellectual property (&#8220;IP&#8221;) industry to pursue these opportunities. In some cases, these opportunities will
complement, and/or supplement Acacia&#8217;s primary licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries generate revenues and
related cash flows from the granting of IP rights (hereinafter &#8220;IP Rights&#8221;) for the use of patented technologies that
its operating subsidiaries control or own. Acacia&#8217;s operating subsidiaries assist patent owners with the prosecution and
development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing
revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their
patented technologies through the filing of patent infringement litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries are principals in the
licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.
Acacia&#8217;s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain
foreign counterparts, covering technologies used in a wide variety of industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP
through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#8217;s
operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be
able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended
September 30, 2020, Acacia obtained control of four <span id="xdx_90C_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20200101__20200930_zh7nbsdkupS5" title="Number of new patent portfolios acquired" style="display: none"><ix:nonFraction name="ACTG:NumberOfPatentPortfoliosAcquired" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">4</ix:nonFraction></span> new patent portfolios. During fiscal year 2019, Acacia obtained control
of five <span id="xdx_902_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20190101__20191231_zn2FWCeypwof" title="Number of new patent portfolios acquired" style="display: none"><ix:nonFraction name="ACTG:NumberOfPatentPortfoliosAcquired" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Integer">5</ix:nonFraction></span> new patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAHYR1QGEwDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial
statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany
transactions and balances have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_23C_z6OwfDzkPcWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zzf4jvHaRmfj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zonXfqsz0IEg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 9 -->
    <div id="xdx_23E_zggTjGYsqrXi" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_235_zo3wROjttnV6" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td id="xdx_23C_znBTGkbRDQ2k" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_230_zfJWAIDcFP2l" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23A_zbZQehSpJAy9" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zbrx5yzYH688" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly,
certain information and footnotes required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance
with quarterly reporting requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;). These interim unaudited condensed
consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes
thereto for the year ended December 31, 2019, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March
16, 2020, as well as in our other public filings with the SEC. The condensed consolidated interim financial statements of Acacia
include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of
Acacia&#8217;s consolidated financial position as of September 30, 2020, and results of its operations and its cash flows for
the interim periods presented. The consolidated results of operations for the three and nine months ended September 30, 2020 are
not necessarily indicative of the results to be expected for the entire fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_847_eus-gaap--UseOfEstimates_zgNDy7D6wtaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S.
GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the
significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of
the equity instruments, the valuation of Series A redeemable convertible preferred stock (the &#8220;Series A Redeemable Convertible
Preferred Stock&#8221;) embedded derivatives, Series A warrants (the &#8220;Series A Warrants&#8221;), Series B warrants (the &#8220;Series
B Warrants&#8221;), equity securities derivative and forward contract, stock-based compensation expense, impairment of patent related
intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances
against net deferred tax assets, require its most difficult, subjective or complex judgments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_znVi8bw6TNse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassifications</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made to the prior fiscal
year financial information to conform with the current fiscal year presentation. Such reclassifications had no impact on net income
or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_z2cPuNtIBTPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2. <span>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zVTJGv8cLg5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue Recognition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue is recognized upon transfer of control of promised bundled
IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to
receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist
at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue
recognition criteria have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the periods presented, revenue contracts executed by the
Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the
grant of certain IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based
revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license
fees based on quarterly sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). Revenues may
also include court ordered settlements or awards related to our patent portfolio. IP Rights granted included the following, as
applicable: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented
technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any
pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents.
The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the
context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise
to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer
IP Rights in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_23E_z47DUDlPwd0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zbrbNdKlKPxi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zcCkFUqFBrOf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 10 -->
    <div id="xdx_23C_zWJmCzuqkBh8" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23D_zZTErTHcM4k5" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td id="xdx_23A_zkcQx5odUG21" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zsrlD3gNZRa7" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_zSDLsLBktqx" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zIbPBxkU4Rl3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the promised IP Rights are not individually distinct,
the Company combines each individual IP Right in the contract into a bundle of IP rights that is distinct and accounts for all
of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted generally are &#8220;functional
IP rights&#8221; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that
functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating
subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain
or upgrade the technology, or provide future support or services. The contracts provide for the grant (i.e., transfer of control)
of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally
obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized
upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have been met. Revenue
contracts generally provide for payment of contractual amounts within 30-90 days of execution of the contract, or the end of the
quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally
non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal
in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is
subsequently resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP
Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the
sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues from contracts with significant financing components
(either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee
had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the
promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust
the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception,
that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights
will be one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, the Company is required to make certain judgments
and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance
obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to
grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point
in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain
a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues were composed of the following for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zV3hnwRzqTli" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BA_zrRtoFE2jE6b" style="display: none">Disaggregation of revenue</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-size: 10pt; text-align: left">Paid-up Revenue Agreements</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" title="Revenues" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,385</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" title="Revenues" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-07-012019-09-30_custom_PaidUpRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,203</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" title="Revenues" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30_custom_PaidUpRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,477</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" title="Revenues" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-09-30_custom_PaidUpRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,067</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Recurring Revenue Agreements</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" title="Revenues" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30_custom_RecurringRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" title="Revenues" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-07-012019-09-30_custom_RecurringRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">508</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" title="Revenues" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-012020-09-30_custom_RecurringRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">922</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" title="Revenues" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-09-30_custom_RecurringRevenueAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,491</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,466</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,711</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,399</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930_pn3n3" title="Revenues" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,558</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A7_zIOa7M6K8RK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Refer to &#8220;<i>Inventor Royalties and Contingent Legal Expenses</i>&#8221;
below for information on related direct costs of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="ACTG:PortfolioOperationsPolicyTextBlock"><p id="xdx_845_ecustom--PortfolioOperationsPolicyTextBlock_z0PQej27meF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Portfolio Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues include the costs and expenses incurred in
connection with Acacia&#8217;s patent licensing and enforcement activities, including inventor royalties paid to patent owners,
contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing
and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment
costs. These costs are included under the caption &#8220;Portfolio operations&#8221; in the accompanying condensed consolidated
statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_236_zOJXAJb3RPPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zxYRAA5OlX83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zHXexLpSM4al" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div id="xdx_23B_zFFbMsOBFiJe" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_zO0O3pe8WMY7" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td id="xdx_231_zJFJljD2SJg2" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_zTFWNUmxKmq7" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_zfW2wJ3dSnw5" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zwdpGGqrXD5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Inventor Royalties and Contingent Legal Expenses </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventor royalties are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of
the underlying inventor agreements, upfront advances paid to patent owners by Acacia&#8217;s operating subsidiaries are recoverable
from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic
useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense
is included in amortization expense in the condensed consolidated statements of operations. Any unamortized upfront advances recovered
from net revenues are expensed in the period recovered and included in amortization expense in the condensed consolidated statements
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Contingent legal fees are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from
potential infringers, no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for certain
out of pocket legal costs incurred pursuant to the underlying legal services agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventor royalty and contingent legal agreements typically provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee
payments are received from licensees by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentrations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, trading securities and accounts receivable. Acacia places its cash equivalents and trading
securities primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are
also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not
experienced any significant losses on its deposits of cash and cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One licensee accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z9PB9Iy8QFX5" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">98</ix:nonFraction></span>% of revenues recognized during
the three months ended September 30, 2020, and four licensees accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zEIckxnT6oXa" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_z0flroiVykVf" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zdPgccVRIOTd" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z10yUkRMa4B1" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee4Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4</ix:nonFraction></span>% of revenues recognized during the
nine months ended September 30, 2020. Three licensees individually accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z6lYye00U4Gb" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">52</ix:nonFraction></span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAu13o9juE95" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zfoUUzQGMiX3" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% of revenues recognized during
the three months ended September 30, 2019, and three licensees individually accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zBDpPFZbq1Kj" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">46</ix:nonFraction></span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zQa3HNYTxCGj" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">23</ix:nonFraction></span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zqrHYPld61yh" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">14</ix:nonFraction></span>% of revenues recognized
during the nine months ended September 30, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have any material foreign operations. Based
on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for
the three and nine months ended September 30, 2020, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zgKuW8Ya9Eya" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zioeaPVhaa6a" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions. For the three and nine months ended September 30, 2019, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zdLNezg5HTF7" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">75</ix:nonFraction></span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_z3rdUQVsvQ3l" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">38</ix:nonFraction></span>%, respectively, of revenues were attributable
to licensees domiciled in foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Four licensees individually represented approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zCMLLREbR1A5" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">57</ix:nonFraction></span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAwJRQASb4v8" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25</ix:nonFraction></span>%,
<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_z9kDn3aEUHvi" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4</ix:nonFraction></span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z8dTWIWEruvc" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee4Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3</ix:nonFraction></span>% of accounts receivable at September 30, 2020. Two licensees individually represented approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zc6SME9mx9fk" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_OneLicenseeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70</ix:nonFraction></span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zepBPNtR6haa" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_OneLicensee2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">17</ix:nonFraction></span>% of accounts
receivable at December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zOwy2OfZDHf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Patents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patents include the cost of patents or patent rights (hereinafter,
collectively &#8220;patents&#8221;) acquired from third-parties or obtained in connection with business combinations. Patent costs
are amortized utilizing the straight-line method over their remaining economic useful lives. Refer to Note 4 for additional information
regarding our patents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:exclude><p id="xdx_23C_zgAULadAnHQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_z0J1N9Tqnnp5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zkYMK1U8qaU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div id="xdx_230_zJ1Sv5KLpgGj" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_zdmF3nltc278" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td id="xdx_23E_zY13PsPAXVTd" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_239_zzdx9c8Df2ga" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_231_zvxFlfhJdAV1" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zqqaXMmUy4X9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zTc3XJcDJb0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impairment of Long-lived Assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset
may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than
the carrying amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#8217;s carrying
value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active
markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques,
including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources
to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 4 for additional
information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fair value is generally estimated using the &#8220;Income Approach,&#8221;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic
useful life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221; including
an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows
are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated
cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied
to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s
licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio
including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology
coverage and other pertinent information that could impact future net cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zi23fhAEv8r1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia considers all highly liquid, trading securities with
original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#8217;s cash
equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily
includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations,
and fully collateralized repurchase agreements. Acacia&#8217;s cash equivalents are measured at fair value using quoted prices
that represent Level 1 inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"><p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zdU7TBKEHj96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Long Term Restricted Cash </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-term restricted cash relates to the proceeds received from
the issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account. The amounts are to be released
to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii) the
conversion of Series A Redeemable Convertible Preferred Stock into common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="ACTG:PrepaidInvestmentPoliciesTextBlock"><p id="xdx_840_ecustom--PrepaidInvestmentPoliciesTextBlock_zyfejGKarNFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid Investment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid investment relates to the cash transferred to an escrow
account in connection with a Transaction Agreement with LF Equity Income Fund (&#8220;Seller&#8221;), pursuant to which the Company
will purchase from Seller certain equity securities. Refer to Note 14 for additional information on the Transaction Agreement.
The amounts are to be released to Seller upon transfer of the specified equity securities at set prices at various future dates
following various terms and conditions per the Transaction Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="ACTG:EquitySecurityForwardContractPoliciesTextBlock"><p id="xdx_84A_ecustom--EquitySecurityForwardContractPoliciesTextBlock_zydGaHPrZCN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Equity Securities Derivative and Forward Contract</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The equity security forward contract includes both private and
public equity securities not yet transferred, as of September 30, 2020, under the Company&#8217;s Transaction Agreement with Seller.
Refer to Note 14 for additional information on the agreement. The public company equity security forward contracts are accounted
for as derivatives and are carried at fair market value with changes in fair market value recorded in the condensed consolidated
statements of operations in other income (expense). The private company equity security forward contracts do not meet the definition
of a derivative as the underlying equity securities are not readily convertible to cash. Therefore, as the forward contracts do
not have readily determinable fair value, these forward contracts are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions involving securities similar to those underlying the forward
contract. Changes in fair market value are reported in the condensed consolidated statements of operations in other income (expense).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:exclude><p id="xdx_234_zsJ9Zb5TvsNf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zhOL24Xv6Zg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zStAUlEn168c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div id="xdx_23C_zyIKbVm8LLvh" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_235_zPplHFqtHRal" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td id="xdx_234_zaoVfSWKhrj1" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_238_zfJlHa0dmP48" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_zUmt5Xnwa6Se" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zL34Mru1yL9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:AvailableForSaleSecuritiesPurchasedOptionsPricePolicy"><p id="xdx_846_eus-gaap--AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_zJcyTLcbHe0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Trading Securities- Debt</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in debt securities are reported at fair value on
a recurring basis, with related realized and unrealized gains and losses recorded in the condensed consolidated statements of operations
in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest
is included in the condensed consolidated statements of operations in other income (expense). Accrued interest is included in the
trading securities balance on the condensed consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:EquityMethodInvestmentsPolicy"><p id="xdx_840_eus-gaap--EquityMethodInvestmentsPolicy_z2TY0Mrhx7Oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Trading Securities - Equity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in equity securities are reported at fair value
on a recurring basis, with related realized and unrealized gains and losses in the value of such securities recorded in the condensed
consolidated statements of operations in other income (expense). Dividend income is included in the condensed consolidated statements
of operations in other income (expense).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trading securities for the periods presented were comprised
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:AvailableForSaleSecuritiesTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--AvailableForSaleSecuritiesTextBlock_pn3n3_ze1v2CdeE3J2" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B8_zw6BmweOEiOa" style="display: none">Gain (loss) on trading securities</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross<br /> Unrealized<br /> Gain</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross<br /> Unrealized<br /> Loss</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left">Security&#160;Type</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">September 30, 2020:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; font-size: 10pt; text-align: left">Trading securities - equity</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermInvestments_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesrEquityMember_zeFIAbmCs501" title="Short-term Investments" style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2020-09-30_custom_TradingSecuritesrEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,851</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_z6poe2yi2Vwa" title="Available-for-sale Securities, Gross Unrealized Gain" style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains" contextRef="From2020-01-012020-09-30_custom_TradingSecuritesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,218</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_znOLVRShnDbe" title="Available-for-sale Securities, Gross Unrealized Loss" style="width: 9%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" contextRef="From2020-01-012020-09-30_custom_TradingSecuritesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,598</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_zAoUfUHKvcld" title="Investment Owned, at Fair Value" style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtFairValue" contextRef="AsOf2020-09-30_custom_TradingSecuritesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,471</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Trading securities - debt</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" title="Short-term Investments" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2019-12-31_custom_TradingSecuritesDebtMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93,712</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains" contextRef="From2019-01-012019-12-31_custom_TradingSecuritesDebtMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_ziLjQ8vjsE3f" title="Available-for-sale Securities, Gross Unrealized Loss" style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" contextRef="From2019-01-012019-12-31_custom_TradingSecuritesDebtMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" title="Investment Owned, at Fair Value" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtFairValue" contextRef="AsOf2019-12-31_custom_TradingSecuritesDebtMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93,843</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Trading securities - equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" title="Short-term Investments" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2019-12-31_custom_TradingSecuritesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,674</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains" contextRef="From2019-01-012019-12-31_custom_TradingSecuritesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">211</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_ztgOqQxKZgx3" title="Available-for-sale Securities, Gross Unrealized Loss" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" contextRef="From2019-01-012019-12-31_custom_TradingSecuritesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">745</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" title="Investment Owned, at Fair Value" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtFairValue" contextRef="AsOf2019-12-31_custom_TradingSecuritesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,140</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortTermInvestments_c20191231_pn3n3" title="Short-term Investments" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">111,386</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231_pn3n3" title="Available-for-sale Securities, Gross Unrealized Gain" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">354</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231_zI2YltaXl7q6" title="Available-for-sale Securities, Gross Unrealized Loss" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">757</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_c20191231_pn3n3" title="Investment Owned, at Fair Value" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InvestmentOwnedAtFairValue" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">110,983</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8AF_zIxHhxktIfA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_ziVBDgH3Dorg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value Measurements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S. GAAP defines fair value as the price that would be received
for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly
transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an
entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established
to measure fair value is defined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(i) <b>Level 1 &#8211;
<i>Observable Inputs</i></b>: Quoted prices in active markets for identical investments;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(ii) <b>Level 2</b>
&#8211; <b><i>Pricing Models with Significant Observable Inputs</i></b>: Other significant observable inputs, including quoted
prices for similar investments, interest rates, credit risk, etc.; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(iii) <b>Level 3 </b>&#8211;
<b><i>Unobservable Inputs</i></b>: Significant unobservable inputs, including the entity&#8217;s own assumptions in determining
the fair value of investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;</p>

<ix:exclude><p id="xdx_235_zoWd34FgtoW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zsF9TDrGT8j6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zbpnEnSe2yTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_23F_z30SFZmHUPPe" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_230_zwH33iZ2xlI2" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td id="xdx_23B_zw0KxJ2Qb8ge" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_235_zXuBrkTxy1l8" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_zVk6xE6o4F27" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_z1ehq2rzvVYj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whenever possible, the Company is required
to use observable market inputs (Level 1 &#8211; quoted market prices) when measuring fair value. In such cases, the level at which
the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement.
The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability
being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial
assets and liabilities measured at fair value on a recurring basis were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zy1ErhJzuWa9" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B7_zwiVHwXkj41l" style="display: none">Schedule of fair value of financial assets and liabilities on a recurring basis</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal">Assets as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020:</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Trading securities - equity</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" title="Assets" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,471</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zdHQ3b5Ukm42" title="Assets" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zZyvFEAX6v67" title="Assets" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Equity securities derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativetMember_zCcuV3csw7Vb" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativetMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,818</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_zFuktMcuGvBd" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativeMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_z1sLqYnzphdc" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativeMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - warrants (Note 5)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zXMUkDeMwDDe" title="Assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" title="Assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">982</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zNL3fhQ4J0L4" title="Assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Total recurring fair value measurements as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,289</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">982</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2gJaVBc0f14" title="Assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Assets as of December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Trading securities - debt</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zJWfNJyJfZ1h" title="Assets" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_pn3n3" title="Assets" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93,843</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zGw6aHE3eMf9" title="Assets" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Trading securities - equity</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,140</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zrjCAk54uysh" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zHHOgrXWj1kb" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Investment at fair value - warrants (Note 5)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z27SfLm2Rvvj" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">757</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zZlq3yHytRWk" title="Assets" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - common stock (Note 5)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_pn3n3" title="Assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">743</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zH0sBseCWzr6" title="Assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zbcg9bq0MbWe" title="Assets" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total recurring fair value measurements as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,883</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94,600</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIZZjFqvhGPd" title="Assets" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal">Liabilities as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020:</span></td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Series A warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6CELBHDVJSk" title="Liabilities" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" title="Liabilities" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z9P2RBRtgwxg" title="Liabilities" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zkRFn7cJUCnk" title="Liabilities" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z8GfR69kkhB" title="Liabilities" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" title="Liabilities" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,796</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z0XfU5arLd1e" title="Liabilities" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zBW0vcRi2x5f" title="Liabilities" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" title="Liabilities" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,682</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Total liabilities as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zihAXRXdxwFb" title="Liabilities" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Liabilities" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Liabilities" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68,478</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Liabilities as of December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Series A warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zI2UbZUHJRSc" title="Liabilities" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" title="Liabilities" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,568</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zIQGSEqHNMC5" title="Liabilities" style="width: 11%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z2aoRdMWkFM" title="Liabilities" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zuVliFxeh6ke" title="Liabilities" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" title="Liabilities" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,974</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total liabilities as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxkw24lIyvD5" title="Liabilities" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Liabilities" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,568</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" title="Liabilities" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,974</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A0_zQwtFdX4xap2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of the changes in the
estimated fair value of the Company&#8217;s Level 3 liabilities, which are measured at fair value as a on a recurring basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zeOiNDynHOg1" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span id="xdx_8B8_z9soetpk7fra" style="display: none">Summary of changes in financial liability Level 3</span></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Series A Preferred Stock Embedded Derivative Liability</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Series B Warrants Liability</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; font-size: 10pt">Opening balance as of December 31, 2019</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zqMdu5Eq6Xu1" title="Fair value ending balance" style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,974</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zjxDzA0Rh557" title="Fair value ending balance" style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Issuance of Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_d0_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zNvn8DVtyFie" title="Issuance of Series B warrants" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" contextRef="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" title="Issuance of Series B warrants" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" contextRef="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,600</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Remeasurement to fair value</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" title="Remeasurement to fair value" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,708</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" title="Remeasurement to fair value" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,196</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Balance as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrG5sEJsgE7c" title="Fair value ending balance" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,682</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zof7bg0bcoQ1" title="Fair value ending balance" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,796</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_8A9_zXcuuRk4sjVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>

<ix:exclude><p id="xdx_238_zDq1mcxAyTyc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z4zaySY6umA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zJSXAWy3DOCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div id="xdx_238_zovwLhN01H91" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_z4zuk19TFcX3" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td id="xdx_235_zQqG42IrzwCd" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23D_zCqjzJwExz5l" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_zX29ymjgPWM3" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zSytnQLumcW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>



</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="ACTG:SeriesAWarrantsPolicyTextBlock"><p id="xdx_84B_ecustom--SeriesAWarrantsPolicyTextBlock_zw5IVOoN786l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Series A Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series A Warrants is estimated using a
Black-Scholes option-pricing model. The fair value of the Series A Warrants as of September 30, 2020 was estimated based on the
following assumptions: volatility of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">32 percent</ix:nonNumeric></span>, risk-free rate of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0.47 percent</ix:nonNumeric></span>, term of <span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">7.04 years</ix:nonNumeric></span> and a dividend yield of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0 percent</ix:nonNumeric></span>.
Refer to Notes 10 and 11 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="ACTG:SeriesBWarrantsPolicyTextBlock"><p id="xdx_84A_ecustom--SeriesBWarrantsPolicyTextBlock_z6Jin3VhDXle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Series B Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series B
Warrants is estimated using Monte Carlo valuation technique. The fair value of the Series B Warrants as of September 30, 2020
was estimated based on event probabilities of future exercise scenarios and the following weighted-average assumptions: (1)
volatility of <span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">32
percent</ix:nonNumeric></span>, risk-free rate of <span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0.48
percent</ix:nonNumeric></span>, term of <span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">7.12
years</ix:nonNumeric></span>, a dividend yield of <span id="xdx_905_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0
percent</ix:nonNumeric></span>, and a discount for lack of marketability of <span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputDiscountRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">10
percent</ix:nonNumeric></span>, and (2) volatility of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">51
percent</ix:nonNumeric></span>, risk-free rate of <span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0.13
percent</ix:nonNumeric></span>, term of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">1.9
years</ix:nonNumeric></span> and a dividend yield of <span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0
percent</ix:nonNumeric></span>, and a discount for lack of marketability of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputDiscountRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">10
percent</ix:nonNumeric></span>. Refer to Notes 10 and 12 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:DerivativesEmbeddedDerivatives"><p id="xdx_843_eus-gaap--DerivativesEmbeddedDerivatives_zA3CZMcKCzI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Embedded derivatives</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Embedded derivatives that are required to be bifurcated from
their host contract are valued separately from host instrument. A binomial lattice framework is used to estimate the fair value
of the embedded derivative in the Series A Redeemable Convertible Preferred Stock. The binomial model utilizes the Tsiveriotis
and Fernandes implementation in which a convertible instrument is split into two separate components: a cash-only component which
is subject to the selected risk-adjusted discount rate and an equity component which is subject only to the risk-free rate. The
model considers the (i) implied volatility of the value of our common stock, (ii) appropriate risk-free interest rate, (iii) credit
spread, (iv) dividend yield, (v) dividend accrual (and a step-up in rates), and (vi) event probabilities of the various conversion
and redemption scenarios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The implied volatility of the Company&#8217;s common stock is
estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe a commonly
observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt is lower
than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining until
November 15, 2027, the maturity date. The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining term
equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&#8217;s
valuation of the embedded derivative at September 30, 2020 are as follows: volatility of <span id="xdx_90F_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_EmbeddedDerivativeMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">32 percent</ix:nonNumeric></span>, risk-free rate of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_EmbeddedDerivativeMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0.47 percent</ix:nonNumeric></span>,
a credit spread of <span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputCreditSpreadMember_custom_EmbeddedDerivativeMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">21 percent</ix:nonNumeric></span> and a dividend yield of <span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"><ix:nonNumeric contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_EmbeddedDerivativeMember" name="us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">0 percent</ix:nonNumeric></span>. The fair value measurement of the embedded derivative is sensitive
to these assumptions and changes in these assumptions could result in a materially different fair value measurement. Refer to Note
10 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_8A9_zXcuuRk4sxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>

<ix:exclude><p id="xdx_238_zDq1mcxAyxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z4zaySY6uxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zJSXAWy3Dxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div id="xdx_238_zovwLhN01xxx" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_z4zuk19TFxxx" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td id="xdx_235_zQqG42Irzxxx" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23D_zCqjzJwExxxx" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_zX29ymjgPxxx" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zSytnQLumxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zS8cxDceF2if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investments at Fair Value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On an individual investment basis, Acacia may elect to account
for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies
of the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under
the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e.,
common stock and warrants). We elected the fair value method for our investment in Veritone upon acquisition of the investment.
As of September 30, 2020, our investment in Veritone warrants totaled $<span id="xdx_90A_eus-gaap--Investments_iI_pn3p0_c20200930__us-gaap--InvestmentsInAndAdvancesToAffiliatesCategorizationAxis__custom--VeritoneMember_zWWmSPR8uAD3" title="Investment in Veritone"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2020-09-30_custom_VeritoneMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">982,000</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:EquityAndCostMethodInvestmentsPolicy"><p id="xdx_844_eus-gaap--EquityAndCostMethodInvestmentsPolicy_zzu8Ha3HJ5rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity investments in common stock and in-substance common stock
without readily determinable fair values in companies over which the Company has the ability to exercise significant influence,
are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its
equity method investees in equity in earnings (losses) of investees in the condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in preferred stock with substantive liquidation
preferences are accounted for at cost (subject to impairment considerations, as described below, if any), as adjusted for the impact
of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.
In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar
to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is
not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference
is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation
to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a
fair value perspective is substantive because, in the event of liquidation, the investor will not participate in substantially
all of the investee's losses, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial determination of whether an investment is substantially
similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence
over the operating and financial policies of the investee. That determination is reconsidered if:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">contractual terms of the investment are changed,</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(iii)</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7IMkSefF09g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stock-Based Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation cost for all stock-based awards is measured
at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#8217;s
requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value
of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and
the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant
using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<ix:exclude><p id="xdx_235_zylhtDX29A9b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_z6znmQNF5vij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zXQK8QLi7HJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div id="xdx_23D_zcdUkWlDFzF6" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23B_zUqsWm9SF4qe" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td id="xdx_23B_zhYPCbceuZSl" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23F_z1c5WFddQRga" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_235_z6q8J0sO3Jq1" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zv7FW4srgNe3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Restricted stock units granted in September 2019 with market-based
vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of
a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique.
Compensation cost is recognized with a market-based vesting condition provided that the requisite service is rendered, regardless
of when, if ever, the market condition is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique
included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected volatility of 38 percent; and expected
dividend yield of 0 percent. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon
issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on
expectations regarding dividend payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Profits Interest Units (&#8220;Units&#8221;) were accounted
for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock Compensation.&#8221;
The vesting conditions did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such,
the Units were classified as liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion
of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s
requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award,
which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized
in the period. The Company has a purchase option to purchase the vested Units that are not otherwise forfeited after termination
of continuous service. The exercise price of the purchase option is the fair market value of the Units on the date of termination
of continuous service. As of September 30, 2020, the Units totaled $591,000, which was their fair value as of December 31, 2018
after termination of service.</p>



<ix:exclude><p id="xdx_237_zd4Kg2clrnql" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b>&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:StockholdersEquityPolicyTextBlock"><p id="xdx_849_eus-gaap--StockholdersEquityPolicyTextBlock_ztHNv9JfSzSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Treasury Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Repurchases of the Company&#8217;s outstanding common stock
are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the
formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to
additional paid-in capital, and reflected as treasury stock on the condensed consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:CostMethodInvestmentsPolicy"><p id="xdx_844_eus-gaap--CostMethodInvestmentsPolicy_zbcnh16MCdQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impairment of Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative
and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value,
Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than
cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee,
including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline
in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements
of operations and a new cost basis in the investment is established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i>&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zxSGe5tiGsse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income taxes are accounted for using an asset and liability
approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events
that have been recognized in Acacia&#8217;s condensed consolidated financial statements or consolidated income tax returns. A valuation
allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized,
or if it is determined that there is uncertainty regarding future realization of such assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The provision for income taxes for interim periods is determined
using an estimate of Acacia&#8217;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account
in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate
changes, a cumulative adjustment is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s effective tax rates were <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200701__20200930_zsHjYk2Pbsx6" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>% and <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200101__20200930_ziGt7tz8vM53" title="Effective tax rate">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">4</ix:nonFraction>%)</span> for
the three and nine months ended September 30, 2020, respectively and <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190701__20190930_z5M0RaWlYfZ2" title="Effective tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>% and <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190101__20190930_ziYsdARV37Pd" title="Effective tax rate">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2</ix:nonFraction>%)</span> for the three and nine months ended September
30, 2019, respectively. Tax benefit (expense) for the periods presented primarily reflects the impact of state taxes and foreign
taxes withholding or refund incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.
The Company has recorded full valuation allowance against our net deferred tax assets as of September 30, 2020 and 2019. These
assets primarily consist of foreign tax credits, capital loss carryforwards and net operating loss carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<ix:exclude><p id="xdx_23D_z7vPSMP2k5si" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zWe89CmqC2Al" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zDNvV3bJZGDf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 19 -->
    <div id="xdx_23C_z6RsbklQ22k2" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_236_z3iLW3uIJ3x8" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td id="xdx_239_zIhrbG8OOM14" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_233_zSmfnZhooNw5" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23F_zQKzW0avhCI1" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_z7hargvAuJkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_z1W8kWwVCB2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. <span>INCOME (LOSS) PER SHARE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the shares of common stock outstanding
used in the calculation of basic and diluted net income (loss) per share:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zrMs58AlTb4h" summary="xdx: Disclosure - 3. INCOME (LOSS) PER SHARE (Details)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8B8_zyt1E8bRR0wa" style="display: none">Calculation of basic and diluted net loss per share</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_491_20200701__20200930_z29qq7agZcq5" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49F_20190701__20190930_zIKWN8QuKJr9" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49D_20200101__20200930_zExwxzrYQcwl" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_498_20190101__20190930_zRSH2DotCJha" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><b>Three Months Ended</b></td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><b>Nine Months Ended</b></td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="text-align: center; font-size: 10pt">(In thousands, except share and per share information)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Numerator:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Net income (loss) attributable to Acacia Research Corporation</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,348</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,205</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,749</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di0_zxqOwbKWKiAd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Dividend on Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,118</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di0_zU9h3DvHXiAi" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Accretion of Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockAccretionOfRedemptionDiscount" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">733</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockAccretionOfRedemptionDiscount" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockAccretionOfRedemptionDiscount" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,045</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockAccretionOfRedemptionDiscount" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zv0jupxlZjH2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Undistributed earnings allocated to participating securities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,619</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,204</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net income (loss) attributable to common stockholders - basic</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,529</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,838</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,749</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DividendsPreferredStock_pn3n3_d0_zM3VNy1tOFwh" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Dividend on Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_pn3n3_d0_z9tIs3mLY24b" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Accretion of Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">733</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_pn3n3_d0_zjULQdByivRe" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,831</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" contextRef="From2020-01-01to2020-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ChangeInFairValueOfSeriesWarrants_pn3n3_d0_zsQ37QG9a9ni" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of Series A warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesWarrants" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,348</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesWarrants" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesWarrants" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,348</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfSeriesWarrants" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_pn3n3_d0_zsGmaSXRZ4Hi" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of dilutive Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,557</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(<ix:nonFraction name="ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,557</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--InterestExpenseOther_pn3n3_d0_zkHw9SievXb3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Interest expense associated with Starboard Notes, net of tax</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,889</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,889</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseOther" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_pn3n3_d0_zZC20vagXWoj" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Undistributed earnings allocated to participating securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,619</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,204</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_pn3n3_d0_z3W83rx7FVjb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Reallocation of undistributed earnings to participating securities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">296</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,645</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_zP5FDOoxTZQ6" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) attributable to common stockholders - diluted</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,204</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,380</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,749</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Denominator:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pip0_zK4sOlONYiu1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - basic</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">48,467,885</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,828,361</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">48,949,706</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,727,385</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Potentially dilutive common shares:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A Preferred Stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zVtgD3VH6oVl" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">9,589,041</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKUOueVrvJe" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-07-012019-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zMDPj1aStmSi" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zUhrrxgIp7Qk" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-01-012019-09-30_us-gaap_SeriesAPreferredStockMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Restricted stock units</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zwGsQ2YBMcy" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_custom_RestrictedStockUnitsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">728,936</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zpLQyOdbF9k" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-07-012019-09-30_custom_RestrictedStockUnitsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zz7SeVr6OoEe" title="Potentially dilutive common shares:" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_custom_RestrictedStockUnitsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">598,328</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_z9ofT9abmOLd" title="Potentially dilutive common shares:" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-01-012019-09-30_custom_RestrictedStockUnitsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Employee stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_z6VL88jIbVa3" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_custom_EmployeeStockOptionsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">21,624</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zb6RDqbZ5ki5" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-07-012019-09-30_custom_EmployeeStockOptionsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zpJswYj5bsQ9" title="Potentially dilutive common shares:" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_custom_EmployeeStockOptionsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zAOXioeMlmXl" title="Potentially dilutive common shares:" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-01-012019-09-30_custom_EmployeeStockOptionsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A Warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1lhACTATp3i" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">310,367</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxn4k1MYdK7c" title="Potentially dilutive common shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-07-012019-09-30_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zjcGTuf1R6p9" title="Potentially dilutive common shares:" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">103,456</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0nMwksJ1qg7" title="Potentially dilutive common shares:" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-01-012019-09-30_custom_SeriesAWarrantsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Series B Warrants</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zqmIiEXuNrD9" title="Potentially dilutive common shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">31,506,849</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z4zQrePeS6nh" title="Potentially dilutive common shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-07-012019-09-30_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zjcXXqjEYMw8" title="Potentially dilutive common shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">10,502,283</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z7dWJW1fxZl9" title="Potentially dilutive common shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2019-01-012019-09-30_custom_SeriesBWarrantsMember" format="ixt:zerodash" decimals="INF" scale="0" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pip0_zEYLLRBoi9Fl" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - diluted</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">90,624,702</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,828,361</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">60,153,773</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">49,727,385</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareBasic_pip0_zrQ6VsuNV5jh" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Basic net income (loss) per common share</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.63</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="USDPShares">0.15</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.51</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="USDPShares">0.36</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pip0_zcs77cO8o7Cf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net income (loss) per common share</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.32</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="USDPShares">0.15</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.36</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" sign="-" unitRef="USDPShares">0.36</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left">Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Equity-based incentive awards</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_custom_EquityBasedIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">191,312</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012019-09-30_custom_EquityBasedIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">442,864</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-09-30_custom_EquityBasedIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">310,083</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-01-012019-09-30_custom_EquityBasedIncentiveAwardsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">442,864</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zciNzaCD66le" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_custom_SeriesAWarrantsMember132390937" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zEoez9xVbfQ2" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012019-09-30_custom_SeriesAWarrantsMember132390953" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zIJ6U2DopC07" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-09-30_custom_SeriesAWarrantsMember132390968" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zQAW7w0xfhXg" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-01-012019-09-30_custom_SeriesAWarrantsMember132390984" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Series B warrants</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" title="Antidilutive shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember132391000" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">68,493,151</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zvW7NH40Z111" title="Antidilutive shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012019-09-30_custom_SeriesBWarrantsMember132391000" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" title="Antidilutive shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132391015" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">68,493,151</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zhJkZV7HMvK5" title="Antidilutive shares" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-01-012019-09-30_custom_SeriesBWarrantsMember132391031" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Total</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930_pii" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">68,684,463</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930_pii" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">442,864</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930_pii" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">68,803,234</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930_pii" title="Antidilutive shares" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">442,864</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_23C_zsGK0TbyihS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zqKwrTYp9svf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zhjQTt0hdlQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 20 -->
    <div id="xdx_23D_zIexQvBrE03c" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23F_z254I7tPS9Q1" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td id="xdx_238_zVmsrojzdG03" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_230_z5Orj7jsuAFd" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_237_zmQFQnJjSLIe" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zBrf5QNYsqE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80D_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVCypg06ecej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4. <span>PATENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s only identifiable intangible assets at September
30, 2020 and December 31, 2019 are patents and patent rights. Patent-related accumulated amortization totaled $<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3p0_c20200930_zCDVMi8l99n5" title="Accumulated amortization"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">326,296,000</ix:nonFraction></span> and
$<span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3p0_c20191231_zLT8vH6m2iDh" title="Accumulated amortization"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">322,774,000</ix:nonFraction></span> as of September 30, 2020 and December 31, 2019, respectively. Acacia&#8217;s patents have remaining estimated economic
useful lives ranging from three to fifty-five months. The weighted-average remaining estimated economic useful life of Acacia&#8217;s
patents is approximately four years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the scheduled annual aggregate
amortization expense as of September 30, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zY2ENlAczsA8" summary="xdx: Disclosure - 4. PATENTS (Details)" style="border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B4_zdkcEXwBHCEk" style="display: none">Schedule of intangible assets</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_497_20200930_zRGrGBAmH1W" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt">For&#160;the&#160;years&#160;ending&#160;December&#160;31,</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJ1C_zT4eK4C8Tby6" style="vertical-align: bottom; background-color: White">
    <td style="width: 33%; font-size: 10pt">Remainder of 2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,158</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJ1C_z9Tr7DvbAvMa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,451</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJ1C_zLTnG0LYCXEj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2022</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,451</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJ1C_zvawWHBTYQEe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,376</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJ1C_zJpG7y6MLKtc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,005</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJ1C_ztzRKw6jUsZc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">630</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJ1C_zYiMF6lKPArk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;&#160;<span style="color: White">Patents, net</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,071</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:InvestmentHoldingsTextBlock"><p id="xdx_80D_eus-gaap--InvestmentHoldingsTextBlock_zblEjhQBjTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>5. <span>INVESTMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Investment at Fair Value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2016 and 2017, Acacia made certain investments in Veritone,
Inc. (&#8220;Veritone&#8221;). As a result of these transactions, Acacia received an aggregate total of 4,119,521 shares of Veritone
common stock and warrants to purchase a total of <span id="xdx_905_ecustom--NumberOfWarrants_pip0_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z7fffCUVDXNj" title="Number of warrants"><ix:nonFraction name="ACTG:NumberOfWarrants" contextRef="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">1,120,432</ix:nonFraction></span> shares of Veritone common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Warrants price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.61</ix:nonFraction></span> per share
expiring between 2020 and 2027. During the year ended December 31, 2018, Acacia sold <span id="xdx_906_ecustom--InvestmentSharesSold_c20180101__20181231__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold"><ix:nonFraction name="ACTG:InvestmentSharesSold" contextRef="From2018-01-012018-12-31_custom_VeritoneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,700,000</ix:nonFraction></span> shares Veritone common stock and
recorded a realized loss of $<span id="xdx_90E_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20180101__20181231__srt--CounterpartyNameAxis__custom--VeritoneMember_zIUOBatk7hAh" title="Loss from sale of investment"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2018-01-012018-12-31_custom_VeritoneMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">19.1</ix:nonFraction></span> million. During the year ended December 31, 2019, Acacia sold <span id="xdx_908_ecustom--InvestmentSharesSold_c20190101__20191231__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold"><ix:nonFraction name="ACTG:InvestmentSharesSold" contextRef="From2019-01-012019-12-31_custom_VeritoneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,121,071</ix:nonFraction></span> shares Veritone common
stock and recorded a realized loss of $<span id="xdx_903_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20190101__20191231__srt--CounterpartyNameAxis__custom--VeritoneMember_zwE38mgRIzP9" title="Loss from sale of investment"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2019-01-012019-12-31_custom_VeritoneMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">9.2</ix:nonFraction></span> million. During the three months ended March 31, 2020, Acacia sold all remaining <span id="xdx_90B_ecustom--InvestmentSharesSold_c20200101__20200331__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold"><ix:nonFraction name="ACTG:InvestmentSharesSold" contextRef="From2020-01-012020-03-31_custom_VeritoneMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">298,450</ix:nonFraction></span>
shares Veritone common stock and recorded a realized loss of $<span id="xdx_906_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20200101__20200331__srt--CounterpartyNameAxis__custom--VeritoneMember_zJR5Te0IE5Xa" title="Loss from sale of investment"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2020-01-012020-03-31_custom_VeritoneMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">3.3</ix:nonFraction></span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended June 30, 2020, Acacia exercised
<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_c20200930_pii" title="Warrants exercised"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">154,312</ix:nonFraction></span> warrants of the total <span id="xdx_90A_ecustom--NumberOfWarrants_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Number of warrants"><ix:nonFraction name="ACTG:NumberOfWarrants" contextRef="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,120,432</ix:nonFraction></span> Veritone common stock purchase warrants at a price of $13.61 per warrant, and then sold
the <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Number of stock sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">154,312</ix:nonFraction></span> shares of Veritone stock received at $<span id="xdx_907_eus-gaap--SharePrice_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Share Price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.23</ix:nonFraction></span> per share, and recorded a realized gain of $<span id="xdx_904_eus-gaap--GainLossOnSaleOfInvestments_pn3p0_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zyQdLBJouoB8" title="Realized gain"><ix:nonFraction name="us-gaap:GainLossOnSaleOfInvestments" contextRef="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">554,000</ix:nonFraction></span>. At September 30, 2020,
the fair value of the <span id="xdx_901_ecustom--InvestmentWarrants_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Investment warrants"><ix:nonFraction name="ACTG:InvestmentWarrants" contextRef="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">966,120</ix:nonFraction></span> remaining warrants held by Acacia totaled $<span id="xdx_90D_eus-gaap--FinancialInstrumentsOwnedAtFairValue_iI_pn3p0_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zQLuDbMEqiO3" title="Fair value of investment"><ix:nonFraction name="us-gaap:FinancialInstrumentsOwnedAtFairValue" contextRef="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">982,000</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the fair value of Acacia&#8217;s investment in Veritone
are recorded as unrealized gains or losses in the condensed consolidated statements of operations. For the three and nine months
ended September 30, 2020 and 2019, the accompanying condensed consolidated statements of operations reflected the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:GainLossOnInvestmentsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_z9s2dcLYaMj7" summary="xdx: Disclosure - 5. INVESTMENTS (Details)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8BC_ziaOgnpgcot8" style="display: none">Schedule of gain (loss) on investments</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Change in fair value of investment, warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" title="Change in fair value of investment" style="width: 9%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,081</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" title="Change in fair value of investment" style="width: 9%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-07-012019-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,216</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" title="Change in fair value of investment" style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" title="Change in fair value of investment" style="width: 9%; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-01-012019-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">822</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of investment, common stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zCysRFZGlMU6" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" title="Change in fair value of investment" style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-07-012019-09-30_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,050</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,479</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-01-012019-09-30_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,444</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Gain on sale of investment, warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zsnPClIS32pl" title="Gain on sale of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainOnSaleOfInvestments" contextRef="From2020-07-012020-09-30_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zxZNaTd6GJef" title="Gain on sale of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainOnSaleOfInvestments" contextRef="From2019-07-012019-09-30_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zSNNy7Zj2KN7" title="Gain on sale of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainOnSaleOfInvestments" contextRef="From2020-01-012020-09-30_custom_WarrantInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">554</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zlfZtKRYwmif" title="Gain on sale of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainOnSaleOfInvestments" contextRef="From2019-01-012019-09-30_custom_WarrantInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Loss on sale of investment, common stock</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zu5zqdgT9jn" title="Loss on sale of investment" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z6MTWm9O8X8d" title="Loss on sale of investment" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2019-07-012019-09-30_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">915</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zifsbseloMIl" title="Loss on sale of investment" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2020-01-012020-09-30_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,316</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zEhIlcKgmQfe" title="Loss on sale of investment" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:LossOnSaleOfInvestments" contextRef="From2019-01-012019-09-30_custom_CommonStockInvestmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,147</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net realized and unrealized gain (loss) on investment at fair value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--GainLossOnInvestments_c20200701__20200930_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,081</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20190701__20190930_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,181</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">942</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20190101__20190930_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:exclude><p id="xdx_23B_zACHbPGFSvY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zMVSVUASet2l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zy3HW7frnp0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 21 -->
    <div id="xdx_23A_zzFXQ1XJ95pj" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_232_ziIbgin3ZOk9" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td id="xdx_23D_ztgR8ppIm27f" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_239_zvBkigcF0upf" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_235_zMYrVlM4ZHW9" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zQlK8EbvHaz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zGKCWkxrvCd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>6. <span>COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Patent Enforcement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain of Acacia&#8217;s operating subsidiaries are often required
to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia&#8217;s operating subsidiaries&#8217;
patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has
violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive
or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating
subsidiaries or award attorney&#8217;s fees and/or expenses to a defendant(s), which could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Facility Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company primarily leases office facilities under operating
lease arrangements that will end in various years through July 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 7, 2019, we entered into a building lease agreement
(the &#8220;New Lease&#8221;) with Jamboree Center 4 LLC (the &#8220;Landlord&#8221;). Pursuant to the New Lease, we have leased
approximately 8,293 square feet of office space for our corporate headquarters in Irvine, California. The New Lease commenced on
August 1, 2019. The term of the New Lease is 60 months from the commencement date, provides for annual rent increases, and does
not provide us the right to early terminate or extend our lease terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leased a facility under an operating lease agreement
(the &#8220;Old Lease&#8221;), the term of which ended on January 31, 2020. The Company ceased using the facility in December 2018
and the subleased the facility for the remainder of the Old Lease term. All sublease income under the Old Lease was received and
recorded in 2019. No sublease income on the Old Lease was recognized in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 7, 2020, we entered into a building lease agreement
(the &#8220;New York Office Lease&#8221;) with Sage Realty Corporation (the &#8220;New York Office Landlord&#8221;). Pursuant to
the New York Office Lease, we have leased approximately 4,000 square feet of office space in New York, New York. The New York Office
Lease commenced on February 1, 2020. The term of the New York Office Lease is 24 months from the commencement date, provides for
annual rent increases, and does not provide us the right to early terminate or extend our lease terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating lease costs, net of sublease income, were $<span id="xdx_90D_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20200701__20200930_zQG3Ry3U6Bvl" title="Operating lease costs, net of sublease income"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">174,000</ix:nonFraction></span>
and $<span id="xdx_90A_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20190701__20190930_zlNaqHwBZGmk" title="Operating lease costs, net of sublease income"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2019-07-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">96,000</ix:nonFraction></span> for the three months ended September 30, 2020 and 2019, respectively. Operating lease costs, net of sublease income,
were $<span id="xdx_90B_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20200101__20200930_zHNDYfFJmTB9" title="Operating lease costs, net of sublease income"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">459,000</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20190101__20190930_zgEOLGL6MPT7" title="Operating lease costs, net of sublease income"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">301,000</ix:nonFraction></span> for the nine months ended September 30, 2020 and 2019, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below presents aggregate future minimum payments
due under the New Lease and the New York Office Lease discussed above, reconciled to lease liabilities included in the condensed
consolidated balance sheet as of September 30, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_pn3n3_zQy0J47soJT" summary="xdx: Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)" style="border-collapse: collapse; width: 50%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BD_zRqTouLlfun1" style="display: none">Schedule of future minimum operating lease payments</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49A_20200930_zqEvJuZNmSKa" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Operating Leases</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_pn3n3_maOLFMPzu8U_zZMc47WWRwp7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 33%; font-size: 10pt; text-align: left">2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">144</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pn3n3_maOLFMPzu8U_zBvGSiCMroX8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">589</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pn3n3_maOLFMPzu8U_z2wVp7aiANAk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2022</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">370</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pn3n3_maOLFMPzu8U_zENbv2ehdnWf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">364</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pn3n3_maOLFMPzu8U_zeMWQ9Lb0UP8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">2024</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">218</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_pn3n3_mtOLFMPzu8U_zkpxRETVod22" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Total minimum payments</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,685</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zta1dyCKj2ih" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Less: short-term lease liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">584</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Long-term lease liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,101</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>

<ix:exclude><p id="xdx_239_zYeTCupBvpGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zlgXdzM7P7U9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zDmjmGyT3x54" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 22 -->
    <div id="xdx_23D_zeObtGA4l6j3" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_236_zRQ5HZBLYDc3" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td id="xdx_231_zM0d1w4jNRIj" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zC0YDDTmV8Z2" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_zuH6DfczPqre" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zMcqmTVYjGzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Other Matters</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia is subject to claims, counterclaims and legal actions
that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and
legal actions, if any, will not have a material effect on Acacia&#8217;s condensed consolidated financial position, results of
operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 6, 2019, Slingshot Technologies, LLC (&#8220;Slingshot&#8221;)
filed a lawsuit in Delaware Chancery Court against the Company, Acacia Research Group, LLC, and Monarch Networking Solutions LLC
(collectively, the &#8220;Acacia Entities&#8221;), Acacia board member Katharine Wolanyk, and Transpacific IP Group, Ltd. (&#8220;Transpacific&#8221;).
Slingshot alleges that the Acacia Entities misappropriated its confidential and proprietary information, purportedly furnished
to the Acacia Entities by Ms. Wolanyk, in acquiring a patent portfolio from Transpacific after Slingshot&#8217;s exclusive option
to purchase the same patent portfolio from Transpacific had already expired. Slingshot seeks monetary damages, as well as equitable
and injunctive relief related to its alleged right to own the portfolio. The Acacia Entities maintain that Slingshot&#8217;s allegations
are baseless, that Ms. Wolanyk had no involvement in the acquisition, that the Acacia Entities neither had access to nor used Slingshot&#8217;s
information in acquiring the portfolio, that the Acacia Entities acquired the portfolio as a result of the independent efforts
of its IP licensing group, and that Slingshot suffered no damages given its exclusive option to purchase the portfolio had already
ended and it has proven itself incapable of closing on the portfolio purchase.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a separate case, on December 6, 2017, the Federal Court of
Canada allowed a counterclaim for invalidity of a patent asserted by Rapid Completions LLC and awarded costs payable by Rapid Completions
LLC in an amount to be determined.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended September 30, 2020, operating expenses
included a net income for settlement offset by contingency accruals totaling $<span id="xdx_90E_eus-gaap--OperatingLeasesIncomeStatementContingentRevenue_pn3p0_c20200101__20200930_zxDu3LEhThX2" title="Income from settlement"><ix:nonFraction name="us-gaap:OperatingLeasesIncomeStatementContingentRevenue" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">308,000</ix:nonFraction></span>, net of prior accruals. During the nine months
ended September 30, 2019, operating expenses included expenses for settlement and contingency accruals totaling $<span id="xdx_904_eus-gaap--OperatingLeasesIncomeStatementContingentRevenue_pn3p0_c20190101__20190930_zbYWB3ht3D1l" title="Income from settlement"><ix:nonFraction name="us-gaap:OperatingLeasesIncomeStatementContingentRevenue" contextRef="From2019-01-012019-09-30" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">175,000</ix:nonFraction></span>. At September
30, 2020, our contingency accruals totaled $<span id="xdx_904_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_dm_c20200930_zyF3T6ZoL0b2" title="Contingency accruals"><ix:nonFraction name="us-gaap:LossContingencyAccrualAtCarryingValue" contextRef="AsOf2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.4</ix:nonFraction></span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zF89CvvKk2ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>7. <span>STOCKHOLDERS&#8217; EQUITY</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Repurchases of Common Stock </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 5, 2019, Acacia&#8217;s Board of Directors approved
a stock repurchase program, which authorized the purchase of up to $<span id="xdx_90C_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_dm_c20190805__us-gaap--ShareRepurchaseProgramAxis__custom--StockRepurchaseProgramMember_z25cHR2BZ066" title="Value of shares authorized for repurchase"><ix:nonFraction name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" contextRef="AsOf2019-08-05_custom_StockRepurchaseProgramMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">10.0</ix:nonFraction></span> million of the Company's common stock through open market
purchases, through block trades, through 10b5-1 plans, or by means of private purchases, from time to time, through July 31, 2020.
Stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:AcceleratedShareRepurchasesTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_pn3n3_zyKsHg8pwXHb" summary="xdx: Disclosure - 7. STOCKHOLDERS&apos; EQUITY (Details)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: justify"><span id="xdx_8B9_z9FXUkUNJmBh" style="display: none">Schedule of repurchased shares</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total Number<br /> of Shares<br /> Purchased</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Average<br /> Price<br /> paid per<br /> Share</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Approximate Dollar<br /> Value of Shares that<br /> May Yet be Purchased<br /> under the Program</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Plan Expiration Date</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 32%; font-size: 10pt; text-align: center">March 20, 2020 - March 31, 2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" title="Number of shares repurchased" style="width: 15%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:TreasuryStockSharesAcquired" contextRef="From2020-03-202020-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">576,898</ix:nonFraction></td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" title="Average price paid per share" style="width: 15%; font-size: 10pt; text-align: center">$<ix:nonFraction name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="From2020-03-202020-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.28</ix:nonFraction></td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_989_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" title="Approximate value of shares that may yet be purchased" style="width: 15%; font-size: 10pt; text-align: center">$<ix:nonFraction name="ACTG:ApproximateValueOfSharesThatMayYetBePurchased" contextRef="From2020-03-202020-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,686,000</ix:nonFraction></td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_980_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3XFtIb7dl8i" title="Plan expiration date" style="width: 15%; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="From2020-03-202020-03-31_us-gaap_CommonStockMember" format="ixt:datemonthdayyearen" name="us-gaap:StockRepurchaseProgramExpirationDate">July 31, 2020</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt">April 1, 2020 - April 23, 2020</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" title="Number of shares repurchased" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:TreasuryStockSharesAcquired" contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,107,639</ix:nonFraction></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" title="Average price paid per share" style="padding-bottom: 1pt; font-size: 10pt; text-align: center">$<ix:nonFraction name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.42</ix:nonFraction></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98B_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" title="Approximate value of shares that may yet be purchased" style="padding-bottom: 1pt; font-size: 10pt; text-align: center">$<ix:nonFraction name="ACTG:ApproximateValueOfSharesThatMayYetBePurchased" contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,001,000</ix:nonFraction></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_987_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkVK26nS2Xrf" title="Plan expiration date" style="font-size: 10pt; text-align: center; padding-bottom: 1pt"><ix:nonNumeric contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember" format="ixt:datemonthdayyearen" name="us-gaap:StockRepurchaseProgramExpirationDate">July 31, 2020</ix:nonNumeric></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt">Totals for 2020</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" title="Number of shares repurchased" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:TreasuryStockSharesAcquired" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember132393281" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,684,537</ix:nonFraction></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" title="Average price paid per share" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: center">$<ix:nonFraction name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember132393281" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.37</ix:nonFraction></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td></tr>
</table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining whether or not to repurchase any shares of Acacia&#8217;s
common stock, Acacia&#8217;s Board of Directors consider such factors as the impact of the repurchase on Acacia&#8217;s cash position,
as well as Acacia&#8217;s capital needs and whether there is a better alternative use of Acacia&#8217;s capital. Acacia has no
obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the
open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce
the outstanding share count and enhance stockholder value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<ix:exclude><p id="xdx_234_z2h5H8aPlXc8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<ix:exclude><p id="xdx_238_zJLNKZJVHHH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zXSnXYQRZEn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 23 -->
    <div id="xdx_239_z6k1cwdoFQc7" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_234_zJeev6nIeqmb" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td id="xdx_237_z5x5EPslnR73" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_233_zvXGvxKFVQ5a" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23A_zOHMagZshNx3" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_z9MNvMmMDCTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Tax Benefits Preservation Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 12, 2019, Acacia&#8217;s Board of Directors announced
that it had unanimously approved the adoption of a Tax Benefits Preservation Plan (the &#8220;Plan&#8221;). Our stockholders ratified
the adoption of the Plan in July 2019. The purpose of the Plan is to protect the Company&#8217;s ability to utilize potential tax
assets, such as net operating loss carryforwards and tax credits to offset potential future taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan is designed to reduce the likelihood that the Company
will experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership of 4.9% or more
of the Company&#8217;s outstanding common stock and (ii) any existing stockholders who, as of the time of the first public announcement
of the adoption of the Plan, beneficially own more than 4.9% of the Company&#8217;s then-outstanding shares of the Company&#8217;s
common stock from acquiring additional shares of the Company&#8217;s common stock (subject to certain exceptions). There is no
guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the adoption of the Plan, Acacia&#8217;s
Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company&#8217;s
common stock to stockholders of record at the close of business on March 16, 2019. On or after the distribution date, each right
would initially entitle the holder to purchase one one-thousandth of a share of the Company&#8217;s Series B Junior Participating
Preferred Stock, $0.001 par value for a purchase price of $12.00.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also has a provision in its Amended and Restated
Certificate of Incorporation, as amended (the &#8220;Charter Provision&#8221;) which generally prohibits transfers of its common
stock that could result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect the Company&#8217;s
ability to utilize potential tax assets, such as net operating loss carryforwards and tax credits to offset potential future taxable
income. The Charter Provision was approved by the Company&#8217;s stockholders on July 15, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"><p id="xdx_801_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_znyBcjVpxSId" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>8. <span>RECENT ACCOUNTING PRONOUNCEMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Recent Accounting Pronouncements - Not Yet Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;)
issued ASU No. 2019-12 Income Taxes (Topic 740) &#8212; Simplifying the Accounting for Income Taxes, to remove certain exceptions
and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted
change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date.
The amendments in this update will be effective for the Company beginning with fiscal year 2021, with early adoption permitted.
Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied
on a retrospective or modified retrospective basis. Management is currently evaluating the impact that the amendments in this update
will have on the Company&#8217;s condensed consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU No. 2016-13,Financial Instruments&#8212;Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, to replace the incurred loss methodology with an expected
credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of
the asset, including current conditions and reasonable and supportable forecasts in addition to historical loss information, to
determine expected credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required.
Also, in April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments&#8212;Credit
Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, to clarify the inclusion of recoveries of trade
receivables previously written off when estimating an allowance for credit losses. The amendments in this update will be effective
for the Company in fiscal year 2023, with early adoption permitted. Management is currently evaluating the impact that the amendments
in this update will have on the Company&#8217;s condensed consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_802_eus-gaap--FairValueDisclosuresTextBlock_z8sPHQu1v2F" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>9. <span>FAIR VALUE DISCLOSURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia holds the following types of financial instruments at
September 30, 2020 and December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Trading securities - debt. </i>Debt securities include corporate
bonds with fair value that is determined by third party quotations from outside pricing services and/or computerized pricing models,
which may be based on transactions, bids or estimates. Acacia classifies the fair value of corporate bonds within Level 2 of the
valuation hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<ix:exclude><p id="xdx_230_zLru6GpYbu24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<ix:exclude><p id="xdx_232_zOz2uXaPWB54" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<ix:exclude><p id="xdx_239_zTHYxsoMzouj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 24 -->
    <div id="xdx_231_zhufAG00z027" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_znJ8BxPvqnFg" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td id="xdx_235_zuo583lOi7Ik" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_239_zxWrt1syBDM6" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_232_zUfFxcTOkUQd" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zh991Vz9rFzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Trading securities - equity. </i>Equity securities include
investments in public companies&#8217; common stock and are recorded at fair value based on the quoted market price of each share
on the valuation date. The fair value of these securities are within Level 1 of the valuation hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity securities derivative.</i> Public company equity securities
derivative are recorded at fair value based on the quoted market price of the underlying shares on the valuation date and settlement
expectations. The fair value of these equity securities derivative are within Level 1 of the valuation hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investments at fair value - common stock</i>. Acacia&#8217;s
equity investment in Veritone common stock is recorded at fair value based on the quoted market price of Veritone&#8217;s common
stock on the applicable valuation date (Level 1).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investments at fair value - warrants. </i>Warrants are recorded
at fair value, as based on the Black-Scholes option-pricing model (Level 2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Series A Warrants. </i>Series A Warrants are recorded at
fair value, using Black-Scholes option-pricing model (Level 2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Series B Warrants. </i>Series B Warrants are recorded at
fair value, using Monte Carlo valuation technique (Level 3).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Embedded derivative liability. </i>Embedded derivatives that
are required to be bifurcated from their host contract are evaluated and valued separately from the host instrument. A binomial
lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred
Stock issued by the Company in 2019 (Level 3).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:PreferredStockTextBlock"><p id="xdx_80F_eus-gaap--PreferredStockTextBlock_zC7XW9r0dRU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>10. <span>SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 18, 2019, the Company entered into a Securities
Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) with Starboard Value LP (&#8220;Starboard&#8221;) and the
investors set forth in the Securities Purchase Agreement (the &#8220;Buyers&#8221;) pursuant to which the Company issued (i) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember_pii" title="Stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,000</ix:nonFraction></span>
shares of Series A Redeemable Convertible Preferred Stock with a par value of $0.001 per share and a stated value of $100 per share,
and (ii) Series A Warrants to purchase up to <span id="xdx_908_ecustom--WarrantsIssued_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Warrants issued"><ix:nonFraction name="ACTG:WarrantsIssued" contextRef="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span> shares of the Company&#8217;s common stock to the Buyers. The Securities
Purchase Agreement also established the terms of certain senior secured notes (the &#8220;Notes&#8221;) and Series B Warrants that
may be issued to the Buyers on a subsequent date. Refer to Notes 11 and 12 for additional information regarding the issuance of
the Series A and Series B Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Redeemable Convertible Preferred Stock can be converted
into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends, divided by (ii)
the conversion price of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.65</ix:nonFraction></span> (subject to certain anti-dilution adjustments). Holders may elect to convert the Series A Redeemable
Convertible Preferred Stock into common stock at any time. The Company may elect to convert the Series A Redeemable Convertible
Preferred Stock into shares of Common Stock any time on or after November 15, 2025, provided that the closing price of the Company&#8217;s
common stock equals or exceeds 190% of the conversion price for 30 consecutive trading days and assuming certain other conditions
of the common stock have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders have the option to redeem all or a portion of the Series
A Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and May 15, 2022 through August
15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of Notes to the Buyers pursuant
to the Securities Purchase Agreement. Holders also have the option to redeem all or a portion of the Series A Redeemable Convertible
Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally, holders have the option to redeem
all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of (i) a change of control or (ii)
various other triggering events, such as the suspension from trading or delisting of the Company&#8217;s common stock. If the
Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price may include a make-whole
amount or a stated premium, depending on the redemption scenario.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may redeem all, and not less than all, of the Series
A Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May 15, 2022 through August
15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of the Notes, and assuming certain
conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred Stock is redeemed at the option
of the Company, the redemption price would include a make-whole amount or a 15% premium depending on the circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_23A_zCyV6B4TKISi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zHP8dopiTJm8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zUcoDMdrANdh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 25 -->
    <div id="xdx_23D_z9C3CTK6Quya" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23E_zvdpbGV1TdSh" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td id="xdx_232_zhzj6CfRxxR5" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_238_z5C6u29l7FIh" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_231_zfxAn5F9HT79" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zCfNOlzIk3Ml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any Series A Redeemable Convertible Preferred Stock remains
outstanding on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In all redemption scenarios, the redemption price for the Series
A Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In addition, depending on
the redemption scenario, the redemption price may also include a make-whole amount or stated premium as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Company issues Notes, the Holder may exchange the Series
A Redeemable Convertible Preferred Stock for (i) Notes and (ii) Series B Warrants to purchase common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Redeemable Convertible Preferred Stock accrues
cumulative dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of an approved investment (an investment
to be identified and approved by each of the Company and Starboard), the dividend rate will increase to 8.0% on the stated value.
Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering event occurs before an approved investment
or 10.0% on the stated value if the triggering event occurs after an approved investment. The Series A Redeemable Convertible Preferred
Stock also participates on an as-converted basis in any regular or special dividends paid to common stockholders. There are <span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pn3n3_do_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zCmWnix7w69l" title="Accrued and unpaid dividends"><ix:nonFraction name="us-gaap:DividendsPayableCurrent" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">no</ix:nonFraction></span>
accrued and unpaid dividends as of September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of the Series A Redeemable Convertible Preferred Stock
have the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable Convertible
Preferred Stock will also be entitled to a separate class vote with respect to amendments to the Company&#8217;s organizational
documents that generally have an adverse effect on the Series A Redeemable Convertible Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon liquidation of the Company, holders of Series A Redeemable
Convertible Preferred Stock have a liquidation preference over holders of our common stock and will be entitled to receive, prior
to any distribution to holders of our common stock, an amount equal to the greater of (i) the stated value plus accrued and unpaid
dividends or (ii) the amount that would have been received if the Series A Redeemable Convertible Preferred Stock had been converted
into common stock immediately prior to the liquidation event at the then effective conversion price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determined that certain features of the Series A
Redeemable Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features are bundled
together as a single, compound embedded derivative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total proceeds received and transaction costs incurred from
the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $35 million and $1.2 million, respectively. Proceeds
received were allocated based on the fair value of the instrument without the Series A Warrants and of the Series A Warrants themselves
at the time of issuance. The proceeds allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated
between the host preferred stock instrument and the embedded derivative, with the embedded derivative recorded at fair value and
the Series A Redeemable Convertible Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the
Series A Warrants, embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and
$8.9 million, respectively. Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock and
the Series A Warrants on the same basis as the proceeds. The transaction costs allocated to the Series A Redeemable Convertible
Preferred Stock were treated as a discount to the Series A Redeemable Convertible Preferred Stock. The transaction costs allocated
to the Series A Warrants were expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company classifies the Series A Redeemable Convertible Preferred
Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various scenarios or otherwise
on November 15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become redeemable, the Company
accretes the instrument to its redemption value using the effective interest method and recognizes any changes against additional
paid in capital in the absence of retained earnings. Accretion was $<span id="xdx_907_eus-gaap--AccretionExpense_pn3n3_dm_c20200701__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zBeYQReQQE7g" title="Accretion"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">0.7</ix:nonFraction></span> million and $<span id="xdx_901_eus-gaap--AccretionExpense_pn3n3_dm_c20200101__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zbFObga2BzHg" title="Accretion"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">2.0</ix:nonFraction></span> million, respectively, for the three and
nine months ended September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the issuance of the Series A Redeemable Convertible
Preferred Stock, the Company executed a Registration Rights Agreement with Starboard and the Buyers, and a Governance Agreement
with Starboard and certain affiliates of Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain
registration rights with respect to the Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon
conversion. In accordance with the Governance Agreement, the Company agreed to (i) increase the size of the Board of Directors
from six to seven members, (ii) appoint a director of the Company, (iii) grant Starboard and its affiliates the right to recommend
two additional directors for appointment to the board, (iv) form a Strategic Committee of the Board tasked with sourcing and performing
due diligence on potential acquisition targets, (v) appoint certain directors to the Strategic Committee, and (vi) appoint a director
to the Nominating and Corporate Governance Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_236_zg4pm8fqYxn2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zYl1Orf3EAVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_z6iw1DYDmXg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 26 -->
    <div id="xdx_239_zuRpDZR8eEA7" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_234_z94mPlEnOkC7" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td id="xdx_238_zCknzBU25Mvg" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23F_zZkJhuOwMhka" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23F_zbLPwiEl5xj7" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zoD4bUgsJUOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following features of the Series A Redeemable Convertible
Preferred Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded derivative:
(i) the right of the holders to redeem the shares (put option), (ii) the right of the holders to receive common stock upon conversion
of the shares (conversion option), (iii) the right of the Company to redeem the shares (call option), and (iv) the change in dividend
rate upon consummation of an approved investment or a triggering event (contingent dividend rate feature).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These features are required to be accounted for separately from
the Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly and closely related
to the debt-like host and also did not meet any other scope exceptions for derivative accounting. Therefore, these features are
bundled together and are accounted for as a single, compound embedded derivative liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, we have recorded an embedded derivative liability
representing the combined fair value of each of these features. The embedded derivative liability is adjusted to reflect fair value
at each period end with changes in fair value recorded in the &#8220;Change in fair value of redeemable preferred stock embedded
derivative&#8221; financial statement line item of the accompanying condensed consolidated statements of operations. As of September
30, 2020, the fair value of the Series A embedded derivative was $<span id="xdx_90E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_z9fbr93dIQSe" title="Fair value of Series A embedded derivative"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">25.7</ix:nonFraction></span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="ACTG:WarrantDisclosureTextBlock"><p id="xdx_80A_ecustom--WarrantDisclosureTextBlock_z7M7a9RY9U78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>11. <span>SERIES A WARRANTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 18, 2019, in connection with the issuance of the
Series A Redeemable Convertible Preferred Stock, the Company issued detachable Series A Warrants to acquire up to <span id="xdx_907_ecustom--WarrantsIssuedShares_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Warrants issued, shares"><ix:nonFraction name="ACTG:WarrantsIssuedShares" contextRef="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,000</ix:nonFraction></span> shares
of common stock at a price of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pip0_c20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zQz4wZWxGudk" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">3.65</ix:nonFraction></span> per share (subject to certain antidilution adjustments) at any time during a period of eight
years beginning on the instrument&#8217;s issuance date of the Series A Warrants. As of September 30, 2020, the Series A Warrants
have <span id="xdx_907_ecustom--WarrantsExercised_pii_do_c20200101__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zDICLBPCqs11" title="Warrants exercised"><ix:nonFraction name="ACTG:WarrantsExercised" contextRef="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span>t been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Warrants will be recognized at fair value at each
reporting period until exercised, with changes in fair value recognized in the condensed consolidated statements of operations
in other income (expense) in the accompanying condensed consolidated statements of operations. As of December 31, 2019, the fair
value of the Series A Warrants was $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20191231__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zhOInMhEl6ta" title="Fair value of warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">3.6</ix:nonFraction></span> million. As of September 30, 2020, the fair value of the Series A Warrants was $<span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zCeChSpd2WKl" title="Fair value of warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">5.6</ix:nonFraction></span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Warrants are classified as a liability in accordance
with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="ACTG:SeriesBWarrantsTextBlock"><p id="xdx_809_ecustom--SeriesBWarrantsTextBlock_zfFravHjlkIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>12. <span>SERIES B WARRANTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 25, 2020, pursuant to the terms of the Securities
Purchase Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to <span id="xdx_905_ecustom--WarrantsIssuedShares_pn3n3_dm_c20200101__20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zNJfwcB6Mzr1" title="Warrants issued, shares"><ix:nonFraction name="ACTG:WarrantsIssuedShares" contextRef="From2020-01-012020-02-25_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="Shares">100</ix:nonFraction></span> million shares of
the Company&#8217;s common stock at an exercise price (subject to certain price-based anti-dilution adjustments) of either (i)
$<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pii" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2020-02-25_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.25</ix:nonFraction></span> per share, if exercising by cash payment, within 30 months from the issuance date (i.e., August 25, 2022); or (ii) $3.65
per share, if exercising by cancellation of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase
price of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfWarrants_pn3n3_dm_c20200101__20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_z5ltS97JhSA8" title="Proceeds from issuance of warrants"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2020-01-012020-02-25_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">4.6</ix:nonFraction></span> million. The Series B Warrants expire on <span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zuujuKqSF0lb" title="Warrant expiration date"><ix:nonNumeric contextRef="AsOf2020-02-25_custom_SeriesBWarrantsMember" format="ixt:datemonthdayyearen" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">November 15, 2027</ix:nonNumeric></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the issuance of the Notes on June 4, 2020,
the terms of certain of the Series B Warrants were amended to permit the payment of the lower exercise price of $3.65 through the
payment of cash, rather than only through the cancellation of Notes outstanding, at any time until the expiration date of November
15, 2027. Only <span title="Warrants Description">31,506,849 of the Series B Warrants are subject to this adjustment with the remaining balance of 68,493,151 Series
B Warrants continuing under their original terms.</span> Refer to Note 13 for additional information on the modifications to Series A
Redeemable Convertible Preferred Stock and Series B Warrants. As of September 30, 2020, the Series B Warrants have <span id="xdx_90D_ecustom--WarrantsExercisedShares_pip0_do_c20200101__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zm6D0c8BbMfl" title="Warrants exercised"><ix:nonFraction name="ACTG:WarrantsExercisedShares" contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132394531" format="ixt-sec:numwordsen" decimals="INF" scale="0" unitRef="Shares">no</ix:nonFraction></span>t been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series B Warrants will be recognized at fair value at each
reporting period until exercised, with changes in fair value recognized in the condensed consolidated statements of operations
in other income (expense). As of September 30, 2020, the fair value of the Series B Warrants was $<span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zxyU4PExGay2" title="Fair value of warrants"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2020-09-30_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">42.8</ix:nonFraction></span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series B Warrants are classified as a liability in accordance
with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:exclude><p id="xdx_230_zFclzDx1P0Wc" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zMyymabRLu07" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zDh0wCiphAah" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 27 -->
    <div id="xdx_239_ztoyLh1VCqIe" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zHSm42oq10p2" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td id="xdx_23D_zGCqM5lrQta8" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zlwOZIMc6kh" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_232_zn32NOHZLHGc" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zbyLhr4Avm6i" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zt9L64DPotwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>13. <span>SENIOR SECURED NOTES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Securities Purchase
Agreement dated November 18, 2019 with Starboard and the Buyers, on June 4, 2020, the Company issued $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zLqTn44DJEt" title="Proceeds from issuance of debt"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">115</ix:nonFraction></span>
million in Notes to the Buyers. Also on June 4, 2020, in connection with the issuance of the Notes, the Company entered into
a Supplemental Agreement with Starboard (the &#8220;Supplemental Agreement&#8221;), pursuant to which the Company agreed to
redeem $<span id="xdx_90E_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zXZ4fIqPgVR6" title="Repayment of debt"><ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">80</ix:nonFraction></span>
million aggregate principal amount of the Notes by September 30, 2020, and $<span id="xdx_901_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20201231__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zraSBrsG9ES2" title="Repayment of debt"><ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2020-01-012020-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">35</ix:nonFraction></span>
million aggregate principal amount of the Notes by December 31, 2020, resulting in the total principal outstanding being paid
by December 31, 2020. Per the Supplemental Agreement, interest is payable semiannually at a rate of 6.00% per annum, and in
an event of default, the interest rate is increased to <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zNkvbb2FTykc" title="Interest Rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>%
per annum. The Notes include certain financial and non-financial covenants. Additionally, all or any portion of the principal
amount outstanding under the Notes may, at the election of Starboard, be surrendered to the Company for cancellation in
payment of the exercise price upon the exercise of Series B Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2020, the Company entered into an Exchange Agreement
(the &#8220;Exchange Agreement&#8221;) with Merton Acquisition HoldCo LLC, a Delaware limited liability company and wholly-owned
subsidiary of the Company (&#8220;Merton&#8221;) and Starboard, on behalf of itself and on behalf of certain funds and accounts
under its management, including the holders of the Notes. Pursuant to the Exchange Agreement, the holders of the Notes exchanged
the entire outstanding principal amount for new senior notes (the &#8220;New Notes&#8221;) issued by Merton having an aggregate
outstanding original principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zTG70nH9bU0h" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">115</ix:nonFraction></span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The New Notes bear interest at a rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pii_dp_c20200101__20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zgOtyG1Z2rbj" title="Interest Rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2020-01-012020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.00</ix:nonFraction></span>% per annum and
will mature on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20200101__20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_z8vXz1EFOHyg" title="Maturity Date"><ix:nonNumeric contextRef="From2020-01-012020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">December 31, 2020</ix:nonNumeric></span>. The New Notes are fully guaranteed by the Company and are secured by an all-assets pledge of
the Company and Merton and non-recourse equity pledges of each of the Company&#8217;s material subsidiaries. Pursuant to the Exchange
Agreement, the New Notes (i) are deemed to be &#8220;Notes&#8221; for purposes of the Securities Purchase Agreement, (ii) are deemed
to be &#8220;June 2020 Approved Investment Notes&#8221; for purposes of the Supplemental Agreement, and therefore the Company has
agreed to redeem $<span id="xdx_908_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zNVaVS80kWe2" title="Repayment of debt"><ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">80</ix:nonFraction></span> million principal amount of the New Notes by September 30, 2020 (the &#8220;Initial Redemption Date&#8221;)
and $<span id="xdx_909_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotes1Member_z17L7mjnhE3i" title="Repayment of debt"><ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotes1Member" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">35</ix:nonFraction></span> million principal amount of the New Notes by December 31, 2020 (the &#8220;Final Redemption Date&#8221;), and (iii) are
deemed to be &#8220;Notes&#8221; for the purposes of the Series B Warrants, and therefore may be tendered pursuant to a Note Cancellation
under the Series B Warrants on the terms set forth in the Series B Warrants and the New Notes. Delivery of notes in the form of
the New Notes will satisfy the delivery of Exchange Notes pursuant to Section 16(i) of the Certificate of Designations of the Company&#8217;s
Series A Convertible Preferred Stock, par value $<span id="xdx_907_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_pii" title="Series A redeemable convertible preferred stock, par value"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share. The New Notes will not be deemed to be &#8220;Notes&#8221; for
the purposes of the Registration Rights Agreement, dated as of November 18, 2019, by and among the Company, Starboard and the Buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the New Notes will be settled within twelve months pursuant
to their terms, they are classified as current liabilities on the balance sheet. The Company capitalized $<span title="Payment of lender fees"><span id="xdx_909_eus-gaap--PaymentsOfFinancingCosts_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zkDuDsO3Y1ii" title="Payment of lenders fees"><ix:nonFraction name="us-gaap:PaymentsOfFinancingCosts" contextRef="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">4.6</ix:nonFraction></span></span> million in lender
fees and $<span title="Other issuance costs"><span id="xdx_903_eus-gaap--PaymentsOfDebtIssuanceCosts_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zrYUF2SWw826" title="Payment of other issuance costs"><ix:nonFraction name="us-gaap:PaymentsOfDebtIssuanceCosts" contextRef="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">0.5</ix:nonFraction></span></span> million in other issuance costs associated with the issuance of the Notes. The $4.6 million of lender fees are recognized
as long term deferred debt issuance cost and will be amortized to interest expense until November 15, 2027, the maturity date of
Series A Redeemable Convertible Preferred Stock. The $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zQuEXFGhLPVf" title="Discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million issuance costs are recognized as a discount on the Notes and
will be amortized to interest expense over the contractual life of the Notes. There is $<span title="Accrued and unpaid dividends"><span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zitnjNQ1RJ0e" title="Accrued and unpaid dividends"><ix:nonFraction name="us-gaap:DividendsPayableCurrent" contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesARedeemableConvertibleStockMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.7</ix:nonFraction></span></span> million accrued and unpaid interest on
the New Note as of September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Initial Redemption Date was subsequently extended by the
parties to November 9, 2020 and the Final Redemption Date was extended to January 15, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Modifications to Series A Redeemable Convertible Preferred
Stock and Series B Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The June 4, 2020 Supplemental Agreement also provided for (i)
a waiver of increased dividends under the original terms of the Series A Preferred Stock that would have otherwise accrued due
to the Company&#8217;s use of the $35 million proceeds received from Starboard and the Buyers upon the issuance of the Series A
Redeemable Convertible Preferred Stock in November 2019, (ii) the replacement of original optional redemption rights for the Series
A Redeemable Convertible Preferred Stock provided to both the Company and the holders that otherwise would have been nullified
through the issuance of the Notes, and (iii) an amendment to the terms of the previously issued Series B Warrants to permit the
payment of the lower exercise price of $3.65 through the payment of cash, rather than only through the cancellation of Notes outstanding,
at any time until the expiration of the Series B Warrants on November 15, 2027. Only <span title="Warrants Description">31,506,849 of the Series B Warrants are subject
to this adjustment with the remaining balance of 68,493,151 Series B Warrants continuing under their original terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We analyzed the amendments to the Series A Redeemable Convertible
Preferred Stock and determined that the amendments were not significant. Therefore, the amendments are accounted for as a modification
on a prospective basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_23B_zAxDWvvVMnK4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_z0qFLeZ2EBXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zYZbIhfxLDm4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 28 -->
    <div id="xdx_234_zoDYy4jyDtQ3" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23F_zp9VRiCHz0A5" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td id="xdx_23B_zVuh8AJJdHVl" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zBSyq4FgFT41" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_z0A99EFYeCc6" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zBZUv4yey7za" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The incremental fair value of the Series B Warrants associated
with their modification in connection with the issuance of the Notes is $<span id="xdx_90F_ecustom--OriginalIssueDiscount_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_ztkOTNvawrmk" title="Original Issue Discount"><ix:nonFraction name="ACTG:OriginalIssueDiscount" contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">1.3</ix:nonFraction></span> million and is recognized as a discount on the Notes
and will be amortized to interest expense over the contractual life of the Notes. For the three and nine months ended September
30, 2020, respectively, $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pn3p0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zREdr43vSJj9" title="Interest expense"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember132395046" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">532,000</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_pn3p0_c20200101__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_znRWuywov9Y4" title="Unamortized Discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132394531" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">697,000</ix:nonFraction></span> were amortized to interest expense. As of September 30, 2020, $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3p0_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zxjTHtVpuD3" title="Remaining discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember" format="ixt:numdotdecimal" decimals="-3" scale="0" unitRef="USD">632,000</ix:nonFraction></span> is remaining
to be amortized until the Final Redemption Date of January 15, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"><p id="xdx_801_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zCvvVUrnhmR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>14. <span>LF EQUITY INCOME FUND PORTFOLIO INVESTMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 3, 2020, the Company entered into
an Option Agreement with Seller, which included general terms through which the Company was provided the option to purchase life
sciences equity securities in a portfolio of public and private companies (&#8220;Portfolio Companies&#8221;) for an aggregate
purchase price of &#163;<span id="xdx_90E_eus-gaap--PaymentsToAcquireAvailableForSaleSecuritiesEquity_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_z3KWMMZn94fh" title="Payment to acquire equity securities"><ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity" contextRef="From2020-01-012020-06-04_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">223.9</ix:nonFraction></span> million, approximately $<span id="xdx_906_eus-gaap--PaymentsToAcquireAvailableForSaleSecuritiesEquity_pn3n3_dm_c20200101__20200403__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zo3AQdix0F9e" title="Payment to acquire equity securities"><ix:nonFraction name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity" contextRef="From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">277.5</ix:nonFraction></span> million at the exchange rate on April 3, 2020. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 4, 2020, the Company executed the
Transaction Agreement between Link Fund Solutions Limited, Seller, and the Company. Pursuant to the Transaction Agreement, the
Company will purchase from Seller and Seller will transfer to the Company the specified equity securities of all Portfolio Companies
at set prices at various future dates. The transfer dates will vary among the Portfolio Companies as the Transaction Agreement
gives the Company the exclusive right to determine when to call for transfer of each security, and because each Portfolio Company
(or its existing equity holders) may be required to approve the transfer due to rights of first refusals and other company-specific
terms and conditions. Thus, the execution of the Transaction Agreement resulted in forward contracts for the Company to purchase
equity securities in each public and private company at a specified price on a future date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the Transaction Agreement,
the Company transferred the total purchase price of &#163;223.9 million into an escrow account. As each of the equity securities
in the Portfolio are transferred to the Company, the associated funds will be released from the escrow account to Seller based
on the consideration amount assigned to the equity securities in the Transaction Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For accounting purposes, the total purchase price of the portfolio
was allocated to the individual equity securities based on their individual fair values as of April 3, 2020, in order to establish
an appropriate cost basis for each of the acquired securities. The fair values of the public company securities were based on their
quoted market price. The fair values of the private company securities were estimated based on recent financing transactions and
secondary market transactions and factoring in a discount for the illiquidity of these securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended September 30, 2020, Seller returned
a total of &#163;<span id="xdx_901_ecustom--ReturnOnPrepayment_pn3n3_dm_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_zAcUmHfRUNa" title="Return on prepayment"><ix:nonFraction name="ACTG:ReturnOnPrepayment" contextRef="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">4.5</ix:nonFraction></span> million of the Company&#8217;s prepaid investment upon the failure to obtain the approval of the existing
equity holders, pursuant to their rights of first refusals, of one of the Portfolio Companies in connection with the transfer of
its securities. In addition, due to an ownership restriction applicable to one of the Portfolio Companies, the Company sold a small
portion of an equity securities derivative for &#163;<span id="xdx_90B_eus-gaap--ProceedsFromSaleOfAvailableForSaleSecurities_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_pn3n3" title="Proceeds from sale of securities"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" contextRef="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,000</ix:nonFraction></span> before the remaining shares of such Portfolio Company could be transferred
to us. The Company recognized a net gain of $<span id="xdx_90A_eus-gaap--EquitySecuritiesFvNiRealizedGain_pn3n3_dm_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zvCe6bFIjlU6" title="Gain on sale of deriviative"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiRealizedGain" contextRef="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">2.8</ix:nonFraction></span> million related to the returned prepaid investments and sale of the derivative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in the fair value of Acacia&#8217;s investment in the
Portfolio Companies are recorded as unrealized gains or losses in the condensed consolidated statements of operations. For the
three and nine months ended September 30, 2020 and 2019, the accompanying condensed consolidated statements of operations reflected
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zepeP87rkN5k" summary="xdx: Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8BB_z58Oa7OcEZ0h" style="display: none">Changes in fair value of Acacias Investment</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49E_20200701__20200930_zW5j2zNiwn7h" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_494_20190701__20190930_zpiKyYHn3643" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_492_20200101__20200930_zva1bbiqQYVb" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_490_20190101__20190930_zDiQvy1w7Zfj" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Change in fair value of trading securities - LF Fund public securities</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" title="Change in fair value of investment" style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,403</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zUZgIMo2uB87" title="Change in fair value of investment" style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-07-012019-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" title="Change in fair value of investment" style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,334</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zm7I5B0PCRD7" title="Change in fair value of investment" style="width: 9%; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-01-012019-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zwBJ36vuQ0M2" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesDerivativeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,651</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zrDGADWnIJeh" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-07-012019-09-30_custom_EquitySecuritiesDerivativeMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zsFUZu7k857e" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesDerivativeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,542</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_z1133gWw9bO6" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-01-012019-09-30_custom_EquitySecuritiesDerivativeMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities - LF Fund private securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zVSFO2lNfWf2" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">80,896</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z7ysG3TB4F44" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-07-012019-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z3sk4jBRpnHk" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">80,896</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zo8j4ONbD2Zg" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-01-012019-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities forward contract</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zmmP3IofhU67" title="Change in fair value of investment" style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesForwardContractMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">74,662</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zVoFbxdBxw2l" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-07-012019-09-30_custom_EquitySecuritiesForwardContractMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zruyd7HkfZBi" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesForwardContractMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_ziG4zeheCtwk" title="Change in fair value of investment" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2019-01-012019-09-30_custom_EquitySecuritiesForwardContractMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Gain (loss) on sale of trading securities - LF Fund public securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zoJ5KTT9TL6a" title="Gain (loss) on sale of trading securities" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfEquityInvestments" contextRef="From2020-07-012020-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,908</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zcfv5FvxsDv" title="Gain (loss) on sale of trading securities" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfEquityInvestments" contextRef="From2019-07-012019-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zDZyrmDggnc6" title="Gain (loss) on sale of trading securities" style="font-size: 10pt; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnSaleOfEquityInvestments" contextRef="From2020-01-012020-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,202</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zCcWCXm6WxE3" title="Gain (loss) on sale of trading securities" style="font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfEquityInvestments" contextRef="From2019-01-012019-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--GainLossOnSaleOfDerivatives_pn3n3_d0_zReEvh8i047l" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Gain on sale of prepaid investment and derivative</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2020-07-012020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2019-07-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2020-01-01to2020-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,845</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnSaleOfDerivatives" contextRef="From2019-01-012019-09-30" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net realized and unrealized gain on investment in LF Fund securities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2020-07-012020-09-30_custom_TradingSecuritesLfFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,041</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zQD40jp4UGU2" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2019-07-012019-09-30_custom_TradingSecuritesLfFundSecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2020-01-012020-09-30_custom_TradingSecuritesLfFundSecuritiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99,415</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zJzaJkH3xEY2" title="Net realized and unrealized gain (loss) on investment" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="From2019-01-012019-09-30_custom_TradingSecuritesLfFundSecuritiesMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2020-01-01to2020-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zNn9TTHdhJok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>15. <span>SUBSEQUENT EVENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

</ix:nonNumeric><p id="xdx_81E_zuEOILM0RxVj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a8"></span><b>Item 2. Management&#8217;s Discussion and Analysis of Financial
Condition and Results of Operation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>The following discussion and analysis of our financial
condition and results of operations should be read together with our unaudited condensed consolidated financial statements
and the related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q for the three months ended September
30, 2020, or this Report. This discussion and analysis contains forward-looking statements that are based on our current
expectations and reflect our plans, estimates and anticipated future financial performance. See the section of this Report
entitled &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; for additional information. These statements
involve numerous risks and uncertainties. Our actual results may differ materially from those expressed or implied by these
forward-looking statements as a result of many factors, including those set forth in &#8220;Risk Factors&#8221; in Part II,
Item 1A of this Report.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As used in this Quarterly Report on Form 10-Q, &#8220;we&#8221;
&#8220;us&#8221; &#8220;our&#8221; and &#8220;Company&#8221; refer to Acacia Research Corporation, a Delaware corporation, and/or
its wholly and majority-owned and controlled operating subsidiaries, and/or where applicable, its management. All IP acquisition,
development, licensing and enforcement activities are conducted solely by certain of Acacia Research Corporation&#8217;s wholly
and majority-owned and controlled operating subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We invest in IP and related absolute return assets and engage
in the licensing and enforcement of patented technologies. We partner with inventors and patent owners, applying our legal and
technology expertise to patent assets to unlock the financial value in their patented inventions. We generate revenues and related
cash flows from the granting of patent rights for the use of patented technologies that our operating subsidiaries control or own.
We assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions
from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with
the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation.
We are principals in the licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control
of the patent portfolio outright.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have a proven track record of licensing and enforcement success
with over 1,580 license agreements executed to date, across nearly 200 patent portfolio licensing and enforcement programs. Currently,
on a consolidated basis, our operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S.
patents and certain foreign counterparts, covering technologies used in a variety of industries. To date, we have generated gross
licensing revenue of approximately $1.6 billion, and have returned more than $796 million to our patent partners.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our team&#8217;s expertise in identifying and evaluating complex
IP, and in developing and cultivating long-term business relationships, provides us a unique window into innovation and technological
advancement. We are increasing our efforts to leverage our expertise and experience to create new avenues and monetize our existing
IP assets, which we believe will lead to increased stockholder value. We intend to leverage our experience, expertise, data and
relationships developed as a leader in the IP industry to pursue these opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Summary</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Overview</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our operating activities during the periods presented were focused
on the continued operation of our patent licensing and enforcement business, including the continued pursuit of our ongoing patent
licensing and enforcement programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Patent Licensing and Enforcement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><i>Patent Litigation Trial Dates and Related Trials</i></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of the date of this report, our operating subsidiaries have
one pending patent infringement case with a scheduled trial date in the next twelve months. Patent infringement trials are components
of our overall patent licensing process and are one of many factors that contribute to possible future revenue generating opportunities
for us. Scheduled trial dates, as promulgated by the respective court, merely provide an indication of when, in future periods,
the trials may occur according to the court&#8217;s scheduling calendar at a specific point in time. A court may change previously
scheduled trial dates. In fact, courts often reschedule trial dates for various reasons that are unrelated to the underlying patent
assets and typically for reasons that are beyond our control. While scheduled trial dates provide an indication of the timing of
possible future revenue generating opportunities for us, the trials themselves and the immediately preceding periods represent
the possible future revenue generating opportunities. These future opportunities can result in varying outcomes. In fact, it is
difficult to predict the outcome of patent enforcement litigation at the trial level and outcomes can be unfavorable. It can be
difficult to understand complex patented technologies, and as a result, this may lead to a higher rate of unfavorable litigation
outcomes. Moreover, in the event of a favorable outcome, there is, in our experience, a higher rate of successful appeals in patent
enforcement litigation than more standard business litigation. Such appeals are expensive and time consuming, resulting in increased
costs and a potential for delayed or foregone revenue opportunities in the event of modification or reversal of favorable outcomes.
Although we diligently pursue enforcement litigation, we cannot predict with reliability the decisions made by juries and trial
courts. Please refer to Item 1A. &#8220;Risk Factors&#8221; for additional information regarding trials, patent litigation and
related risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><i>Litigation and Licensing Expense</i></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We expect patent-related legal expenses to continue to fluctuate
from period to period based on the factors summarized herein, in connection with future trial dates, international enforcement,
strategic patent portfolio prosecution and our current and future patent portfolio investment, prosecution, licensing and enforcement
activities. The pursuit of enforcement actions in connection with our licensing and enforcement programs can involve certain risks
and uncertainties, including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Increases in patent-related legal expenses associated with patent infringement litigation, including, but not limited to, increases in costs billed by outside legal counsel for discovery, depositions, economic analyses, damages assessments, expert witnesses and other consultants, re-exam and inter partes review costs, case-related audio/video presentations and other litigation support and administrative costs, could increase our operating costs and decrease our profit generating opportunities;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Our patented technologies and enforcement actions are complex and, as a result, we may be required to appeal adverse decisions by trial courts in order to successfully enforce our patents. Moreover, such appeals may not be successful;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">New legislation, regulations or rules related to enforcement actions, including any fee or cost shifting provisions, could significantly increase our operating costs and decrease our profit generating opportunities. Increased focus on the growing number of patent-related lawsuits may result in legislative changes which increase our costs and related risks of asserting patent enforcement actions;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Courts may rule that our subsidiaries have violated certain statutory, regulatory, federal, local or governing rules or standards by pursuing such enforcement actions, which may expose us and our operating subsidiaries to material liabilities, which could harm our operating results and our financial position;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">The complexity of negotiations and potential magnitude of exposure for potential infringers associated with higher quality patent portfolios may lead to increased intervals of time between the filing of litigation and potential revenue events (i.e., markman dates, trial dates), which may lead to increased legal expenses, consistent with the higher revenue potential of such portfolios; and</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.25pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above could harm our operating results and our financial position.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Investments in Patent Portfolios</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With respect to our licensing, enforcement and overall business,
neither we nor our operating subsidiaries invent new technologies or products; rather, we depend upon the identification and investment
in patents, inventions and companies that own IP through our relationships with inventors, universities, research institutions,
technology companies and others. If our operating subsidiaries are unable to maintain those relationships and identify and grow
new relationships, then we may not be able to identify new technology-based patent opportunities for sustainable revenue and /or
revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our current or future relationships may not provide the volume
or quality of technologies necessary to sustain our licensing, enforcement and overall business. In some cases, universities and
other technology sources compete against us as they seek to develop and commercialize technologies. Universities may receive financing
for basic research in exchange for the exclusive right to commercialize resulting inventions. These and other strategies employed
by potential partners may reduce the number of technology sources and potential clients to whom we can market our solutions. If
we are unable to maintain current relationships and sources of technology or to secure new relationships and sources of technology,
such inability may have a material adverse effect on our revenues, operating results, financial condition and ability to maintain
our licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Patent Portfolio Intake </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">One of the significant challenges in our industry continues
to be quality patent intake due to the challenges and complexity associated with the current patent environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2020, we acquired
four new patent portfolios consisting of (i) flash memory technology, (ii) voice activation and control technology, (iii) wireless
networks, and (iv) internet search, advertising and cloud computing technology. The patents and patent rights acquired in 2020
have estimated economic useful lives of approximately five years. In fiscal year 2019, we acquired five patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Starboard Securities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2019, as part of its strategy to grow, the Company began
evaluating a wide range of strategic opportunities that culminated in the strategic investment in the Company by certain funds
and accounts, or the Buyers, affiliated with, or managed by, Starboard Value LP, or Starboard. On November 18, 2019, the Company
entered into a Securities Purchase Agreement with Starboard and the Buyers, or the Securities Purchase Agreement, pursuant to which
the Buyers purchased (i) 350,000 shares of the Company&#8217;s newly designated Series A Convertible Preferred Stock, or Series
A Preferred Stock, at an aggregate purchase price of $35,000,000, and warrants to purchase up to 5,000,000 shares of the Company&#8217;s
common stock, or Series A Warrants. The Securities Purchase Agreements also established the terms of certain senior secured notes,
or Notes, and additional warrants, or the Series B Warrants, which may be issued to the Buyers in the future. Refer to Notes 2,
10, 11 and 12 to the condensed consolidated financial statements elsewhere herein for more information related to the Series A
Preferred Stock, Series A Warrants and Series B Warrants. In connection with the Buyers&#8217; investment, Starboard was granted
certain corporate governance rights, including the right to appoint Jonathan Sagal, Managing Director of Starboard, as a director
of the Company and recommend two additional directors for appointment to our Board of Directors. The investment by the Buyers is
referred to herein as the &#8220;Starboard Investment,&#8221; and the Series A Preferred Stock, Series A Warrants and Series B
Warrants are referred to herein as, collectively, the &#8220;Starboard Securities.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 14, 2020, the Company&#8217;s stockholders approved,
for purposes of Nasdaq Rules 5635(b) and 5635(d), as applicable, (i) the voting of the Series A Preferred Stock on an as-converted
basis and (ii) the issuance of the maximum number of shares of common stock issuable in connection with the potential future (A)
conversion of the Series A Preferred Stock and (B) exercise of the Series A and Series B Warrants, in each case, without giving
effect to the exchange cap set forth in the Series A Preferred Stock Certificate of Designations and in the Series A Warrants,
issued pursuant to the Securities Purchase Agreement dated November 18, 2019. Refer to Notes 10 and 11 to the condensed consolidated
financial statements elsewhere herein for additional information. The Company&#8217;s stockholders also approved an amendment to
the Company&#8217;s Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common
stock by 200,000,000 shares, from 100,000,000 shares to 300,000,000 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 25, 2020, pursuant to the terms of the Securities
Purchase Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to 100 million shares of
the Company&#8217;s common stock at an exercise price of either (i) $5.25 per share, if exercising by cash payment, or (ii) $3.65
per share, if exercising by cancellation of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase
price of $4.6 million. Refer to Note 12 to the condensed consolidated financial statements elsewhere herein for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the terms of the Securities Purchase Agreement with
Starboard and the Buyers, on June 4, 2020, the Company issued $115 million in Notes to the Buyers. Also on June 4, 2020, in connection
with the issuance of the Notes, the Company entered into a Supplemental Agreement with Starboard, or the Supplemental Agreement,
through which, the Company agreed to redeem $80 million aggregate principal amount of the Notes by September 30, 2020, and $35
million aggregate principal amount of the Notes by December 31, 2020, resulting in the total principal outstanding being paid by
December 31, 2020. Per the Supplemental Agreement, interest is payable semiannually at a rate of 6.00% per annum, and in an event
of default, the interest rate is increased to 10% per annum. The Notes outlined certain financial and non-financial covenants.
Additionally, all or any portion of the principal amount outstanding under the Notes may, at the election of the holders, be surrendered
to the Company for cancellation in payment of the exercise price upon the exercise of the Series B Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 30, 2020, the Company entered into an Exchange Agreement,
or the Exchange Agreement, with Merton Acquisition HoldCo LLC, a Delaware limited liability company and wholly-owned subsidiary
of the Company, or Merton and Starboard, on behalf of itself and on behalf of the Buyers, including the holders of the Notes.
Pursuant to the Exchange Agreement, the holders of the Notes exchanged the entire outstanding principal amount for new senior
notes, or the Notes, issued by Merton having an aggregate outstanding original principal amount of $115 million. The New Notes
bear interest at a rate of 6.00% per annum and will mature December 31, 2020. The New Notes are fully guaranteed by the Company
and are secured by an all-assets pledge of the Company and Merton and non-recourse equity pledges of each of the Company&#8217;s
material subsidiaries. Pursuant to the Exchange Agreement, the New Notes (i) are deemed to be &#8220;Notes&#8221; for purposes
of the Securities Purchase Agreement, (ii) are deemed to be &#8220;June 2020 Approved Investment Notes&#8221; for purposes of
the Supplemental Agreement, and therefore the Company has agreed to redeem $80 million principal amount of the New Notes by September
30, 2020, or the Initial Redemption Date, and $35 million principal amount of the New Notes by December 31, 2020, or the Final
Redemption Date, and (iii) are deemed to be &#8220;Notes&#8221; for the purposes of the Series B Warrants, and therefore may be
tendered pursuant to a Note Cancellation under the Series B Warrants on the terms set forth in the Series B Warrants and the New
Notes. Delivery of notes in the form of the New Notes will satisfy the delivery of Exchange Notes pursuant to Section 16(i) of
the Certificate of Designations of the Company&#8217;s Series A Convertible Preferred Stock, par value $0.001 per share. The New
Notes will not be deemed to be &#8220;Notes&#8221; for the purposes of the Registration Rights Agreement, dated as of November
18, 2019, by and between the Company, Starboard and the Buyers. The Initial Redemption Date was subsequently extended by the parties
to November 9, 2020 and the Final Redemption Date was extended to January 15, 2021. Refer to Note 13 to the condensed consolidated
financial statements elsewhere herein for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>LF Equity Income Fund Portfolio Investment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 3, 2020, the Company entered into
an Option Agreement with LF Equity Income Fund, or Seller, to purchase equity securities in a portfolio of public and private companies,
or Portfolio Companies, for an aggregate purchase price of &#163;223.9 million, approximately $277.5 million at the exchange rate
on April 3, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 4, 2020, the Company executed the
Transaction Agreement between Link Fund Solutions Limited, or Link, Seller, and the Company. Pursuant to the Transaction Agreement,
the Company will purchase from Seller and Seller will transfer to the Company the specified equity securities of all Portfolio
Companies at set prices at various future dates. In accordance with the Transaction Agreement, the Company transferred the total
purchase price of &#163;223.9 million into an escrow account. As each of the equity securities in the Portfolio are transferred
to the Company, the associated funds will be released from the escrow account to Seller based on the consideration amount assigned
to the equity securities in the Transaction Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Transaction Agreement includes an initial consideration
amount for each of the equity securities as noted above, which represents the amount of cash that will be withdrawn from the escrow
account upon the transfer of each security to the Company. Refer to Note 14 to the condensed consolidated financial statements
elsewhere herein for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Operating Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our revenues historically have fluctuated quarterly, and can
vary significantly, based on a number of factors including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the dollar amount of agreements executed each period, which can be driven by the nature and characteristics of the technology or technologies being licensed and the magnitude of infringement associated with a specific licensee;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the specific terms and conditions of agreements executed each period including the nature and characteristics of rights granted, and the periods of infringement or term of use contemplated by the respective payments; </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">fluctuations in the total number of agreements executed each period;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the number of, timing, results and uncertainties associated with patent licensing negotiations, mediations, patent infringement actions, trial dates and other enforcement proceedings relating to our patent licensing and enforcement programs;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the relative maturity of licensing programs during the applicable periods; &#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">other external factors, including the periodic status or results of ongoing negotiations, the status or results of ongoing litigations and appeals, actual or perceived shifts in the regulatory environment, impact of unrelated patent related judicial proceedings and other macroeconomic factors;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">the willingness of prospective licensees to settle significant patent infringement cases and pay reasonable license fees for the use of our patented technology, as such infringement cases approached a court determined trial date; and</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">fluctuations in overall patent portfolio related enforcement activities which are impacted by the portfolio intake challenges discussed above.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our management does not attempt to manage for smooth sequential
periodic growth in revenues from period to period, and therefore, periodic results can be uneven. Unlike most operating businesses
and industries, licensing revenues not generated in a current period are not necessarily foregone but, depending on whether negotiations,
litigation or both continue into subsequent periods, and depending on a number of other factors, such potential revenues may be
pushed into subsequent fiscal periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues for the nine months ended September 30, 2020 and 2019
included fees from the following technology licensing and enforcement programs:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: middle; background-color: rgb(238,238,238)">
    <td style="width: 1%">&#8226;</td>
    <td style="width: 45%">Bone Wedge technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)(2)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#8226;</td>
    <td style="width: 52%">Semiconductor and Memory-Related technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: middle">&#8226;</td>
    <td style="vertical-align: middle">Internet search, advertising and cloud computing technology <span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: middle">&#8226;</td>
    <td style="vertical-align: middle">Speech codecs used in wireless and wireline systems technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)(2)</sup></span></td></tr>
<tr style="vertical-align: middle; background-color: rgb(238,238,238)">
    <td>&#8226;</td>
    <td>Internet radio ad placement<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td>&#8226;</td>
    <td>Super Resolutions Microscopy technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)(2)</sup></span></td></tr>
<tr style="vertical-align: middle; background-color: White">
    <td>&#8226;</td>
    <td>MIPI DSI technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td>&#8226;</td>
    <td>Video Conferencing technology<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)(2)</sup></span></td></tr>
<tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: middle">__________________________</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr style="background-color: White">
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="4" style="vertical-align: middle"><sup>(1)</sup> <span style="font: normal 400 10pt Times New Roman, Times, Serif">Licensing and enforcement program generating revenue during the nine months ended September 30, 2020.</span></td></tr>
<tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="4" style="vertical-align: middle"><sup>(2)</sup> <span style="font: normal 400 10pt Times New Roman, Times, Serif">Licensing and enforcement program generating revenue during the nine months ended September 30, 2019.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Summary of Consolidated Results of Operations - Overview</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>For the Three months Ended September 30, 2020 and 2019</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-align: center; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-align: center; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-align: center; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%
    Change</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage
    change values)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-left: 5pt; width: 20%; text-indent: -5pt"><span style="font-size: 8pt">Revenues</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">19,466</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,711</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">17,755</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,038%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">25,399</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">10,558</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">14,841</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">141%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Operating costs
    and expenses</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">22,248</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,816</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">15,432</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">226%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">38,498</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">26,542</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">11,956</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">45%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Operating loss</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(2,782</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(5,105</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,323</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(46%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(13,099</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(15,984</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,885</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(18%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Other income (expense), net</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">41,213</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(2,503</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">43,716</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,747%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">45,047</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(1,456</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">46,503</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,194%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Income (loss) before provision for income taxes</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">38,431</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(7,608</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">46,039</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">605%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">31,948</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(17,440</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">49,388</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">283%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font: normal 400 10pt Times New Roman, Times, Serif; padding-left: 5pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Provision for
    income taxes</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(83</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(83</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">n/a</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,257</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(323</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,580</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(489%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Net income (loss) attributable to Acacia Research
    Corporation</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">38,348</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(7,608</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">45,956</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">604%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">33,205</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(17,749</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">50,954</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">287%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i></i></b></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Results of Operations - Three months ended September 30,
2020 compared with the three months ended September 30, 2019</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues increased $17.8 million to $19.5 million for the three
months ended September 30, 2020, as compared to $1.7 million in the comparable prior year quarter, primarily due to an increase
in revenues from the new agreements executed during the quarter. Refer to &#8220;<i>Investments in Patent Portfolios&#8221; </i>above
for additional information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement
related revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income before provision for income taxes was $38.4 million for
the three months ended September 30, 2020, as compared to a loss of $7.6 million for the three months ended September 30, 2019.
The net change was comprised of the change in revenues described above and other changes in operating expenses and other income
and expenses as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Paid-up revenue
increased $18.2 million due to increase in revenue from newly executed licensing agreements during the quarter, offset by decrease
of $0.4 million in recurring revenue that provides for quarterly sales-based license fees. Refer to Note 2 to the condensed consolidated
financial statements elsewhere herein for additional information regarding certain sales-based revenue contracts that provide
for the payment of quarterly license fees based on quarterly sales of applicable product units by licensees.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span><span style="font-family: Times New Roman, Times, Serif">Inventor
royalties and contingent legal fees, on a combined basis, increased $11.6 million, from $0.8 million to $12.4 million, primarily
due to increase in revenues as describe above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Litigation
and licensing expenses - patents increased $14,000, from $1,001,000 to $987,000, primarily due to a net increase in litigation
support and third-party technical consulting expenses associated with ongoing litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span><span style="font-family: Times New Roman, Times, Serif">Amortization
expense increased $0.3 million, from $0.9 million to $1.2 million, due to an increase in scheduled amortization resulting from
the new portfolios acquired in 2019 and 2020.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span><span style="font-family: Times New Roman, Times, Serif">Other
portfolio income decreased $0.5 million, due to reversal of expenses for settlement and contingency accruals recorded in the comparable
prior year quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>General and
administrative expenses, excluding non-cash stock compensation, increased $2.9 million, from $4.3 million to $7.2 million, primarily
due to higher corporate, general and administrative costs related to legal and other business development expenses, <span>including
$1.6 million in legal and advisory fees related to our LF Equity Income Fund Portfolio Investment</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Net non-cash
stock compensation expense increased $0.2 million, from $0.3 million to $0.5 million, primarily due to stock grants issued to
employees and the Board of Directors in 2019 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183;</span> Unrealized
loss on our equity investment in Veritone, Inc., or Veritone, decreased from an unrealized loss of $4.3 million for the three months
ended September 30, 2019 to an unrealized loss of $3.1 million for the three months ended September 30, 2020. There was no realized
gain or loss on our equity investment in Veritone for the three months ended September 30, 2020, as compared to a realized loss
of $0.9 million for the three months ended September 30, 2019. Refer to Note 5 to the condensed consolidated financial statements
elsewhere herein for additional information regarding our investment in Veritone.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Unrealized
gain or loss from trading securities and other equity securities increased from an unrealized loss of $0.5 million for the three
months ended September 30, 2019 to an unrealized gain of $20.5 million for the three months ended September 30, 2020. Refer to
Notes 2 and 14 to the condensed consolidated financial statements elsewhere herein for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Realized
gain from sale of our trading securities increased from a gain of $0.2 million for the three months ended September 30, 2019 to
a gain of $2.7 million for the three months ended September 30, 2020. We also recognized a net gain of $2.8 million related to
returned prepaid investments and the sale of an equity security derivative. Refer to Notes 2 and 14 to the condensed consolidated
financial statements elsewhere herein for additional information regarding our investment in trading securities and <span>LF
Equity Income Fund Portfolio Investment</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Interest income
and other decreased $1.0 million from a net income of $1.0 million for the three months ended September 30, 2019 to a net income
of $10,000 for the three months ended September 30, 2020, mainly due to decrease in interest income from our investment in trading
securities. Refer to Note 2 to the condensed consolidated financial statements elsewhere herein for additional information regarding
our investment in trading securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>We incurred
interest expense of $2.4 million during the quarter from the Notes issued in June 2020. Refer to Note 13 to the condensed consolidated
financial statements elsewhere herein for additional information regarding the Notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Loss on foreign
currency exchange decreased $58,000 from a loss of $106,000 for the three months ended September 30, 2019 to a loss of $48,000
for the three months ended September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>We incurred
an unrealized net gain of $20.7 million from the fair value measurements of the Series A and Series B warrants and the embedded
derivative for the three months ended September 30, 2020. Refer to Notes 10, 11 and 12 to the condensed consolidated financial
statements elsewhere herein for additional information regarding the Starboard Securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Results of Operations - Nine months ended September 30,
2020 compared with the nine months ended September 30, 2019</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues increased $14.8 million to $25.4 million for the nine
months ended September 30, 2020, as compared to $10.6 million in the comparable prior year period, primarily due to increase in
revenues from the new agreements executed during the current year period. Refer to &#8220;<i>Investments in Patent Portfolios&#8221;
</i>above for additional information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement
related revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income before provision for income taxes was $31.9 million for
the nine months ended September 30, 2020, as compared to a loss of $17.4 million for the nine months ended September 30, 2019.
The net change was comprised of the change in revenues described above and other changes in operating expenses and other income
and expenses as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Paid-up revenue
increased $18.4 million due to increase in newly executed licensing, offset by a decrease of $3.6 million in recurring revenue
due to a decrease in revenue provided by quarterly sales-based license fees agreements, during the nine months ended September
30, 2020 as compared to the nine months ended September 30, 2019. Refer to Note 2 to the condensed consolidated financial statements
elsewhere herein for additional information regarding certain sales-based revenue contracts that provide for the payment of quarterly
license fees based on quarterly sales of applicable product units by licensees.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Inventor
royalties and contingent legal fees, on a combined basis, increased $8.4 million, from $5.3 million to $13.7 million, primarily
due to increase in revenues as describe above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Litigation
and licensing expenses - patents decreased $3.1 million, from $6.6 million to $3.5 million, due primarily to a net decrease in
litigation support and third-party technical consulting expenses associated with ongoing litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Amortization
expense increased $1.2 million, from $2.3 million to $3.5 million, due to an increase in scheduled amortization resulting from
the new portfolios acquired in 2019 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Other portfolio
expenses decreased $0.5 million, from an expense of $0.2 million to an income of $0.3 million, primarily due to reversal of expenses
for settlement and contingency accruals recorded in the third quarter of 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>General and
administrative expenses, excluding non-cash stock compensation, increased $5.5 million, from $11.3 million to $16.8 million, primarily
due to higher corporate, general and administrative costs related to legal and other business development expenses, <span>including
$1.9 million in legal and advisory fees related to our LF Equity Income Fund Portfolio Investment</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Net non-cash
stock compensation expense increased $0.4 million, from $0.8 million to $1.2 million, primarily due to stock grants issued to
employees and the Board of Directors in 2019 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183;</span> Unrealized
gain or loss on our equity investment in Veritone, decreased from an unrealized gain of $9.6 million for the nine months ended
September 30, 2019 to an unrealized gain of $3.7 million for the nine months ended September 30, 2020. Realized loss on our equity
investment in Veritone decreased from a loss of $8.1 million for the nine months ended September 30, 2019 to a loss of $2.8 million
for the nine months ended September 30, 2020. Refer to Note 5 to the condensed consolidated financial statements elsewhere herein
for additional information regarding our investment in Veritone.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Unrealized
gain or loss from trading securities and other equity securities increased from an unrealized gain of $0.1 million for the nine
months ended September 30, 2019 to an unrealized gain of $99.4 million for the nine months ended September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Realized
loss from sale of our trading securities increased $4.5 million from a gain of $0.2 million for the nine months ended September
30, 2019 to a loss of $4.3 million for the nine months ended September 30, 2020. We also recognized a net gain of $2.8 million
related to returned prepaid investments and the sale of an equity security derivative. Refer to Notes 2 and 14 to the condensed
consolidated financial statements elsewhere herein for additional information regarding our investment in trading securities and
<span>LF Equity Income Fund Portfolio Investment</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Interest income
and other decreased $2.2 million, from a net income of $3.0 million for the nine months ended September 30, 2019 to a net income
of $0.8 million for the nine months ended September 30, 2020, mainly due to decrease in interest income from our investment in
trading securities. Refer to Note 2 to the condensed consolidated financial statements elsewhere herein for additional information
regarding our investment in trading securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>We incurred
interest expense of $3.2 million for the nine months ended September 30, 2020 from the Notes issued in June 2020. Refer to Note
13 to the condensed consolidated financial statements elsewhere herein for additional information regarding the Notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>Loss on foreign
currency exchange increased $4.8 million from a loss of $0.1 million for the nine months ended September 30, 2019 to a loss of
$4.9 million for the nine months ended September 30, 2020, primarily from our transaction related to the LF Income Equity Fund
securities. Refer to Note 14 to the condensed consolidated financial statements elsewhere herein for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Symbol">&#183; </span>We incurred
an unrealized net loss of $46.6 million from the fair value measurements of the Series A and Series B warrants and the embedded
derivative for the nine months ended September 30, 2020. Refer to Notes 10, 11, 12 and 13 to the condensed consolidated financial
statements elsewhere herein for additional information regarding the Starboard Securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Revenues and Pretax Net Loss</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenue for the periods presented included the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; padding-bottom: 1pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 5pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$    </span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 20%; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Revenues (in thousands, except percentage
    change values)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">19,466</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,711</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">17,755</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,038%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">25,399</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">10,558</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">14,841</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">141%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">New agreements executed</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">0%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">11</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">4</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">7</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">175%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Licensing and enforcement programs generating revenues</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">5</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">4</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">25%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">8</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">4</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">4</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">100%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Licensing and enforcement programs with initial
    revenues</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">n/a</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">2</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">2</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">n/a</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">New patent portfolios</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">2</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(2</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(100%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">4</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">5</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(1</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">(20%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the periods presented herein, the majority of the revenue
agreements executed provided for the payment of one-time, paid-up license fees in consideration for the grant of certain IP Rights
for patented technology rights owned by our operating subsidiaries. These rights were primarily granted on a perpetual basis, extending
until the expiration of the underlying patents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Refer to Note 2 to the condensed consolidated financial statements
elsewhere herein for additional information regarding our revenue concentrations for the periods presented herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Refer to &#8220;<i>Investments in Patent Portfolios</i>&#8221;
above for information regarding the impact of portfolio acquisition trends on current and future licensing and enforcement related
revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage
    change values)</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="30" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt; width: 20%"><span style="font-size: 8pt">Income (loss) before provision for
    income taxes</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">$</span></td><td style="font-size: 10pt; text-align: right; width: 7%"><span style="font-size: 8pt">38,431</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">$</span></td><td style="font-size: 10pt; text-align: right; width: 7%"><span style="font-size: 8pt">(7,608</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">$</span></td><td style="font-size: 10pt; text-align: right; width: 7%"><span style="font-size: 8pt">46,039</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right; width: 7%"><span style="font-size: 8pt">605%</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">$</span></td><td style="font-size: 10pt; text-align: right; width: 7%"><span style="font-size: 8pt">31,948</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">$</span></td><td style="font-size: 10pt; text-align: right; width: 7%"><span style="font-size: 8pt">(17,440</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">)</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">$</span></td><td style="font-size: 10pt; text-align: right; width: 7%"><span style="font-size: 8pt">49,388</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right; width: 7%"><span style="font-size: 8pt">283%</span></td><td style="font-size: 10pt; text-align: left; width: 1%"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cost of Revenues</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Inventor Royalties, Contingent Legal Fees Expense and Other</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Inventor royalties and contingent legal fee expenses fluctuate
from period to period based on the amount of revenues recognized each period, the terms and conditions of agreements executed each
period and the mix of specific patent portfolios, with varying economic terms and obligations, generating revenues each period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage
    change values)</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="30" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 20%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">Inventor royalties</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">5,772</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">776</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">4,996</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">644%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,843</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">4,752</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,091</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">44%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">Contingent legal fees</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,609</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">35</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,574</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">18,783%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,855</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">587</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,268</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,068%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Litigation and Licensing Expenses - Patents </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three months ended September 30, 2020, litigation and
licensing expenses-patents increased $14,000, or 1%. For the nine months ended September 30, 2020, litigation and licensing expenses-patents
decreased $3.1 million, or 47%. The decrease for the nine months period was due to a net decrease in litigation support and third-party
technical consulting expenses, as compared to the same nine months period in the prior year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Amortization of Patents</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the three months ended September 30, 2020, amortization
expense increased $0.3 million, or 36%, as compared to the three months ended September 30, 2019. For the nine months ended September
30, 2020, amortization expense increased $1.2 million, or 51%, as compared to the nine months ended September 30, 2019. These increases
were due to our new patents acquired in 2019 and 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage
    change values)</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="30" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt; width: 20%"><span style="font-size: 8pt">Litigation and licensing expenses -
    patents</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,001</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">987</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">14</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,497</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,643</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(3,146</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">(47%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">Amortization of patents</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,174</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">863</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">311</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">36%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,522</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,337</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,185</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; text-align: right"><span style="font-size: 8pt">51%</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Operating Expenses</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General and Administrative Expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Three Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">Nine Months Ended</span></td><td style="font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">September
    30,</span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt"><span style="font-size: 8pt"><b>Change</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt; text-align: center; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2020</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">2019</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">$</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 8pt">%</span></td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="font-size: 10pt; text-align: center"><span style="font-size: 8pt">(In thousands, except percentage
    change values)</span></td><td style="font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-indent: -5pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="30" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 5pt; width: 20%; font-size: 10pt; text-align: left; text-indent: -5pt"><span style="font-size: 8pt">General and administrative expenses</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">7,204</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">4,330</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">2,874</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">66%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">16,846</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">11,295</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">5,551</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; font-size: 10pt; text-align: right"><span style="font-size: 8pt">49%</span></td><td style="width: 1%; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -5pt"><span style="font-size: 8pt">Non-cash stock compensation
    expense - G&amp;A</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">488</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">300</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">188</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">63%</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">1,243</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">753</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">490</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="font-size: 8pt">65%</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 8pt">Total
    general and administrative expenses</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">7,692</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">4,630</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">3,062</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">66%</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">18,089</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">12,048</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">6,041</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="font-size: 8pt">50%</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="font: 9pt Sans-Serif; color: Red"><b></b></span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A summary of the main drivers of the change in general and administrative
expenses for the periods presented, is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020 vs. 2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020 vs. 2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-style: italic">&#160;</td><td style="font-size: 10pt; font-style: italic">&#160;</td>
    <td style="font-size: 10pt; font-style: italic; text-align: left">&#160;</td><td style="font-size: 10pt; font-style: italic; text-align: right">&#160;</td><td style="font-size: 10pt; font-style: italic; text-align: left">&#160;</td><td style="font-size: 10pt; font-style: italic">&#160;</td>
    <td style="font-size: 10pt; font-style: italic; text-align: left">&#160;</td><td style="font-size: 10pt; font-style: italic; text-align: right">&#160;</td><td style="font-size: 10pt; font-style: italic; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left">Personnel costs and board fees</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(429</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(556</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Variable performance-based compensation costs</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">65</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,440</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Corporate, general and administrative costs</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,239</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,798</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Non-cash stock compensation expense</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">188</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">490</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Non-recurring employee severance costs</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(1</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(131</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total change in general and administrative expenses</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">3,062</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">6,041</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span><span style="font: 9pt Sans-Serif; color: Red"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The increases in corporate, general and administrative costs
were primarily due to higher legal and business development related expenses, <span>including legal and advisory
fees related to our LF Equity Income Fund Portfolio Investment</span>. The increase in variance performance-based compensation
costs were primarily due to higher performance-based compensation accruals. The changes in non-cash stock compensation expense
were primarily due to stock grants issued to employees and the Board of Directors in the quarters ended June 30, 2019, September
30, 2019, and June 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Operating Income (Expense)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Change in Fair Value of Investment, net</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acacia&#8217;s investment in Veritone is recorded at fair value,
and marked to market at each balance sheet date, with changes in fair value, primarily based on changes in Veritone's stock price,
reflected in the statements of operations each period. Results for the three and nine months ended September 30, 2020 included
an unrealized loss totaling $3.1 million and an unrealized gain totaling $3.7 million, respectively, on our investment in Veritone.
Results for the three and nine months ended September 30, 2019 included unrealized losses totaling $4.3 million and unrealized
gain totaling $9.6 million, respectively, on our investment in Veritone. Refer to Note 5 to the condensed consolidated financial
statements elsewhere herein for additional information regarding our investment in Veritone.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 48%; font-size: 10pt; text-align: left">Income taxes (in thousands)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">(83</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">1,257</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 9%; font-size: 10pt; text-align: right">(323</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Effective tax rate</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0%</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">0%</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(4%</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(2%</td><td style="font-size: 10pt; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tax expense for the periods presented primarily reflects the
impact of state taxes and foreign taxes withholding or refund incurred on revenue agreements executed with third-party licensees
domiciled in foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our primary sources of liquidity are cash and cash equivalents
on hand generated from our operating activities. Our management believes that our cash and cash equivalent balances and anticipated
cash flows from operations will be sufficient to meet our cash requirements through at least twelve months from the date of this
report and for the foreseeable future. We may, however, encounter unforeseen difficulties that may deplete our capital resources
more rapidly than anticipated, including those set forth under Part II, Item 1A, &#8220;Risk Factors&#8221;. Any efforts to seek
additional funding could be made through issuances of equity or debt, or other external financing. However, additional funding
may not be available to us on favorable terms, or at all. The capital and credit markets have experienced extreme volatility and
disruption in recent years, and the volatility and impact of the disruption may continue. At times during this period, the volatility
and disruption has reached unprecedented levels. In several cases, the markets have exerted downward pressure on stock prices and
credit capacity for certain issuers, and the commercial paper markets may not be a reliable source of short-term financing for
us. If we fail to obtain additional financing when needed, we may not be able to execute our business plans and our business, conducted
by our operating subsidiaries, may suffer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain of our operating subsidiaries are often required to
engage in litigation to enforce their patents and patent rights. In connection with any of our operating subsidiaries&#8217; patent
enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has violated
statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive
or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against us or our operating
subsidiaries or award attorney&#8217;s fees and/or expenses to a defendant(s), which could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash, Cash Equivalents and Investments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our consolidated cash, cash equivalents, trading securities,
and restricted cash totaled $222.0 million at September 30, 2020, compared to $203.3 million at December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The net change in cash, cash equivalents and restricted cash
for the periods presented was comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Net cash provided by (used in):</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 66%; font-size: 10pt; text-align: left">Operating activities</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">5,549</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(846</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left">Investing activities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(9,815</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(61,181</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Financing activities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">109,471</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">79</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Increases (decrease) in cash and cash equivalents and restricted cash</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">105,205</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(61,948</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b></b></span></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash Flows from Operating Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash receipts from licensees for the nine months ended September
30, 2020 decreased $16.5 million to $25.6 million, as compared to $42.1 million in the comparable 2019 period, mainly due to the
timing on cash collected from accounts receivables in prior year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash inflows from operations for the nine months ended September
30, 2020 increased $6.3 million to $5.5 million, as compared to a net outflow of $0.8 million in the comparable 2019 period, primarily
due to cash receipts from revenue during the nine months in the current year period, and higher royalty and contingent legal fees
paid in the same period last year. Refer to &#8220;Working Capital&#8221; below for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash Flows from Investing Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash flows from investing activities and related changes were
comprised of the following for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span><span style="font: 9pt Sans-Serif; color: Red"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left">Patent acquisition costs</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(13,780</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(4,420</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left">Sale of investment at fair value<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,460</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6,260</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; text-align: left">(Purchase) Sale of other investments<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,000</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Net sale (purchase) of trading securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">282,946</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(64,902</td><td style="font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Purchases of prepaid investment</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(276,275</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Equity securities derivative and forward contract acquisition cost</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(3,989</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(177</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(119</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net cash used in investing activities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(9,815</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(61,181</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
</table>


<p style="margin: 0">_________________</p>

<p style="font-size: 10pt; margin-top: 3pt; margin-bottom: 0pt"><span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1) </sup>Refer
to Note 5 to the condensed consolidated financial statements elsewhere herein for additional information</span> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash Flows from Financing Activities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cash flows from financing activities and related changes were
comprised of the following for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span><span style="font: 9pt Sans-Serif; color: Red"><b></b></span></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; font-size: 10pt; text-align: left">Repurchase of common stock</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">(3,998</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Dividend on Series A Redeemable Convertible Preferred Stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,120</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Issuance of Senior Secured Notes, net of lender fee</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">110,437</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Senior Secured Notes issuance costs paid to other parties</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(496</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Issuance of Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,600</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Proceeds from exercise of stock options</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">48</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">79</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net cash provided by financing activities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">109,471</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">79</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Stock Repurchase Program</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 5, 2019, our Board of Directors approved a stock repurchase
program, which authorized the purchase of up to $10.0 million of the Company's common stock through open market purchases, through
block trades, through 10b5-1 plans, or by means of private purchases, from time to time, through July 31, 2020. In determining
whether or not to repurchase any shares of Acacia&#8217;s common stock, Acacia&#8217;s Board of Directors consider such factors
as the impact of the repurchase on Acacia&#8217;s cash position, as well as Acacia&#8217;s capital needs and whether there is a
better alternative use of Acacia&#8217;s capital. Acacia has no obligation to repurchase any amount of its common stock under the
Stock Repurchase Program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the six months ended June 30, 2020, we repurchased 1,684,537
shares at an average price of $2.37 per share for $3,999,000. Repurchases to date were made in the open market in compliance with
applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce the outstanding share count and
enhance stockholder value. Refer to Note 7 to the condensed consolidated financial statements elsewhere herein for additional
information regarding our stock repurchases in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Starboard Investment </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On November 18, 2019, the Company entered into the Securities
Purchase Agreement with Starboard and the Buyers pursuant to which the Buyers purchased (i) 350,000 shares of Series A Preferred
Stock at an aggregate purchase price of $35,000,000, and Series A Warrants to purchase up to 5,000,000 shares of the Company&#8217;s
common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On February 25, 2020, pursuant to the terms of the Securities
Purchase Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to 100 million shares of
the Company&#8217;s common stock at an exercise price of either (i) $5.25 per share, if exercising by cash payment, or (ii) $3.65
per share, if exercising by cancellation of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase
price of $4.6 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 4, 2020, pursuant to the Securities Purchase Agreement
signed in November 2019, the Company issued $115 million in Notes to the Buyers. Per the Supplemental Agreement, interest is payable
semiannually at a rate of 6.00% per annum, and in an event of default, the interest rate is increased to 10% per annum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 30, 2020, the Company entered into the Exchange Agreement
with Merton and Starboard, on behalf of itself and on behalf of certain funds and accounts under its management, including the
holders of the Notes. Pursuant to the Exchange Agreement, the holders of the Notes exchanged the entire outstanding principal amount
for New Notes issued by Merton having an aggregate outstanding original principal amount of $115 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Refer to Notes 2, 10, 11, 12 and 13 to the condensed consolidated
financial statements and elsewhere herein for more information related to the Starboard Securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Working Capital</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Working capital at September 30, 2020 increased to $227.7 million,
as compared to $160.1 million at December 31, 2019. Consolidated accounts receivable from licensees decreased to $0.3 million
at September 30, 2020, compared to $0.5 million at December 31, 2019. Accounts payable, accrued expenses and accrued compensation
increased to $10.2 million at September 30, 2020, from $9.5 million at December 31, 2019. Consolidated royalties and contingent
legal fees payable increased to $14.2 million at September 30, 2020, from $2.2 million at December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The royalties and contingent legal fees payable are generally
scheduled to be paid in the subsequent quarter upon our receipt of the related fee payments from licensees, in accordance with
the underlying contractual arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Critical Accounting Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our unaudited interim condensed consolidated financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America. Preparation of
these condensed consolidated statements requires management to make assumptions, judgments and estimates that can have a significant
impact on amounts reported in these condensed consolidated financial statements. We base our assumptions, judgments and estimates
on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could
differ materially from these estimates under different assumptions or conditions. On a regular basis, we evaluate our assumptions,
judgments and estimates and make changes accordingly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SEC has defined a company&#8217;s critical accounting policies
as the ones that are most important to the portrayal of a company&#8217;s financial condition and results of operations, and which
require a company to make its most difficult and subjective judgments. A summary of significant accounting policies and a description
of accounting policies that are considered critical may be found in the audited condensed consolidated financial statements and
notes thereto and under the caption &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations
- Critical Accounting Policies&#8221; included in our Annual Report. In addition, as set forth in Note 2 to the condensed consolidated
financial statements included in this report, certain accounting policies were identified during the current period, based on
activities occurring during the current period, as critical and requiring significant judgments and estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recently Adopted Accounting Pronouncements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Refer to Note 8 to the condensed consolidated financial statements
elsewhere herein for additional information regarding our recently adopted accounting pronouncements for the periods presented
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Off-Balance Sheet Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2020, we did not have any relationships
with any unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special
purpose entities, which would have been established to facilitate any off-balance sheet arrangements or for any other contractually
specified purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a9"></span><b>Item 3. Quantitative and Qualitative Disclosures about Market
Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The primary objective of our short-term investment activities
is to preserve principal while concurrently maximizing the income we receive from our trading securities without significantly
increasing risk. Some of the securities that we invest in may be subject to interest rate risk and/or market risk. This means that
a change in prevailing interest rates, with respect to interest rate risk, or a change in the value of the United States equity
markets, with respect to market risk, may cause the principal amount or market value of the trading securities to fluctuate. For
example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the prevailing interest
rate later rises, the current value of the principal amount of our investment may decline. To minimize these risks in the future,
we intend to maintain our portfolio of cash equivalents and trading securities in a variety of securities, including commercial
paper, money market funds, high-grade corporate bonds, government and non-government debt securities and certificates of deposit.
In general, money market funds are not subject to market risk because the interest paid on such funds fluctuates with the prevailing
interest rate. Accordingly, a 100 basis point increase in interest rates or a 10% decline in the value of the United States equity
markets would not be expected to have a material impact on the value of such money market funds. Investments in U.S. government
and corporate fixed income securities are subject to interest rate risk and will decline in value if interest rates increase. However,
due to the relatively short duration of our debt trading securities portfolio, an immediate 100 basis point increase in interest
rates would have no material impact on our financial condition, results of operations or cash flows. Declines in interest rates
over time will, however, reduce our interest income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the quarter ended June 30, 2020, we sold all of our
investment in debt trading securities, comprised of AAA rated money market funds that invest in first-tier only securities, which
primarily include domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank
obligations, and fully collateralized repurchase agreements (included in cash and cash equivalents in the accompanying condensed
consolidated balance sheets), and direct investments in short term, highly liquid, investment grade, U.S. government and corporate
securities (included in &#8220;Trading securities &#8211; debt&#8221; in the accompanying condensed consolidated balance sheets).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Investment Risk</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are exposed to investment risks related to changes in the
underlying financial condition of certain of our equity investments in these technology companies. The fair value of these investments
can be significantly impacted by the risk of adverse changes in securities markets generally, as well as risks related to the performance
of the companies whose securities we have invested in, risks associated with specific industries, and other factors. These investments
are subject to significant fluctuations in fair value due to the volatility of the securities markets and of the underlying businesses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of September 30, 2020 and December 31, 2019, the carrying
value of our common stock and warrants, including equity securities forward contract and derivatives, in public and private companies
was $159.6 million and $18.6 million, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We record our common stock and warrant investments in publicly
traded companies at fair value, which are subject to market price volatility. As of September 30, 2020, a hypothetical 10% adverse
change in the market price of our investments in publicly traded common stock would have resulted in a decrease of approximately
$0.3 million in the fair value of our equity warrant investments in Veritone and a decrease of approximately $4.3 million in our
other equity investments. We evaluate our equity and equity warrant investments in private companies for impairment when events
and circumstances indicate that the decline in fair value of such assets below the carrying value is other-than temporary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a10"></span><b>Item 4. Controls and Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(i). Evaluation of Disclosure Controls and Procedures</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the supervision and with the participation of our management,
including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures,
as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based on this evaluation, our Chief Executive Officer and Chief
Financial Officer concluded that, as of September 30, 2020, our disclosure controls and procedures were effective to ensure that
the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and
communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely
decisions regarding required disclosure, and that such information is recorded, processed, summarized and reported within the time
periods prescribed by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(ii). Changes in Internal Control Over Financial Reporting</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There were no changes in our internal control over financial
reporting that occurred during our last fiscal quarter (the quarter ended September 30, 2020) that have materially affected, or
are reasonably likely to materially affect, our internal control over financial reporting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(iii). Inherent Limitations on Effectiveness of Controls</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our management, including our Chief Executive Officer and Chief
Financial Officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or
detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute,
assurance that the control system&#8217;s objectives will be met. The design of a control system must reflect the fact that there
are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent
limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or
fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of
controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any
design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness
of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions
or deterioration in the degree of compliance with policies or procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a11"></span><b>PART II--OTHER INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a12"></span><b>Item 1. Legal Proceedings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 6, 2019, Slingshot Technologies, LLC, or Slingshot,
filed a lawsuit in Delaware Chancery Court against the Company, Acacia Research Group, LLC, and Monarch Networking Solutions LLC,
or collectively, the Acacia Entities, Acacia board member Katharine Wolanyk, and Transpacific IP Group, Ltd., or Transpacific.
Slingshot alleges that the Acacia Entities misappropriated its confidential and proprietary information, purportedly furnished
to the Acacia Entities by Ms. Wolanyk, in acquiring a patent portfolio from Transpacific after Slingshot&#8217;s exclusive option
to purchase the same patent portfolio from Transpacific had already expired. Slingshot seeks monetary damages, as well as equitable
and injunctive relief related to its alleged right to own the portfolio. The Acacia Entities maintain that Slingshot&#8217;s allegations
are baseless, that Ms. Wolanyk had no involvement in the acquisition, that the Acacia Entities neither had access to nor used Slingshot&#8217;s
information in acquiring the portfolio, that the Acacia Entities acquired the portfolio as a result of the independent efforts
of its IP licensing group, and that Slingshot suffered no damages given its exclusive option to purchase the portfolio had already
ended and it has proven itself incapable of closing on the portfolio purchase. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a13"></span><b>Item 1A. Risk Factors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">An investment in our common stock involves risks. Before making
an investment decision, you should carefully consider all of the information in this Quarterly Report on Form 10-Q, including in
the section entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;
in Part II, Item 1A in this Quarterly Report on Form 10-Q, as well as our condensed consolidated financial statements and the accompanying
notes thereto. In addition, you should carefully consider the risks and uncertainties described below, and in the section entitled
&#8220;Risk Factors&#8221; in Part I, Item 1A of our Annual Report, as well as in our other public filings with the SEC. If any
of the identified risks are realized, our business, financial condition, operating results and prospects could be materially and
adversely affected. In that case, the trading price of our common stock may decline, and you could lose all or part of your investment.
In addition, other risks of which we are currently unaware, or which we do not currently view as material, could have a material
adverse effect on our business, financial condition, operating results and prospects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">Risks related to COVID-19</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Public health threats such as COVID-19 could have a material
adverse effect on our operations, the operations of our business partners, and the global economy as a whole.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Public health threats and other highly communicable diseases,
outbreaks of which have already occurred in various parts of the world, could adversely impact our operations, as well as the operations
of our licensees and other business partners. <span style="background-color: white">With regard to COVID-19, we do not expect the
current situation to present direct risks to our business. Our cash is held in major financial institutions in government instruments
and high quality short-term bonds. &#160;Our business is fully able to operate in a socially-distanced and/or remote capacity and
in accordance with applicable laws, policies, and best practices. Our workforce is provided ample paid sick leave, and we have
in place robust disaster recovery and business continuity policies that have been revised to account for a long-term remote work
contingency such as this. However, the ongoing pandemic may present risks that we do not currently consider material or risks that
may evolve quickly that could have a materially adverse effect on our business, financial condition, operating results, and/or
prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a14"></span><b>Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a15"></span><b>Item 3. Defaults Upon Senior Securities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a16"></span><b>Item 4. Mine Safety Disclosures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a17"></span><b>Item 5. Other Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a18"></span><b>Item 6. Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="width: 15%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>EXHIBIT</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">NUMBER</span></b></p></td>
    <td style="width: 85%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span style="text-decoration: underline">EXHIBIT</span></b></span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">31.1#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><a href="acacia_ex3101.htm">Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934</a></span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">31.2#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><a href="acacia_ex3102.htm">Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934</a></span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">32.1**#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><a href="acacia_ex3201.htm">Certification of Principal Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350</a></span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">32.2**#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif"><a href="acacia_ex3202.htm">Certification of Principal Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350</a></span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">101#</span></td>
    <td style="vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">Interactive Data Files Pursuant to Rule 405 of Regulation S-T</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">___________________________</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 20px"><span style="font: 10pt Times New Roman, Times, Serif">#</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Filed herewith.</span></td></tr>
<tr style="vertical-align: top">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*</p></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If any, indicates management contract or compensatory plan.</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 20px"><span style="font: 10pt Times New Roman, Times, Serif">**</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, shall not be deemed &#8220;filed&#8221; by the Registrant for purposes of Section 18 of the Exchange Act and are not to be incorporated by reference into any of the Registrant&#8217;s filings under the Securities Act or the Exchange Act, irrespective of any general incorporation language contained in any such filing.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 50%"><span style="font: 10pt Times New Roman, Times, Serif"><b>ACACIA RESEARCH CORPORATION</b></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Date: November 9, 2020</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">/s/ Clifford Press&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">By: <b>Clifford Press</b></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>Chief Executive Officer</b></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>(Principal Executive Officer and Duly Authorized Signatory)</b></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Date: November 9, 2020 </span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">/s/ Richard Rosenstein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">By: <b>Richard Rosenstein</b></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>Chief Financial Officer</b></span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><b>(Principal Financial Officer)</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 47; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>acacia_ex3101.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>EXHIBIT 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Clifford Press, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. I have reviewed
this Quarterly Report on Form 10-Q of Acacia Research Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2. Based on my knowledge, this
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3. Based on my knowledge, the
financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">4. The registrant&rsquo;s other
certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(c). Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(d). Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">5. The registrant&rsquo;s other certifying officer
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November 9, 2020</FONT></TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/
        Clifford Press&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Clifford Press</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Chief Executive Officer</I></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>acacia_ex3102.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL
OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Richard Rosenstein, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. I have reviewed
this Quarterly Report on Form 10-Q of Acacia Research Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">2. Based on my knowledge, this
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by
this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">3. Based on my knowledge, the
financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">4. The registrant&rsquo;s other
certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(c). Evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(d). Disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect,
the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">5. The registrant&rsquo;s other certifying officer
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a). All significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b). Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November 9, 2020</FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Richard Rosenstein&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Richard Rosenstein</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Chief Financial Officer</I></B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>acacia_ex3201.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER AND PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Quarterly Report
of Acacia Research Corporation (the &ldquo;Company&rdquo;) on Form 10-Q for the quarterly period ended September 30, 2020, as filed
with the Securities and Exchange Commission on November 9, 2020 (the &ldquo;Report&rdquo;), I, Clifford Press, Chief Executive
Officer of the Company, hereby certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and
18 U.S.C. Section 1350, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. The information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November 9, 2020</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: <U>/s/ Clifford Press&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Clifford Press</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification accompanies the Report
pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not
be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability
of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act
of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>acacia_ex3202.htm
<DESCRIPTION>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 32.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER AND PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Quarterly Report
of Acacia Research Corporation (the &ldquo;Company&rdquo;) on Form 10-Q for the quarterly period ended September 30, 2020, as filed
with the Securities and Exchange Commission on November 9, 2020 (the &ldquo;Report&rdquo;), I, Richard Rosenstein, Chief Financial
Officer of the Company, hereby certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and
18 U.S.C. Section 1350, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. The information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November 9, 2020</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: <U>/s/ Richard Rosenstein&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Richard Rosenstein</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This certification accompanies the Report
pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not
be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability
of that section. This certification will not be deemed to be incorporated by reference into any filing under the Securities Act
of 1933 or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>actg-20200930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaSFaaPty552aYkxvmR0fen67yIjUmvYPCahC3u2ISYL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ACTG="http://acaciaresearch.com/20200930" elementFormDefault="qualified" targetNamespace="http://acaciaresearch.com/20200930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://acaciaresearch.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" id="UnauditedCondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" id="UnauditedCondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" id="UnauditedCondensedConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" id="UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical">
	  <link:definition>00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" id="UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity">
	  <link:definition>00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" id="UnauditedCondensedConsolidatedStatementsOfCashFlows">
	  <link:definition>00000007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
	  <link:definition>00000008 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000009 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeLossPerShare" id="IncomeLossPerShare">
	  <link:definition>00000010 - Disclosure - 3. INCOME (LOSS) PER SHARE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Patents" id="Patents">
	  <link:definition>00000011 - Disclosure - 4. PATENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/Investments" id="Investments">
	  <link:definition>00000012 - Disclosure - 5. INVESTMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000013 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000014 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncements" id="RecentAccountingPronouncements">
	  <link:definition>00000015 - Disclosure - 8. RECENT ACCOUNTING PRONOUNCEMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/FairValueDisclosures" id="FairValueDisclosures">
	  <link:definition>00000016 - Disclosure - 9. FAIR VALUE DISCLOSURES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" id="SeriesRedeemableConvertiblePreferredStock">
	  <link:definition>00000017 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesWarrants" id="SeriesWarrants">
	  <link:definition>00000018 - Disclosure - 11. SERIES A WARRANTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesBWarrants" id="SeriesBWarrants">
	  <link:definition>00000019 - Disclosure - 12. SERIES B WARRANTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeniorSecuredNotes" id="SeniorSecuredNotes">
	  <link:definition>00000020 - Disclosure - 13. SENIOR SECURED NOTES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment" id="LfEquityIncomeFundPortfolioInvestment">
	  <link:definition>00000021 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000022 - Disclosure - 15. SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" id="DescriptionOfBusinessAndBasisOfPresentationPolicies">
	  <link:definition>00000023 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000024 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000025 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeLossPerShareTables" id="IncomeLossPerShareTables">
	  <link:definition>00000026 - Disclosure - 3. INCOME (LOSS) PER SHARE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsTables" id="PatentsTables">
	  <link:definition>00000027 - Disclosure - 4. PATENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentsTables" id="InvestmentsTables">
	  <link:definition>00000028 - Disclosure - 5. INVESTMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000029 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
	  <link:definition>00000030 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables" id="LfEquityIncomeFundPortfolioInvestmentTables">
	  <link:definition>00000031 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" id="DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative">
	  <link:definition>00000032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" id="SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails">
	  <link:definition>00000033 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" id="SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails">
	  <link:definition>00000034 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" id="SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails">
	  <link:definition>00000035 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" id="SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details">
	  <link:definition>00000036 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000037 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/IncomeLossPerShareDetails" id="IncomeLossPerShareDetails">
	  <link:definition>00000038 - Disclosure - 3. INCOME (LOSS) PER SHARE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsDetails" id="PatentsDetails">
	  <link:definition>00000039 - Disclosure - 4. PATENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/PatentsDetailsNarrative" id="PatentsDetailsNarrative">
	  <link:definition>00000040 - Disclosure - 4. PATENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentsDetails" id="InvestmentsDetails">
	  <link:definition>00000041 - Disclosure - 5. INVESTMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" id="InvestmentsDetailsNarrative">
	  <link:definition>00000042 - Disclosure - 5. INVESTMENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
	  <link:definition>00000043 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000044 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
	  <link:definition>00000045 - Disclosure - 7. STOCKHOLDERS' EQUITY (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
	  <link:definition>00000046 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" id="SeriesRedeemableConvertiblePreferredStockDetailsNarrative">
	  <link:definition>00000047 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" id="SeriesWarrantsDetailsNarrative">
	  <link:definition>00000048 - Disclosure - 11. SERIES A WARRANTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative" id="SeriesBWarrantsDetailsNarrative">
	  <link:definition>00000049 - Disclosure - 12. SERIES B WARRANTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative" id="SeniorSecuredNotesDetailsNarrative">
	  <link:definition>00000050 - Disclosure - 13. SENIOR SECURED NOTES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails" id="LfEquityIncomeFundPortfolioInvestmentDetails">
	  <link:definition>00000051 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" id="LfEquityIncomeFundPortfolioInvestmentDetailsNarrative">
	  <link:definition>00000052 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="actg-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="ACTG_NonCashStockCompensationExpenseMember" name="NonCashStockCompensationExpenseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesARedeemableConvertiblePreferredStockMember" name="SeriesARedeemableConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PaidUpRevenueAgreementsMember" name="PaidUpRevenueAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RecurringRevenueAgreementsMember" name="RecurringRevenueAgreementsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicenseeMember" name="OneLicenseeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicensee2Member" name="OneLicensee2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicensee3Member" name="OneLicensee3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OneLicensee4Member" name="OneLicensee4Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ForeignLicenseeMember" name="ForeignLicenseeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritesrEquityMember" name="TradingSecuritesrEquityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritesEquityMember" name="TradingSecuritesEquityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritesDebtMember" name="TradingSecuritesDebtMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritiesEquityMember" name="TradingSecuritiesEquityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesDerivativetMember" name="EquitySecuritiesDerivativetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesDerivativeMember" name="EquitySecuritiesDerivativeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantInvestmentMember" name="WarrantInvestmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritiesDebtMember" name="TradingSecuritiesDebtMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_CommonStockInvestmentMember" name="CommonStockInvestmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesAWarrantsMember" name="SeriesAWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesBWarrantsMember" name="SeriesBWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EmbeddedDerivativeLiabilityMember" name="EmbeddedDerivativeLiabilityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesAEmbeddedDerivativeLiabilityMember" name="SeriesAEmbeddedDerivativeLiabilityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesBWarrantsLiabilityMember" name="SeriesBWarrantsLiabilityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_BlackScholesModelMember" name="BlackScholesModelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_MonteCarloMethodMember" name="MonteCarloMethodMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantPrice525Member" name="WarrantPrice525Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantPrice365Member" name="WarrantPrice365Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EmbeddedDerivativeMember" name="EmbeddedDerivativeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_VeritoneMember" name="VeritoneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RestrictedStockUnitsMember" name="RestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EmployeeStockOptionsMember" name="EmployeeStockOptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquityBasedIncentiveAwardsMember" name="EquityBasedIncentiveAwardsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StockRepurchaseProgramMember" name="StockRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_StarboardValueMember" name="StarboardValueMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesARedeemableConvertibleStockMember" name="SeriesARedeemableConvertibleStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeniorSecuredNotesMember" name="SeniorSecuredNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ExchangeAgreementMember" name="ExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_MertonMember" name="MertonMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeniorSecuredNotes1Member" name="SeniorSecuredNotes1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OptionAgreementMember" name="OptionAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PortfolioCompaniesMember" name="PortfolioCompaniesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritesLfFundPublicSecuritiesMember" name="TradingSecuritesLfFundPublicSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember" name="EquitySecuritiesLFFundPrivateSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecuritiesForwardContractMember" name="EquitySecuritiesForwardContractMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritiesLFFundPublicSecuritiesMember" name="TradingSecuritiesLFFundPublicSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_TradingSecuritesLfFundSecuritiesMember" name="TradingSecuritesLfFundSecuritiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PrepaidInvestment" name="PrepaidInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_RoyaltiesAndContingentLegalFeesPayable" name="RoyaltiesAndContingentLegalFeesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DerivativeLiabilitiesNoncurrent1" name="DerivativeLiabilitiesNoncurrent1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ContingentLegalFees" name="ContingentLegalFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_LitigationAndLicensingExpensesPatents" name="LitigationAndLicensingExpensesPatents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NetPortfolioIncomeLoss" name="NetPortfolioIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NoncashStockBasedCompensationCredit" name="NoncashStockBasedCompensationCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" name="AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" name="ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_UnrealizedGainLossOnDerivatives1" name="UnrealizedGainLossOnDerivatives1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" name="IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AcquisitionOfPrepaidInvestmentSecurities" name="AcquisitionOfPrepaidInvestmentSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesWarrantsAbstract" name="SeriesWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantDisclosureTextBlock" name="WarrantDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesBWarrantsAbstract" name="SeriesBWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesBWarrantsTextBlock" name="SeriesBWarrantsTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_DescriptionOfBusinessPolicyTextBlock" name="DescriptionOfBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PortfolioOperationsPolicyTextBlock" name="PortfolioOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_PrepaidInvestmentPoliciesTextBlock" name="PrepaidInvestmentPoliciesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EquitySecurityForwardContractPoliciesTextBlock" name="EquitySecurityForwardContractPoliciesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesAWarrantsPolicyTextBlock" name="SeriesAWarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_SeriesBWarrantsPolicyTextBlock" name="SeriesBWarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NumberOfPatentPortfoliosAcquired" name="NumberOfPatentPortfoliosAcquired" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" name="AccretionOfSeriesRedeemableConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" name="ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfSeriesWarrants" name="ChangeInFairValueOfSeriesWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" name="ChangeInFairValueOfDilutiveSeriesBWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" name="EarningsPerShareBasicAndDilutedDeniminatorAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_NumberOfWarrants" name="NumberOfWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_InvestmentSharesSold" name="InvestmentSharesSold" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_InvestmentWarrants" name="InvestmentWarrants" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" name="ApproximateValueOfSharesThatMayYetBePurchased" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantsIssued" name="WarrantsIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantsIssuedShares" name="WarrantsIssuedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantsExercised" name="WarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_WarrantsExercisedShares" name="WarrantsExercisedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_OriginalIssueDiscount" name="OriginalIssueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ACTG_ReturnOnPrepayment" name="ReturnOnPrepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>actg-20200930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20200930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShare" xlink:href="actg-20200930.xsd#IncomeLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Patents" xlink:href="actg-20200930.xsd#Patents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Investments" xlink:href="actg-20200930.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20200930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20200930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:href="actg-20200930.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueDisclosures" xlink:href="actg-20200930.xsd#FairValueDisclosures" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:href="actg-20200930.xsd#SeriesRedeemableConvertiblePreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrants" xlink:href="actg-20200930.xsd#SeriesWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesBWarrants" xlink:href="actg-20200930.xsd#SeriesBWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeniorSecuredNotes" xlink:href="actg-20200930.xsd#SeniorSecuredNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvents" xlink:href="actg-20200930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShareTables" xlink:href="actg-20200930.xsd#IncomeLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsTables" xlink:href="actg-20200930.xsd#PatentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsTables" xlink:href="actg-20200930.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20200930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShareDetails" xlink:href="actg-20200930.xsd#IncomeLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetails" xlink:href="actg-20200930.xsd#PatentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:href="actg-20200930.xsd#PatentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetails" xlink:href="actg-20200930.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:href="actg-20200930.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20200930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20200930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesBWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative" xlink:href="actg-20200930.xsd#SeniorSecuredNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesEquitySecuritiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaapEquitySecuritiesFvNi" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapEquitySecuritiesFvNi" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent" xlink:label="loc_us-gaapDerivativeAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDerivativeAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="loc_us-gaapEquitySecuritiesFvNiCost" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapEquitySecuritiesFvNiCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PrepaidInvestment" xlink:label="loc_ACTGPrepaidInvestment" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_ACTGPrepaidInvestment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaapSecuredDebtCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapSecuredDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_DerivativeLiabilitiesNoncurrent1" xlink:label="loc_ACTGDerivativeLiabilitiesNoncurrent1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ACTGDerivativeLiabilitiesNoncurrent1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaapPreferredStockRedemptionAmount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapPreferredStockRedemptionAmount" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ContingentLegalFees" xlink:label="loc_ACTGContingentLegalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_ACTGContingentLegalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="loc_ACTGLitigationAndLicensingExpensesPatents" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_ACTGLitigationAndLicensingExpensesPatents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostOfGoodsAndServicesSold" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="loc_ACTGNetPortfolioIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ACTGNetPortfolioIncomeLoss" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ACTGNetPortfolioIncomeLoss" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_ACTGNetPortfolioIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:label="loc_us-gaapIncreaseDecreaseInEquitySecuritiesFvNi" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapIncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesTradingUnrealizedGainLoss" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDebtSecuritiesTradingUnrealizedGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:title="00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_UnrealizedGainLossOnDerivatives1" xlink:label="loc_ACTGUnrealizedGainLossOnDerivatives1" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGUnrealizedGainLossOnDerivatives1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_us-gaapUnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapUnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesRealizedGainLoss" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDebtSecuritiesRealizedGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:label="loc_us-gaapIncreaseDecreaseInEquitySecuritiesFvNi" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfOtherInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities" xlink:label="loc_us-gaapPaymentsForHedgeInvestingActivities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForHedgeInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaapPaymentsOfDividends" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividends" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShare" xlink:title="00000010 - Disclosure - 3. INCOME (LOSS) PER SHARE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Patents" xlink:title="00000011 - Disclosure - 4. PATENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Investments" xlink:title="00000012 - Disclosure - 5. INVESTMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000014 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:title="00000015 - Disclosure - 8. RECENT ACCOUNTING PRONOUNCEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueDisclosures" xlink:title="00000016 - Disclosure - 9. FAIR VALUE DISCLOSURES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:title="00000017 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrants" xlink:title="00000018 - Disclosure - 11. SERIES A WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesBWarrants" xlink:title="00000019 - Disclosure - 12. SERIES B WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeniorSecuredNotes" xlink:title="00000020 - Disclosure - 13. SENIOR SECURED NOTES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment" xlink:title="00000021 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - 15. SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:title="00000023 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000025 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShareTables" xlink:title="00000026 - Disclosure - 3. INCOME (LOSS) PER SHARE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsTables" xlink:title="00000027 - Disclosure - 4. PATENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsTables" xlink:title="00000028 - Disclosure - 5. INVESTMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000029 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000030 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables" xlink:title="00000031 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:title="00000033 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:title="00000034 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:title="00000035 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:title="00000036 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000037 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShareDetails" xlink:title="00000038 - Disclosure - 3. INCOME (LOSS) PER SHARE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetails" xlink:title="00000039 - Disclosure - 4. PATENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:title="00000040 - Disclosure - 4. PATENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetails" xlink:title="00000041 - Disclosure - 5. INVESTMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:title="00000042 - Disclosure - 5. INVESTMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000043 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000044 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000045 - Disclosure - 7. STOCKHOLDERS&apos; EQUITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000046 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:title="00000047 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:title="00000048 - Disclosure - 11. SERIES A WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative" xlink:title="00000049 - Disclosure - 12. SERIES B WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative" xlink:title="00000050 - Disclosure - 13. SENIOR SECURED NOTES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails" xlink:title="00000051 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:title="00000052 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>actg-20200930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20200930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShare" xlink:href="actg-20200930.xsd#IncomeLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Patents" xlink:href="actg-20200930.xsd#Patents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Investments" xlink:href="actg-20200930.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20200930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20200930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:href="actg-20200930.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueDisclosures" xlink:href="actg-20200930.xsd#FairValueDisclosures" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:href="actg-20200930.xsd#SeriesRedeemableConvertiblePreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrants" xlink:href="actg-20200930.xsd#SeriesWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesBWarrants" xlink:href="actg-20200930.xsd#SeriesBWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeniorSecuredNotes" xlink:href="actg-20200930.xsd#SeniorSecuredNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvents" xlink:href="actg-20200930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShareTables" xlink:href="actg-20200930.xsd#IncomeLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsTables" xlink:href="actg-20200930.xsd#PatentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsTables" xlink:href="actg-20200930.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20200930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShareDetails" xlink:href="actg-20200930.xsd#IncomeLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetails" xlink:href="actg-20200930.xsd#PatentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:href="actg-20200930.xsd#PatentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetails" xlink:href="actg-20200930.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:href="actg-20200930.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20200930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20200930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesBWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative" xlink:href="actg-20200930.xsd#SeniorSecuredNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="loc_us-gaapRedeemablePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapRedeemablePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares_50" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NonCashStockCompensationExpenseMember" xlink:label="loc_ACTGNonCashStockCompensationExpenseMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ACTGNonCashStockCompensationExpenseMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NoncashStockBasedCompensationCredit" xlink:label="loc_ACTGNoncashStockBasedCompensationCredit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGNoncashStockBasedCompensationCredit_130" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:title="00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" xlink:label="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="loc_us-gaapDividendsPreferredStockStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockStock_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_80" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShare" xlink:title="00000010 - Disclosure - 3. INCOME (LOSS) PER SHARE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Patents" xlink:title="00000011 - Disclosure - 4. PATENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Investments" xlink:title="00000012 - Disclosure - 5. INVESTMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000014 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:title="00000015 - Disclosure - 8. RECENT ACCOUNTING PRONOUNCEMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueDisclosures" xlink:title="00000016 - Disclosure - 9. FAIR VALUE DISCLOSURES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:title="00000017 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrants" xlink:title="00000018 - Disclosure - 11. SERIES A WARRANTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesBWarrants" xlink:title="00000019 - Disclosure - 12. SERIES B WARRANTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeniorSecuredNotes" xlink:title="00000020 - Disclosure - 13. SENIOR SECURED NOTES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment" xlink:title="00000021 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - 15. SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:title="00000023 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000025 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShareTables" xlink:title="00000026 - Disclosure - 3. INCOME (LOSS) PER SHARE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsTables" xlink:title="00000027 - Disclosure - 4. PATENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsTables" xlink:title="00000028 - Disclosure - 5. INVESTMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000029 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000030 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables" xlink:title="00000031 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:title="00000033 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="loc_ACTGPaidUpRevenueAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGPaidUpRevenueAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="loc_ACTGRecurringRevenueAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGRecurringRevenueAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:title="00000034 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:label="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_us-gaapInvestmentTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesrEquityMember" xlink:label="loc_ACTGTradingSecuritesrEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesrEquityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesEquityMember" xlink:label="loc_ACTGTradingSecuritesEquityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesEquityMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesDebtMember" xlink:label="loc_ACTGTradingSecuritesDebtMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesDebtMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapShortTermInvestments_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue_100" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:title="00000035 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:label="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember" xlink:label="loc_us-gaapAssetsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAssetsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesEquityMember" xlink:label="loc_ACTGTradingSecuritiesEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGTradingSecuritiesEquityMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesDerivativetMember" xlink:label="loc_ACTGEquitySecuritiesDerivativetMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritiesDerivativetMember_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesDerivativeMember" xlink:label="loc_ACTGEquitySecuritiesDerivativeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritiesDerivativeMember_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember_60" xlink:type="arc" order="64" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesDebtMember" xlink:label="loc_ACTGTradingSecuritiesDebtMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGTradingSecuritiesDebtMember_120" xlink:type="arc" order="124" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGCommonStockInvestmentMember_210" xlink:type="arc" order="214" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_270" xlink:type="arc" order="274" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_300" xlink:type="arc" order="304" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGEmbeddedDerivativeLiabilityMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmbeddedDerivativeLiabilityMember_330" xlink:type="arc" order="334" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_490" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure_490" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:title="00000036 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:label="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsLiabilityMember" xlink:label="loc_ACTGSeriesBWarrantsLiabilityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsLiabilityMember_10" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000037 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicenseeMember" xlink:label="loc_ACTGOneLicenseeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicenseeMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee2Member" xlink:label="loc_ACTGOneLicensee2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee2Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee3Member" xlink:label="loc_ACTGOneLicensee3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee3Member_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee4Member" xlink:label="loc_ACTGOneLicensee4Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee4Member_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ForeignLicenseeMember" xlink:label="loc_ACTGForeignLicenseeMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGForeignLicenseeMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="loc_us-gaapMeasurementInputCreditSpreadMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputCreditSpreadMember_370" xlink:type="arc" order="371" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_BlackScholesModelMember" xlink:label="loc_ACTGBlackScholesModelMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ACTGBlackScholesModelMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_MonteCarloMethodMember" xlink:label="loc_ACTGMonteCarloMethodMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ACTGMonteCarloMethodMember_250" xlink:type="arc" order="252" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_210" xlink:type="arc" order="213" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_250" xlink:type="arc" order="253" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmbeddedDerivativeMember" xlink:label="loc_ACTGEmbeddedDerivativeMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGEmbeddedDerivativeMember_350" xlink:type="arc" order="352" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantPrice525Member" xlink:label="loc_ACTGWarrantPrice525Member_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGWarrantPrice525Member_250" xlink:type="arc" order="254" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantPrice365Member" xlink:label="loc_ACTGWarrantPrice365Member_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGWarrantPrice365Member_300" xlink:type="arc" order="304" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_VeritoneMember" xlink:label="loc_ACTGVeritoneMember_390" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_ACTGVeritoneMember_390" xlink:type="arc" order="391" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_450" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_450" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapInvestments_450" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_450" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShareDetails" xlink:title="00000038 - Disclosure - 3. INCOME (LOSS) PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RestrictedStockUnitsMember" xlink:label="loc_ACTGRestrictedStockUnitsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGRestrictedStockUnitsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmployeeStockOptionsMember" xlink:label="loc_ACTGEmployeeStockOptionsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmployeeStockOptionsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquityBasedIncentiveAwardsMember" xlink:label="loc_ACTGEquityBasedIncentiveAwardsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGEquityBasedIncentiveAwardsMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapNetIncomeLoss_370" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact_370" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount_370" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:label="loc_us-gaapUndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapUndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_370" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract_370" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_370" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapDividendsPreferredStock_370" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:label="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStock_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStock_370" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_370" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesWarrants" xlink:label="loc_ACTGChangeInFairValueOfSeriesWarrants_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfSeriesWarrants_370" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:label="loc_ACTGChangeInFairValueOfDilutiveSeriesBWarrants_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfDilutiveSeriesBWarrants_370" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapInterestExpenseOther_370" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_370" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:label="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_370" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted_370" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:label="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract_370" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract_370" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_370" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract_370" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_370" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract_370" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_370" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_370" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_370" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_370" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetails" xlink:title="00000039 - Disclosure - 4. PATENTS (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:title="00000040 - Disclosure - 4. PATENTS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetails" xlink:title="00000041 - Disclosure - 5. INVESTMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="loc_us-gaapInvestmentHoldingsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="loc_us-gaapInvestmentHoldingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapInvestmentHoldingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapInvestmentHoldingsTable" xlink:to="loc_us-gaapInvestmentTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGWarrantInvestmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGCommonStockInvestmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaapGainOnSaleOfInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainOnSaleOfInvestments_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainLossOnInvestments_130" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:title="00000042 - Disclosure - 5. INVESTMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyLineItems" xlink:label="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_VeritoneMember" xlink:label="loc_ACTGVeritoneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGVeritoneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NumberOfWarrants" xlink:label="loc_ACTGNumberOfWarrants_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_ACTGNumberOfWarrants_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_InvestmentSharesSold" xlink:label="loc_ACTGInvestmentSharesSold_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_ACTGInvestmentSharesSold_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapSharePrice_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_InvestmentWarrants" xlink:label="loc_ACTGInvestmentWarrants_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_ACTGInvestmentWarrants_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="loc_us-gaapFinancialInstrumentsOwnedAtFairValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapFinancialInstrumentsOwnedAtFairValue_70" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000043 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000044 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000045 - Disclosure - 7. STOCKHOLDERS&apos; EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapScheduleOfStockByClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaapTreasuryStockSharesAcquired_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTreasuryStockSharesAcquired_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="loc_us-gaapStockRepurchaseProgramExpirationDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramExpirationDate_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000046 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="loc_us-gaapEquityClassOfTreasuryStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="loc_us-gaapClassOfTreasuryStockTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEquityClassOfTreasuryStockLineItems" xlink:to="loc_us-gaapClassOfTreasuryStockTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfTreasuryStockTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="loc_ACTGStockRepurchaseProgramMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_ACTGStockRepurchaseProgramMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityClassOfTreasuryStockLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_20" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:title="00000047 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionLineItems" xlink:label="loc_us-gaapSecuritiesFinancingTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTable" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="loc_ACTGSecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertibleStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeriesARedeemableConvertibleStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsIssued" xlink:label="loc_ACTGWarrantsIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_ACTGWarrantsIssued_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapDividendsPayableCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapAccretionExpense_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:title="00000048 - Disclosure - 11. SERIES A WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionLineItems" xlink:label="loc_us-gaapSecuritiesFinancingTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTable" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="loc_ACTGSecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsIssuedShares" xlink:label="loc_ACTGWarrantsIssuedShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_ACTGWarrantsIssuedShares_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsExercised" xlink:label="loc_ACTGWarrantsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_ACTGWarrantsExercised_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative" xlink:title="00000049 - Disclosure - 12. SERIES B WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="loc_us-gaapScheduleOfCapitalizationEquityLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsIssuedShares" xlink:label="loc_ACTGWarrantsIssuedShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_ACTGWarrantsIssuedShares_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsExercisedShares" xlink:label="loc_ACTGWarrantsExercisedShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_ACTGWarrantsExercisedShares_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative" xlink:title="00000050 - Disclosure - 13. SENIOR SECURED NOTES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingLiabilitiesLineItems" xlink:label="loc_us-gaapOffsettingLiabilitiesLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="loc_ACTGSecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGSecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ExchangeAgreementMember" xlink:label="loc_ACTGExchangeAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGExchangeAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeniorSecuredNotesMember" xlink:label="loc_ACTGSeniorSecuredNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ACTGSeniorSecuredNotesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeniorSecuredNotes1Member" xlink:label="loc_ACTGSeniorSecuredNotes1Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ACTGSeniorSecuredNotes1Member_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_MertonMember" xlink:label="loc_ACTGMertonMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGMertonMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertibleStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeriesARedeemableConvertibleStockMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfSecuredDebt_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfSecuredDebt_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapPaymentsOfFinancingCosts_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDividendsPayableCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OriginalIssueDiscount" xlink:label="loc_ACTGOriginalIssueDiscount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_ACTGOriginalIssueDiscount_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_130" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails" xlink:title="00000051 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:label="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_us-gaapInvestmentTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesLfFundPublicSecuritiesMember" xlink:label="loc_ACTGTradingSecuritesLfFundPublicSecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesLfFundPublicSecuritiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesDerivativeMember" xlink:label="loc_ACTGEquitySecuritiesDerivativeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGEquitySecuritiesDerivativeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember" xlink:label="loc_ACTGEquitySecuritiesLFFundPrivateSecuritiesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGEquitySecuritiesLFFundPrivateSecuritiesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesForwardContractMember" xlink:label="loc_ACTGEquitySecuritiesForwardContractMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGEquitySecuritiesForwardContractMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesLFFundPublicSecuritiesMember" xlink:label="loc_ACTGTradingSecuritiesLFFundPublicSecuritiesMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritiesLFFundPublicSecuritiesMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesLfFundSecuritiesMember" xlink:label="loc_ACTGTradingSecuritesLfFundSecuritiesMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesLfFundSecuritiesMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfEquityInvestments_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfEquityInvestments_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapGainLossOnInvestments_290" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:title="00000052 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingLiabilitiesLineItems" xlink:label="loc_us-gaapOffsettingLiabilitiesLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OptionAgreementMember" xlink:label="loc_ACTGOptionAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGOptionAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PortfolioCompaniesMember" xlink:label="loc_ACTGPortfolioCompaniesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGPortfolioCompaniesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP" xlink:label="loc_currencyGBP_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyGBP_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity" xlink:label="loc_us-gaapPaymentsToAcquireAvailableForSaleSecuritiesEquity_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapPaymentsToAcquireAvailableForSaleSecuritiesEquity_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ReturnOnPrepayment" xlink:label="loc_ACTGReturnOnPrepayment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_ACTGReturnOnPrepayment_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:label="loc_us-gaapEquitySecuritiesFvNiRealizedGain_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiRealizedGain_50" xlink:type="arc" order="3" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>actg-20200930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="us-gaap_RedeemablePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemablePreferredStockMember" xlink:to="us-gaap_RedeemablePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemablePreferredStockMember_lbl" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NonCashStockCompensationExpenseMember" xlink:label="ACTG_NonCashStockCompensationExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NonCashStockCompensationExpenseMember" xlink:to="ACTG_NonCashStockCompensationExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NonCashStockCompensationExpenseMember_lbl" xml:lang="en-US">Non Cash Stock Compensation Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="ACTG_SeriesARedeemableConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:to="ACTG_SeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesARedeemableConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series A Redeemable Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="ACTG_PaidUpRevenueAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PaidUpRevenueAgreementsMember" xlink:to="ACTG_PaidUpRevenueAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PaidUpRevenueAgreementsMember_lbl" xml:lang="en-US">Paid Up Revenue Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="ACTG_RecurringRevenueAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RecurringRevenueAgreementsMember" xlink:to="ACTG_RecurringRevenueAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RecurringRevenueAgreementsMember_lbl" xml:lang="en-US">Recurring Revenue Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicenseeMember" xlink:label="ACTG_OneLicenseeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicenseeMember" xlink:to="ACTG_OneLicenseeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicenseeMember_lbl" xml:lang="en-US">One Licensee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee2Member" xlink:label="ACTG_OneLicensee2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicensee2Member" xlink:to="ACTG_OneLicensee2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicensee2Member_lbl" xml:lang="en-US">One Licensee 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee3Member" xlink:label="ACTG_OneLicensee3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicensee3Member" xlink:to="ACTG_OneLicensee3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicensee3Member_lbl" xml:lang="en-US">One Licensee 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee4Member" xlink:label="ACTG_OneLicensee4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OneLicensee4Member" xlink:to="ACTG_OneLicensee4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OneLicensee4Member_lbl" xml:lang="en-US">One Licensee 4 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ForeignLicenseeMember" xlink:label="ACTG_ForeignLicenseeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ForeignLicenseeMember" xlink:to="ACTG_ForeignLicenseeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ForeignLicenseeMember_lbl" xml:lang="en-US">Foreign Licensee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesrEquityMember" xlink:label="ACTG_TradingSecuritesrEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritesrEquityMember" xlink:to="ACTG_TradingSecuritesrEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritesrEquityMember_lbl" xml:lang="en-US">Trading Securitesr Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesEquityMember" xlink:label="ACTG_TradingSecuritesEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritesEquityMember" xlink:to="ACTG_TradingSecuritesEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritesEquityMember_lbl" xml:lang="en-US">Trading Securites Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesDebtMember" xlink:label="ACTG_TradingSecuritesDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritesDebtMember" xlink:to="ACTG_TradingSecuritesDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritesDebtMember_lbl" xml:lang="en-US">Trading Securites Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember" xlink:label="us-gaap_AssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsMember" xlink:to="us-gaap_AssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsMember_lbl" xml:lang="en-US">Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesEquityMember" xlink:label="ACTG_TradingSecuritiesEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritiesEquityMember" xlink:to="ACTG_TradingSecuritiesEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritiesEquityMember_lbl" xml:lang="en-US">Trading Securities Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesDerivativetMember" xlink:label="ACTG_EquitySecuritiesDerivativetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesDerivativetMember" xlink:to="ACTG_EquitySecuritiesDerivativetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesDerivativetMember_lbl" xml:lang="en-US">Equity Securities Derivativet [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesDerivativeMember" xlink:label="ACTG_EquitySecuritiesDerivativeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesDerivativeMember" xlink:to="ACTG_EquitySecuritiesDerivativeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesDerivativeMember_lbl" xml:lang="en-US">Equity Securities Derivative [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantInvestmentMember" xlink:label="ACTG_WarrantInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantInvestmentMember" xlink:to="ACTG_WarrantInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantInvestmentMember_lbl" xml:lang="en-US">Warrant Investment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesDebtMember" xlink:label="ACTG_TradingSecuritiesDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritiesDebtMember" xlink:to="ACTG_TradingSecuritiesDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritiesDebtMember_lbl" xml:lang="en-US">Trading Securities Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_CommonStockInvestmentMember" xlink:label="ACTG_CommonStockInvestmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_CommonStockInvestmentMember" xlink:to="ACTG_CommonStockInvestmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_CommonStockInvestmentMember_lbl" xml:lang="en-US">Common Stock Investment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember" xlink:label="us-gaap_LiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityMember" xlink:to="us-gaap_LiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilityMember_lbl" xml:lang="en-US">Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="ACTG_SeriesAWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAWarrantsMember" xlink:to="ACTG_SeriesAWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesAWarrantsMember_lbl" xml:lang="en-US">Series A Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="ACTG_SeriesBWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsMember" xlink:to="ACTG_SeriesBWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesBWarrantsMember_lbl" xml:lang="en-US">Series B Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmbeddedDerivativeLiabilityMember" xlink:label="ACTG_EmbeddedDerivativeLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EmbeddedDerivativeLiabilityMember" xlink:to="ACTG_EmbeddedDerivativeLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EmbeddedDerivativeLiabilityMember_lbl" xml:lang="en-US">Embedded Derivative Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:label="ACTG_SeriesAEmbeddedDerivativeLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:to="ACTG_SeriesAEmbeddedDerivativeLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesAEmbeddedDerivativeLiabilityMember_lbl" xml:lang="en-US">Series A Embedded Derivative Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsLiabilityMember" xlink:label="ACTG_SeriesBWarrantsLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsLiabilityMember" xlink:to="ACTG_SeriesBWarrantsLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesBWarrantsLiabilityMember_lbl" xml:lang="en-US">Series B Warrants Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_BlackScholesModelMember" xlink:label="ACTG_BlackScholesModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_BlackScholesModelMember" xlink:to="ACTG_BlackScholesModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_BlackScholesModelMember_lbl" xml:lang="en-US">Black Scholes Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_MonteCarloMethodMember" xlink:label="ACTG_MonteCarloMethodMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_MonteCarloMethodMember" xlink:to="ACTG_MonteCarloMethodMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_MonteCarloMethodMember_lbl" xml:lang="en-US">Monte Carlo Method [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantPrice525Member" xlink:label="ACTG_WarrantPrice525Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantPrice525Member" xlink:to="ACTG_WarrantPrice525Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantPrice525Member_lbl" xml:lang="en-US">Warrant Price 525 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="us-gaap_MeasurementInputDiscountRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputDiscountRateMember" xlink:to="us-gaap_MeasurementInputDiscountRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputDiscountRateMember_lbl" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantPrice365Member" xlink:label="ACTG_WarrantPrice365Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantPrice365Member" xlink:to="ACTG_WarrantPrice365Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantPrice365Member_lbl" xml:lang="en-US">Warrant Price 365 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmbeddedDerivativeMember" xlink:label="ACTG_EmbeddedDerivativeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EmbeddedDerivativeMember" xlink:to="ACTG_EmbeddedDerivativeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EmbeddedDerivativeMember_lbl" xml:lang="en-US">Embedded Derivative [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="us-gaap_MeasurementInputCreditSpreadMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputCreditSpreadMember" xlink:to="us-gaap_MeasurementInputCreditSpreadMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputCreditSpreadMember_lbl" xml:lang="en-US">Measurement Input, Credit Spread [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis_lbl" xml:lang="en-US">Investments in and Advances to Affiliates Categorization [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_VeritoneMember" xlink:label="ACTG_VeritoneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_VeritoneMember" xlink:to="ACTG_VeritoneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_VeritoneMember_lbl" xml:lang="en-US">Veritone [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RestrictedStockUnitsMember" xlink:label="ACTG_RestrictedStockUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RestrictedStockUnitsMember" xlink:to="ACTG_RestrictedStockUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RestrictedStockUnitsMember_lbl" xml:lang="en-US">Restricted Stock Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmployeeStockOptionsMember" xlink:label="ACTG_EmployeeStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EmployeeStockOptionsMember" xlink:to="ACTG_EmployeeStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EmployeeStockOptionsMember_lbl" xml:lang="en-US">Employee Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquityBasedIncentiveAwardsMember" xlink:label="ACTG_EquityBasedIncentiveAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquityBasedIncentiveAwardsMember" xlink:to="ACTG_EquityBasedIncentiveAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquityBasedIncentiveAwardsMember_lbl" xml:lang="en-US">Equity Based Incentive Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="us-gaap_ShareRepurchaseProgramAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareRepurchaseProgramAxis" xlink:to="us-gaap_ShareRepurchaseProgramAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareRepurchaseProgramAxis_lbl" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="ACTG_StockRepurchaseProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StockRepurchaseProgramMember" xlink:to="ACTG_StockRepurchaseProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StockRepurchaseProgramMember_lbl" xml:lang="en-US">Stock Repurchase Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesFinancingTransactionAxis_lbl" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="ACTG_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SecuritiesPurchaseAgreementMember" xlink:to="ACTG_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_StarboardValueMember" xlink:label="ACTG_StarboardValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_StarboardValueMember" xlink:to="ACTG_StarboardValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_StarboardValueMember_lbl" xml:lang="en-US">Starboard Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="ACTG_SeriesARedeemableConvertibleStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesARedeemableConvertibleStockMember" xlink:to="ACTG_SeriesARedeemableConvertibleStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesARedeemableConvertibleStockMember_lbl" xml:lang="en-US">Series A Redeemable Convertible Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeniorSecuredNotesMember" xlink:label="ACTG_SeniorSecuredNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeniorSecuredNotesMember" xlink:to="ACTG_SeniorSecuredNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeniorSecuredNotesMember_lbl" xml:lang="en-US">Senior Secured Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ExchangeAgreementMember" xlink:label="ACTG_ExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ExchangeAgreementMember" xlink:to="ACTG_ExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ExchangeAgreementMember_lbl" xml:lang="en-US">Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_MertonMember" xlink:label="ACTG_MertonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_MertonMember" xlink:to="ACTG_MertonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_MertonMember_lbl" xml:lang="en-US">Merton [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeniorSecuredNotes1Member" xlink:label="ACTG_SeniorSecuredNotes1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeniorSecuredNotes1Member" xlink:to="ACTG_SeniorSecuredNotes1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeniorSecuredNotes1Member_lbl" xml:lang="en-US">Senior Secured Notes 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OptionAgreementMember" xlink:label="ACTG_OptionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OptionAgreementMember" xlink:to="ACTG_OptionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OptionAgreementMember_lbl" xml:lang="en-US">Option Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PortfolioCompaniesMember" xlink:label="ACTG_PortfolioCompaniesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PortfolioCompaniesMember" xlink:to="ACTG_PortfolioCompaniesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PortfolioCompaniesMember_lbl" xml:lang="en-US">Portfolio Companies [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP" xlink:label="currency_GBP" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_GBP" xlink:to="currency_GBP_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_GBP_lbl" xml:lang="en-US">United Kingdom, Pounds</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesLfFundPublicSecuritiesMember" xlink:label="ACTG_TradingSecuritesLfFundPublicSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritesLfFundPublicSecuritiesMember" xlink:to="ACTG_TradingSecuritesLfFundPublicSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritesLfFundPublicSecuritiesMember_lbl" xml:lang="en-US">Trading Securites Lf Fund Public Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember" xlink:label="ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember" xlink:to="ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember_lbl" xml:lang="en-US">Equity Securities L F Fund Private Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesForwardContractMember" xlink:label="ACTG_EquitySecuritiesForwardContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecuritiesForwardContractMember" xlink:to="ACTG_EquitySecuritiesForwardContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecuritiesForwardContractMember_lbl" xml:lang="en-US">Equity Securities Forward Contract [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesLFFundPublicSecuritiesMember" xlink:label="ACTG_TradingSecuritiesLFFundPublicSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritiesLFFundPublicSecuritiesMember" xlink:to="ACTG_TradingSecuritiesLFFundPublicSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritiesLFFundPublicSecuritiesMember_lbl" xml:lang="en-US">Trading Securities L F Fund Public Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesLfFundSecuritiesMember" xlink:label="ACTG_TradingSecuritesLfFundSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_TradingSecuritesLfFundSecuritiesMember" xlink:to="ACTG_TradingSecuritesLfFundSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_TradingSecuritesLfFundSecuritiesMember_lbl" xml:lang="en-US">Trading Securites Lf Fund Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xml:lang="en-US">Trading securities - debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent_lbl" xml:lang="en-US">Trading securities - equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNi" xlink:to="us-gaap_EquitySecuritiesFvNi_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNi_lbl" xml:lang="en-US">Equity securities - private</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent" xlink:label="us-gaap_DerivativeAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeAssetsCurrent" xlink:to="us-gaap_DerivativeAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeAssetsCurrent_lbl" xml:lang="en-US">Equity securities derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="us-gaap_EquitySecuritiesFvNiCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiCost" xlink:to="us-gaap_EquitySecuritiesFvNiCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiCost_lbl" xml:lang="en-US">Equity securities forward contract</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PrepaidInvestment" xlink:label="ACTG_PrepaidInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PrepaidInvestment" xlink:to="ACTG_PrepaidInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PrepaidInvestment_lbl" xml:lang="en-US">Prepaid investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndInvestmentsNoncurrent_lbl" xml:lang="en-US">Long-term restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Investment at fair value (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Patents, net of accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Leased right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="ACTG_RoyaltiesAndContingentLegalFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_RoyaltiesAndContingentLegalFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_RoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="us-gaap_SecuredDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebtCurrent" xlink:to="us-gaap_SecuredDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuredDebtCurrent_lbl" xml:lang="en-US">Senior Secured Notes Payable - short-term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US">Series A warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_lbl" xml:lang="en-US">Series A embedded derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_DerivativeLiabilitiesNoncurrent1" xlink:label="ACTG_DerivativeLiabilitiesNoncurrent1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DerivativeLiabilitiesNoncurrent1" xlink:to="ACTG_DerivativeLiabilitiesNoncurrent1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DerivativeLiabilitiesNoncurrent1_lbl" xml:lang="en-US">Series B warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Long-term lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="us-gaap_PreferredStockRedemptionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionAmount" xlink:to="us-gaap_PreferredStockRedemptionAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionAmount_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of September 30, 2020 and December 31, 2019, respectively; aggregate liquidation preference of $35,000 as of September 30, 2020 and December 31, 2019, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $0.001 per share; 300,000,000 shares authorized; 49,279,453 and 50,370,987 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost, 4,604,365 and 2,919,828 shares as of September 30, 2020 and December 31, 2019, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Acacia Research Corporation stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, redeemable convertible preferred stock, and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xml:lang="en-US">Series A redeemable convertible preferred stock, liquidation preference</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="us-gaap_CostOfRevenueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenueAbstract" xlink:to="us-gaap_CostOfRevenueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenueAbstract_lbl" xml:lang="en-US">Portfolio operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Inventor royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ContingentLegalFees" xlink:label="ACTG_ContingentLegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ContingentLegalFees" xlink:to="ACTG_ContingentLegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ContingentLegalFees_lbl" xml:lang="en-US">Contingent legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="ACTG_LitigationAndLicensingExpensesPatents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_LitigationAndLicensingExpensesPatents" xlink:to="ACTG_LitigationAndLicensingExpensesPatents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_LitigationAndLicensingExpensesPatents_lbl" xml:lang="en-US">Litigation and licensing expenses - patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xml:lang="en-US">Other portfolio expenses (income)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Total portfolio operations</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="ACTG_NetPortfolioIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetPortfolioIncomeLoss" xlink:to="ACTG_NetPortfolioIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NetPortfolioIncomeLoss_lbl" xml:lang="en-US">Net portfolio income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses(1)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Change in fair value of investment, net (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="us-gaap_GainLossOnSaleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfInvestments" xlink:to="us-gaap_GainLossOnSaleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfInvestments_lbl" xml:lang="en-US">Loss on sale of investment (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="us-gaap_ImpairmentOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ImpairmentOfInvestments_lbl" xml:lang="en-US">Impairment of other investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_lbl" xml:lang="en-US">Gain on disposal of other investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet_lbl" xml:lang="en-US">Change in fair value of the Series A and B warrants and embedded derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl" xml:lang="en-US">Change in fair value of equity securities derivative and forward contract</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="us-gaap_GainLossOnSaleOfDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfDerivatives" xlink:to="us-gaap_GainLossOnSaleOfDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfDerivatives_lbl" xml:lang="en-US">Gain on sale of prepaid investment and derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesTradingUnrealizedGainLoss_lbl" xml:lang="en-US">Change in fair value of trading securities and equity securities - private</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet_lbl" xml:lang="en-US">Gain (loss) on sale of trading securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Loss on foreign currency exchange</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense on Senior Secured Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest income and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income (loss) before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax benefit (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net income (loss) including noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss attributable to noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income (loss) attributable to Acacia Research Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net income (loss) attributable to common stockholders - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net income (loss) per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of shares outstanding - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Net income (loss) attributable to common stockholders - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net income (loss) per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average number of shares outstanding - diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NoncashStockBasedCompensationCredit" xlink:label="ACTG_NoncashStockBasedCompensationCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NoncashStockBasedCompensationCredit" xlink:to="ACTG_NoncashStockBasedCompensationCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NoncashStockBasedCompensationCredit_lbl" xml:lang="en-US">Non-cash stock based compensation credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income (loss) attributable to Acacia Research Corporation</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" xlink:label="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" xlink:to="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue_lbl" xml:lang="en-US">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="us-gaap_DividendsPreferredStockStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockStock" xlink:to="us-gaap_DividendsPreferredStockStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStockStock_lbl" xml:lang="en-US">Dividend on Series A Redeemable Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Compensation expense for share-based awards, net of forfeitures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Compensation expense for share-based awards, net of forfeitures, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Repurchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Repurchase of common stock, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net income attributable to noncontrolling interests in subsidiaries</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net income (loss) including noncontrolling interests in subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income (loss) including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xml:lang="en-US">Change in fair value of investment, net (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="us-gaap_LossOnSaleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnSaleOfInvestments" xlink:to="us-gaap_LossOnSaleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LossOnSaleOfInvestments_lbl" xml:lang="en-US">Loss on sale of investment (Note 5)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfInvestments" xlink:to="us-gaap_ImpairmentOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfInvestments_2_lbl" xml:lang="en-US">Impairment of other investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2_lbl" xml:lang="en-US">Gain on disposal of other investment (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt discount and issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_lbl" xml:lang="en-US">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_lbl" xml:lang="en-US">Change in fair value of Series A warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_UnrealizedGainLossOnDerivatives1" xlink:label="ACTG_UnrealizedGainLossOnDerivatives1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_UnrealizedGainLossOnDerivatives1" xlink:to="ACTG_UnrealizedGainLossOnDerivatives1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ACTG_UnrealizedGainLossOnDerivatives1_lbl" xml:lang="en-US">Change in fair value of Series B warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Non-cash stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:to="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_lbl" xml:lang="en-US">Loss on foreign currency exchange</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:to="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_lbl" xml:lang="en-US">Change in fair value of trading securities and equity securities - private</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesRealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesRealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesRealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtSecuritiesRealizedGainLoss_lbl" xml:lang="en-US">Loss on sale of trading securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_2_lbl" xml:lang="en-US">Change in fair value of equity securities derivative and forward contract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfDerivatives" xlink:to="us-gaap_GainLossOnSaleOfDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfDerivatives_2_lbl" xml:lang="en-US">Gain on sale of prepaid investment and derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">Changes in assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_lbl" xml:lang="en-US">Royalties and contingent legal fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Patent acquisition costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment_lbl" xml:lang="en-US">Sale of investment at fair value (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_lbl" xml:lang="en-US">(Purchase) Sale of other investments (Note 5)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchases of trading securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xml:lang="en-US">Maturities and sales of trading securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Purchases of prepaid investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities" xlink:label="us-gaap_PaymentsForHedgeInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForHedgeInvestingActivities" xlink:to="us-gaap_PaymentsForHedgeInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForHedgeInvestingActivities_lbl" xml:lang="en-US">Equity securities derivative and forward contract acquisition cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Repurchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Issuance of Senior Secured Notes, net of lender fee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="us-gaap_RepaymentsOfSecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfSecuredDebt_lbl" xml:lang="en-US">Senior Secured Notes issuance costs paid to other parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividends_lbl" xml:lang="en-US">Dividend on Series A Redeemable Convertible Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Issuance of Series B warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Increase (decrease) in cash and cash equivalents and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents and restricted cash, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Supplemental schedule of noncash investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_AcquisitionOfPrepaidInvestmentSecurities" xlink:label="ACTG_AcquisitionOfPrepaidInvestmentSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AcquisitionOfPrepaidInvestmentSecurities" xlink:to="ACTG_AcquisitionOfPrepaidInvestmentSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AcquisitionOfPrepaidInvestmentSecurities_lbl" xml:lang="en-US">Acquisition of prepaid investment securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">3. INCOME (LOSS) PER SHARE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">4. PATENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfInvestmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract_lbl" xml:lang="en-US">Schedule of Investments [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTextBlock" xlink:label="us-gaap_InvestmentHoldingsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTextBlock" xlink:to="us-gaap_InvestmentHoldingsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsTextBlock_lbl" xml:lang="en-US">5. INVESTMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">6. COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">7. STOCKHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US">8. RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">9. FAIR VALUE DISCLOSURES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="us-gaap_PreferredStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesWarrantsAbstract" xlink:label="ACTG_SeriesWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesWarrantsAbstract" xlink:to="ACTG_SeriesWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesWarrantsAbstract_lbl" xml:lang="en-US">Series Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantDisclosureTextBlock" xlink:label="ACTG_WarrantDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantDisclosureTextBlock" xlink:to="ACTG_WarrantDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantDisclosureTextBlock_lbl" xml:lang="en-US">11. SERIES A WARRANTS</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsAbstract" xlink:label="ACTG_SeriesBWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsAbstract" xlink:to="ACTG_SeriesBWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesBWarrantsAbstract_lbl" xml:lang="en-US">Series B Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsTextBlock" xlink:label="ACTG_SeriesBWarrantsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsTextBlock" xlink:to="ACTG_SeriesBWarrantsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesBWarrantsTextBlock_lbl" xml:lang="en-US">12. SERIES B WARRANTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">13. SENIOR SECURED NOTES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">15. SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_DescriptionOfBusinessPolicyTextBlock" xlink:label="ACTG_DescriptionOfBusinessPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DescriptionOfBusinessPolicyTextBlock" xlink:to="ACTG_DescriptionOfBusinessPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_DescriptionOfBusinessPolicyTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PortfolioOperationsPolicyTextBlock" xlink:label="ACTG_PortfolioOperationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PortfolioOperationsPolicyTextBlock" xlink:to="ACTG_PortfolioOperationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PortfolioOperationsPolicyTextBlock_lbl" xml:lang="en-US">Portfolio Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Long Term Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PrepaidInvestmentPoliciesTextBlock" xlink:label="ACTG_PrepaidInvestmentPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PrepaidInvestmentPoliciesTextBlock" xlink:to="ACTG_PrepaidInvestmentPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_PrepaidInvestmentPoliciesTextBlock_lbl" xml:lang="en-US">Prepaid Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecurityForwardContractPoliciesTextBlock" xlink:label="ACTG_EquitySecurityForwardContractPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecurityForwardContractPoliciesTextBlock" xlink:to="ACTG_EquitySecurityForwardContractPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EquitySecurityForwardContractPoliciesTextBlock_lbl" xml:lang="en-US">Equity Securities Derivative and Forward Contract</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:label="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:to="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_lbl" xml:lang="en-US">Trading Securities- Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US">Trading Securities - Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsPolicyTextBlock" xlink:label="ACTG_SeriesAWarrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAWarrantsPolicyTextBlock" xlink:to="ACTG_SeriesAWarrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesAWarrantsPolicyTextBlock_lbl" xml:lang="en-US">Series A Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsPolicyTextBlock" xlink:label="ACTG_SeriesBWarrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsPolicyTextBlock" xlink:to="ACTG_SeriesBWarrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_SeriesBWarrantsPolicyTextBlock_lbl" xml:lang="en-US">Series B Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesEmbeddedDerivatives" xlink:label="us-gaap_DerivativesEmbeddedDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesEmbeddedDerivatives" xlink:to="us-gaap_DerivativesEmbeddedDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesEmbeddedDerivatives_lbl" xml:lang="en-US">Embedded derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investments at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAndCostMethodInvestmentsPolicy" xlink:label="us-gaap_EquityAndCostMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAndCostMethodInvestmentsPolicy" xlink:to="us-gaap_EquityAndCostMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAndCostMethodInvestmentsPolicy_lbl" xml:lang="en-US">Other Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xml:lang="en-US">Treasury Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostMethodInvestmentsPolicy" xlink:label="us-gaap_CostMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostMethodInvestmentsPolicy" xlink:to="us-gaap_CostMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostMethodInvestmentsPolicy_lbl" xml:lang="en-US">Impairment of Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Disaggregation of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:to="us-gaap_AvailableForSaleSecuritiesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock_lbl" xml:lang="en-US">Gain (loss) on trading securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of fair value of financial assets and liabilities on a recurring basis</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Summary of changes in financial liability Level 3</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Calculation of basic and diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="us-gaap_GainLossOnInvestmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock_lbl" xml:lang="en-US">Schedule of gain (loss) on investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of future minimum operating lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:label="us-gaap_AcceleratedShareRepurchasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:to="us-gaap_AcceleratedShareRepurchasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcceleratedShareRepurchasesTextBlock_lbl" xml:lang="en-US">Schedule of repurchased shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl" xml:lang="en-US">Changes in fair value of Acacias Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NumberOfPatentPortfoliosAcquired" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NumberOfPatentPortfoliosAcquired" xlink:to="ACTG_NumberOfPatentPortfoliosAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired_lbl" xml:lang="en-US">Number of new patent portfolios acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_lbl" xml:lang="en-US">Investment Income [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:label="srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems_lbl" xml:lang="en-US">SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xml:lang="en-US">Available-for-sale Securities, Gross Unrealized Gain</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xml:lang="en-US">Available-for-sale Securities, Gross Unrealized Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="us-gaap_InvestmentOwnedAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl" xml:lang="en-US">Investment Owned, at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:label="us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems_lbl" xml:lang="en-US">Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Fair value ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_lbl" xml:lang="en-US">Issuance of Series B warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xml:lang="en-US">Remeasurement to fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Fair value ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:to="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_lbl" xml:lang="en-US">Assumptions used for derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investment in Veritone</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Numerator:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xml:lang="en-US">Dividend on Series A redeemable convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_lbl" xml:lang="en-US">Accretion of Series A redeemable convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:label="us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:to="us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_lbl" xml:lang="en-US">Undistributed earnings allocated to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStock" xlink:label="us-gaap_DividendsPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStock_lbl" xml:lang="en-US">Add: Dividend on Series A redeemable convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:label="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:to="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock_lbl" xml:lang="en-US">Add: Accretion of Series A redeemable convertible preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_lbl" xml:lang="en-US">Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesWarrants" xlink:label="ACTG_ChangeInFairValueOfSeriesWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesWarrants" xlink:to="ACTG_ChangeInFairValueOfSeriesWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfSeriesWarrants_lbl" xml:lang="en-US">Less: Change in fair value of Series A warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:label="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:to="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants_lbl" xml:lang="en-US">Less: Change in fair value of dilutive Series B warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="us-gaap_InterestExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseOther_lbl" xml:lang="en-US">Add: Interest expense associated with Starboard Notes, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_lbl" xml:lang="en-US">Add: Undistributed earnings allocated to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_lbl" xml:lang="en-US">Reallocation of undistributed earnings to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_lbl" xml:lang="en-US">Denominator:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Potentially dilutive common shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xml:lang="en-US">Remainder of 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">&#160;&#160;Patents, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_InvestmentHoldingsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsTable_lbl" xml:lang="en-US">Investment Holdings [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="us-gaap_InvestmentHoldingsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentHoldingsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentHoldingsLineItems_lbl" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_3_lbl" xml:lang="en-US">Change in fair value of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="us-gaap_GainOnSaleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainOnSaleOfInvestments" xlink:to="us-gaap_GainOnSaleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainOnSaleOfInvestments_lbl" xml:lang="en-US">Gain on sale of investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnSaleOfInvestments" xlink:to="us-gaap_LossOnSaleOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LossOnSaleOfInvestments_2_lbl" xml:lang="en-US">Loss on sale of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="us-gaap_GainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestments_lbl" xml:lang="en-US">Net realized and unrealized gain (loss) on investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyLineItems" xlink:label="us-gaap_RepurchaseAgreementCounterpartyLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepurchaseAgreementCounterpartyLineItems" xlink:to="us-gaap_RepurchaseAgreementCounterpartyLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepurchaseAgreementCounterpartyLineItems_lbl" xml:lang="en-US">Repurchase Agreement Counterparty [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NumberOfWarrants" xlink:label="ACTG_NumberOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NumberOfWarrants" xlink:to="ACTG_NumberOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_NumberOfWarrants_lbl" xml:lang="en-US">Number of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrants price</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_InvestmentSharesSold" xlink:label="ACTG_InvestmentSharesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InvestmentSharesSold" xlink:to="ACTG_InvestmentSharesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_InvestmentSharesSold_lbl" xml:lang="en-US">Investment shares sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossOnSaleOfInvestments" xlink:to="us-gaap_LossOnSaleOfInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossOnSaleOfInvestments_3_lbl" xml:lang="en-US">Loss from sale of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of stock sold</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfInvestments" xlink:to="us-gaap_GainLossOnSaleOfInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnSaleOfInvestments_2_lbl" xml:lang="en-US">Realized gain</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_InvestmentWarrants" xlink:label="ACTG_InvestmentWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InvestmentWarrants" xlink:to="ACTG_InvestmentWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_InvestmentWarrants_lbl" xml:lang="en-US">Investment warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl" xml:lang="en-US">Fair value of investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total minimum payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Less: short-term lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US">Operating lease costs, net of sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementContingentRevenue" xlink:label="us-gaap_OperatingLeasesIncomeStatementContingentRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesIncomeStatementContingentRevenue" xlink:to="us-gaap_OperatingLeasesIncomeStatementContingentRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesIncomeStatementContingentRevenue_lbl" xml:lang="en-US">Income from settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xml:lang="en-US">Contingency accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Class of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xml:lang="en-US">Number of shares repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="us-gaap_TreasuryStockAcquiredAverageCostPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="us-gaap_TreasuryStockAcquiredAverageCostPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockAcquiredAverageCostPerShare_lbl" xml:lang="en-US">Average price paid per share</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:to="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_lbl" xml:lang="en-US">Approximate value of shares that may yet be purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramExpirationDate" xlink:to="us-gaap_StockRepurchaseProgramExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate_lbl" xml:lang="en-US">Plan expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="us-gaap_ClassOfTreasuryStockTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfTreasuryStockTable" xlink:to="us-gaap_ClassOfTreasuryStockTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfTreasuryStockTable_lbl" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="us-gaap_EquityClassOfTreasuryStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityClassOfTreasuryStockLineItems_lbl" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Value of shares authorized for repurchase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTable" xlink:label="us-gaap_SecuritiesFinancingTransactionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionTable" xlink:to="us-gaap_SecuritiesFinancingTransactionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesFinancingTransactionTable_lbl" xml:lang="en-US">Securities Financing Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionLineItems" xlink:label="us-gaap_SecuritiesFinancingTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesFinancingTransactionLineItems" xlink:to="us-gaap_SecuritiesFinancingTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesFinancingTransactionLineItems_lbl" xml:lang="en-US">Securities Financing Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsIssued" xlink:label="ACTG_WarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsIssued" xlink:to="ACTG_WarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantsIssued_lbl" xml:lang="en-US">Warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrent" xlink:to="us-gaap_DividendsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xml:lang="en-US">Accrued and unpaid dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionExpense" xlink:label="us-gaap_AccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpense_lbl" xml:lang="en-US">Accretion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_2_lbl" xml:lang="en-US">Fair value of Series A embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsIssuedShares" xlink:label="ACTG_WarrantsIssuedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsIssuedShares" xlink:to="ACTG_WarrantsIssuedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantsIssuedShares_lbl" xml:lang="en-US">Warrants issued, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsExercised" xlink:label="ACTG_WarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercised" xlink:to="ACTG_WarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_WarrantsExercised_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:to="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCapitalizationEquityLineItems_lbl" xml:lang="en-US">Schedule of Capitalization, Equity [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xml:lang="en-US">Proceeds from issuance of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US">Warrant expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsExercisedShares" xlink:label="ACTG_WarrantsExercisedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercisedShares" xlink:to="ACTG_WarrantsExercisedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ACTG_WarrantsExercisedShares_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingLiabilitiesLineItems" xlink:label="us-gaap_OffsettingLiabilitiesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingLiabilitiesLineItems" xlink:to="us-gaap_OffsettingLiabilitiesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingLiabilitiesLineItems_lbl" xml:lang="en-US">Offsetting Liabilities [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfSecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt_lbl" xml:lang="en-US">Proceeds from issuance of debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfSecuredDebt_2_lbl" xml:lang="en-US">Repayment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US">Payment of lenders fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Payment of other issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xml:lang="en-US">Discount</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OriginalIssueDiscount" xlink:label="ACTG_OriginalIssueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_OriginalIssueDiscount" xlink:to="ACTG_OriginalIssueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_OriginalIssueDiscount_lbl" xml:lang="en-US">Original Issue Discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Unamortized Discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Remaining discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments" xlink:label="us-gaap_GainLossOnSaleOfEquityInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfEquityInvestments" xlink:to="us-gaap_GainLossOnSaleOfEquityInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnSaleOfEquityInvestments_lbl" xml:lang="en-US">Gain (loss) on sale of trading securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity_lbl" xml:lang="en-US">Payment to acquire equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ReturnOnPrepayment" xlink:label="ACTG_ReturnOnPrepayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ReturnOnPrepayment" xlink:to="ACTG_ReturnOnPrepayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ReturnOnPrepayment_lbl" xml:lang="en-US">Return on prepayment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_lbl" xml:lang="en-US">Proceeds from sale of securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:to="us-gaap_EquitySecuritiesFvNiRealizedGain_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiRealizedGain_lbl" xml:lang="en-US">Gain on sale of deriviative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PrepaidInvestment" xlink:to="ACTG_PrepaidInvestment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_PrepaidInvestment_doc" xml:lang="en-US">Prepaid Investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_RoyaltiesAndContingentLegalFeesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_RoyaltiesAndContingentLegalFeesPayable_doc" xml:lang="en-US">Royalties and contingent legal fees payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DerivativeLiabilitiesNoncurrent1" xlink:to="ACTG_DerivativeLiabilitiesNoncurrent1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_DerivativeLiabilitiesNoncurrent1_doc" xml:lang="en-US">Series B warrant liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ContingentLegalFees" xlink:to="ACTG_ContingentLegalFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ContingentLegalFees_doc" xml:lang="en-US">Contingent legal fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_LitigationAndLicensingExpensesPatents" xlink:to="ACTG_LitigationAndLicensingExpensesPatents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_LitigationAndLicensingExpensesPatents_doc" xml:lang="en-US">Litigation and licensing expenses, patents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NetPortfolioIncomeLoss" xlink:to="ACTG_NetPortfolioIncomeLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NetPortfolioIncomeLoss_doc" xml:lang="en-US">Net portfolio income loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NoncashStockBasedCompensationCredit" xlink:to="ACTG_NoncashStockBasedCompensationCredit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NoncashStockBasedCompensationCredit_doc" xml:lang="en-US">Non-cash stock based compensation credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NonCashStockCompensationExpenseMember" xlink:to="ACTG_NonCashStockCompensationExpenseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NonCashStockCompensationExpenseMember_doc" xml:lang="en-US">Non-cash stock compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:to="ACTG_SeriesARedeemableConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_SeriesARedeemableConvertiblePreferredStockMember_doc" xml:lang="en-US">Series A Redeemable Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" xlink:to="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue_doc" xml:lang="en-US">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_doc" xml:lang="en-US">Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_UnrealizedGainLossOnDerivatives1" xlink:to="ACTG_UnrealizedGainLossOnDerivatives1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_UnrealizedGainLossOnDerivatives1_doc" xml:lang="en-US">Change in fair value of Series B warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_doc" xml:lang="en-US">Increase Decrease In Royalties And Contingent Legal Fees Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantDisclosureTextBlock" xlink:to="ACTG_WarrantDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantDisclosureTextBlock_doc" xml:lang="en-US">Warrant disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsTextBlock" xlink:to="ACTG_SeriesBWarrantsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_SeriesBWarrantsTextBlock_doc" xml:lang="en-US">Series B Warrants [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_DescriptionOfBusinessPolicyTextBlock" xlink:to="ACTG_DescriptionOfBusinessPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_DescriptionOfBusinessPolicyTextBlock_doc" xml:lang="en-US">Description of Business [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PortfolioOperationsPolicyTextBlock" xlink:to="ACTG_PortfolioOperationsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_PortfolioOperationsPolicyTextBlock_doc" xml:lang="en-US">Portfolio Operations [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_PrepaidInvestmentPoliciesTextBlock" xlink:to="ACTG_PrepaidInvestmentPoliciesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_PrepaidInvestmentPoliciesTextBlock_doc" xml:lang="en-US">Prepaid Investment [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EquitySecurityForwardContractPoliciesTextBlock" xlink:to="ACTG_EquitySecurityForwardContractPoliciesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_EquitySecurityForwardContractPoliciesTextBlock_doc" xml:lang="en-US">Equity Security Forward Contract [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesAWarrantsPolicyTextBlock" xlink:to="ACTG_SeriesAWarrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_SeriesAWarrantsPolicyTextBlock_doc" xml:lang="en-US">Series A Warrants [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsPolicyTextBlock" xlink:to="ACTG_SeriesBWarrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_SeriesBWarrantsPolicyTextBlock_doc" xml:lang="en-US">Series B Warrants [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NumberOfPatentPortfoliosAcquired" xlink:to="ACTG_NumberOfPatentPortfoliosAcquired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NumberOfPatentPortfoliosAcquired_doc" xml:lang="en-US">Number of patent portfolios acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract_doc" xml:lang="en-US">Denominator [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:to="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock_doc" xml:lang="en-US">Accretion of Series A redeemable convertible preferred stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_NumberOfWarrants" xlink:to="ACTG_NumberOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_NumberOfWarrants_doc" xml:lang="en-US">Number of warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InvestmentSharesSold" xlink:to="ACTG_InvestmentSharesSold_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_InvestmentSharesSold_doc" xml:lang="en-US">Investment shares sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_InvestmentWarrants" xlink:to="ACTG_InvestmentWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_InvestmentWarrants_doc" xml:lang="en-US">Investment warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:to="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ApproximateValueOfSharesThatMayYetBePurchased_doc" xml:lang="en-US">Approximate value of shares that may yet be purchased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsIssued" xlink:to="ACTG_WarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantsIssued_doc" xml:lang="en-US">Warrants issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsIssuedShares" xlink:to="ACTG_WarrantsIssuedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantsIssuedShares_doc" xml:lang="en-US">Warrants issued, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercised" xlink:to="ACTG_WarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantsExercised_doc" xml:lang="en-US">Warrants exercised, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercisedShares" xlink:to="ACTG_WarrantsExercisedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_WarrantsExercisedShares_doc" xml:lang="en-US">Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesWarrants" xlink:to="ACTG_ChangeInFairValueOfSeriesWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ChangeInFairValueOfSeriesWarrants_doc" xml:lang="en-US">Change in fair value of Series A warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:to="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants_doc" xml:lang="en-US">Change in fair value of dilutive Series B warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_doc" xml:lang="en-US">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ReturnOnPrepayment" xlink:to="ACTG_ReturnOnPrepayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ACTG_ReturnOnPrepayment_doc" xml:lang="en-US">Return on prepayment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_2_lbl" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_2_lbl" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_2_lbl" xml:lang="en-US">Interest Expense, Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStockStock" xlink:to="us-gaap_DividendsPreferredStockStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStockStock_2_lbl" xml:lang="en-US">Dividends, Preferred Stock, Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:to="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative_3_lbl" xml:lang="en-US">ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnDerivatives_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_UnrealizedGainLossOnDerivatives1" xlink:to="ACTG_UnrealizedGainLossOnDerivatives1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_UnrealizedGainLossOnDerivatives1_3_lbl" xml:lang="en-US">UnrealizedGainLossOnDerivatives1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:to="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:to="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_2_lbl" xml:lang="en-US">Trading Securities, Change in Unrealized Holding Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesRealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesRealizedGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesRealizedGainLoss_2_lbl" xml:lang="en-US">Debt Securities, Realized Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:to="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable_3_lbl" xml:lang="en-US">IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForHedgeInvestingActivities" xlink:to="us-gaap_PaymentsForHedgeInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForHedgeInvestingActivities_2_lbl" xml:lang="en-US">Payments for Hedge, Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividends_2_lbl" xml:lang="en-US">Payments of Dividends</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_SeriesBWarrantsPolicyTextBlock" xlink:to="ACTG_SeriesBWarrantsPolicyTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_SeriesBWarrantsPolicyTextBlock_3_lbl" xml:lang="en-US">SeriesBWarrantsPolicyTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_2_lbl" xml:lang="en-US">Available-for-sale Securities, Gross Unrealized Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_2_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_2_lbl" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:to="us-gaap_PreferredStockAccretionOfRedemptionDiscount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockAccretionOfRedemptionDiscount_2_lbl" xml:lang="en-US">Preferred Stock, Accretion of Redemption Discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercised" xlink:to="ACTG_WarrantsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantsExercised_3_lbl" xml:lang="en-US">WarrantsExercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ACTG_WarrantsExercisedShares" xlink:to="ACTG_WarrantsExercisedShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ACTG_WarrantsExercisedShares_3_lbl" xml:lang="en-US">WarrantsExercisedShares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfEquityInvestments" xlink:to="us-gaap_GainLossOnSaleOfEquityInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfEquityInvestments_2_lbl" xml:lang="en-US">Gain (Loss) on Sale of Equity Investments</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>actg-20200930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://acaciaresearch.com/role/Cover" xlink:href="actg-20200930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:href="actg-20200930.xsd#UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShare" xlink:href="actg-20200930.xsd#IncomeLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Patents" xlink:href="actg-20200930.xsd#Patents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/Investments" xlink:href="actg-20200930.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:href="actg-20200930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquity" xlink:href="actg-20200930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:href="actg-20200930.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/FairValueDisclosures" xlink:href="actg-20200930.xsd#FairValueDisclosures" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:href="actg-20200930.xsd#SeriesRedeemableConvertiblePreferredStock" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrants" xlink:href="actg-20200930.xsd#SeriesWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesBWarrants" xlink:href="actg-20200930.xsd#SeriesBWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeniorSecuredNotes" xlink:href="actg-20200930.xsd#SeniorSecuredNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SubsequentEvents" xlink:href="actg-20200930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShareTables" xlink:href="actg-20200930.xsd#IncomeLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsTables" xlink:href="actg-20200930.xsd#PatentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsTables" xlink:href="actg-20200930.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:href="actg-20200930.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="actg-20200930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="actg-20200930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/IncomeLossPerShareDetails" xlink:href="actg-20200930.xsd#IncomeLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetails" xlink:href="actg-20200930.xsd#PatentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:href="actg-20200930.xsd#PatentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetails" xlink:href="actg-20200930.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:href="actg-20200930.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="actg-20200930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:href="actg-20200930.xsd#StockholdersEquityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:href="actg-20200930.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative" xlink:href="actg-20200930.xsd#SeriesBWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative" xlink:href="actg-20200930.xsd#SeniorSecuredNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:href="actg-20200930.xsd#LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:label="loc_us-gaapAvailableForSaleSecuritiesEquitySecuritiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesEquitySecuritiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="loc_us-gaapEquitySecuritiesFvNi" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapEquitySecuritiesFvNi" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetsCurrent" xlink:label="loc_us-gaapDerivativeAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDerivativeAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiCost" xlink:label="loc_us-gaapEquitySecuritiesFvNiCost" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapEquitySecuritiesFvNiCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PrepaidInvestment" xlink:label="loc_ACTGPrepaidInvestment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_ACTGPrepaidInvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapRestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ACTGRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaapSecuredDebtCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapSecuredDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_DerivativeLiabilitiesNoncurrent1" xlink:label="loc_ACTGDerivativeLiabilitiesNoncurrent1" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_ACTGDerivativeLiabilitiesNoncurrent1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockRedemptionAmount" xlink:label="loc_us-gaapPreferredStockRedemptionAmount" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockRedemptionAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockMember" xlink:label="loc_us-gaapRedeemablePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapRedeemablePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="loc_us-gaapTemporaryEquityRedemptionPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityRedemptionPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreference" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreference" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaapCostOfRevenueAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenueAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ContingentLegalFees" xlink:label="loc_ACTGContingentLegalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGContingentLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_LitigationAndLicensingExpensesPatents" xlink:label="loc_ACTGLitigationAndLicensingExpensesPatents" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGLitigationAndLicensingExpensesPatents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NetPortfolioIncomeLoss" xlink:label="loc_ACTGNetPortfolioIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_ACTGNetPortfolioIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostOfRevenueAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:label="loc_us-gaapIncreaseDecreaseInEquitySecuritiesFvNi" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesTradingUnrealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesTradingUnrealizedGainLoss" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapDebtSecuritiesTradingUnrealizedGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossRealizedGainLossNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NonCashStockCompensationExpenseMember" xlink:label="loc_ACTGNonCashStockCompensationExpenseMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_ACTGNonCashStockCompensationExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NoncashStockBasedCompensationCredit" xlink:label="loc_ACTGNoncashStockBasedCompensationCredit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGNoncashStockBasedCompensationCredit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity" xlink:title="00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_ACTGSeriesARedeemableConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" xlink:label="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStockStock" xlink:label="loc_us-gaapDividendsPreferredStockStock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStockStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_us-gaapImpairmentOfInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapImpairmentOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:label="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives" xlink:label="loc_us-gaapUnrealizedGainLossOnDerivatives" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_UnrealizedGainLossOnDerivatives1" xlink:label="loc_ACTGUnrealizedGainLossOnDerivatives1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ACTGUnrealizedGainLossOnDerivatives1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_us-gaapUnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLoss" xlink:label="loc_us-gaapDebtSecuritiesRealizedGainLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDebtSecuritiesRealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:label="loc_us-gaapIncreaseDecreaseInEquitySecuritiesFvNi" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:label="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_ACTGIncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfOtherInvestments" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForHedgeInvestingActivities" xlink:label="loc_us-gaapPaymentsForHedgeInvestingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForHedgeInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaapPaymentsOfDividends" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividends" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_AcquisitionOfPrepaidInvestmentSecurities" xlink:label="loc_ACTGAcquisitionOfPrepaidInvestmentSecurities" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_ACTGAcquisitionOfPrepaidInvestmentSecurities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShare" xlink:title="00000010 - Disclosure - 3. INCOME (LOSS) PER SHARE">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Patents" xlink:title="00000011 - Disclosure - 4. PATENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/Investments" xlink:title="00000012 - Disclosure - 5. INVESTMENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTextBlock" xlink:label="loc_us-gaapInvestmentHoldingsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapInvestmentHoldingsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquity" xlink:title="00000014 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/RecentAccountingPronouncements" xlink:title="00000015 - Disclosure - 8. RECENT ACCOUNTING PRONOUNCEMENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingChangesAndErrorCorrectionsAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/FairValueDisclosures" xlink:title="00000016 - Disclosure - 9. FAIR VALUE DISCLOSURES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock" xlink:title="00000017 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockTextBlock" xlink:label="loc_us-gaapPreferredStockTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapPreferredStockTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrants" xlink:title="00000018 - Disclosure - 11. SERIES A WARRANTS">
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesWarrantsAbstract" xlink:label="loc_ACTGSeriesWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantDisclosureTextBlock" xlink:label="loc_ACTGWarrantDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGSeriesWarrantsAbstract" xlink:to="loc_ACTGWarrantDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesBWarrants" xlink:title="00000019 - Disclosure - 12. SERIES B WARRANTS">
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsAbstract" xlink:label="loc_ACTGSeriesBWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsTextBlock" xlink:label="loc_ACTGSeriesBWarrantsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGSeriesBWarrantsAbstract" xlink:to="loc_ACTGSeriesBWarrantsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeniorSecuredNotes" xlink:title="00000020 - Disclosure - 13. SENIOR SECURED NOTES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment" xlink:title="00000021 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - 15. SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies" xlink:title="00000023 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_DescriptionOfBusinessPolicyTextBlock" xlink:label="loc_ACTGDescriptionOfBusinessPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_ACTGDescriptionOfBusinessPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000024 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PortfolioOperationsPolicyTextBlock" xlink:label="loc_ACTGPortfolioOperationsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGPortfolioOperationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PrepaidInvestmentPoliciesTextBlock" xlink:label="loc_ACTGPrepaidInvestmentPoliciesTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGPrepaidInvestmentPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecurityForwardContractPoliciesTextBlock" xlink:label="loc_ACTGEquitySecurityForwardContractPoliciesTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGEquitySecurityForwardContractPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:label="loc_us-gaapAvailableForSaleSecuritiesPurchasedOptionsPricePolicy" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesPurchasedOptionsPricePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityMethodInvestmentsPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsPolicyTextBlock" xlink:label="loc_ACTGSeriesAWarrantsPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGSeriesAWarrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsPolicyTextBlock" xlink:label="loc_ACTGSeriesBWarrantsPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ACTGSeriesBWarrantsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesEmbeddedDerivatives" xlink:label="loc_us-gaapDerivativesEmbeddedDerivatives" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesEmbeddedDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAndCostMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityAndCostMethodInvestmentsPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityAndCostMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="loc_us-gaapStockholdersEquityPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStockholdersEquityPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostMethodInvestmentsPolicy" xlink:label="loc_us-gaapCostMethodInvestmentsPolicy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000025 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:label="loc_us-gaapAvailableForSaleSecuritiesTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAvailableForSaleSecuritiesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShareTables" xlink:title="00000026 - Disclosure - 3. INCOME (LOSS) PER SHARE (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsTables" xlink:title="00000027 - Disclosure - 4. PATENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsTables" xlink:title="00000028 - Disclosure - 5. INVESTMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="loc_us-gaapGainLossOnInvestmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapGainLossOnInvestmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesTables" xlink:title="00000029 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityTables" xlink:title="00000030 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTextBlock" xlink:label="loc_us-gaapAcceleratedShareRepurchasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAcceleratedShareRepurchasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables" xlink:title="00000031 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestmentsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NumberOfPatentPortfoliosAcquired" xlink:label="loc_ACTGNumberOfPatentPortfoliosAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_ACTGNumberOfPatentPortfoliosAcquired" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails" xlink:title="00000033 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PaidUpRevenueAgreementsMember" xlink:label="loc_ACTGPaidUpRevenueAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGPaidUpRevenueAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RecurringRevenueAgreementsMember" xlink:label="loc_ACTGRecurringRevenueAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ACTGRecurringRevenueAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails" xlink:title="00000034 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:label="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_us-gaapInvestmentTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesrEquityMember" xlink:label="loc_ACTGTradingSecuritesrEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesrEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesEquityMember" xlink:label="loc_ACTGTradingSecuritesEquityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesDebtMember" xlink:label="loc_ACTGTradingSecuritesDebtMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails" xlink:title="00000035 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:label="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember" xlink:label="loc_us-gaapAssetsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesEquityMember" xlink:label="loc_ACTGTradingSecuritiesEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGTradingSecuritiesEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesDerivativetMember" xlink:label="loc_ACTGEquitySecuritiesDerivativetMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritiesDerivativetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesDerivativeMember" xlink:label="loc_ACTGEquitySecuritiesDerivativeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEquitySecuritiesDerivativeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesDebtMember" xlink:label="loc_ACTGTradingSecuritiesDebtMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGTradingSecuritiesDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGCommonStockInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGEmbeddedDerivativeLiabilityMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmbeddedDerivativeLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details" xlink:title="00000036 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:label="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember" xlink:label="loc_us-gaapLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAEmbeddedDerivativeLiabilityMember" xlink:label="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAEmbeddedDerivativeLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsLiabilityMember" xlink:label="loc_ACTGSeriesBWarrantsLiabilityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000037 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicenseeMember" xlink:label="loc_ACTGOneLicenseeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicenseeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee2Member" xlink:label="loc_ACTGOneLicensee2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee3Member" xlink:label="loc_ACTGOneLicensee3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OneLicensee4Member" xlink:label="loc_ACTGOneLicensee4Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGOneLicensee4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ForeignLicenseeMember" xlink:label="loc_ACTGForeignLicenseeMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_ACTGForeignLicenseeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaapMeasurementInputDiscountRateMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputDiscountRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputCreditSpreadMember" xlink:label="loc_us-gaapMeasurementInputCreditSpreadMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputCreditSpreadMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_BlackScholesModelMember" xlink:label="loc_ACTGBlackScholesModelMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ACTGBlackScholesModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_MonteCarloMethodMember" xlink:label="loc_ACTGMonteCarloMethodMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_ACTGMonteCarloMethodMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmbeddedDerivativeMember" xlink:label="loc_ACTGEmbeddedDerivativeMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGEmbeddedDerivativeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapAwardTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantPrice525Member" xlink:label="loc_ACTGWarrantPrice525Member" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGWarrantPrice525Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantPrice365Member" xlink:label="loc_ACTGWarrantPrice365Member" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ACTGWarrantPrice365Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:label="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationAxis" xlink:to="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_VeritoneMember" xlink:label="loc_ACTGVeritoneMember" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsInAndAdvancesToAffiliatesCategorizationDomain" xlink:to="loc_ACTGVeritoneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:label="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapDerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/IncomeLossPerShareDetails" xlink:title="00000038 - Disclosure - 3. INCOME (LOSS) PER SHARE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_RestrictedStockUnitsMember" xlink:label="loc_ACTGRestrictedStockUnitsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGRestrictedStockUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EmployeeStockOptionsMember" xlink:label="loc_ACTGEmployeeStockOptionsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGEmployeeStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquityBasedIncentiveAwardsMember" xlink:label="loc_ACTGEquityBasedIncentiveAwardsMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGEquityBasedIncentiveAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember_2" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGSeriesAWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ACTGSeriesBWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount" xlink:label="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapPreferredStockAccretionOfRedemptionDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:label="loc_us-gaapUndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapUndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapDividendsPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:label="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGAccretionOfSeriesRedeemableConvertiblePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" xlink:label="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfSeriesWarrants" xlink:label="loc_ACTGChangeInFairValueOfSeriesWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfSeriesWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants" xlink:label="loc_ACTGChangeInFairValueOfDilutiveSeriesBWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGChangeInFairValueOfDilutiveSeriesBWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:label="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:label="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapUndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:label="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGEarningsPerShareBasicAndDilutedDeniminatorAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetails" xlink:title="00000039 - Disclosure - 4. PATENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/PatentsDetailsNarrative" xlink:title="00000040 - Disclosure - 4. PATENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetails" xlink:title="00000041 - Disclosure - 5. INVESTMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="loc_us-gaapInvestmentHoldingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapInvestmentHoldingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="loc_us-gaapInvestmentHoldingsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsTable" xlink:to="loc_us-gaapInvestmentHoldingsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsTable" xlink:to="loc_us-gaapInvestmentTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGWarrantInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_CommonStockInvestmentMember" xlink:label="loc_ACTGCommonStockInvestmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGCommonStockInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="loc_us-gaapGainOnSaleOfInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentHoldingsLineItems" xlink:to="loc_us-gaapGainLossOnInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/InvestmentsDetailsNarrative" xlink:title="00000042 - Disclosure - 5. INVESTMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentsAbstract" xlink:label="loc_us-gaapScheduleOfInvestmentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyLineItems" xlink:label="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtCounterpartyNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_VeritoneMember" xlink:label="loc_ACTGVeritoneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGVeritoneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantInvestmentMember" xlink:label="loc_ACTGWarrantInvestmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ACTGWarrantInvestmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_NumberOfWarrants" xlink:label="loc_ACTGNumberOfWarrants" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_ACTGNumberOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_InvestmentSharesSold" xlink:label="loc_ACTGInvestmentSharesSold" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_ACTGInvestmentSharesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossOnSaleOfInvestments" xlink:label="loc_us-gaapLossOnSaleOfInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapLossOnSaleOfInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfInvestments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_InvestmentWarrants" xlink:label="loc_ACTGInvestmentWarrants" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_ACTGInvestmentWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:label="loc_us-gaapFinancialInstrumentsOwnedAtFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRepurchaseAgreementCounterpartyLineItems" xlink:to="loc_us-gaapFinancialInstrumentsOwnedAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000043 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000044 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementContingentRevenue" xlink:label="loc_us-gaapOperatingLeasesIncomeStatementContingentRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesIncomeStatementContingentRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaapLossContingencyAccrualAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLossContingencyAccrualAtCarryingValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetails" xlink:title="00000045 - Disclosure - 7. STOCKHOLDERS&apos; EQUITY (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaapScheduleOfStockByClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockByClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaapClassOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapClassOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfStockByClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaapTreasuryStockSharesAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTreasuryStockSharesAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:label="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapTreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ApproximateValueOfSharesThatMayYetBePurchased" xlink:label="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_ACTGApproximateValueOfSharesThatMayYetBePurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramExpirationDate" xlink:label="loc_us-gaapStockRepurchaseProgramExpirationDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramExpirationDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000046 - Disclosure - 7. STOCKHOLDERS&#8217; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfTreasuryStockTable" xlink:label="loc_us-gaapClassOfTreasuryStockTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfTreasuryStockTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems" xlink:label="loc_us-gaapEquityClassOfTreasuryStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfTreasuryStockTable" xlink:to="loc_us-gaapEquityClassOfTreasuryStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfTreasuryStockTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_StockRepurchaseProgramMember" xlink:label="loc_ACTGStockRepurchaseProgramMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_ACTGStockRepurchaseProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityClassOfTreasuryStockLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative" xlink:title="00000047 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTable" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionLineItems" xlink:label="loc_us-gaapSecuritiesFinancingTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="loc_ACTGSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertibleStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeriesARedeemableConvertibleStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsIssued" xlink:label="loc_ACTGWarrantsIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_ACTGWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative" xlink:title="00000048 - Disclosure - 11. SERIES A WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesWarrantsAbstract" xlink:label="loc_ACTGSeriesWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTable" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGSeriesWarrantsAbstract" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionLineItems" xlink:label="loc_us-gaapSecuritiesFinancingTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="loc_ACTGSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_StarboardValueMember" xlink:label="loc_ACTGStarboardValueMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGStarboardValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesAWarrantsMember" xlink:label="loc_ACTGSeriesAWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_ACTGSeriesAWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsIssuedShares" xlink:label="loc_ACTGWarrantsIssuedShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_ACTGWarrantsIssuedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsExercised" xlink:label="loc_ACTGWarrantsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_ACTGWarrantsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative" xlink:title="00000049 - Disclosure - 12. SERIES B WARRANTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsAbstract" xlink:label="loc_ACTGSeriesBWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ACTGSeriesBWarrantsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCapitalizationEquityLineItems" xlink:label="loc_us-gaapScheduleOfCapitalizationEquityLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapScheduleOfCapitalizationEquityLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ACTGSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsIssuedShares" xlink:label="loc_ACTGWarrantsIssuedShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_ACTGWarrantsIssuedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_WarrantsExercisedShares" xlink:label="loc_ACTGWarrantsExercisedShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_ACTGWarrantsExercisedShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCapitalizationEquityLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative" xlink:title="00000050 - Disclosure - 13. SENIOR SECURED NOTES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingLiabilitiesLineItems" xlink:label="loc_us-gaapOffsettingLiabilitiesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingLiabilitiesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SecuritiesPurchaseAgreementMember" xlink:label="loc_ACTGSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ExchangeAgreementMember" xlink:label="loc_ACTGExchangeAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeniorSecuredNotesMember" xlink:label="loc_ACTGSeniorSecuredNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ACTGSeniorSecuredNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeniorSecuredNotes1Member" xlink:label="loc_ACTGSeniorSecuredNotes1Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_ACTGSeniorSecuredNotes1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_MertonMember" xlink:label="loc_ACTGMertonMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGMertonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis" xlink:label="loc_us-gaapSecuritiesFinancingTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapSecuritiesFinancingTransactionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:label="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionAxis" xlink:to="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesARedeemableConvertibleStockMember" xlink:label="loc_ACTGSeriesARedeemableConvertibleStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSecuritiesFinancingTransactionTypeDomain" xlink:to="loc_ACTGSeriesARedeemableConvertibleStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_SeriesBWarrantsMember" xlink:label="loc_ACTGSeriesBWarrantsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ACTGSeriesBWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaapPaymentsOfFinancingCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapPaymentsOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent" xlink:label="loc_us-gaapDividendsPayableCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDividendsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OriginalIssueDiscount" xlink:label="loc_ACTGOriginalIssueDiscount" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_ACTGOriginalIssueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails" xlink:title="00000051 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:label="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_us-gaapInvestmentTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesLfFundPublicSecuritiesMember" xlink:label="loc_ACTGTradingSecuritesLfFundPublicSecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesLfFundPublicSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesDerivativeMember" xlink:label="loc_ACTGEquitySecuritiesDerivativeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGEquitySecuritiesDerivativeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember" xlink:label="loc_ACTGEquitySecuritiesLFFundPrivateSecuritiesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGEquitySecuritiesLFFundPrivateSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_EquitySecuritiesForwardContractMember" xlink:label="loc_ACTGEquitySecuritiesForwardContractMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGEquitySecuritiesForwardContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritiesLFFundPublicSecuritiesMember" xlink:label="loc_ACTGTradingSecuritiesLFFundPublicSecuritiesMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritiesLFFundPublicSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_TradingSecuritesLfFundSecuritiesMember" xlink:label="loc_ACTGTradingSecuritesLfFundSecuritiesMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_ACTGTradingSecuritesLfFundSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments" xlink:label="loc_us-gaapGainLossOnSaleOfEquityInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfEquityInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfDerivatives" xlink:label="loc_us-gaapGainLossOnSaleOfDerivatives" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapGainLossOnSaleOfDerivatives" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaapGainLossOnInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems" xlink:to="loc_us-gaapGainLossOnInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative" xlink:title="00000052 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingLiabilitiesLineItems" xlink:label="loc_us-gaapOffsettingLiabilitiesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingLiabilitiesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_OptionAgreementMember" xlink:label="loc_ACTGOptionAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_ACTGOptionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_PortfolioCompaniesMember" xlink:label="loc_ACTGPortfolioCompaniesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_ACTGPortfolioCompaniesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_srtCurrencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd#currency_GBP" xlink:label="loc_currencyGBP" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyGBP" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity" xlink:label="loc_us-gaapPaymentsToAcquireAvailableForSaleSecuritiesEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapPaymentsToAcquireAvailableForSaleSecuritiesEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="actg-20200930.xsd#ACTG_ReturnOnPrepayment" xlink:label="loc_ACTGReturnOnPrepayment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_ACTGReturnOnPrepayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:label="loc_us-gaapEquitySecuritiesFvNiRealizedGain" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingLiabilitiesLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiRealizedGain" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>acacia_i10q-093020_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ACTG="http://acaciaresearch.com/20200930"
  xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="actg-20200930.xsd" xlink:type="simple"/>
    <context id="From2020-01-01to2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-11-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2020-11-02</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_NonCashStockCompensationExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:NonCashStockCompensationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_NonCashStockCompensationExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:NonCashStockCompensationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_NonCashStockCompensationExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:NonCashStockCompensationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_NonCashStockCompensationExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ACTG:NonCashStockCompensationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="AsOf2020-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ACTG:SeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_PaidUpRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_PaidUpRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_PaidUpRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:PaidUpRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_RecurringRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_RecurringRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_RecurringRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_RecurringRevenueAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ACTG:RecurringRevenueAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:ForeignLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_OneLicenseeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicenseeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_OneLicensee2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">ACTG:OneLicensee2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_TradingSecuritesrEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesrEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_TradingSecuritesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_TradingSecuritesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_TradingSecuritesDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TradingSecuritesDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_TradingSecuritesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_TradingSecuritesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesDerivativetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:TradingSecuritiesEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAEmbeddedDerivativeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputDiscountRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputDiscountRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ACTG:WarrantPrice365Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ACTG:MonteCarloMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_EmbeddedDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_EmbeddedDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputCreditSpreadMember_custom_EmbeddedDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCreditSpreadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_EmbeddedDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:EmbeddedDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_VeritoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentsInAndAdvancesToAffiliatesCategorizationAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_EmployeeStockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:EmployeeStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquityBasedIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_EquityBasedIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquityBasedIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_EquityBasedIncentiveAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:EquityBasedIncentiveAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesAWarrantsMember132390937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_SeriesAWarrantsMember132390953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesAWarrantsMember132390968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_SeriesAWarrantsMember132390984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember132391000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_SeriesBWarrantsMember132391000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132391015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_SeriesBWarrantsMember132391031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2018-01-012018-12-31_custom_VeritoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_VeritoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-03-31_custom_VeritoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:VeritoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_WarrantInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:WarrantInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_CommonStockInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:CommonStockInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-08-05_custom_StockRepurchaseProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ACTG:StockRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-05</instant>
        </period>
    </context>
    <context id="From2020-03-202020-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-20</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-04-23_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-23</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_us-gaap_CommonStockMember132393281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-11-18</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-11-18</endDate>
        </period>
    </context>
    <context id="AsOf2019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-18</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:StarboardValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">ACTG:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-01-012020-02-25_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-02-25</endDate>
        </period>
    </context>
    <context id="AsOf2020-02-25_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-25</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132394531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-04</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotes1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotes1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesARedeemableConvertibleStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">ACTG:SeriesARedeemableConvertibleStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:MertonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">ACTG:SeniorSecuredNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_SeriesBWarrantsMember132395046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ACTG:SeriesBWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-06-04_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-04</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-04-03</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ACTG:PortfolioCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">ACTG:OptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquitySecuritiesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_EquitySecuritiesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquitySecuritiesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_EquitySecuritiesDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesLFFundPrivateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesLFFundPrivateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesLFFundPrivateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesLFFundPrivateSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_EquitySecuritiesForwardContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesForwardContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_EquitySecuritiesForwardContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesForwardContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_EquitySecuritiesForwardContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesForwardContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_EquitySecuritiesForwardContractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:EquitySecuritiesForwardContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritiesLFFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritiesLFFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritiesLFFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritiesLFFundPublicSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-07-012020-09-30_custom_TradingSecuritesLfFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-07-012019-09-30_custom_TradingSecuritesLfFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-09-30_custom_TradingSecuritesLfFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-09-30_custom_TradingSecuritesLfFundSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000934549</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">ACTG:TradingSecuritesLfFundSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>ACTG:Integer</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-09-30">0000934549</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-09-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-09-30">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-09-30">Q3</dei:DocumentFiscalPeriodFocus>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0453"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0469"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0474"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0502"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0506"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0507"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-07-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-07-012019-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-07-012019-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-07-012019-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0518"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-07-012019-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0532"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0548"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0549"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0550"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0551"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0553"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0557"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0558"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0561"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0564"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0566"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0569"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0573"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0579"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0581"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0582"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0594"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0595"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2018-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0621"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0625"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0626"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0627"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0628"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0630"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0634"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-01-012019-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0635"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0637"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0638"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0643"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0644"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0645"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0647"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0648"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0653"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0654"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0655"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0656"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0657"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0661"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      id="xdx2ixbrl0669"
      unitRef="Shares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2020-01-01to2020-09-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2020-01-01to2020-09-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-09-30">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2020-01-01to2020-09-30">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2020-01-01to2020-09-30">1-37721</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-09-30">Acacia Research Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-01-01to2020-09-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-01-01to2020-09-30">95-4405754</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-01-01to2020-09-30">4 Park Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2020-01-01to2020-09-30">Suite 550</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2020-01-01to2020-09-30">Irvine</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-01-01to2020-09-30">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-01-01to2020-09-30">92614</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-01-01to2020-09-30">(949)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-01-01to2020-09-30">480-8300</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2020-01-01to2020-09-30">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-01-01to2020-09-30">ACTG</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-01-01to2020-09-30">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-09-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-09-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-09-30">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-09-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-09-30">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2020-11-02" decimals="INF" unitRef="Shares">49279453</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">162564000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">57359000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">93843000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">24471000</us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">17140000</us-gaap:AvailableForSaleSecuritiesEquitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">116009000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssetsCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">17818000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">0</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">340000</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNiCost contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">0</us-gaap:EquitySecuritiesFvNiCost>
    <ACTG:PrepaidInvestment contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">42900000</ACTG:PrepaidInvestment>
    <ACTG:PrepaidInvestment contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">0</ACTG:PrepaidInvestment>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">263000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">511000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">1685000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">2912000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">366050000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">171765000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">35000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">35000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">982000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">1500000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">18071000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">7814000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">1101000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">1264000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">5311000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">818000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">426515000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">218161000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">2707000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">1765000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">4849000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">7265000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">2595000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">507000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <ACTG:RoyaltiesAndContingentLegalFeesPayable contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">14230000</ACTG:RoyaltiesAndContingentLegalFeesPayable>
    <ACTG:RoyaltiesAndContingentLegalFeesPayable contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">2178000</ACTG:RoyaltiesAndContingentLegalFeesPayable>
    <us-gaap:SecuredDebtCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">113933000</us-gaap:SecuredDebtCurrent>
    <us-gaap:SecuredDebtCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">0</us-gaap:SecuredDebtCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">138314000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">11715000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">5604000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">3568000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">25682000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">17974000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <ACTG:DerivativeLiabilitiesNoncurrent1 contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">42796000</ACTG:DerivativeLiabilitiesNoncurrent1>
    <ACTG:DerivativeLiabilitiesNoncurrent1 contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">0</ACTG:DerivativeLiabilitiesNoncurrent1>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">1101000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">1264000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">593000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">593000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">214090000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">35114000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">100</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">100</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="AsOf2020-09-30_us-gaap_RedeemablePreferredStockMember"
      decimals="-3"
      unitRef="USD">35000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="AsOf2019-12-31_us-gaap_RedeemablePreferredStockMember"
      decimals="-3"
      unitRef="USD">35000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:PreferredStockRedemptionAmount contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">10134000</us-gaap:PreferredStockRedemptionAmount>
    <us-gaap:PreferredStockRedemptionAmount contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">8089000</us-gaap:PreferredStockRedemptionAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2019-12-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">49279453</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">49279453</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">50370987</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">50370987</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">49000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">50000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockShares contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">4604365</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2019-12-31" decimals="INF" unitRef="Shares">2919828</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">43270000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">39272000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">650130000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">652003000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">-406451000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">-439656000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">200458000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">173125000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">1833000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">1833000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">202291000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">174958000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">426515000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">218161000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">19466000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">1711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">25399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">10558000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RoyaltyExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">5772000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">776000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">6843000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">4752000</us-gaap:RoyaltyExpense>
    <ACTG:ContingentLegalFees
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">6609000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">35000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">6855000</ACTG:ContingentLegalFees>
    <ACTG:ContingentLegalFees
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">587000</ACTG:ContingentLegalFees>
    <ACTG:LitigationAndLicensingExpensesPatents
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1001000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">987000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3497000</ACTG:LitigationAndLicensingExpensesPatents>
    <ACTG:LitigationAndLicensingExpensesPatents
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">6643000</ACTG:LitigationAndLicensingExpensesPatents>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1174000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">863000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3522000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">2337000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">475000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">308000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-175000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">14556000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">2186000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">20409000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">14494000</us-gaap:CostOfGoodsAndServicesSold>
    <ACTG:NetPortfolioIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">4910000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-475000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">4990000</ACTG:NetPortfolioIncomeLoss>
    <ACTG:NetPortfolioIncomeLoss
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-3936000</ACTG:NetPortfolioIncomeLoss>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">7692000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">4630000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">18089000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">12048000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-2782000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-5105000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-13099000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-15984000</us-gaap:OperatingIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-3081000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-4266000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3704000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">9622000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-915000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-2762000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-8147000</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">8195000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">2000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">2000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">20672000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-46612000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-64011000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">17542000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2845000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">2845000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:DebtSecuritiesTradingUnrealizedGainLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">84499000</us-gaap:DebtSecuritiesTradingUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesTradingUnrealizedGainLoss
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-482000</us-gaap:DebtSecuritiesTradingUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesTradingUnrealizedGainLoss
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">81907000</us-gaap:DebtSecuritiesTradingUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesTradingUnrealizedGainLoss
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">132000</us-gaap:DebtSecuritiesTradingUnrealizedGainLoss>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2737000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">238000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-4272000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
    <us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">226000</us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-48000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-106000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-4938000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-106000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InterestExpenseDebt
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2410000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3178000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">10000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">1028000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">811000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">3012000</us-gaap:InterestAndOtherIncome>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">41213000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-2503000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">45047000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-1456000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38431000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">31948000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17440000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">83000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-1257000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17763000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-14000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17749000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">30529000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">24838000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17749000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">48467885</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="Shares">49828361</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="Shares">48949706</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="Shares">49727385</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">29204000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">21380000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17749000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">90624702</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="Shares">49828361</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="Shares">60153773</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="Shares">49727385</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-07-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      unitRef="USD">7204000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-07-012019-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      unitRef="USD">4330000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      unitRef="USD">16846000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      unitRef="USD">11295000</us-gaap:GeneralAndAdministrativeExpense>
    <ACTG:NoncashStockBasedCompensationCredit
      contextRef="From2020-07-012020-09-30_custom_NonCashStockCompensationExpenseMember"
      decimals="-3"
      unitRef="USD">488000</ACTG:NoncashStockBasedCompensationCredit>
    <ACTG:NoncashStockBasedCompensationCredit
      contextRef="From2019-07-012019-09-30_custom_NonCashStockCompensationExpenseMember"
      decimals="-3"
      unitRef="USD">300000</ACTG:NoncashStockBasedCompensationCredit>
    <ACTG:NoncashStockBasedCompensationCredit
      contextRef="From2020-01-012020-09-30_custom_NonCashStockCompensationExpenseMember"
      decimals="-3"
      unitRef="USD">1243000</ACTG:NoncashStockBasedCompensationCredit>
    <ACTG:NoncashStockBasedCompensationCredit
      contextRef="From2019-01-012019-09-30_custom_NonCashStockCompensationExpenseMember"
      decimals="-3"
      unitRef="USD">753000</ACTG:NoncashStockBasedCompensationCredit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">7692000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">4630000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">18089000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">12048000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">9400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49306137</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">650843000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-444799000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-06-30" decimals="-3" unitRef="USD">164656000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:NetIncomeLoss>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">734000</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-734000</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-734000</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">467000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">467000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-26684</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">488000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">488000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">10134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49279453</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">650130000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-406451000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">202291000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">50132871</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-39272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">651688000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-432682000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-06-30" decimals="-3" unitRef="USD">181617000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2019-07-012019-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">210434</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-07-012019-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">50343305</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-39272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">651988000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-440290000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-09-30" decimals="-3" unitRef="USD">174309000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">8089000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">50370987</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-39272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">652003000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-439656000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">174958000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:NetIncomeLoss>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">2045000</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-2045000</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-2045000</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1119000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:DividendsPreferredStockStock
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">1119000</us-gaap:DividendsPreferredStockStock>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">48000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">48000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">593003</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-012020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">1243000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">1243000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">-1684537</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2020-01-012020-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">3998000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3999000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertiblePreferredStockMember"
      decimals="-3"
      unitRef="USD">10134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49279453</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">49000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-43270000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">650130000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-406451000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2020-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">202291000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">49639319</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-39272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">651156000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-422541000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2018-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1847000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2018-12-31" decimals="-3" unitRef="USD">191240000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-17749000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17749000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">25136</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">79000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">79000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2019-01-012019-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">678850</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">753000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">753000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-14000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-14000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">50343305</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-39272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">651988000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-440290000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2019-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2019-09-30" decimals="-3" unitRef="USD">174309000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17763000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3704000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">9622000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">2762000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">8147000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">8195000</us-gaap:ImpairmentOfInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">2000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3609000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">2344000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">955000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-7708000</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-2036000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:UnrealizedGainLossOnDerivatives>
    <ACTG:UnrealizedGainLossOnDerivatives1
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-36867000</ACTG:UnrealizedGainLossOnDerivatives1>
    <ACTG:UnrealizedGainLossOnDerivatives1
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</ACTG:UnrealizedGainLossOnDerivatives1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">1243000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">753000</us-gaap:ShareBasedCompensation>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-4938000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">81907000</us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss>
    <us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">914000</us-gaap:TradingSecuritiesUnrealizedHoldingGainLoss>
    <us-gaap:DebtSecuritiesRealizedGainLoss
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-4272000</us-gaap:DebtSecuritiesRealizedGainLoss>
    <us-gaap:DebtSecuritiesRealizedGainLoss
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:DebtSecuritiesRealizedGainLoss>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">17542000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">2845000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-248000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-31085000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-1038000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">983000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">614000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">326000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">12052000</ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
    <ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-20414000</ACTG:IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">5549000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-846000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">13780000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">4420000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">1460000</us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment>
    <us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">6260000</us-gaap:ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">2000000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">33800000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">103718000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">316746000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">38816000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">276275000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3989000</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:PaymentsForHedgeInvestingActivities
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PaymentsForHedgeInvestingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">177000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">119000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-9815000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-61181000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">3998000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">110437000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">496000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">1120000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">4600000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">48000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">79000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">109471000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">79000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">105205000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-61948000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">92359000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2018-12-31" decimals="-3" unitRef="USD">128809000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">197564000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-09-30" decimals="-3" unitRef="USD">66861000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <ACTG:AcquisitionOfPrepaidInvestmentSecurities
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">231480000</ACTG:AcquisitionOfPrepaidInvestmentSecurities>
    <ACTG:AcquisitionOfPrepaidInvestmentSecurities
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:AcquisitionOfPrepaidInvestmentSecurities>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_804_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zcOvkbxxmSQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;1. &lt;span&gt;DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_z32GuCyYITk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Description of Business&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As used herein, &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d;
&#x201c;Acacia&#x201d; and the &#x201c;Company&#x201d; refer to Acacia Research Corporation and/or its wholly and majority-owned and
controlled operating subsidiaries, and/or where applicable, its management.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia was incorporated on January 25, 1993 under the laws of
the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia&#x2019;s operating subsidiaries invest in, license and
enforce patented technologies. Acacia&#x2019;s operating subsidiaries partner with inventors and patent owners, applying their legal
and technology expertise to patent assets to unlock the financial value in their patented inventions. In recent years, Acacia has
also invested in technology companies. Acacia leverages its experience, expertise, data and relationships developed as a leader
in the intellectual property (&#x201c;IP&#x201d;) industry to pursue these opportunities. In some cases, these opportunities will
complement, and/or supplement Acacia&#x2019;s primary licensing and enforcement business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia&#x2019;s operating subsidiaries generate revenues and
related cash flows from the granting of IP rights (hereinafter &#x201c;IP Rights&#x201d;) for the use of patented technologies that
its operating subsidiaries control or own. Acacia&#x2019;s operating subsidiaries assist patent owners with the prosecution and
development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing
revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their
patented technologies through the filing of patent infringement litigation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia&#x2019;s operating subsidiaries are principals in the
licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.
Acacia&#x2019;s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain
foreign counterparts, covering technologies used in a wide variety of industries.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP
through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#x2019;s
operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be
able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the nine months ended
September 30, 2020, Acacia obtained control of four &lt;span id="xdx_90C_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20200101__20200930_zh7nbsdkupS5" style="display: none" title="Number of new patent portfolios acquired"&gt;4&lt;/span&gt; new patent portfolios. During fiscal year 2019, Acacia obtained control
of five &lt;span id="xdx_902_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20190101__20191231_zn2FWCeypwof" style="display: none" title="Number of new patent portfolios acquired"&gt;5&lt;/span&gt; new patent portfolios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAHYR1QGEwDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated financial
statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany
transactions and balances have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly,
certain information and footnotes required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance
with quarterly reporting requirements of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). These interim unaudited condensed
consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes
thereto for the year ended December 31, 2019, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March
16, 2020, as well as in our other public filings with the SEC. The condensed consolidated interim financial statements of Acacia
include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of
Acacia&#x2019;s consolidated financial position as of September 30, 2020, and results of its operations and its cash flows for
the interim periods presented. The consolidated results of operations for the three and nine months ended September 30, 2020 are
not necessarily indicative of the results to be expected for the entire fiscal year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--UseOfEstimates_zgNDy7D6wtaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements in conformity with U.S.
GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the
significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of
the equity instruments, the valuation of Series A redeemable convertible preferred stock (the &#x201c;Series A Redeemable Convertible
Preferred Stock&#x201d;) embedded derivatives, Series A warrants (the &#x201c;Series A Warrants&#x201d;), Series B warrants (the &#x201c;Series
B Warrants&#x201d;), equity securities derivative and forward contract, stock-based compensation expense, impairment of patent related
intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances
against net deferred tax assets, require its most difficult, subjective or complex judgments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_znVi8bw6TNse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Reclassifications&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certain reclassifications have been made to the prior fiscal
year financial information to conform with the current fiscal year presentation. Such reclassifications had no impact on net income
or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <ACTG:DescriptionOfBusinessPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_z32GuCyYITk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Description of Business&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As used herein, &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d;
&#x201c;Acacia&#x201d; and the &#x201c;Company&#x201d; refer to Acacia Research Corporation and/or its wholly and majority-owned and
controlled operating subsidiaries, and/or where applicable, its management.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia was incorporated on January 25, 1993 under the laws of
the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia&#x2019;s operating subsidiaries invest in, license and
enforce patented technologies. Acacia&#x2019;s operating subsidiaries partner with inventors and patent owners, applying their legal
and technology expertise to patent assets to unlock the financial value in their patented inventions. In recent years, Acacia has
also invested in technology companies. Acacia leverages its experience, expertise, data and relationships developed as a leader
in the intellectual property (&#x201c;IP&#x201d;) industry to pursue these opportunities. In some cases, these opportunities will
complement, and/or supplement Acacia&#x2019;s primary licensing and enforcement business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia&#x2019;s operating subsidiaries generate revenues and
related cash flows from the granting of IP rights (hereinafter &#x201c;IP Rights&#x201d;) for the use of patented technologies that
its operating subsidiaries control or own. Acacia&#x2019;s operating subsidiaries assist patent owners with the prosecution and
development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing
revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their
patented technologies through the filing of patent infringement litigation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia&#x2019;s operating subsidiaries are principals in the
licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.
Acacia&#x2019;s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain
foreign counterparts, covering technologies used in a wide variety of industries.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP
through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#x2019;s
operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be
able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the nine months ended
September 30, 2020, Acacia obtained control of four &lt;span id="xdx_90C_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20200101__20200930_zh7nbsdkupS5" style="display: none" title="Number of new patent portfolios acquired"&gt;4&lt;/span&gt; new patent portfolios. During fiscal year 2019, Acacia obtained control
of five &lt;span id="xdx_902_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20190101__20191231_zn2FWCeypwof" style="display: none" title="Number of new patent portfolios acquired"&gt;5&lt;/span&gt; new patent portfolios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

</ACTG:DescriptionOfBusinessPolicyTextBlock>
    <ACTG:NumberOfPatentPortfoliosAcquired
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="Integer">4</ACTG:NumberOfPatentPortfoliosAcquired>
    <ACTG:NumberOfPatentPortfoliosAcquired
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Integer">5</ACTG:NumberOfPatentPortfoliosAcquired>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAHYR1QGEwDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed consolidated financial
statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany
transactions and balances have been eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly,
certain information and footnotes required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance
with quarterly reporting requirements of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). These interim unaudited condensed
consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes
thereto for the year ended December 31, 2019, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March
16, 2020, as well as in our other public filings with the SEC. The condensed consolidated interim financial statements of Acacia
include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of
Acacia&#x2019;s consolidated financial position as of September 30, 2020, and results of its operations and its cash flows for
the interim periods presented. The consolidated results of operations for the three and nine months ended September 30, 2020 are
not necessarily indicative of the results to be expected for the entire fiscal year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_847_eus-gaap--UseOfEstimates_zgNDy7D6wtaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements in conformity with U.S.
GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the
significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of
the equity instruments, the valuation of Series A redeemable convertible preferred stock (the &#x201c;Series A Redeemable Convertible
Preferred Stock&#x201d;) embedded derivatives, Series A warrants (the &#x201c;Series A Warrants&#x201d;), Series B warrants (the &#x201c;Series
B Warrants&#x201d;), equity securities derivative and forward contract, stock-based compensation expense, impairment of patent related
intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances
against net deferred tax assets, require its most difficult, subjective or complex judgments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_znVi8bw6TNse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Reclassifications&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certain reclassifications have been made to the prior fiscal
year financial information to conform with the current fiscal year presentation. Such reclassifications had no impact on net income
or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_z2cPuNtIBTPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;2. &lt;span&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zVTJGv8cLg5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenue is recognized upon transfer of control of promised bundled
IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to
receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist
at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue
recognition criteria have been met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the periods presented, revenue contracts executed by the
Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the
grant of certain IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based
revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license
fees based on quarterly sales of applicable product units by licensees (&#x201c;Recurring Revenue Agreements&#x201d;). Revenues may
also include court ordered settlements or awards related to our patent portfolio. IP Rights granted included the following, as
applicable: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented
technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any
pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents.
The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the
context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise
to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer
IP Rights in the contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Since the promised IP Rights are not individually distinct,
the Company combines each individual IP Right in the contract into a bundle of IP rights that is distinct and accounts for all
of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted generally are &#x201c;functional
IP rights&#x201d; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that
functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&#x2019;s operating
subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain
or upgrade the technology, or provide future support or services. The contracts provide for the grant (i.e., transfer of control)
of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally
obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized
upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have been met. Revenue
contracts generally provide for payment of contractual amounts within 30-90 days of execution of the contract, or the end of the
quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally
non-refundable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal
in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is
subsequently resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP
Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the
sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenues from contracts with significant financing components
(either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee
had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the
promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust
the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception,
that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights
will be one year or less.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In general, the Company is required to make certain judgments
and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance
obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to
grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point
in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain
a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Revenues were composed of the following for the periods presented:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zV3hnwRzqTli" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zrRtoFE2jE6b" style="display: none"&gt;Disaggregation of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; font-size: 10pt; text-align: left"&gt;Paid-up Revenue Agreements&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;19,385&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;1,203&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;24,477&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;6,067&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Recurring Revenue Agreements&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;81&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;508&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;4,491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total Revenue&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;19,466&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;1,711&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;25,399&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;10,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A7_zIOa7M6K8RK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Refer to &#x201c;&lt;i&gt;Inventor Royalties and Contingent Legal Expenses&lt;/i&gt;&#x201d;
below for information on related direct costs of revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--PortfolioOperationsPolicyTextBlock_z0PQej27meF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Portfolio Operations&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cost of revenues include the costs and expenses incurred in
connection with Acacia&#x2019;s patent licensing and enforcement activities, including inventor royalties paid to patent owners,
contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing
and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment
costs. These costs are included under the caption &#x201c;Portfolio operations&#x201d; in the accompanying condensed consolidated
statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Inventor Royalties and Contingent Legal Expenses &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventor royalties are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of
the underlying inventor agreements, upfront advances paid to patent owners by Acacia&#x2019;s operating subsidiaries are recoverable
from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic
useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense
is included in amortization expense in the condensed consolidated statements of operations. Any unamortized upfront advances recovered
from net revenues are expensed in the period recovered and included in amortization expense in the condensed consolidated statements
of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Contingent legal fees are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from
potential infringers, no contingent legal fees are paid; however, Acacia&#x2019;s operating subsidiaries may be liable for certain
out of pocket legal costs incurred pursuant to the underlying legal services agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventor royalty and contingent legal agreements typically provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee
payments are received from licensees by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, trading securities and accounts receivable. Acacia places its cash equivalents and trading
securities primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are
also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not
experienced any significant losses on its deposits of cash and cash equivalents.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;One licensee accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z9PB9Iy8QFX5" title="Concentration risk percentage"&gt;98&lt;/span&gt;% of revenues recognized during
the three months ended September 30, 2020, and four licensees accounted for &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zEIckxnT6oXa" title="Concentration risk percentage"&gt;75&lt;/span&gt;%, &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_z0flroiVykVf" title="Concentration risk percentage"&gt;9&lt;/span&gt;%, &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zdPgccVRIOTd" title="Concentration risk percentage"&gt;8&lt;/span&gt;% and &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z10yUkRMa4B1" title="Concentration risk percentage"&gt;4&lt;/span&gt;% of revenues recognized during the
nine months ended September 30, 2020. Three licensees individually accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z6lYye00U4Gb" title="Concentration risk percentage"&gt;52&lt;/span&gt;%, &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAu13o9juE95" title="Concentration risk percentage"&gt;21&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zfoUUzQGMiX3" title="Concentration risk percentage"&gt;12&lt;/span&gt;% of revenues recognized during
the three months ended September 30, 2019, and three licensees individually accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zBDpPFZbq1Kj" title="Concentration risk percentage"&gt;46&lt;/span&gt;%, &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zQa3HNYTxCGj" title="Concentration risk percentage"&gt;23&lt;/span&gt;% and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zqrHYPld61yh" title="Concentration risk percentage"&gt;14&lt;/span&gt;% of revenues recognized
during the nine months ended September 30, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company does not have any material foreign operations. Based
on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for
the three and nine months ended September 30, 2020, &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zgKuW8Ya9Eya" title="Concentration risk percentage"&gt;0.1&lt;/span&gt;% and &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zioeaPVhaa6a" title="Concentration risk percentage"&gt;5&lt;/span&gt;%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions. For the three and nine months ended September 30, 2019, &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zdLNezg5HTF7" title="Concentration risk percentage"&gt;75&lt;/span&gt;% and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_z3rdUQVsvQ3l" title="Concentration risk percentage"&gt;38&lt;/span&gt;%, respectively, of revenues were attributable
to licensees domiciled in foreign jurisdictions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Four licensees individually represented approximately &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zCMLLREbR1A5" title="Concentration risk percentage"&gt;57&lt;/span&gt;%, &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAwJRQASb4v8" title="Concentration risk percentage"&gt;25&lt;/span&gt;%,
&lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_z9kDn3aEUHvi" title="Concentration risk percentage"&gt;4&lt;/span&gt;% and &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z8dTWIWEruvc" title="Concentration risk percentage"&gt;3&lt;/span&gt;% of accounts receivable at September 30, 2020. Two licensees individually represented approximately &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zc6SME9mx9fk" title="Concentration risk percentage"&gt;70&lt;/span&gt;% and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zepBPNtR6haa" title="Concentration risk percentage"&gt;17&lt;/span&gt;% of accounts
receivable at December 31, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zOwy2OfZDHf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Patents include the cost of patents or patent rights (hereinafter,
collectively &#x201c;patents&#x201d;) acquired from third-parties or obtained in connection with business combinations. Patent costs
are amortized utilizing the straight-line method over their remaining economic useful lives. Refer to Note 4 for additional information
regarding our patents.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











&lt;p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zTc3XJcDJb0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Impairment of Long-lived Assets&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset
may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than
the carrying amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#x2019;s carrying
value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active
markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques,
including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources
to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 4 for additional
information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fair value is generally estimated using the &#x201c;Income Approach,&#x201d;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic
useful life. Estimates of future after-tax cash flows are converted to present value through &#x201c;discounting,&#x201d; including
an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows
are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated
cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied
to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#x2019;s
licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio
including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology
coverage and other pertinent information that could impact future net cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zi23fhAEv8r1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia considers all highly liquid, trading securities with
original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#x2019;s cash
equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily
includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations,
and fully collateralized repurchase agreements. Acacia&#x2019;s cash equivalents are measured at fair value using quoted prices
that represent Level 1 inputs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zdU7TBKEHj96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Long Term Restricted Cash &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Long-term restricted cash relates to the proceeds received from
the issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account. The amounts are to be released
to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii) the
conversion of Series A Redeemable Convertible Preferred Stock into common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--PrepaidInvestmentPoliciesTextBlock_zyfejGKarNFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Prepaid Investment&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prepaid investment relates to the cash transferred to an escrow
account in connection with a Transaction Agreement with LF Equity Income Fund (&#x201c;Seller&#x201d;), pursuant to which the Company
will purchase from Seller certain equity securities. Refer to Note 14 for additional information on the Transaction Agreement.
The amounts are to be released to Seller upon transfer of the specified equity securities at set prices at various future dates
following various terms and conditions per the Transaction Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--EquitySecurityForwardContractPoliciesTextBlock_zydGaHPrZCN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Equity Securities Derivative and Forward Contract&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The equity security forward contract includes both private and
public equity securities not yet transferred, as of September 30, 2020, under the Company&#x2019;s Transaction Agreement with Seller.
Refer to Note 14 for additional information on the agreement. The public company equity security forward contracts are accounted
for as derivatives and are carried at fair market value with changes in fair market value recorded in the condensed consolidated
statements of operations in other income (expense). The private company equity security forward contracts do not meet the definition
of a derivative as the underlying equity securities are not readily convertible to cash. Therefore, as the forward contracts do
not have readily determinable fair value, these forward contracts are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions involving securities similar to those underlying the forward
contract. Changes in fair market value are reported in the condensed consolidated statements of operations in other income (expense).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











&lt;p id="xdx_846_eus-gaap--AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_zJcyTLcbHe0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Trading Securities- Debt&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments in debt securities are reported at fair value on
a recurring basis, with related realized and unrealized gains and losses recorded in the condensed consolidated statements of operations
in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest
is included in the condensed consolidated statements of operations in other income (expense). Accrued interest is included in the
trading securities balance on the condensed consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--EquityMethodInvestmentsPolicy_z2TY0Mrhx7Oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Trading Securities - Equity&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments in equity securities are reported at fair value
on a recurring basis, with related realized and unrealized gains and losses in the value of such securities recorded in the condensed
consolidated statements of operations in other income (expense). Dividend income is included in the condensed consolidated statements
of operations in other income (expense).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trading securities for the periods presented were comprised
of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--AvailableForSaleSecuritiesTextBlock_pn3n3_ze1v2CdeE3J2" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B8_zw6BmweOEiOa" style="display: none"&gt;Gain (loss) on trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Gain&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"&gt;Security&#160;Type&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;September 30, 2020:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShortTermInvestments_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesrEquityMember_zeFIAbmCs501" style="width: 9%; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;23,851&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_z6poe2yi2Vwa" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;4,218&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_znOLVRShnDbe" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(3,598&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_zAoUfUHKvcld" style="width: 9%; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;24,471&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Trading securities - debt&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Short-term Investments"&gt;93,712&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;143&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_ziLjQ8vjsE3f" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(12&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;93,843&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;17,674&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;211&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_ztgOqQxKZgx3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(745&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;17,140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShortTermInvestments_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;111,386&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;354&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231_zI2YltaXl7q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(757&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;110,983&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AF_zIxHhxktIfA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_ziVBDgH3Dorg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;U.S. GAAP defines fair value as the price that would be received
for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly
transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an
entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established
to measure fair value is defined as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;(i) &lt;b&gt;Level 1 &#x2013;
&lt;i&gt;Observable Inputs&lt;/i&gt;&lt;/b&gt;: Quoted prices in active markets for identical investments;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;(ii) &lt;b&gt;Level 2&lt;/b&gt;
&#x2013; &lt;b&gt;&lt;i&gt;Pricing Models with Significant Observable Inputs&lt;/i&gt;&lt;/b&gt;: Other significant observable inputs, including quoted
prices for similar investments, interest rates, credit risk, etc.; and&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;(iii) &lt;b&gt;Level 3 &lt;/b&gt;&#x2013;
&lt;b&gt;&lt;i&gt;Unobservable Inputs&lt;/i&gt;&lt;/b&gt;: Significant unobservable inputs, including the entity&#x2019;s own assumptions in determining
the fair value of investments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&#160;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Whenever possible, the Company is required
to use observable market inputs (Level 1 &#x2013; quoted market prices) when measuring fair value. In such cases, the level at which
the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement.
The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability
being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial
assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zy1ErhJzuWa9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B7_zwiVHwXkj41l" style="display: none"&gt;Schedule of fair value of financial assets and liabilities on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal"&gt;Assets as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;24,471&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zdHQ3b5Ukm42" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zZyvFEAX6v67" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Equity securities derivative&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativetMember_zCcuV3csw7Vb" style="font-size: 10pt; text-align: right" title="Assets"&gt;17,818&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_zFuktMcuGvBd" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_z1sLqYnzphdc" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Investment at fair value - warrants (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zXMUkDeMwDDe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zNL3fhQ4J0L4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Total recurring fair value measurements as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;42,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2gJaVBc0f14" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;Assets as of December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Trading securities - debt&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zJWfNJyJfZ1h" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;93,843&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zGw6aHE3eMf9" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets"&gt;17,140&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zrjCAk54uysh" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zHHOgrXWj1kb" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Investment at fair value - warrants (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z27SfLm2Rvvj" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets"&gt;757&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zZlq3yHytRWk" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Investment at fair value - common stock (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;743&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zH0sBseCWzr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zbcg9bq0MbWe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total recurring fair value measurements as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;17,883&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;94,600&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIZZjFqvhGPd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal"&gt;Liabilities as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Series A warrants&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6CELBHDVJSk" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;5,604&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z9P2RBRtgwxg" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zkRFn7cJUCnk" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z8GfR69kkhB" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;42,796&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Embedded derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z0XfU5arLd1e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zBW0vcRi2x5f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;25,682&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Total liabilities as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zihAXRXdxwFb" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;5,604&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;68,478&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;Liabilities as of December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Series A warrants&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zI2UbZUHJRSc" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;3,568&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zIQGSEqHNMC5" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Embedded derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z2aoRdMWkFM" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zuVliFxeh6ke" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;17,974&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total liabilities as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxkw24lIyvD5" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;3,568&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;17,974&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A0_zQwtFdX4xap2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth a summary of the changes in the
estimated fair value of the Company&#x2019;s Level 3 liabilities, which are measured at fair value as a on a recurring basis:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zeOiNDynHOg1" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B8_z9soetpk7fra" style="display: none"&gt;Summary of changes in financial liability Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Series A Preferred Stock Embedded Derivative Liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Series B Warrants Liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; font-size: 10pt"&gt;Opening balance as of December 31, 2019&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zqMdu5Eq6Xu1" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;17,974&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zjxDzA0Rh557" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Issuance of Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_d0_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zNvn8DVtyFie" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants"&gt;4,600&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Remeasurement to fair value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value"&gt;7,708&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value"&gt;38,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Balance as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrG5sEJsgE7c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;25,682&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zof7bg0bcoQ1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;42,796&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_8A9_zXcuuRk4sjVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 9pt Sans-Serif; color: Red"&gt;&#160;&lt;/span&gt;&lt;/p&gt;













&lt;p id="xdx_84B_ecustom--SeriesAWarrantsPolicyTextBlock_zw5IVOoN786l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series A Warrants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Series A Warrants is estimated using a
Black-Scholes option-pricing model. The fair value of the Series A Warrants as of September 30, 2020 was estimated based on the
following assumptions: volatility of &lt;span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"&gt;32 percent&lt;/span&gt;, risk-free rate of &lt;span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"&gt;0.47 percent&lt;/span&gt;, term of &lt;span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"&gt;7.04 years&lt;/span&gt; and a dividend yield of &lt;span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"&gt;0 percent&lt;/span&gt;.
Refer to Notes 10 and 11 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p id="xdx_84A_ecustom--SeriesBWarrantsPolicyTextBlock_z6Jin3VhDXle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series B Warrants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Series B
Warrants is estimated using Monte Carlo valuation technique. The fair value of the Series B Warrants as of September 30, 2020
was estimated based on event probabilities of future exercise scenarios and the following weighted-average assumptions: (1)
volatility of &lt;span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;32
percent&lt;/span&gt;, risk-free rate of &lt;span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;0.48
percent&lt;/span&gt;, term of &lt;span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;7.12
years&lt;/span&gt;, a dividend yield of &lt;span id="xdx_905_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;0
percent&lt;/span&gt;, and a discount for lack of marketability of &lt;span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;10
percent&lt;/span&gt;, and (2) volatility of &lt;span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;51
percent&lt;/span&gt;, risk-free rate of &lt;span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;0.13
percent&lt;/span&gt;, term of &lt;span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;1.9
years&lt;/span&gt; and a dividend yield of &lt;span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;0
percent&lt;/span&gt;, and a discount for lack of marketability of &lt;span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;10
percent&lt;/span&gt;. Refer to Notes 10 and 12 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--DerivativesEmbeddedDerivatives_zA3CZMcKCzI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Embedded derivatives&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Embedded derivatives that are required to be bifurcated from
their host contract are valued separately from host instrument. A binomial lattice framework is used to estimate the fair value
of the embedded derivative in the Series A Redeemable Convertible Preferred Stock. The binomial model utilizes the Tsiveriotis
and Fernandes implementation in which a convertible instrument is split into two separate components: a cash-only component which
is subject to the selected risk-adjusted discount rate and an equity component which is subject only to the risk-free rate. The
model considers the (i) implied volatility of the value of our common stock, (ii) appropriate risk-free interest rate, (iii) credit
spread, (iv) dividend yield, (v) dividend accrual (and a step-up in rates), and (vi) event probabilities of the various conversion
and redemption scenarios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The implied volatility of the Company&#x2019;s common stock is
estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe a commonly
observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt is lower
than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining until
November 15, 2027, the maturity date. The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining term
equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&#x2019;s
valuation of the embedded derivative at September 30, 2020 are as follows: volatility of &lt;span id="xdx_90F_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"&gt;32 percent&lt;/span&gt;, risk-free rate of &lt;span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"&gt;0.47 percent&lt;/span&gt;,
a credit spread of &lt;span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"&gt;21 percent&lt;/span&gt; and a dividend yield of &lt;span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"&gt;0 percent&lt;/span&gt;. The fair value measurement of the embedded derivative is sensitive
to these assumptions and changes in these assumptions could result in a materially different fair value measurement. Refer to Note
10 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_8A9_zXcuuRk4sxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 9pt Sans-Serif; color: Red"&gt;&#160;&lt;/span&gt;&lt;/p&gt;











&lt;p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zS8cxDceF2if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Investments at Fair Value&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On an individual investment basis, Acacia may elect to account
for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies
of the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under
the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e.,
common stock and warrants). We elected the fair value method for our investment in Veritone upon acquisition of the investment.
As of September 30, 2020, our investment in Veritone warrants totaled $&lt;span id="xdx_90A_eus-gaap--Investments_iI_pn3p0_c20200930__us-gaap--InvestmentsInAndAdvancesToAffiliatesCategorizationAxis__custom--VeritoneMember_zWWmSPR8uAD3" title="Investment in Veritone"&gt;982,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--EquityAndCostMethodInvestmentsPolicy_zzu8Ha3HJ5rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Other Investments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Equity investments in common stock and in-substance common stock
without readily determinable fair values in companies over which the Company has the ability to exercise significant influence,
are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its
equity method investees in equity in earnings (losses) of investees in the condensed consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments in preferred stock with substantive liquidation
preferences are accounted for at cost (subject to impairment considerations, as described below, if any), as adjusted for the impact
of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.
In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar
to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is
not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference
is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation
to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a
fair value perspective is substantive because, in the event of liquidation, the investor will not participate in substantially
all of the investee's losses, if any.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The initial determination of whether an investment is substantially
similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence
over the operating and financial policies of the investee. That determination is reconsidered if:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;contractual terms of the investment are changed,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Refer to Note 5 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7IMkSefF09g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Stock-Based Compensation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The compensation cost for all stock-based awards is measured
at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#x2019;s
requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value
of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and
the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant
using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Restricted stock units granted in September 2019 with market-based
vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of
a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique.
Compensation cost is recognized with a market-based vesting condition provided that the requisite service is rendered, regardless
of when, if ever, the market condition is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique
included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected volatility of 38 percent; and expected
dividend yield of 0 percent. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon
issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on
expectations regarding dividend payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Profits Interest Units (&#x201c;Units&#x201d;) were accounted
for in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 718-10, &#x201c;Compensation - Stock Compensation.&#x201d;
The vesting conditions did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such,
the Units were classified as liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion
of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#x2019;s
requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award,
which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized
in the period. The Company has a purchase option to purchase the vested Units that are not otherwise forfeited after termination
of continuous service. The exercise price of the purchase option is the fair market value of the Units on the date of termination
of continuous service. As of September 30, 2020, the Units totaled $591,000, which was their fair value as of December 31, 2018
after termination of service.&lt;/p&gt;





&lt;p id="xdx_849_eus-gaap--StockholdersEquityPolicyTextBlock_ztHNv9JfSzSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Treasury Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Repurchases of the Company&#x2019;s outstanding common stock
are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the
formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to
additional paid-in capital, and reflected as treasury stock on the condensed consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--CostMethodInvestmentsPolicy_zbcnh16MCdQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Impairment of Investments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative
and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value,
Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than
cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee,
including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline
in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements
of operations and a new cost basis in the investment is established.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zxSGe5tiGsse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income taxes are accounted for using an asset and liability
approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events
that have been recognized in Acacia&#x2019;s condensed consolidated financial statements or consolidated income tax returns. A valuation
allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized,
or if it is determined that there is uncertainty regarding future realization of such assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The provision for income taxes for interim periods is determined
using an estimate of Acacia&#x2019;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account
in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate
changes, a cumulative adjustment is recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s effective tax rates were &lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200701__20200930_zsHjYk2Pbsx6" title="Effective tax rate"&gt;0&lt;/span&gt;% and &lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200101__20200930_ziGt7tz8vM53" title="Effective tax rate"&gt;(4%)&lt;/span&gt; for
the three and nine months ended September 30, 2020, respectively and &lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190701__20190930_z5M0RaWlYfZ2" title="Effective tax rate"&gt;0&lt;/span&gt;% and &lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190101__20190930_ziYsdARV37Pd" title="Effective tax rate"&gt;(2%)&lt;/span&gt; for the three and nine months ended September
30, 2019, respectively. Tax benefit (expense) for the periods presented primarily reflects the impact of state taxes and foreign
taxes withholding or refund incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.
The Company has recorded full valuation allowance against our net deferred tax assets as of September 30, 2020 and 2019. These
assets primarily consist of foreign tax credits, capital loss carryforwards and net operating loss carryforwards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;











</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zVTJGv8cLg5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Revenue Recognition&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenue is recognized upon transfer of control of promised bundled
IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to
receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist
at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue
recognition criteria have been met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the periods presented, revenue contracts executed by the
Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the
grant of certain IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based
revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license
fees based on quarterly sales of applicable product units by licensees (&#x201c;Recurring Revenue Agreements&#x201d;). Revenues may
also include court ordered settlements or awards related to our patent portfolio. IP Rights granted included the following, as
applicable: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented
technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any
pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents.
The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the
context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise
to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer
IP Rights in the contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Since the promised IP Rights are not individually distinct,
the Company combines each individual IP Right in the contract into a bundle of IP rights that is distinct and accounts for all
of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted generally are &#x201c;functional
IP rights&#x201d; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that
functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&#x2019;s operating
subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain
or upgrade the technology, or provide future support or services. The contracts provide for the grant (i.e., transfer of control)
of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally
obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized
upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have been met. Revenue
contracts generally provide for payment of contractual amounts within 30-90 days of execution of the contract, or the end of the
quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally
non-refundable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal
in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is
subsequently resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP
Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the
sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenues from contracts with significant financing components
(either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee
had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the
promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust
the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception,
that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights
will be one year or less.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In general, the Company is required to make certain judgments
and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance
obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to
grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point
in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain
a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Revenues were composed of the following for the periods presented:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zV3hnwRzqTli" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zrRtoFE2jE6b" style="display: none"&gt;Disaggregation of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; font-size: 10pt; text-align: left"&gt;Paid-up Revenue Agreements&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;19,385&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;1,203&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;24,477&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;6,067&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Recurring Revenue Agreements&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;81&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;508&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;4,491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total Revenue&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;19,466&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;1,711&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;25,399&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;10,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A7_zIOa7M6K8RK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Refer to &#x201c;&lt;i&gt;Inventor Royalties and Contingent Legal Expenses&lt;/i&gt;&#x201d;
below for information on related direct costs of revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zV3hnwRzqTli" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zrRtoFE2jE6b" style="display: none"&gt;Disaggregation of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; font-size: 10pt; text-align: left"&gt;Paid-up Revenue Agreements&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;19,385&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;1,203&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;24,477&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues"&gt;6,067&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Recurring Revenue Agreements&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;81&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;508&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues"&gt;4,491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Total Revenue&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;19,466&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;1,711&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;25,399&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues"&gt;10,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">19385000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-07-012019-09-30_custom_PaidUpRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">1203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30_custom_PaidUpRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">24477000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-09-30_custom_PaidUpRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">6067000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30_custom_RecurringRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">81000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-07-012019-09-30_custom_RecurringRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-012020-09-30_custom_RecurringRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">922000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-09-30_custom_RecurringRevenueAgreementsMember"
      decimals="-3"
      unitRef="USD">4491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">19466000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">1711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">25399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">10558000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ACTG:PortfolioOperationsPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_845_ecustom--PortfolioOperationsPolicyTextBlock_z0PQej27meF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Portfolio Operations&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cost of revenues include the costs and expenses incurred in
connection with Acacia&#x2019;s patent licensing and enforcement activities, including inventor royalties paid to patent owners,
contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing
and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment
costs. These costs are included under the caption &#x201c;Portfolio operations&#x201d; in the accompanying condensed consolidated
statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Inventor Royalties and Contingent Legal Expenses &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventor royalties are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of
the underlying inventor agreements, upfront advances paid to patent owners by Acacia&#x2019;s operating subsidiaries are recoverable
from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic
useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense
is included in amortization expense in the condensed consolidated statements of operations. Any unamortized upfront advances recovered
from net revenues are expensed in the period recovered and included in amortization expense in the condensed consolidated statements
of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Contingent legal fees are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from
potential infringers, no contingent legal fees are paid; however, Acacia&#x2019;s operating subsidiaries may be liable for certain
out of pocket legal costs incurred pursuant to the underlying legal services agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventor royalty and contingent legal agreements typically provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee
payments are received from licensees by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, trading securities and accounts receivable. Acacia places its cash equivalents and trading
securities primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are
also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not
experienced any significant losses on its deposits of cash and cash equivalents.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;One licensee accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z9PB9Iy8QFX5" title="Concentration risk percentage"&gt;98&lt;/span&gt;% of revenues recognized during
the three months ended September 30, 2020, and four licensees accounted for &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zEIckxnT6oXa" title="Concentration risk percentage"&gt;75&lt;/span&gt;%, &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_z0flroiVykVf" title="Concentration risk percentage"&gt;9&lt;/span&gt;%, &lt;span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zdPgccVRIOTd" title="Concentration risk percentage"&gt;8&lt;/span&gt;% and &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z10yUkRMa4B1" title="Concentration risk percentage"&gt;4&lt;/span&gt;% of revenues recognized during the
nine months ended September 30, 2020. Three licensees individually accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z6lYye00U4Gb" title="Concentration risk percentage"&gt;52&lt;/span&gt;%, &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAu13o9juE95" title="Concentration risk percentage"&gt;21&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zfoUUzQGMiX3" title="Concentration risk percentage"&gt;12&lt;/span&gt;% of revenues recognized during
the three months ended September 30, 2019, and three licensees individually accounted for &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zBDpPFZbq1Kj" title="Concentration risk percentage"&gt;46&lt;/span&gt;%, &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zQa3HNYTxCGj" title="Concentration risk percentage"&gt;23&lt;/span&gt;% and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zqrHYPld61yh" title="Concentration risk percentage"&gt;14&lt;/span&gt;% of revenues recognized
during the nine months ended September 30, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company does not have any material foreign operations. Based
on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for
the three and nine months ended September 30, 2020, &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zgKuW8Ya9Eya" title="Concentration risk percentage"&gt;0.1&lt;/span&gt;% and &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zioeaPVhaa6a" title="Concentration risk percentage"&gt;5&lt;/span&gt;%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions. For the three and nine months ended September 30, 2019, &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zdLNezg5HTF7" title="Concentration risk percentage"&gt;75&lt;/span&gt;% and &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_z3rdUQVsvQ3l" title="Concentration risk percentage"&gt;38&lt;/span&gt;%, respectively, of revenues were attributable
to licensees domiciled in foreign jurisdictions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Four licensees individually represented approximately &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zCMLLREbR1A5" title="Concentration risk percentage"&gt;57&lt;/span&gt;%, &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAwJRQASb4v8" title="Concentration risk percentage"&gt;25&lt;/span&gt;%,
&lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_z9kDn3aEUHvi" title="Concentration risk percentage"&gt;4&lt;/span&gt;% and &lt;span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z8dTWIWEruvc" title="Concentration risk percentage"&gt;3&lt;/span&gt;% of accounts receivable at September 30, 2020. Two licensees individually represented approximately &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zc6SME9mx9fk" title="Concentration risk percentage"&gt;70&lt;/span&gt;% and &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zepBPNtR6haa" title="Concentration risk percentage"&gt;17&lt;/span&gt;% of accounts
receivable at December 31, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&#160;&lt;/p&gt;

</ACTG:PortfolioOperationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.98</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.75</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member"
      decimals="INF"
      unitRef="Pure">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee4Member"
      decimals="INF"
      unitRef="Pure">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.52</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member"
      decimals="INF"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member"
      decimals="INF"
      unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee2Member"
      decimals="INF"
      unitRef="Pure">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_OneLicensee3Member"
      decimals="INF"
      unitRef="Pure">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-07-012020-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.001</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-07-012019-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.75</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-09-30_us-gaap_SalesRevenueNetMember_custom_ForeignLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.57</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee2Member"
      decimals="INF"
      unitRef="Pure">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee3Member"
      decimals="INF"
      unitRef="Pure">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2020-01-012020-09-30_us-gaap_AccountsReceivableMember_custom_OneLicensee4Member"
      decimals="INF"
      unitRef="Pure">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_OneLicenseeMember"
      decimals="INF"
      unitRef="Pure">0.70</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-01-012019-12-31_us-gaap_AccountsReceivableMember_custom_OneLicensee2Member"
      decimals="INF"
      unitRef="Pure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zOwy2OfZDHf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Patents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Patents include the cost of patents or patent rights (hereinafter,
collectively &#x201c;patents&#x201d;) acquired from third-parties or obtained in connection with business combinations. Patent costs
are amortized utilizing the straight-line method over their remaining economic useful lives. Refer to Note 4 for additional information
regarding our patents.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zTc3XJcDJb0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Impairment of Long-lived Assets&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset
may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than
the carrying amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#x2019;s carrying
value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active
markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques,
including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources
to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 4 for additional
information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fair value is generally estimated using the &#x201c;Income Approach,&#x201d;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic
useful life. Estimates of future after-tax cash flows are converted to present value through &#x201c;discounting,&#x201d; including
an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows
are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated
cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied
to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#x2019;s
licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio
including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology
coverage and other pertinent information that could impact future net cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zi23fhAEv8r1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia considers all highly liquid, trading securities with
original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#x2019;s cash
equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily
includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations,
and fully collateralized repurchase agreements. Acacia&#x2019;s cash equivalents are measured at fair value using quoted prices
that represent Level 1 inputs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zdU7TBKEHj96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Long Term Restricted Cash &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Long-term restricted cash relates to the proceeds received from
the issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account. The amounts are to be released
to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii) the
conversion of Series A Redeemable Convertible Preferred Stock into common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <ACTG:PrepaidInvestmentPoliciesTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_840_ecustom--PrepaidInvestmentPoliciesTextBlock_zyfejGKarNFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Prepaid Investment&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prepaid investment relates to the cash transferred to an escrow
account in connection with a Transaction Agreement with LF Equity Income Fund (&#x201c;Seller&#x201d;), pursuant to which the Company
will purchase from Seller certain equity securities. Refer to Note 14 for additional information on the Transaction Agreement.
The amounts are to be released to Seller upon transfer of the specified equity securities at set prices at various future dates
following various terms and conditions per the Transaction Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</ACTG:PrepaidInvestmentPoliciesTextBlock>
    <ACTG:EquitySecurityForwardContractPoliciesTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_84A_ecustom--EquitySecurityForwardContractPoliciesTextBlock_zydGaHPrZCN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Equity Securities Derivative and Forward Contract&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The equity security forward contract includes both private and
public equity securities not yet transferred, as of September 30, 2020, under the Company&#x2019;s Transaction Agreement with Seller.
Refer to Note 14 for additional information on the agreement. The public company equity security forward contracts are accounted
for as derivatives and are carried at fair market value with changes in fair market value recorded in the condensed consolidated
statements of operations in other income (expense). The private company equity security forward contracts do not meet the definition
of a derivative as the underlying equity securities are not readily convertible to cash. Therefore, as the forward contracts do
not have readily determinable fair value, these forward contracts are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions involving securities similar to those underlying the forward
contract. Changes in fair market value are reported in the condensed consolidated statements of operations in other income (expense).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











</ACTG:EquitySecurityForwardContractPoliciesTextBlock>
    <us-gaap:AvailableForSaleSecuritiesPurchasedOptionsPricePolicy contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_846_eus-gaap--AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_zJcyTLcbHe0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Trading Securities- Debt&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments in debt securities are reported at fair value on
a recurring basis, with related realized and unrealized gains and losses recorded in the condensed consolidated statements of operations
in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest
is included in the condensed consolidated statements of operations in other income (expense). Accrued interest is included in the
trading securities balance on the condensed consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:AvailableForSaleSecuritiesPurchasedOptionsPricePolicy>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_840_eus-gaap--EquityMethodInvestmentsPolicy_z2TY0Mrhx7Oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Trading Securities - Equity&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments in equity securities are reported at fair value
on a recurring basis, with related realized and unrealized gains and losses in the value of such securities recorded in the condensed
consolidated statements of operations in other income (expense). Dividend income is included in the condensed consolidated statements
of operations in other income (expense).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trading securities for the periods presented were comprised
of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--AvailableForSaleSecuritiesTextBlock_pn3n3_ze1v2CdeE3J2" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B8_zw6BmweOEiOa" style="display: none"&gt;Gain (loss) on trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Gain&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"&gt;Security&#160;Type&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;September 30, 2020:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShortTermInvestments_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesrEquityMember_zeFIAbmCs501" style="width: 9%; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;23,851&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_z6poe2yi2Vwa" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;4,218&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_znOLVRShnDbe" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(3,598&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_zAoUfUHKvcld" style="width: 9%; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;24,471&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Trading securities - debt&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Short-term Investments"&gt;93,712&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;143&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_ziLjQ8vjsE3f" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(12&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;93,843&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;17,674&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;211&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_ztgOqQxKZgx3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(745&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;17,140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShortTermInvestments_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;111,386&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;354&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231_zI2YltaXl7q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(757&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;110,983&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8AF_zIxHhxktIfA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:AvailableForSaleSecuritiesTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--AvailableForSaleSecuritiesTextBlock_pn3n3_ze1v2CdeE3J2" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B8_zw6BmweOEiOa" style="display: none"&gt;Gain (loss) on trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Gain&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Gross&lt;br/&gt; Unrealized&lt;br/&gt; Loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left"&gt;Security&#160;Type&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;September 30, 2020:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShortTermInvestments_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesrEquityMember_zeFIAbmCs501" style="width: 9%; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;23,851&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_z6poe2yi2Vwa" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;4,218&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_znOLVRShnDbe" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(3,598&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_zAoUfUHKvcld" style="width: 9%; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;24,471&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Trading securities - debt&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Short-term Investments"&gt;93,712&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;143&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_ziLjQ8vjsE3f" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(12&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;93,843&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;17,674&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;211&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_ztgOqQxKZgx3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(745&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;17,140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShortTermInvestments_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Short-term Investments"&gt;111,386&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain"&gt;354&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231_zI2YltaXl7q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss"&gt;(757&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value"&gt;110,983&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:AvailableForSaleSecuritiesTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2020-09-30_custom_TradingSecuritesrEquityMember"
      decimals="-3"
      unitRef="USD">23851000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains
      contextRef="From2020-01-012020-09-30_custom_TradingSecuritesEquityMember"
      decimals="-3"
      unitRef="USD">4218000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="From2020-01-012020-09-30_custom_TradingSecuritesEquityMember"
      decimals="-3"
      unitRef="USD">3598000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="AsOf2020-09-30_custom_TradingSecuritesEquityMember"
      decimals="-3"
      unitRef="USD">24471000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2019-12-31_custom_TradingSecuritesDebtMember"
      decimals="-3"
      unitRef="USD">93712000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains
      contextRef="From2019-01-012019-12-31_custom_TradingSecuritesDebtMember"
      decimals="-3"
      unitRef="USD">143000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="From2019-01-012019-12-31_custom_TradingSecuritesDebtMember"
      decimals="-3"
      unitRef="USD">12000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="AsOf2019-12-31_custom_TradingSecuritesDebtMember"
      decimals="-3"
      unitRef="USD">93843000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2019-12-31_custom_TradingSecuritesEquityMember"
      decimals="-3"
      unitRef="USD">17674000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains
      contextRef="From2019-01-012019-12-31_custom_TradingSecuritesEquityMember"
      decimals="-3"
      unitRef="USD">211000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="From2019-01-012019-12-31_custom_TradingSecuritesEquityMember"
      decimals="-3"
      unitRef="USD">745000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="AsOf2019-12-31_custom_TradingSecuritesEquityMember"
      decimals="-3"
      unitRef="USD">17140000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ShortTermInvestments contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">111386000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">354000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="USD">757000</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">110983000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_846_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_ziVBDgH3Dorg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Fair Value Measurements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;U.S. GAAP defines fair value as the price that would be received
for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly
transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an
entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established
to measure fair value is defined as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;(i) &lt;b&gt;Level 1 &#x2013;
&lt;i&gt;Observable Inputs&lt;/i&gt;&lt;/b&gt;: Quoted prices in active markets for identical investments;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;(ii) &lt;b&gt;Level 2&lt;/b&gt;
&#x2013; &lt;b&gt;&lt;i&gt;Pricing Models with Significant Observable Inputs&lt;/i&gt;&lt;/b&gt;: Other significant observable inputs, including quoted
prices for similar investments, interest rates, credit risk, etc.; and&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"&gt;(iii) &lt;b&gt;Level 3 &lt;/b&gt;&#x2013;
&lt;b&gt;&lt;i&gt;Unobservable Inputs&lt;/i&gt;&lt;/b&gt;: Significant unobservable inputs, including the entity&#x2019;s own assumptions in determining
the fair value of investments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&#160;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Whenever possible, the Company is required
to use observable market inputs (Level 1 &#x2013; quoted market prices) when measuring fair value. In such cases, the level at which
the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement.
The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability
being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial
assets and liabilities measured at fair value on a recurring basis were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zy1ErhJzuWa9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B7_zwiVHwXkj41l" style="display: none"&gt;Schedule of fair value of financial assets and liabilities on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal"&gt;Assets as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;24,471&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zdHQ3b5Ukm42" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zZyvFEAX6v67" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Equity securities derivative&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativetMember_zCcuV3csw7Vb" style="font-size: 10pt; text-align: right" title="Assets"&gt;17,818&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_zFuktMcuGvBd" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_z1sLqYnzphdc" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Investment at fair value - warrants (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zXMUkDeMwDDe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zNL3fhQ4J0L4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Total recurring fair value measurements as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;42,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2gJaVBc0f14" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;Assets as of December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Trading securities - debt&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zJWfNJyJfZ1h" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;93,843&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zGw6aHE3eMf9" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets"&gt;17,140&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zrjCAk54uysh" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zHHOgrXWj1kb" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Investment at fair value - warrants (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z27SfLm2Rvvj" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets"&gt;757&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zZlq3yHytRWk" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Investment at fair value - common stock (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;743&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zH0sBseCWzr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zbcg9bq0MbWe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total recurring fair value measurements as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;17,883&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;94,600&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIZZjFqvhGPd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal"&gt;Liabilities as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Series A warrants&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6CELBHDVJSk" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;5,604&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z9P2RBRtgwxg" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zkRFn7cJUCnk" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z8GfR69kkhB" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;42,796&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Embedded derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z0XfU5arLd1e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zBW0vcRi2x5f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;25,682&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Total liabilities as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zihAXRXdxwFb" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;5,604&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;68,478&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;Liabilities as of December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Series A warrants&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zI2UbZUHJRSc" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;3,568&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zIQGSEqHNMC5" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Embedded derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z2aoRdMWkFM" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zuVliFxeh6ke" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;17,974&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total liabilities as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxkw24lIyvD5" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;3,568&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;17,974&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A0_zQwtFdX4xap2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth a summary of the changes in the
estimated fair value of the Company&#x2019;s Level 3 liabilities, which are measured at fair value as a on a recurring basis:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zeOiNDynHOg1" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B8_z9soetpk7fra" style="display: none"&gt;Summary of changes in financial liability Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Series A Preferred Stock Embedded Derivative Liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Series B Warrants Liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; font-size: 10pt"&gt;Opening balance as of December 31, 2019&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zqMdu5Eq6Xu1" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;17,974&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zjxDzA0Rh557" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Issuance of Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_d0_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zNvn8DVtyFie" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants"&gt;4,600&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Remeasurement to fair value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value"&gt;7,708&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value"&gt;38,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Balance as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrG5sEJsgE7c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;25,682&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zof7bg0bcoQ1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;42,796&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_8A9_zXcuuRk4sjVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 9pt Sans-Serif; color: Red"&gt;&#160;&lt;/span&gt;&lt;/p&gt;













</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zy1ErhJzuWa9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B7_zwiVHwXkj41l" style="display: none"&gt;Schedule of fair value of financial assets and liabilities on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal"&gt;Assets as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;24,471&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zdHQ3b5Ukm42" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zZyvFEAX6v67" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Equity securities derivative&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativetMember_zCcuV3csw7Vb" style="font-size: 10pt; text-align: right" title="Assets"&gt;17,818&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_zFuktMcuGvBd" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_z1sLqYnzphdc" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Investment at fair value - warrants (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zXMUkDeMwDDe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zNL3fhQ4J0L4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Total recurring fair value measurements as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;42,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2gJaVBc0f14" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;Assets as of December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Trading securities - debt&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zJWfNJyJfZ1h" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;93,843&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zGw6aHE3eMf9" style="width: 11%; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Trading securities - equity&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets"&gt;17,140&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zrjCAk54uysh" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zHHOgrXWj1kb" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Investment at fair value - warrants (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z27SfLm2Rvvj" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets"&gt;757&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zZlq3yHytRWk" style="font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Investment at fair value - common stock (Note 5)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;743&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zH0sBseCWzr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zbcg9bq0MbWe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total recurring fair value measurements as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;17,883&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;94,600&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIZZjFqvhGPd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal"&gt;Liabilities as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Series A warrants&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6CELBHDVJSk" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;5,604&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z9P2RBRtgwxg" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zkRFn7cJUCnk" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z8GfR69kkhB" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Liabilities"&gt;42,796&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Embedded derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z0XfU5arLd1e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zBW0vcRi2x5f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;25,682&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Total liabilities as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zihAXRXdxwFb" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;5,604&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;68,478&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt"&gt;Liabilities as of December 31, 2019:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Series A warrants&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zI2UbZUHJRSc" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;3,568&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zIQGSEqHNMC5" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Embedded derivative liability&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z2aoRdMWkFM" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zuVliFxeh6ke" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities"&gt;17,974&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;Total liabilities as of December 31, 2019&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxkw24lIyvD5" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;3,568&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities"&gt;17,974&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember"
      decimals="-3"
      unitRef="USD">24471000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativetMember"
      decimals="-3"
      unitRef="USD">17818000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativeMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EquitySecuritiesDerivativeMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">982000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">42289000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">982000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember"
      decimals="-3"
      unitRef="USD">93843000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesDebtMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember"
      decimals="-3"
      unitRef="USD">17140000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_TradingSecuritiesEquityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">757000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">743000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">17883000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">94600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">5604000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">42796000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">25682000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">5604000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">68478000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">3568000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_EmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">17974000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">3568000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      unitRef="USD">17974000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zeOiNDynHOg1" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8B8_z9soetpk7fra" style="display: none"&gt;Summary of changes in financial liability Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Series A Preferred Stock Embedded Derivative Liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Series B Warrants Liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; font-size: 10pt"&gt;Opening balance as of December 31, 2019&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zqMdu5Eq6Xu1" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;17,974&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zjxDzA0Rh557" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Issuance of Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_d0_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zNvn8DVtyFie" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants"&gt;4,600&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Remeasurement to fair value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value"&gt;7,708&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value"&gt;38,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt"&gt;Balance as of &lt;span style="font: normal 400 10pt Times New Roman, Times, Serif"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrG5sEJsgE7c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;25,682&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zof7bg0bcoQ1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance"&gt;42,796&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">17974000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
      contextRef="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
      contextRef="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">4600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">7708000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2020-01-012020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">38196000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember"
      decimals="-3"
      unitRef="USD">25682000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2020-09-30_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesBWarrantsLiabilityMember"
      decimals="-3"
      unitRef="USD">42796000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <ACTG:SeriesAWarrantsPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_84B_ecustom--SeriesAWarrantsPolicyTextBlock_zw5IVOoN786l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series A Warrants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Series A Warrants is estimated using a
Black-Scholes option-pricing model. The fair value of the Series A Warrants as of September 30, 2020 was estimated based on the
following assumptions: volatility of &lt;span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"&gt;32 percent&lt;/span&gt;, risk-free rate of &lt;span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"&gt;0.47 percent&lt;/span&gt;, term of &lt;span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"&gt;7.04 years&lt;/span&gt; and a dividend yield of &lt;span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives"&gt;0 percent&lt;/span&gt;.
Refer to Notes 10 and 11 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

</ACTG:SeriesAWarrantsPolicyTextBlock>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">32 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">0.47 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">7.04 years</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_BlackScholesModelMember_custom_SeriesAWarrantsMember">0 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <ACTG:SeriesBWarrantsPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_84A_ecustom--SeriesBWarrantsPolicyTextBlock_z6Jin3VhDXle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series B Warrants&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Series B
Warrants is estimated using Monte Carlo valuation technique. The fair value of the Series B Warrants as of September 30, 2020
was estimated based on event probabilities of future exercise scenarios and the following weighted-average assumptions: (1)
volatility of &lt;span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;32
percent&lt;/span&gt;, risk-free rate of &lt;span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;0.48
percent&lt;/span&gt;, term of &lt;span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;7.12
years&lt;/span&gt;, a dividend yield of &lt;span id="xdx_905_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;0
percent&lt;/span&gt;, and a discount for lack of marketability of &lt;span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives"&gt;10
percent&lt;/span&gt;, and (2) volatility of &lt;span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;51
percent&lt;/span&gt;, risk-free rate of &lt;span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;0.13
percent&lt;/span&gt;, term of &lt;span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;1.9
years&lt;/span&gt; and a dividend yield of &lt;span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;0
percent&lt;/span&gt;, and a discount for lack of marketability of &lt;span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives"&gt;10
percent&lt;/span&gt;. Refer to Notes 10 and 12 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</ACTG:SeriesBWarrantsPolicyTextBlock>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">32
percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">0.48
percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">7.12
years</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">0
percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputDiscountRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice525Member">10
percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">51
percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">0.13
percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedTermMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">1.9
years</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">0
percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputDiscountRateMember_custom_MonteCarloMethodMember_custom_SeriesBWarrantsMember_custom_WarrantPrice365Member">10
percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesEmbeddedDerivatives contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_843_eus-gaap--DerivativesEmbeddedDerivatives_zA3CZMcKCzI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Embedded derivatives&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Embedded derivatives that are required to be bifurcated from
their host contract are valued separately from host instrument. A binomial lattice framework is used to estimate the fair value
of the embedded derivative in the Series A Redeemable Convertible Preferred Stock. The binomial model utilizes the Tsiveriotis
and Fernandes implementation in which a convertible instrument is split into two separate components: a cash-only component which
is subject to the selected risk-adjusted discount rate and an equity component which is subject only to the risk-free rate. The
model considers the (i) implied volatility of the value of our common stock, (ii) appropriate risk-free interest rate, (iii) credit
spread, (iv) dividend yield, (v) dividend accrual (and a step-up in rates), and (vi) event probabilities of the various conversion
and redemption scenarios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The implied volatility of the Company&#x2019;s common stock is
estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe a commonly
observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt is lower
than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining until
November 15, 2027, the maturity date. The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining term
equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&#x2019;s
valuation of the embedded derivative at September 30, 2020 are as follows: volatility of &lt;span id="xdx_90F_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"&gt;32 percent&lt;/span&gt;, risk-free rate of &lt;span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"&gt;0.47 percent&lt;/span&gt;,
a credit spread of &lt;span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"&gt;21 percent&lt;/span&gt; and a dividend yield of &lt;span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives"&gt;0 percent&lt;/span&gt;. The fair value measurement of the embedded derivative is sensitive
to these assumptions and changes in these assumptions could result in a materially different fair value measurement. Refer to Note
10 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_8A9_zXcuuRk4sxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 9pt Sans-Serif; color: Red"&gt;&#160;&lt;/span&gt;&lt;/p&gt;











</us-gaap:DerivativesEmbeddedDerivatives>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputPriceVolatilityMember_custom_EmbeddedDerivativeMember">32 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_EmbeddedDerivativeMember">0.47 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputCreditSpreadMember_custom_EmbeddedDerivativeMember">21 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue contextRef="From2020-01-012020-09-30_us-gaap_MeasurementInputExpectedDividendRateMember_custom_EmbeddedDerivativeMember">0 percent</us-gaap:DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zS8cxDceF2if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Investments at Fair Value&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On an individual investment basis, Acacia may elect to account
for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies
of the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under
the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e.,
common stock and warrants). We elected the fair value method for our investment in Veritone upon acquisition of the investment.
As of September 30, 2020, our investment in Veritone warrants totaled $&lt;span id="xdx_90A_eus-gaap--Investments_iI_pn3p0_c20200930__us-gaap--InvestmentsInAndAdvancesToAffiliatesCategorizationAxis__custom--VeritoneMember_zWWmSPR8uAD3" title="Investment in Veritone"&gt;982,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:Investments
      contextRef="AsOf2020-09-30_custom_VeritoneMember"
      decimals="-3"
      unitRef="USD">982000</us-gaap:Investments>
    <us-gaap:EquityAndCostMethodInvestmentsPolicy contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_844_eus-gaap--EquityAndCostMethodInvestmentsPolicy_zzu8Ha3HJ5rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Other Investments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Equity investments in common stock and in-substance common stock
without readily determinable fair values in companies over which the Company has the ability to exercise significant influence,
are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its
equity method investees in equity in earnings (losses) of investees in the condensed consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments in preferred stock with substantive liquidation
preferences are accounted for at cost (subject to impairment considerations, as described below, if any), as adjusted for the impact
of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.
In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar
to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is
not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference
is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation
to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a
fair value perspective is substantive because, in the event of liquidation, the investor will not participate in substantially
all of the investee's losses, if any.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The initial determination of whether an investment is substantially
similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence
over the operating and financial policies of the investee. That determination is reconsidered if:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;contractual terms of the investment are changed,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;(iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Refer to Note 5 for additional information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:EquityAndCostMethodInvestmentsPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7IMkSefF09g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Stock-Based Compensation&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The compensation cost for all stock-based awards is measured
at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#x2019;s
requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value
of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and
the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant
using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Restricted stock units granted in September 2019 with market-based
vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of
a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique.
Compensation cost is recognized with a market-based vesting condition provided that the requisite service is rendered, regardless
of when, if ever, the market condition is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique
included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected volatility of 38 percent; and expected
dividend yield of 0 percent. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon
issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on
expectations regarding dividend payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Profits Interest Units (&#x201c;Units&#x201d;) were accounted
for in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 718-10, &#x201c;Compensation - Stock Compensation.&#x201d;
The vesting conditions did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such,
the Units were classified as liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion
of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#x2019;s
requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award,
which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized
in the period. The Company has a purchase option to purchase the vested Units that are not otherwise forfeited after termination
of continuous service. The exercise price of the purchase option is the fair market value of the Units on the date of termination
of continuous service. As of September 30, 2020, the Units totaled $591,000, which was their fair value as of December 31, 2018
after termination of service.&lt;/p&gt;





</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_849_eus-gaap--StockholdersEquityPolicyTextBlock_ztHNv9JfSzSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Treasury Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Repurchases of the Company&#x2019;s outstanding common stock
are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the
formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to
additional paid-in capital, and reflected as treasury stock on the condensed consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:CostMethodInvestmentsPolicy contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_844_eus-gaap--CostMethodInvestmentsPolicy_zbcnh16MCdQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Impairment of Investments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative
and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value,
Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than
cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee,
including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline
in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements
of operations and a new cost basis in the investment is established.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&#160;&lt;/p&gt;

</us-gaap:CostMethodInvestmentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zxSGe5tiGsse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income taxes are accounted for using an asset and liability
approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events
that have been recognized in Acacia&#x2019;s condensed consolidated financial statements or consolidated income tax returns. A valuation
allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized,
or if it is determined that there is uncertainty regarding future realization of such assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The provision for income taxes for interim periods is determined
using an estimate of Acacia&#x2019;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account
in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate
changes, a cumulative adjustment is recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s effective tax rates were &lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200701__20200930_zsHjYk2Pbsx6" title="Effective tax rate"&gt;0&lt;/span&gt;% and &lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200101__20200930_ziGt7tz8vM53" title="Effective tax rate"&gt;(4%)&lt;/span&gt; for
the three and nine months ended September 30, 2020, respectively and &lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190701__20190930_z5M0RaWlYfZ2" title="Effective tax rate"&gt;0&lt;/span&gt;% and &lt;span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190101__20190930_ziYsdARV37Pd" title="Effective tax rate"&gt;(2%)&lt;/span&gt; for the three and nine months ended September
30, 2019, respectively. Tax benefit (expense) for the periods presented primarily reflects the impact of state taxes and foreign
taxes withholding or refund incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.
The Company has recorded full valuation allowance against our net deferred tax assets as of September 30, 2020 and 2019. These
assets primarily consist of foreign tax credits, capital loss carryforwards and net operating loss carryforwards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;











</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="Pure">-0.04</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="Pure">-0.02</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_z1W8kWwVCB2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;3. &lt;span&gt;INCOME (LOSS) PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents the shares of common stock outstanding
used in the calculation of basic and diluted net income (loss) per share:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zrMs58AlTb4h" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 3. INCOME (LOSS) PER SHARE (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B8_zyt1E8bRR0wa" style="display: none"&gt;Calculation of basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20200701__20200930_z29qq7agZcq5" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20190701__20190930_zIKWN8QuKJr9" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20200101__20200930_zExwxzrYQcwl" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20190101__20190930_zRSH2DotCJha" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-size: 10pt"&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center; font-size: 10pt"&gt;(In thousands, except share and per share information)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;Numerator:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left"&gt;Net income (loss) attributable to Acacia Research Corporation&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;38,348&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;(7,608&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;33,205&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;(17,749&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di0_zxqOwbKWKiAd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Dividend on Series A redeemable convertible preferred stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(467&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,118&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di0_zU9h3DvHXiAi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Accretion of Series A redeemable convertible preferred stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(733&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,045&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zv0jupxlZjH2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Undistributed earnings allocated to participating securities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(6,619&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(5,204&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Net income (loss) attributable to common stockholders - basic&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;30,529&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(7,608&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;24,838&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(17,749&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DividendsPreferredStock_pn3n3_d0_zM3VNy1tOFwh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Add: Dividend on Series A redeemable convertible preferred stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;467&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_pn3n3_d0_z9tIs3mLY24b" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Add: Accretion of Series A redeemable convertible preferred stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;733&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_pn3n3_d0_zjULQdByivRe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(3,831&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ChangeInFairValueOfSeriesWarrants_pn3n3_d0_zsQ37QG9a9ni" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Less: Change in fair value of Series A warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,348&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,348&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_pn3n3_d0_zsGmaSXRZ4Hi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Less: Change in fair value of dilutive Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(5,557&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(5,557&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--InterestExpenseOther_pn3n3_d0_zkHw9SievXb3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Add: Interest expense associated with Starboard Notes, net of tax&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,889&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,889&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_pn3n3_d0_zZC20vagXWoj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Add: Undistributed earnings allocated to participating securities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;6,619&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;5,204&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_pn3n3_d0_z3W83rx7FVjb" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Reallocation of undistributed earnings to participating securities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(296&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(3,645&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_zP5FDOoxTZQ6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss) attributable to common stockholders - diluted&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;29,204&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(7,608&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;21,380&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(17,749&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;Denominator:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pip0_zK4sOlONYiu1" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - basic&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;48,467,885&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;49,828,361&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;48,949,706&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;49,727,385&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Potentially dilutive common shares:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Series A Preferred Stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zVtgD3VH6oVl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;9,589,041&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKUOueVrvJe" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zMDPj1aStmSi" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zUhrrxgIp7Qk" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Restricted stock units&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zwGsQ2YBMcy" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;728,936&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zpLQyOdbF9k" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zz7SeVr6OoEe" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;598,328&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_z9ofT9abmOLd" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Employee stock options&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_z6VL88jIbVa3" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;21,624&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zb6RDqbZ5ki5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zpJswYj5bsQ9" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zAOXioeMlmXl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Series A Warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1lhACTATp3i" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;310,367&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxn4k1MYdK7c" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zjcGTuf1R6p9" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;103,456&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0nMwksJ1qg7" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Series B Warrants&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zqmIiEXuNrD9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;31,506,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z4zQrePeS6nh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zjcXXqjEYMw8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;10,502,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z7dWJW1fxZl9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pip0_zEYLLRBoi9Fl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - diluted&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;90,624,702&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;49,828,361&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;60,153,773&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;49,727,385&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_pip0_zrQ6VsuNV5jh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Basic net income (loss) per common share&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;0.63&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(0.15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;0.51&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(0.36&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pip0_zcs77cO8o7Cf" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Diluted net income (loss) per common share&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;0.32&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(0.15&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;0.36&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(0.36&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left"&gt;Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Equity-based incentive awards&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;191,312&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;442,864&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;310,083&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;442,864&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Series A warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zciNzaCD66le" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zEoez9xVbfQ2" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zIJ6U2DopC07" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zQAW7w0xfhXg" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;68,493,151&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zvW7NH40Z111" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;68,493,151&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zhJkZV7HMvK5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;68,684,463&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;442,864&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;68,803,234&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;442,864&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zrMs58AlTb4h" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 3. INCOME (LOSS) PER SHARE (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B8_zyt1E8bRR0wa" style="display: none"&gt;Calculation of basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20200701__20200930_z29qq7agZcq5" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20190701__20190930_zIKWN8QuKJr9" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20200101__20200930_zExwxzrYQcwl" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20190101__20190930_zRSH2DotCJha" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-size: 10pt"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-size: 10pt"&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center; font-size: 10pt"&gt;(In thousands, except share and per share information)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;Numerator:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left"&gt;Net income (loss) attributable to Acacia Research Corporation&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;38,348&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;(7,608&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;33,205&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-size: 10pt; text-align: right"&gt;(17,749&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di0_zxqOwbKWKiAd" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Dividend on Series A redeemable convertible preferred stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(467&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,118&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di0_zU9h3DvHXiAi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Accretion of Series A redeemable convertible preferred stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(733&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,045&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zv0jupxlZjH2" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Undistributed earnings allocated to participating securities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(6,619&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(5,204&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Net income (loss) attributable to common stockholders - basic&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;30,529&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(7,608&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;24,838&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(17,749&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--DividendsPreferredStock_pn3n3_d0_zM3VNy1tOFwh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Add: Dividend on Series A redeemable convertible preferred stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;467&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_pn3n3_d0_z9tIs3mLY24b" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Add: Accretion of Series A redeemable convertible preferred stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;733&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_pn3n3_d0_zjULQdByivRe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(3,831&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ChangeInFairValueOfSeriesWarrants_pn3n3_d0_zsQ37QG9a9ni" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Less: Change in fair value of Series A warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,348&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(1,348&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_pn3n3_d0_zsGmaSXRZ4Hi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Less: Change in fair value of dilutive Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(5,557&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(5,557&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--InterestExpenseOther_pn3n3_d0_zkHw9SievXb3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Add: Interest expense associated with Starboard Notes, net of tax&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,889&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,889&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_pn3n3_d0_zZC20vagXWoj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Add: Undistributed earnings allocated to participating securities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;6,619&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;5,204&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_pn3n3_d0_z3W83rx7FVjb" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Reallocation of undistributed earnings to participating securities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(296&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(3,645&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_zP5FDOoxTZQ6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Net income (loss) attributable to common stockholders - diluted&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;29,204&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(7,608&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;21,380&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(17,749&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;Denominator:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pip0_zK4sOlONYiu1" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - basic&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;48,467,885&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;49,828,361&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;48,949,706&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;49,727,385&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Potentially dilutive common shares:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Series A Preferred Stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zVtgD3VH6oVl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;9,589,041&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKUOueVrvJe" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zMDPj1aStmSi" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zUhrrxgIp7Qk" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Restricted stock units&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zwGsQ2YBMcy" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;728,936&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zpLQyOdbF9k" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zz7SeVr6OoEe" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;598,328&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_z9ofT9abmOLd" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Employee stock options&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_z6VL88jIbVa3" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;21,624&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zb6RDqbZ5ki5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zpJswYj5bsQ9" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zAOXioeMlmXl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Series A Warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1lhACTATp3i" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;310,367&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxn4k1MYdK7c" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zjcGTuf1R6p9" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;103,456&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0nMwksJ1qg7" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Series B Warrants&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zqmIiEXuNrD9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;31,506,849&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z4zQrePeS6nh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zjcXXqjEYMw8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;10,502,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z7dWJW1fxZl9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pip0_zEYLLRBoi9Fl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - diluted&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;90,624,702&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;49,828,361&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;60,153,773&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;49,727,385&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--EarningsPerShareBasic_pip0_zrQ6VsuNV5jh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Basic net income (loss) per common share&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;0.63&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(0.15&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;0.51&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(0.36&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pip0_zcs77cO8o7Cf" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Diluted net income (loss) per common share&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;0.32&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(0.15&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;0.36&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;(0.36&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left"&gt;Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Equity-based incentive awards&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;191,312&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;442,864&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;310,083&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;442,864&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left"&gt;Series A warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zciNzaCD66le" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zEoez9xVbfQ2" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zIJ6U2DopC07" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zQAW7w0xfhXg" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Series B warrants&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;68,493,151&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zvW7NH40Z111" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;68,493,151&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zhJkZV7HMvK5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;68,684,463&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;442,864&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;68,803,234&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares"&gt;442,864&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">38348000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">33205000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17749000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">467000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">1118000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">733000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">2045000</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:PreferredStockAccretionOfRedemptionDiscount
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-0</us-gaap:PreferredStockAccretionOfRedemptionDiscount>
    <us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-6619000</us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-5204000</us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">30529000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">24838000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17749000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:DividendsPreferredStock
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">467000</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:DividendsPreferredStock>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">733000</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:AccretionOfSeriesRedeemableConvertiblePreferredStock>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-3831000</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives>
    <ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives>
    <ACTG:ChangeInFairValueOfSeriesWarrants
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-1348000</ACTG:ChangeInFairValueOfSeriesWarrants>
    <ACTG:ChangeInFairValueOfSeriesWarrants
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesWarrants>
    <ACTG:ChangeInFairValueOfSeriesWarrants
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-1348000</ACTG:ChangeInFairValueOfSeriesWarrants>
    <ACTG:ChangeInFairValueOfSeriesWarrants
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfSeriesWarrants>
    <ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-5557000</ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants>
    <ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants>
    <ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-5557000</ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants>
    <ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</ACTG:ChangeInFairValueOfDilutiveSeriesBWarrants>
    <us-gaap:InterestExpenseOther
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">1889000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">1889000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:InterestExpenseOther>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">6619000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">5204000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-296000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">-3645000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">29204000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-7608000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">21380000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">-17749000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">48467885</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="Shares">49828361</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="Shares">48949706</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="Shares">49727385</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">9589041</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-07-012019-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-01-012019-09-30_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_custom_RestrictedStockUnitsMember"
      decimals="INF"
      unitRef="Shares">728936</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-07-012019-09-30_custom_RestrictedStockUnitsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_custom_RestrictedStockUnitsMember"
      decimals="INF"
      unitRef="Shares">598328</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-01-012019-09-30_custom_RestrictedStockUnitsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_custom_EmployeeStockOptionsMember"
      decimals="INF"
      unitRef="Shares">21624</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-07-012019-09-30_custom_EmployeeStockOptionsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_custom_EmployeeStockOptionsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-01-012019-09-30_custom_EmployeeStockOptionsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">310367</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-07-012019-09-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">103456</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-01-012019-09-30_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">31506849</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-07-012019-09-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">10502283</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2019-01-012019-09-30_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="Shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">90624702</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="Shares">49828361</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="Shares">60153773</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="Shares">49727385</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="USDPShares">0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="USDPShares">-0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_custom_EquityBasedIncentiveAwardsMember"
      decimals="INF"
      unitRef="Shares">191312</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012019-09-30_custom_EquityBasedIncentiveAwardsMember"
      decimals="INF"
      unitRef="Shares">442864</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-09-30_custom_EquityBasedIncentiveAwardsMember"
      decimals="INF"
      unitRef="Shares">310083</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-01-012019-09-30_custom_EquityBasedIncentiveAwardsMember"
      decimals="INF"
      unitRef="Shares">442864</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_custom_SeriesAWarrantsMember132390937"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012019-09-30_custom_SeriesAWarrantsMember132390953"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-09-30_custom_SeriesAWarrantsMember132390968"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-01-012019-09-30_custom_SeriesAWarrantsMember132390984"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember132391000"
      decimals="INF"
      unitRef="Shares">68493151</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012019-09-30_custom_SeriesBWarrantsMember132391000"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132391015"
      decimals="INF"
      unitRef="Shares">68493151</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-01-012019-09-30_custom_SeriesBWarrantsMember132391031"
      decimals="INF"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-07-012020-09-30"
      decimals="INF"
      unitRef="Shares">68684463</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-07-012019-09-30"
      decimals="INF"
      unitRef="Shares">442864</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2020-01-01to2020-09-30"
      decimals="INF"
      unitRef="Shares">68803234</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2019-01-012019-09-30"
      decimals="INF"
      unitRef="Shares">442864</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_80D_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVCypg06ecej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4. &lt;span&gt;PATENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia&#x2019;s only identifiable intangible assets at September
30, 2020 and December 31, 2019 are patents and patent rights. Patent-related accumulated amortization totaled $&lt;span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3p0_c20200930_zCDVMi8l99n5" title="Accumulated amortization"&gt;326,296,000&lt;/span&gt; and
$&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3p0_c20191231_zLT8vH6m2iDh" title="Accumulated amortization"&gt;322,774,000&lt;/span&gt; as of September 30, 2020 and December 31, 2019, respectively. Acacia&#x2019;s patents have remaining estimated economic
useful lives ranging from three to fifty-five months. The weighted-average remaining estimated economic useful life of Acacia&#x2019;s
patents is approximately four years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents the scheduled annual aggregate
amortization expense as of September 30, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zY2ENlAczsA8" style="border-collapse: collapse; width: 50%" summary="xdx: Disclosure - 4. PATENTS (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B4_zdkcEXwBHCEk" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20200930_zRGrGBAmH1W" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;For&#160;the&#160;years&#160;ending&#160;December&#160;31,&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJ1C_zT4eK4C8Tby6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 33%; font-size: 10pt"&gt;Remainder of 2020&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;1,158&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJ1C_z9Tr7DvbAvMa" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,451&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJ1C_zLTnG0LYCXEj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,451&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJ1C_zvawWHBTYQEe" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,376&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJ1C_zJpG7y6MLKtc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;3,005&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJ1C_ztzRKw6jUsZc" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;630&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJ1C_zYiMF6lKPArk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&#160;&lt;span style="color: White"&gt;Patents, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;18,071&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 9pt Sans-Serif; color: Red"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">326296000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2019-12-31" decimals="-3" unitRef="USD">322774000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zY2ENlAczsA8" style="border-collapse: collapse; width: 50%" summary="xdx: Disclosure - 4. PATENTS (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B4_zdkcEXwBHCEk" style="display: none"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20200930_zRGrGBAmH1W" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;For&#160;the&#160;years&#160;ending&#160;December&#160;31,&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJ1C_zT4eK4C8Tby6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 33%; font-size: 10pt"&gt;Remainder of 2020&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;1,158&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJ1C_z9Tr7DvbAvMa" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,451&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJ1C_zLTnG0LYCXEj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,451&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJ1C_zvawWHBTYQEe" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;4,376&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJ1C_zJpG7y6MLKtc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;3,005&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJ1C_ztzRKw6jUsZc" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;630&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJ1C_zYiMF6lKPArk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&#160;&lt;span style="color: White"&gt;Patents, net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;18,071&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">1158000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">4451000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">4451000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">4376000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">3005000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">630000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">18071000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:InvestmentHoldingsTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_80D_eus-gaap--InvestmentHoldingsTextBlock_zblEjhQBjTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;5. &lt;span&gt;INVESTMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Investment at Fair Value&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During 2016 and 2017, Acacia made certain investments in Veritone,
Inc. (&#x201c;Veritone&#x201d;). As a result of these transactions, Acacia received an aggregate total of 4,119,521 shares of Veritone
common stock and warrants to purchase a total of &lt;span id="xdx_905_ecustom--NumberOfWarrants_pip0_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z7fffCUVDXNj" title="Number of warrants"&gt;1,120,432&lt;/span&gt; shares of Veritone common stock at an exercise price of $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Warrants price"&gt;13.61&lt;/span&gt; per share
expiring between 2020 and 2027. During the year ended December 31, 2018, Acacia sold &lt;span id="xdx_906_ecustom--InvestmentSharesSold_c20180101__20181231__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold"&gt;2,700,000&lt;/span&gt; shares Veritone common stock and
recorded a realized loss of $&lt;span id="xdx_90E_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20180101__20181231__srt--CounterpartyNameAxis__custom--VeritoneMember_zIUOBatk7hAh" title="Loss from sale of investment"&gt;19.1&lt;/span&gt; million. During the year ended December 31, 2019, Acacia sold &lt;span id="xdx_908_ecustom--InvestmentSharesSold_c20190101__20191231__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold"&gt;1,121,071&lt;/span&gt; shares Veritone common
stock and recorded a realized loss of $&lt;span id="xdx_903_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20190101__20191231__srt--CounterpartyNameAxis__custom--VeritoneMember_zwE38mgRIzP9" title="Loss from sale of investment"&gt;9.2&lt;/span&gt; million. During the three months ended March 31, 2020, Acacia sold all remaining &lt;span id="xdx_90B_ecustom--InvestmentSharesSold_c20200101__20200331__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold"&gt;298,450&lt;/span&gt;
shares Veritone common stock and recorded a realized loss of $&lt;span id="xdx_906_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20200101__20200331__srt--CounterpartyNameAxis__custom--VeritoneMember_zJR5Te0IE5Xa" title="Loss from sale of investment"&gt;3.3&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the three months ended June 30, 2020, Acacia exercised
&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_c20200930_pii" title="Warrants exercised"&gt;154,312&lt;/span&gt; warrants of the total &lt;span id="xdx_90A_ecustom--NumberOfWarrants_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Number of warrants"&gt;1,120,432&lt;/span&gt; Veritone common stock purchase warrants at a price of $13.61 per warrant, and then sold
the &lt;span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Number of stock sold"&gt;154,312&lt;/span&gt; shares of Veritone stock received at $&lt;span id="xdx_907_eus-gaap--SharePrice_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Share Price"&gt;17.23&lt;/span&gt; per share, and recorded a realized gain of $&lt;span id="xdx_904_eus-gaap--GainLossOnSaleOfInvestments_pn3p0_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zyQdLBJouoB8" title="Realized gain"&gt;554,000&lt;/span&gt;. At September 30, 2020,
the fair value of the &lt;span id="xdx_901_ecustom--InvestmentWarrants_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Investment warrants"&gt;966,120&lt;/span&gt; remaining warrants held by Acacia totaled $&lt;span id="xdx_90D_eus-gaap--FinancialInstrumentsOwnedAtFairValue_iI_pn3p0_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zQLuDbMEqiO3" title="Fair value of investment"&gt;982,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Changes in the fair value of Acacia&#x2019;s investment in Veritone
are recorded as unrealized gains or losses in the condensed consolidated statements of operations. For the three and nine months
ended September 30, 2020 and 2019, the accompanying condensed consolidated statements of operations reflected the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_z9s2dcLYaMj7" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 5. INVESTMENTS (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BC_ziaOgnpgcot8" style="display: none"&gt;Schedule of gain (loss) on investments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: center; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left"&gt;Change in fair value of investment, warrants&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(3,081&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(3,216&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;225&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(822&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value of investment, common stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zCysRFZGlMU6" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(1,050&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;3,479&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;10,444&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Gain on sale of investment, warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zsnPClIS32pl" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zxZNaTd6GJef" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zSNNy7Zj2KN7" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;554&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zlfZtKRYwmif" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Loss on sale of investment, common stock&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zu5zqdgT9jn" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z6MTWm9O8X8d" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;(915&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zifsbseloMIl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;(3,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zEhIlcKgmQfe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;(8,147&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Net realized and unrealized gain (loss) on investment at fair value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GainLossOnInvestments_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;(3,081&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainLossOnInvestments_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;(5,181&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;942&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;1,475&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











</us-gaap:InvestmentHoldingsTextBlock>
    <ACTG:NumberOfWarrants
      contextRef="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember"
      decimals="INF"
      unitRef="Shares">1120432</ACTG:NumberOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember"
      decimals="INF"
      unitRef="USDPShares">13.61</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ACTG:InvestmentSharesSold
      contextRef="From2018-01-012018-12-31_custom_VeritoneMember"
      decimals="INF"
      unitRef="Shares">2700000</ACTG:InvestmentSharesSold>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2018-01-012018-12-31_custom_VeritoneMember"
      decimals="-3"
      unitRef="USD">19100000</us-gaap:LossOnSaleOfInvestments>
    <ACTG:InvestmentSharesSold
      contextRef="From2019-01-012019-12-31_custom_VeritoneMember"
      decimals="INF"
      unitRef="Shares">1121071</ACTG:InvestmentSharesSold>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2019-01-012019-12-31_custom_VeritoneMember"
      decimals="-3"
      unitRef="USD">9200000</us-gaap:LossOnSaleOfInvestments>
    <ACTG:InvestmentSharesSold
      contextRef="From2020-01-012020-03-31_custom_VeritoneMember"
      decimals="INF"
      unitRef="Shares">298450</ACTG:InvestmentSharesSold>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2020-01-012020-03-31_custom_VeritoneMember"
      decimals="-3"
      unitRef="USD">3300000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2020-09-30" decimals="INF" unitRef="Shares">154312</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <ACTG:NumberOfWarrants
      contextRef="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember"
      decimals="INF"
      unitRef="Shares">1120432</ACTG:NumberOfWarrants>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember"
      decimals="INF"
      unitRef="Shares">154312</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SharePrice
      contextRef="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember"
      decimals="INF"
      unitRef="USDPShares">17.23</us-gaap:SharePrice>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="From2020-07-012020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">554000</us-gaap:GainLossOnSaleOfInvestments>
    <ACTG:InvestmentWarrants
      contextRef="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember"
      decimals="INF"
      unitRef="Shares">966120</ACTG:InvestmentWarrants>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue
      contextRef="AsOf2020-09-30_custom_VeritoneMember_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">982000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:GainLossOnInvestmentsTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_z9s2dcLYaMj7" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 5. INVESTMENTS (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BC_ziaOgnpgcot8" style="display: none"&gt;Schedule of gain (loss) on investments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; text-align: center; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left"&gt;Change in fair value of investment, warrants&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(3,081&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(3,216&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;225&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(822&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value of investment, common stock&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zCysRFZGlMU6" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(1,050&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;3,479&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;10,444&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Gain on sale of investment, warrants&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zsnPClIS32pl" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zxZNaTd6GJef" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zSNNy7Zj2KN7" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;554&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zlfZtKRYwmif" style="font-size: 10pt; text-align: right" title="Gain on sale of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Loss on sale of investment, common stock&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zu5zqdgT9jn" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z6MTWm9O8X8d" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;(915&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zifsbseloMIl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;(3,316&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zEhIlcKgmQfe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment"&gt;(8,147&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Net realized and unrealized gain (loss) on investment at fair value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GainLossOnInvestments_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;(3,081&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainLossOnInvestments_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;(5,181&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;942&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;1,475&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;











</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">-3081000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-07-012019-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">-3216000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">225000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-01-012019-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">-822000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-07-012019-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">-1050000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">3479000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-01-012019-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">10444000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="From2020-07-012020-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="From2019-07-012019-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="From2020-01-012020-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">554000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="From2019-01-012019-09-30_custom_WarrantInvestmentMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2020-07-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2019-07-012019-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">915000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2020-01-012020-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">3316000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="From2019-01-012019-09-30_custom_CommonStockInvestmentMember"
      decimals="-3"
      unitRef="USD">8147000</us-gaap:LossOnSaleOfInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">-3081000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">-5181000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">942000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">1475000</us-gaap:GainLossOnInvestments>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zGKCWkxrvCd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;6. &lt;span&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Patent Enforcement&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certain of Acacia&#x2019;s operating subsidiaries are often required
to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia&#x2019;s operating subsidiaries&#x2019;
patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has
violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive
or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating
subsidiaries or award attorney&#x2019;s fees and/or expenses to a defendant(s), which could be material.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Facility Leases&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company primarily leases office facilities under operating
lease arrangements that will end in various years through July 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 7, 2019, we entered into a building lease agreement
(the &#x201c;New Lease&#x201d;) with Jamboree Center 4 LLC (the &#x201c;Landlord&#x201d;). Pursuant to the New Lease, we have leased
approximately 8,293 square feet of office space for our corporate headquarters in Irvine, California. The New Lease commenced on
August 1, 2019. The term of the New Lease is 60 months from the commencement date, provides for annual rent increases, and does
not provide us the right to early terminate or extend our lease terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company leased a facility under an operating lease agreement
(the &#x201c;Old Lease&#x201d;), the term of which ended on January 31, 2020. The Company ceased using the facility in December 2018
and the subleased the facility for the remainder of the Old Lease term. All sublease income under the Old Lease was received and
recorded in 2019. No sublease income on the Old Lease was recognized in 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 7, 2020, we entered into a building lease agreement
(the &#x201c;New York Office Lease&#x201d;) with Sage Realty Corporation (the &#x201c;New York Office Landlord&#x201d;). Pursuant to
the New York Office Lease, we have leased approximately 4,000 square feet of office space in New York, New York. The New York Office
Lease commenced on February 1, 2020. The term of the New York Office Lease is 24 months from the commencement date, provides for
annual rent increases, and does not provide us the right to early terminate or extend our lease terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Operating lease costs, net of sublease income, were $&lt;span id="xdx_90D_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20200701__20200930_zQG3Ry3U6Bvl" title="Operating lease costs, net of sublease income"&gt;174,000&lt;/span&gt;
and $&lt;span id="xdx_90A_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20190701__20190930_zlNaqHwBZGmk" title="Operating lease costs, net of sublease income"&gt;96,000&lt;/span&gt; for the three months ended September 30, 2020 and 2019, respectively. Operating lease costs, net of sublease income,
were $&lt;span id="xdx_90B_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20200101__20200930_zHNDYfFJmTB9" title="Operating lease costs, net of sublease income"&gt;459,000&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20190101__20190930_zgEOLGL6MPT7" title="Operating lease costs, net of sublease income"&gt;301,000&lt;/span&gt; for the nine months ended September 30, 2020 and 2019, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The table below presents aggregate future minimum payments
due under the New Lease and the New York Office Lease discussed above, reconciled to lease liabilities included in the condensed
consolidated balance sheet as of September 30, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_pn3n3_zQy0J47soJT" style="border-collapse: collapse; width: 50%" summary="xdx: Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BD_zRqTouLlfun1" style="display: none"&gt;Schedule of future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20200930_zqEvJuZNmSKa" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Operating Leases&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_pn3n3_maOLFMPzu8U_zZMc47WWRwp7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 33%; font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;144&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pn3n3_maOLFMPzu8U_zBvGSiCMroX8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;589&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pn3n3_maOLFMPzu8U_z2wVp7aiANAk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;370&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pn3n3_maOLFMPzu8U_zENbv2ehdnWf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;364&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pn3n3_maOLFMPzu8U_zeMWQ9Lb0UP8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;218&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_pn3n3_mtOLFMPzu8U_zkpxRETVod22" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Total minimum payments&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,685&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zta1dyCKj2ih" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Less: short-term lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(584&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Long-term lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;1,101&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 9pt Sans-Serif; color: Red"&gt;&#160;&lt;/span&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Other Matters&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia is subject to claims, counterclaims and legal actions
that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and
legal actions, if any, will not have a material effect on Acacia&#x2019;s condensed consolidated financial position, results of
operations or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 6, 2019, Slingshot Technologies, LLC (&#x201c;Slingshot&#x201d;)
filed a lawsuit in Delaware Chancery Court against the Company, Acacia Research Group, LLC, and Monarch Networking Solutions LLC
(collectively, the &#x201c;Acacia Entities&#x201d;), Acacia board member Katharine Wolanyk, and Transpacific IP Group, Ltd. (&#x201c;Transpacific&#x201d;).
Slingshot alleges that the Acacia Entities misappropriated its confidential and proprietary information, purportedly furnished
to the Acacia Entities by Ms. Wolanyk, in acquiring a patent portfolio from Transpacific after Slingshot&#x2019;s exclusive option
to purchase the same patent portfolio from Transpacific had already expired. Slingshot seeks monetary damages, as well as equitable
and injunctive relief related to its alleged right to own the portfolio. The Acacia Entities maintain that Slingshot&#x2019;s allegations
are baseless, that Ms. Wolanyk had no involvement in the acquisition, that the Acacia Entities neither had access to nor used Slingshot&#x2019;s
information in acquiring the portfolio, that the Acacia Entities acquired the portfolio as a result of the independent efforts
of its IP licensing group, and that Slingshot suffered no damages given its exclusive option to purchase the portfolio had already
ended and it has proven itself incapable of closing on the portfolio purchase.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In a separate case, on December 6, 2017, the Federal Court of
Canada allowed a counterclaim for invalidity of a patent asserted by Rapid Completions LLC and awarded costs payable by Rapid Completions
LLC in an amount to be determined.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the nine months ended September 30, 2020, operating expenses
included a net income for settlement offset by contingency accruals totaling $&lt;span id="xdx_90E_eus-gaap--OperatingLeasesIncomeStatementContingentRevenue_pn3p0_c20200101__20200930_zxDu3LEhThX2" title="Income from settlement"&gt;308,000&lt;/span&gt;, net of prior accruals. During the nine months
ended September 30, 2019, operating expenses included expenses for settlement and contingency accruals totaling $&lt;span id="xdx_904_eus-gaap--OperatingLeasesIncomeStatementContingentRevenue_pn3p0_c20190101__20190930_zbYWB3ht3D1l" title="Income from settlement"&gt;175,000&lt;/span&gt;. At September
30, 2020, our contingency accruals totaled $&lt;span id="xdx_904_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_dm_c20200930_zyF3T6ZoL0b2" title="Contingency accruals"&gt;1.4&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">174000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">96000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">459000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">301000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_pn3n3_zQy0J47soJT" style="border-collapse: collapse; width: 50%" summary="xdx: Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BD_zRqTouLlfun1" style="display: none"&gt;Schedule of future minimum operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20200930_zqEvJuZNmSKa" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Operating Leases&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-size: 10pt; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_pn3n3_maOLFMPzu8U_zZMc47WWRwp7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 33%; font-size: 10pt; text-align: left"&gt;2020&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; font-size: 10pt; text-align: right"&gt;144&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pn3n3_maOLFMPzu8U_zBvGSiCMroX8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2021&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;589&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pn3n3_maOLFMPzu8U_z2wVp7aiANAk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;370&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pn3n3_maOLFMPzu8U_zENbv2ehdnWf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;364&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pn3n3_maOLFMPzu8U_zeMWQ9Lb0UP8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;2024&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;218&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_pn3n3_mtOLFMPzu8U_zkpxRETVod22" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;Total minimum payments&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,685&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zta1dyCKj2ih" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Less: short-term lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(584&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Long-term lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;1,101&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">144000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">589000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">370000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">364000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">218000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">1685000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">584000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">1101000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeasesIncomeStatementContingentRevenue
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">308000</us-gaap:OperatingLeasesIncomeStatementContingentRevenue>
    <us-gaap:OperatingLeasesIncomeStatementContingentRevenue
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">175000</us-gaap:OperatingLeasesIncomeStatementContingentRevenue>
    <us-gaap:LossContingencyAccrualAtCarryingValue contextRef="AsOf2020-09-30" decimals="-3" unitRef="USD">1400000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zF89CvvKk2ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;7. &lt;span&gt;STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Repurchases of Common Stock &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On August 5, 2019, Acacia&#x2019;s Board of Directors approved
a stock repurchase program, which authorized the purchase of up to $&lt;span id="xdx_90C_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_dm_c20190805__us-gaap--ShareRepurchaseProgramAxis__custom--StockRepurchaseProgramMember_z25cHR2BZ066" title="Value of shares authorized for repurchase"&gt;10.0&lt;/span&gt; million of the Company's common stock through open market
purchases, through block trades, through 10b5-1 plans, or by means of private purchases, from time to time, through July 31, 2020.
Stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were
as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_pn3n3_zyKsHg8pwXHb" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 7. STOCKHOLDERS' EQUITY (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span id="xdx_8B9_z9FXUkUNJmBh" style="display: none"&gt;Schedule of repurchased shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Total Number&lt;br/&gt; of Shares&lt;br/&gt; Purchased&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Average&lt;br/&gt; Price&lt;br/&gt; paid per&lt;br/&gt; Share&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Approximate Dollar&lt;br/&gt; Value of Shares that&lt;br/&gt; May Yet be Purchased&lt;br/&gt; under the Program&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Plan Expiration Date&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 32%; font-size: 10pt; text-align: center"&gt;March 20, 2020 - March 31, 2020&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="width: 15%; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;576,898&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="width: 15%; font-size: 10pt; text-align: center" title="Average price paid per share"&gt;$2.28&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="width: 15%; font-size: 10pt; text-align: center" title="Approximate value of shares that may yet be purchased"&gt;$8,686,000&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3XFtIb7dl8i" style="width: 15%; font-size: 10pt; text-align: center" title="Plan expiration date"&gt;July 31, 2020&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 1pt"&gt;April 1, 2020 - April 23, 2020&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;1,107,639&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="padding-bottom: 1pt; font-size: 10pt; text-align: center" title="Average price paid per share"&gt;$2.42&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="padding-bottom: 1pt; font-size: 10pt; text-align: center" title="Approximate value of shares that may yet be purchased"&gt;$6,001,000&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkVK26nS2Xrf" style="font-size: 10pt; text-align: center; padding-bottom: 1pt" title="Plan expiration date"&gt;July 31, 2020&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"&gt;Totals for 2020&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;1,684,537&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: center" title="Average price paid per share"&gt;$2.37&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In determining whether or not to repurchase any shares of Acacia&#x2019;s
common stock, Acacia&#x2019;s Board of Directors consider such factors as the impact of the repurchase on Acacia&#x2019;s cash position,
as well as Acacia&#x2019;s capital needs and whether there is a better alternative use of Acacia&#x2019;s capital. Acacia has no
obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the
open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce
the outstanding share count and enhance stockholder value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Tax Benefits Preservation Plan&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 12, 2019, Acacia&#x2019;s Board of Directors announced
that it had unanimously approved the adoption of a Tax Benefits Preservation Plan (the &#x201c;Plan&#x201d;). Our stockholders ratified
the adoption of the Plan in July 2019. The purpose of the Plan is to protect the Company&#x2019;s ability to utilize potential tax
assets, such as net operating loss carryforwards and tax credits to offset potential future taxable income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Plan is designed to reduce the likelihood that the Company
will experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership of 4.9% or more
of the Company&#x2019;s outstanding common stock and (ii) any existing stockholders who, as of the time of the first public announcement
of the adoption of the Plan, beneficially own more than 4.9% of the Company&#x2019;s then-outstanding shares of the Company&#x2019;s
common stock from acquiring additional shares of the Company&#x2019;s common stock (subject to certain exceptions). There is no
guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the adoption of the Plan, Acacia&#x2019;s
Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company&#x2019;s
common stock to stockholders of record at the close of business on March 16, 2019. On or after the distribution date, each right
would initially entitle the holder to purchase one one-thousandth of a share of the Company&#x2019;s Series B Junior Participating
Preferred Stock, $0.001 par value for a purchase price of $12.00.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also has a provision in its Amended and Restated
Certificate of Incorporation, as amended (the &#x201c;Charter Provision&#x201d;) which generally prohibits transfers of its common
stock that could result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect the Company&#x2019;s
ability to utilize potential tax assets, such as net operating loss carryforwards and tax credits to offset potential future taxable
income. The Charter Provision was approved by the Company&#x2019;s stockholders on July 15, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&#160;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="AsOf2019-08-05_custom_StockRepurchaseProgramMember"
      decimals="-3"
      unitRef="USD">10000000.0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:AcceleratedShareRepurchasesTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_pn3n3_zyKsHg8pwXHb" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 7. STOCKHOLDERS' EQUITY (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span id="xdx_8B9_z9FXUkUNJmBh" style="display: none"&gt;Schedule of repurchased shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Total Number&lt;br/&gt; of Shares&lt;br/&gt; Purchased&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Average&lt;br/&gt; Price&lt;br/&gt; paid per&lt;br/&gt; Share&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Approximate Dollar&lt;br/&gt; Value of Shares that&lt;br/&gt; May Yet be Purchased&lt;br/&gt; under the Program&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;Plan Expiration Date&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 32%; font-size: 10pt; text-align: center"&gt;March 20, 2020 - March 31, 2020&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="width: 15%; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;576,898&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="width: 15%; font-size: 10pt; text-align: center" title="Average price paid per share"&gt;$2.28&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="width: 15%; font-size: 10pt; text-align: center" title="Approximate value of shares that may yet be purchased"&gt;$8,686,000&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3XFtIb7dl8i" style="width: 15%; font-size: 10pt; text-align: center" title="Plan expiration date"&gt;July 31, 2020&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 1pt"&gt;April 1, 2020 - April 23, 2020&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;1,107,639&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="padding-bottom: 1pt; font-size: 10pt; text-align: center" title="Average price paid per share"&gt;$2.42&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="padding-bottom: 1pt; font-size: 10pt; text-align: center" title="Approximate value of shares that may yet be purchased"&gt;$6,001,000&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkVK26nS2Xrf" style="font-size: 10pt; text-align: center; padding-bottom: 1pt" title="Plan expiration date"&gt;July 31, 2020&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt"&gt;Totals for 2020&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares repurchased"&gt;1,684,537&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: center" title="Average price paid per share"&gt;$2.37&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:AcceleratedShareRepurchasesTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="From2020-03-202020-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">576898</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="From2020-03-202020-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">2.28</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <ACTG:ApproximateValueOfSharesThatMayYetBePurchased
      contextRef="From2020-03-202020-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">8686000000</ACTG:ApproximateValueOfSharesThatMayYetBePurchased>
    <us-gaap:StockRepurchaseProgramExpirationDate contextRef="From2020-03-202020-03-31_us-gaap_CommonStockMember">2020-07-31</us-gaap:StockRepurchaseProgramExpirationDate>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">1107639</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">2.42</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <ACTG:ApproximateValueOfSharesThatMayYetBePurchased
      contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">6001000000</ACTG:ApproximateValueOfSharesThatMayYetBePurchased>
    <us-gaap:StockRepurchaseProgramExpirationDate contextRef="From2020-04-012020-04-23_us-gaap_CommonStockMember">2020-07-31</us-gaap:StockRepurchaseProgramExpirationDate>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember132393281"
      decimals="INF"
      unitRef="Shares">1684537</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="From2020-01-012020-09-30_us-gaap_CommonStockMember132393281"
      decimals="INF"
      unitRef="USDPShares">2.37</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_801_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_znyBcjVpxSId" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;8. &lt;span&gt;RECENT ACCOUNTING PRONOUNCEMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Recent Accounting Pronouncements - Not Yet Adopted&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
issued ASU No. 2019-12 Income Taxes (Topic 740) &#x2014; Simplifying the Accounting for Income Taxes, to remove certain exceptions
and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted
change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date.
The amendments in this update will be effective for the Company beginning with fiscal year 2021, with early adoption permitted.
Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied
on a retrospective or modified retrospective basis. Management is currently evaluating the impact that the amendments in this update
will have on the Company&#x2019;s condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In June 2016, the FASB issued ASU No. 2016-13,Financial Instruments&#x2014;Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, to replace the incurred loss methodology with an expected
credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of
the asset, including current conditions and reasonable and supportable forecasts in addition to historical loss information, to
determine expected credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required.
Also, in April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments&#x2014;Credit
Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, to clarify the inclusion of recoveries of trade
receivables previously written off when estimating an allowance for credit losses. The amendments in this update will be effective
for the Company in fiscal year 2023, with early adoption permitted. Management is currently evaluating the impact that the amendments
in this update will have on the Company&#x2019;s condensed consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_802_eus-gaap--FairValueDisclosuresTextBlock_z8sPHQu1v2F" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;9. &lt;span&gt;FAIR VALUE DISCLOSURES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acacia holds the following types of financial instruments at
September 30, 2020 and December 31, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Trading securities - debt. &lt;/i&gt;Debt securities include corporate
bonds with fair value that is determined by third party quotations from outside pricing services and/or computerized pricing models,
which may be based on transactions, bids or estimates. Acacia classifies the fair value of corporate bonds within Level 2 of the
valuation hierarchy.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Trading securities - equity. &lt;/i&gt;Equity securities include
investments in public companies&#x2019; common stock and are recorded at fair value based on the quoted market price of each share
on the valuation date. The fair value of these securities are within Level 1 of the valuation hierarchy.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Equity securities derivative.&lt;/i&gt; Public company equity securities
derivative are recorded at fair value based on the quoted market price of the underlying shares on the valuation date and settlement
expectations. The fair value of these equity securities derivative are within Level 1 of the valuation hierarchy.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Investments at fair value - common stock&lt;/i&gt;. Acacia&#x2019;s
equity investment in Veritone common stock is recorded at fair value based on the quoted market price of Veritone&#x2019;s common
stock on the applicable valuation date (Level 1).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Investments at fair value - warrants. &lt;/i&gt;Warrants are recorded
at fair value, as based on the Black-Scholes option-pricing model (Level 2).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Series A Warrants. &lt;/i&gt;Series A Warrants are recorded at
fair value, using Black-Scholes option-pricing model (Level 2).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Series B Warrants. &lt;/i&gt;Series B Warrants are recorded at
fair value, using Monte Carlo valuation technique (Level 3).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Embedded derivative liability. &lt;/i&gt;Embedded derivatives that
are required to be bifurcated from their host contract are evaluated and valued separately from the host instrument. A binomial
lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred
Stock issued by the Company in 2019 (Level 3).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:PreferredStockTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_80F_eus-gaap--PreferredStockTextBlock_zC7XW9r0dRU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;10. &lt;span&gt;SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 18, 2019, the Company entered into a Securities
Purchase Agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with Starboard Value LP (&#x201c;Starboard&#x201d;) and the
investors set forth in the Securities Purchase Agreement (the &#x201c;Buyers&#x201d;) pursuant to which the Company issued (i) &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember_pii" title="Stock issued"&gt;350,000&lt;/span&gt;
shares of Series A Redeemable Convertible Preferred Stock with a par value of $0.001 per share and a stated value of $100 per share,
and (ii) Series A Warrants to purchase up to &lt;span id="xdx_908_ecustom--WarrantsIssued_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Warrants issued"&gt;5,000,000&lt;/span&gt; shares of the Company&#x2019;s common stock to the Buyers. The Securities
Purchase Agreement also established the terms of certain senior secured notes (the &#x201c;Notes&#x201d;) and Series B Warrants that
may be issued to the Buyers on a subsequent date. Refer to Notes 11 and 12 for additional information regarding the issuance of
the Series A and Series B Warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series A Redeemable Convertible Preferred Stock can be converted
into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends, divided by (ii)
the conversion price of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Conversion price"&gt;3.65&lt;/span&gt; (subject to certain anti-dilution adjustments). Holders may elect to convert the Series A Redeemable
Convertible Preferred Stock into common stock at any time. The Company may elect to convert the Series A Redeemable Convertible
Preferred Stock into shares of Common Stock any time on or after November 15, 2025, provided that the closing price of the Company&#x2019;s
common stock equals or exceeds 190% of the conversion price for 30 consecutive trading days and assuming certain other conditions
of the common stock have been met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Holders have the option to redeem all or a portion of the Series
A Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and May 15, 2022 through August
15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of Notes to the Buyers pursuant
to the Securities Purchase Agreement. Holders also have the option to redeem all or a portion of the Series A Redeemable Convertible
Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally, holders have the option to redeem
all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of (i) a change of control or (ii)
various other triggering events, such as the suspension from trading or delisting of the Company&#x2019;s common stock. If the
Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price may include a make-whole
amount or a stated premium, depending on the redemption scenario.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company may redeem all, and not less than all, of the Series
A Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May 15, 2022 through August
15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of the Notes, and assuming certain
conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred Stock is redeemed at the option
of the Company, the redemption price would include a make-whole amount or a 15% premium depending on the circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If any Series A Redeemable Convertible Preferred Stock remains
outstanding on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in cash.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In all redemption scenarios, the redemption price for the Series
A Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In addition, depending on
the redemption scenario, the redemption price may also include a make-whole amount or stated premium as described above.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Company issues Notes, the Holder may exchange the Series
A Redeemable Convertible Preferred Stock for (i) Notes and (ii) Series B Warrants to purchase common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series A Redeemable Convertible Preferred Stock accrues
cumulative dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of an approved investment (an investment
to be identified and approved by each of the Company and Starboard), the dividend rate will increase to 8.0% on the stated value.
Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering event occurs before an approved investment
or 10.0% on the stated value if the triggering event occurs after an approved investment. The Series A Redeemable Convertible Preferred
Stock also participates on an as-converted basis in any regular or special dividends paid to common stockholders. There are &lt;span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pn3n3_do_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zCmWnix7w69l" title="Accrued and unpaid dividends"&gt;no&lt;/span&gt;
accrued and unpaid dividends as of September 30, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Holders of the Series A Redeemable Convertible Preferred Stock
have the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable Convertible
Preferred Stock will also be entitled to a separate class vote with respect to amendments to the Company&#x2019;s organizational
documents that generally have an adverse effect on the Series A Redeemable Convertible Preferred Stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Upon liquidation of the Company, holders of Series A Redeemable
Convertible Preferred Stock have a liquidation preference over holders of our common stock and will be entitled to receive, prior
to any distribution to holders of our common stock, an amount equal to the greater of (i) the stated value plus accrued and unpaid
dividends or (ii) the amount that would have been received if the Series A Redeemable Convertible Preferred Stock had been converted
into common stock immediately prior to the liquidation event at the then effective conversion price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company determined that certain features of the Series A
Redeemable Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features are bundled
together as a single, compound embedded derivative.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Total proceeds received and transaction costs incurred from
the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $35 million and $1.2 million, respectively. Proceeds
received were allocated based on the fair value of the instrument without the Series A Warrants and of the Series A Warrants themselves
at the time of issuance. The proceeds allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated
between the host preferred stock instrument and the embedded derivative, with the embedded derivative recorded at fair value and
the Series A Redeemable Convertible Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the
Series A Warrants, embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and
$8.9 million, respectively. Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock and
the Series A Warrants on the same basis as the proceeds. The transaction costs allocated to the Series A Redeemable Convertible
Preferred Stock were treated as a discount to the Series A Redeemable Convertible Preferred Stock. The transaction costs allocated
to the Series A Warrants were expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company classifies the Series A Redeemable Convertible Preferred
Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various scenarios or otherwise
on November 15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become redeemable, the Company
accretes the instrument to its redemption value using the effective interest method and recognizes any changes against additional
paid in capital in the absence of retained earnings. Accretion was $&lt;span id="xdx_907_eus-gaap--AccretionExpense_pn3n3_dm_c20200701__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zBeYQReQQE7g" title="Accretion"&gt;0.7&lt;/span&gt; million and $&lt;span id="xdx_901_eus-gaap--AccretionExpense_pn3n3_dm_c20200101__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zbFObga2BzHg" title="Accretion"&gt;2.0&lt;/span&gt; million, respectively, for the three and
nine months ended September 30, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the issuance of the Series A Redeemable Convertible
Preferred Stock, the Company executed a Registration Rights Agreement with Starboard and the Buyers, and a Governance Agreement
with Starboard and certain affiliates of Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain
registration rights with respect to the Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon
conversion. In accordance with the Governance Agreement, the Company agreed to (i) increase the size of the Board of Directors
from six to seven members, (ii) appoint a director of the Company, (iii) grant Starboard and its affiliates the right to recommend
two additional directors for appointment to the board, (iv) form a Strategic Committee of the Board tasked with sourcing and performing
due diligence on potential acquisition targets, (v) appoint certain directors to the Strategic Committee, and (vi) appoint a director
to the Nominating and Corporate Governance Committee.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following features of the Series A Redeemable Convertible
Preferred Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded derivative:
(i) the right of the holders to redeem the shares (put option), (ii) the right of the holders to receive common stock upon conversion
of the shares (conversion option), (iii) the right of the Company to redeem the shares (call option), and (iv) the change in dividend
rate upon consummation of an approved investment or a triggering event (contingent dividend rate feature).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These features are required to be accounted for separately from
the Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly and closely related
to the debt-like host and also did not meet any other scope exceptions for derivative accounting. Therefore, these features are
bundled together and are accounted for as a single, compound embedded derivative liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, we have recorded an embedded derivative liability
representing the combined fair value of each of these features. The embedded derivative liability is adjusted to reflect fair value
at each period end with changes in fair value recorded in the &#x201c;Change in fair value of redeemable preferred stock embedded
derivative&#x201d; financial statement line item of the accompanying condensed consolidated statements of operations. As of September
30, 2020, the fair value of the Series A embedded derivative was $&lt;span id="xdx_90E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_z9fbr93dIQSe" title="Fair value of Series A embedded derivative"&gt;25.7&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</us-gaap:PreferredStockTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember"
      decimals="INF"
      unitRef="Shares">350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ACTG:WarrantsIssued
      contextRef="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">5000000</ACTG:WarrantsIssued>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">3.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DividendsPayableCurrent
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:DividendsPayableCurrent>
    <us-gaap:AccretionExpense
      contextRef="From2020-07-012020-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">700000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2020-01-012020-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">2000000.0</us-gaap:AccretionExpense>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="AsOf2020-09-30_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">25700000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <ACTG:WarrantDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_80A_ecustom--WarrantDisclosureTextBlock_z7M7a9RY9U78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;11. &lt;span&gt;SERIES A WARRANTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 18, 2019, in connection with the issuance of the
Series A Redeemable Convertible Preferred Stock, the Company issued detachable Series A Warrants to acquire up to &lt;span id="xdx_907_ecustom--WarrantsIssuedShares_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Warrants issued, shares"&gt;5,000,000&lt;/span&gt; shares
of common stock at a price of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pip0_c20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zQz4wZWxGudk" title="Conversion price"&gt;3.65&lt;/span&gt; per share (subject to certain antidilution adjustments) at any time during a period of eight
years beginning on the instrument&#x2019;s issuance date of the Series A Warrants. As of September 30, 2020, the Series A Warrants
have &lt;span id="xdx_907_ecustom--WarrantsExercised_pii_do_c20200101__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zDICLBPCqs11" title="Warrants exercised"&gt;no&lt;/span&gt;t been exercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series A Warrants will be recognized at fair value at each
reporting period until exercised, with changes in fair value recognized in the condensed consolidated statements of operations
in other income (expense) in the accompanying condensed consolidated statements of operations. As of December 31, 2019, the fair
value of the Series A Warrants was $&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20191231__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zhOInMhEl6ta" title="Fair value of warrants"&gt;3.6&lt;/span&gt; million. As of September 30, 2020, the fair value of the Series A Warrants was $&lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zCeChSpd2WKl" title="Fair value of warrants"&gt;5.6&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series A Warrants are classified as a liability in accordance
with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ACTG:WarrantDisclosureTextBlock>
    <ACTG:WarrantsIssuedShares
      contextRef="From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">5000000</ACTG:WarrantsIssuedShares>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">3.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <ACTG:WarrantsExercised
      contextRef="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="INF"
      unitRef="Shares">0</ACTG:WarrantsExercised>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2019-12-31_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">3600000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember"
      decimals="-3"
      unitRef="USD">5600000</us-gaap:WarrantsAndRightsOutstanding>
    <ACTG:SeriesBWarrantsTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_809_ecustom--SeriesBWarrantsTextBlock_zfFravHjlkIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;12. &lt;span&gt;SERIES B WARRANTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 25, 2020, pursuant to the terms of the Securities
Purchase Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to &lt;span id="xdx_905_ecustom--WarrantsIssuedShares_pn3n3_dm_c20200101__20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zNJfwcB6Mzr1" title="Warrants issued, shares"&gt;100&lt;/span&gt; million shares of
the Company&#x2019;s common stock at an exercise price (subject to certain price-based anti-dilution adjustments) of either (i)
$&lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pii" title="Conversion price"&gt;5.25&lt;/span&gt; per share, if exercising by cash payment, within 30 months from the issuance date (i.e., August 25, 2022); or (ii) $3.65
per share, if exercising by cancellation of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase
price of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfWarrants_pn3n3_dm_c20200101__20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_z5ltS97JhSA8" title="Proceeds from issuance of warrants"&gt;4.6&lt;/span&gt; million. The Series B Warrants expire on &lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zuujuKqSF0lb" title="Warrant expiration date"&gt;November 15, 2027&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the issuance of the Notes on June 4, 2020,
the terms of certain of the Series B Warrants were amended to permit the payment of the lower exercise price of $3.65 through the
payment of cash, rather than only through the cancellation of Notes outstanding, at any time until the expiration date of November
15, 2027. Only &lt;span title="Warrants Description"&gt;31,506,849 of the Series B Warrants are subject to this adjustment with the remaining balance of 68,493,151 Series
B Warrants continuing under their original terms.&lt;/span&gt; Refer to Note 13 for additional information on the modifications to Series A
Redeemable Convertible Preferred Stock and Series B Warrants. As of September 30, 2020, the Series B Warrants have &lt;span id="xdx_90D_ecustom--WarrantsExercisedShares_pip0_do_c20200101__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zm6D0c8BbMfl" title="Warrants exercised"&gt;no&lt;/span&gt;t been exercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series B Warrants will be recognized at fair value at each
reporting period until exercised, with changes in fair value recognized in the condensed consolidated statements of operations
in other income (expense). As of September 30, 2020, the fair value of the Series B Warrants was $&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zxyU4PExGay2" title="Fair value of warrants"&gt;42.8&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series B Warrants are classified as a liability in accordance
with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;











</ACTG:SeriesBWarrantsTextBlock>
    <ACTG:WarrantsIssuedShares
      contextRef="From2020-01-012020-02-25_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="Shares">100000000</ACTG:WarrantsIssuedShares>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2020-02-25_custom_SeriesBWarrantsMember"
      decimals="INF"
      unitRef="USDPShares">5.25</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2020-01-012020-02-25_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">4600000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate contextRef="AsOf2020-02-25_custom_SeriesBWarrantsMember">2027-11-15</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <ACTG:WarrantsExercisedShares
      contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132394531"
      decimals="INF"
      unitRef="Shares">0</ACTG:WarrantsExercisedShares>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2020-09-30_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">42800000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zt9L64DPotwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;13. &lt;span&gt;SENIOR SECURED NOTES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to the Securities Purchase
Agreement dated November 18, 2019 with Starboard and the Buyers, on June 4, 2020, the Company issued $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zLqTn44DJEt" title="Proceeds from issuance of debt"&gt;115&lt;/span&gt;
million in Notes to the Buyers. Also on June 4, 2020, in connection with the issuance of the Notes, the Company entered into
a Supplemental Agreement with Starboard (the &#x201c;Supplemental Agreement&#x201d;), pursuant to which the Company agreed to
redeem $&lt;span id="xdx_90E_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zXZ4fIqPgVR6" title="Repayment of debt"&gt;80&lt;/span&gt;
million aggregate principal amount of the Notes by September 30, 2020, and $&lt;span id="xdx_901_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20201231__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zraSBrsG9ES2" title="Repayment of debt"&gt;35&lt;/span&gt;
million aggregate principal amount of the Notes by December 31, 2020, resulting in the total principal outstanding being paid
by December 31, 2020. Per the Supplemental Agreement, interest is payable semiannually at a rate of 6.00% per annum, and in
an event of default, the interest rate is increased to &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zNkvbb2FTykc" title="Interest Rate"&gt;10&lt;/span&gt;%
per annum. The Notes include certain financial and non-financial covenants. Additionally, all or any portion of the principal
amount outstanding under the Notes may, at the election of Starboard, be surrendered to the Company for cancellation in
payment of the exercise price upon the exercise of Series B Warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 30, 2020, the Company entered into an Exchange Agreement
(the &#x201c;Exchange Agreement&#x201d;) with Merton Acquisition HoldCo LLC, a Delaware limited liability company and wholly-owned
subsidiary of the Company (&#x201c;Merton&#x201d;) and Starboard, on behalf of itself and on behalf of certain funds and accounts
under its management, including the holders of the Notes. Pursuant to the Exchange Agreement, the holders of the Notes exchanged
the entire outstanding principal amount for new senior notes (the &#x201c;New Notes&#x201d;) issued by Merton having an aggregate
outstanding original principal amount of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zTG70nH9bU0h" title="Principal amount"&gt;115&lt;/span&gt; million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The New Notes bear interest at a rate of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pii_dp_c20200101__20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zgOtyG1Z2rbj" title="Interest Rate"&gt;6.00&lt;/span&gt;% per annum and
will mature on &lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20200101__20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_z8vXz1EFOHyg" title="Maturity Date"&gt;December 31, 2020&lt;/span&gt;. The New Notes are fully guaranteed by the Company and are secured by an all-assets pledge of
the Company and Merton and non-recourse equity pledges of each of the Company&#x2019;s material subsidiaries. Pursuant to the Exchange
Agreement, the New Notes (i) are deemed to be &#x201c;Notes&#x201d; for purposes of the Securities Purchase Agreement, (ii) are deemed
to be &#x201c;June 2020 Approved Investment Notes&#x201d; for purposes of the Supplemental Agreement, and therefore the Company has
agreed to redeem $&lt;span id="xdx_908_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zNVaVS80kWe2" title="Repayment of debt"&gt;80&lt;/span&gt; million principal amount of the New Notes by September 30, 2020 (the &#x201c;Initial Redemption Date&#x201d;)
and $&lt;span id="xdx_909_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotes1Member_z17L7mjnhE3i" title="Repayment of debt"&gt;35&lt;/span&gt; million principal amount of the New Notes by December 31, 2020 (the &#x201c;Final Redemption Date&#x201d;), and (iii) are
deemed to be &#x201c;Notes&#x201d; for the purposes of the Series B Warrants, and therefore may be tendered pursuant to a Note Cancellation
under the Series B Warrants on the terms set forth in the Series B Warrants and the New Notes. Delivery of notes in the form of
the New Notes will satisfy the delivery of Exchange Notes pursuant to Section 16(i) of the Certificate of Designations of the Company&#x2019;s
Series A Convertible Preferred Stock, par value $&lt;span id="xdx_907_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_pii" title="Series A redeemable convertible preferred stock, par value"&gt;0.001&lt;/span&gt; per share. The New Notes will not be deemed to be &#x201c;Notes&#x201d; for
the purposes of the Registration Rights Agreement, dated as of November 18, 2019, by and among the Company, Starboard and the Buyers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Because the New Notes will be settled within twelve months pursuant
to their terms, they are classified as current liabilities on the balance sheet. The Company capitalized $&lt;span title="Payment of lender fees"&gt;&lt;span id="xdx_909_eus-gaap--PaymentsOfFinancingCosts_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zkDuDsO3Y1ii" title="Payment of lenders fees"&gt;4.6&lt;/span&gt;&lt;/span&gt; million in lender
fees and $&lt;span title="Other issuance costs"&gt;&lt;span id="xdx_903_eus-gaap--PaymentsOfDebtIssuanceCosts_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zrYUF2SWw826" title="Payment of other issuance costs"&gt;0.5&lt;/span&gt;&lt;/span&gt; million in other issuance costs associated with the issuance of the Notes. The $4.6 million of lender fees are recognized
as long term deferred debt issuance cost and will be amortized to interest expense until November 15, 2027, the maturity date of
Series A Redeemable Convertible Preferred Stock. The $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zQuEXFGhLPVf" title="Discount"&gt;0.5&lt;/span&gt; million issuance costs are recognized as a discount on the Notes and
will be amortized to interest expense over the contractual life of the Notes. There is $&lt;span title="Accrued and unpaid dividends"&gt;&lt;span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zitnjNQ1RJ0e" title="Accrued and unpaid dividends"&gt;1.7&lt;/span&gt;&lt;/span&gt; million accrued and unpaid interest on
the New Note as of September 30, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Initial Redemption Date was subsequently extended by the
parties to November 9, 2020 and the Final Redemption Date was extended to January 15, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Modifications to Series A Redeemable Convertible Preferred
Stock and Series B Warrants&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The June 4, 2020 Supplemental Agreement also provided for (i)
a waiver of increased dividends under the original terms of the Series A Preferred Stock that would have otherwise accrued due
to the Company&#x2019;s use of the $35 million proceeds received from Starboard and the Buyers upon the issuance of the Series A
Redeemable Convertible Preferred Stock in November 2019, (ii) the replacement of original optional redemption rights for the Series
A Redeemable Convertible Preferred Stock provided to both the Company and the holders that otherwise would have been nullified
through the issuance of the Notes, and (iii) an amendment to the terms of the previously issued Series B Warrants to permit the
payment of the lower exercise price of $3.65 through the payment of cash, rather than only through the cancellation of Notes outstanding,
at any time until the expiration of the Series B Warrants on November 15, 2027. Only &lt;span title="Warrants Description"&gt;31,506,849 of the Series B Warrants are subject
to this adjustment with the remaining balance of 68,493,151 Series B Warrants continuing under their original terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We analyzed the amendments to the Series A Redeemable Convertible
Preferred Stock and determined that the amendments were not significant. Therefore, the amendments are accounted for as a modification
on a prospective basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The incremental fair value of the Series B Warrants associated
with their modification in connection with the issuance of the Notes is $&lt;span id="xdx_90F_ecustom--OriginalIssueDiscount_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_ztkOTNvawrmk" title="Original Issue Discount"&gt;1.3&lt;/span&gt; million and is recognized as a discount on the Notes
and will be amortized to interest expense over the contractual life of the Notes. For the three and nine months ended September
30, 2020, respectively, $&lt;span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pn3p0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zREdr43vSJj9" title="Interest expense"&gt;532,000&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_pn3p0_c20200101__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_znRWuywov9Y4" title="Unamortized Discount"&gt;697,000&lt;/span&gt; were amortized to interest expense. As of September 30, 2020, $&lt;span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3p0_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zxjTHtVpuD3" title="Remaining discount"&gt;632,000&lt;/span&gt; is remaining
to be amortized until the Final Redemption Date of January 15, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2020-01-012020-09-30_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">80000000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2020-01-012020-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">35000000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2020-01-012020-06-04_custom_SecuritiesPurchaseAgreementMember_custom_SeniorSecuredNotesMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">115000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2020-01-012020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember"
      decimals="INF"
      unitRef="Pure">0.0600</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-01-012020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember">2020-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">80000000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotes1Member"
      decimals="-3"
      unitRef="USD">35000000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">4600000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="From2020-01-012020-09-30_custom_ExchangeAgreementMember_custom_MertonMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">500000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember"
      decimals="-3"
      unitRef="USD">500000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesARedeemableConvertibleStockMember"
      decimals="-3"
      unitRef="USD">1700000</us-gaap:DividendsPayableCurrent>
    <ACTG:OriginalIssueDiscount
      contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">1300000</ACTG:OriginalIssueDiscount>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2020-07-012020-09-30_custom_SeriesBWarrantsMember132395046"
      decimals="-3"
      unitRef="USD">532000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2020-01-012020-09-30_custom_SeriesBWarrantsMember132394531"
      decimals="-3"
      unitRef="USD">697000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2020-09-30_custom_MertonMember_custom_SeniorSecuredNotesMember_custom_SeriesBWarrantsMember"
      decimals="-3"
      unitRef="USD">632000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_801_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zCvvVUrnhmR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;14. &lt;span&gt;LF EQUITY INCOME FUND PORTFOLIO INVESTMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 3, 2020, the Company entered into
an Option Agreement with Seller, which included general terms through which the Company was provided the option to purchase life
sciences equity securities in a portfolio of public and private companies (&#x201c;Portfolio Companies&#x201d;) for an aggregate
purchase price of &#xa3;&lt;span id="xdx_90E_eus-gaap--PaymentsToAcquireAvailableForSaleSecuritiesEquity_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_z3KWMMZn94fh" title="Payment to acquire equity securities"&gt;223.9&lt;/span&gt; million, approximately $&lt;span id="xdx_906_eus-gaap--PaymentsToAcquireAvailableForSaleSecuritiesEquity_pn3n3_dm_c20200101__20200403__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zo3AQdix0F9e" title="Payment to acquire equity securities"&gt;277.5&lt;/span&gt; million at the exchange rate on April 3, 2020. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 4, 2020, the Company executed the
Transaction Agreement between Link Fund Solutions Limited, Seller, and the Company. Pursuant to the Transaction Agreement, the
Company will purchase from Seller and Seller will transfer to the Company the specified equity securities of all Portfolio Companies
at set prices at various future dates. The transfer dates will vary among the Portfolio Companies as the Transaction Agreement
gives the Company the exclusive right to determine when to call for transfer of each security, and because each Portfolio Company
(or its existing equity holders) may be required to approve the transfer due to rights of first refusals and other company-specific
terms and conditions. Thus, the execution of the Transaction Agreement resulted in forward contracts for the Company to purchase
equity securities in each public and private company at a specified price on a future date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In accordance with the Transaction Agreement,
the Company transferred the total purchase price of &#xa3;223.9 million into an escrow account. As each of the equity securities
in the Portfolio are transferred to the Company, the associated funds will be released from the escrow account to Seller based
on the consideration amount assigned to the equity securities in the Transaction Agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For accounting purposes, the total purchase price of the portfolio
was allocated to the individual equity securities based on their individual fair values as of April 3, 2020, in order to establish
an appropriate cost basis for each of the acquired securities. The fair values of the public company securities were based on their
quoted market price. The fair values of the private company securities were estimated based on recent financing transactions and
secondary market transactions and factoring in a discount for the illiquidity of these securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the three months ended September 30, 2020, Seller returned
a total of &#xa3;&lt;span id="xdx_901_ecustom--ReturnOnPrepayment_pn3n3_dm_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_zAcUmHfRUNa" title="Return on prepayment"&gt;4.5&lt;/span&gt; million of the Company&#x2019;s prepaid investment upon the failure to obtain the approval of the existing
equity holders, pursuant to their rights of first refusals, of one of the Portfolio Companies in connection with the transfer of
its securities. In addition, due to an ownership restriction applicable to one of the Portfolio Companies, the Company sold a small
portion of an equity securities derivative for &#xa3;&lt;span id="xdx_90B_eus-gaap--ProceedsFromSaleOfAvailableForSaleSecurities_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_pn3n3" title="Proceeds from sale of securities"&gt;33,000&lt;/span&gt; before the remaining shares of such Portfolio Company could be transferred
to us. The Company recognized a net gain of $&lt;span id="xdx_90A_eus-gaap--EquitySecuritiesFvNiRealizedGain_pn3n3_dm_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zvCe6bFIjlU6" title="Gain on sale of deriviative"&gt;2.8&lt;/span&gt; million related to the returned prepaid investments and sale of the derivative.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Changes in the fair value of Acacia&#x2019;s investment in the
Portfolio Companies are recorded as unrealized gains or losses in the condensed consolidated statements of operations. For the
three and nine months ended September 30, 2020 and 2019, the accompanying condensed consolidated statements of operations reflected
the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zepeP87rkN5k" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BB_z58Oa7OcEZ0h" style="display: none"&gt;Changes in fair value of Acacias Investment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20200701__20200930_zW5j2zNiwn7h" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20190701__20190930_zpiKyYHn3643" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20200101__20200930_zva1bbiqQYVb" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20190101__20190930_zDiQvy1w7Zfj" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left"&gt;Change in fair value of trading securities - LF Fund public securities&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;3,403&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zUZgIMo2uB87" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;2,334&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zm7I5B0PCRD7" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value of equity securities derivative&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zwBJ36vuQ0M2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;10,651&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zrDGADWnIJeh" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zsFUZu7k857e" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;17,542&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_z1133gWw9bO6" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value of equity securities - LF Fund private securities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zVSFO2lNfWf2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;80,896&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z7ysG3TB4F44" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z3sk4jBRpnHk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;80,896&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zo8j4ONbD2Zg" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value of equity securities forward contract&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zmmP3IofhU67" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(74,662&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zVoFbxdBxw2l" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zruyd7HkfZBi" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_ziG4zeheCtwk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Gain (loss) on sale of trading securities - LF Fund public securities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zoJ5KTT9TL6a" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities"&gt;1,908&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zcfv5FvxsDv" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zDZyrmDggnc6" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities"&gt;(4,202&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zCcWCXm6WxE3" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--GainLossOnSaleOfDerivatives_pn3n3_d0_zReEvh8i047l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gain on sale of prepaid investment and derivative&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,845&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,845&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Net realized and unrealized gain on investment in LF Fund securities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;25,041&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zQD40jp4UGU2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;99,415&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zJzaJkH3xEY2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity
      contextRef="From2020-01-012020-06-04_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP"
      decimals="-3"
      unitRef="USD">223900000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity
      contextRef="From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember"
      decimals="-3"
      unitRef="USD">277500000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity>
    <ACTG:ReturnOnPrepayment
      contextRef="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP"
      decimals="-3"
      unitRef="USD">4500000</ACTG:ReturnOnPrepayment>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember_currency_GBP"
      decimals="-3"
      unitRef="USD">33000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:EquitySecuritiesFvNiRealizedGain
      contextRef="From2020-07-012020-09-30_custom_OptionAgreementMember_custom_PortfolioCompaniesMember"
      decimals="-3"
      unitRef="USD">2800000</us-gaap:EquitySecuritiesFvNiRealizedGain>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock contextRef="From2020-01-01to2020-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zepeP87rkN5k" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BB_z58Oa7OcEZ0h" style="display: none"&gt;Changes in fair value of Acacias Investment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20200701__20200930_zW5j2zNiwn7h" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20190701__20190930_zpiKyYHn3643" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20200101__20200930_zva1bbiqQYVb" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_490_20190101__20190930_zDiQvy1w7Zfj" style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Three Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;Nine Months Ended&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="font-size: 10pt; text-align: center"&gt;(In thousands)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left"&gt;Change in fair value of trading securities - LF Fund public securities&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;3,403&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zUZgIMo2uB87" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;2,334&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zm7I5B0PCRD7" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value of equity securities derivative&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zwBJ36vuQ0M2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;10,651&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zrDGADWnIJeh" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zsFUZu7k857e" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;17,542&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_z1133gWw9bO6" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value of equity securities - LF Fund private securities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zVSFO2lNfWf2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;80,896&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z7ysG3TB4F44" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z3sk4jBRpnHk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;80,896&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zo8j4ONbD2Zg" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value of equity securities forward contract&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zmmP3IofhU67" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;(74,662&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zVoFbxdBxw2l" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zruyd7HkfZBi" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_ziG4zeheCtwk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Gain (loss) on sale of trading securities - LF Fund public securities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zoJ5KTT9TL6a" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities"&gt;1,908&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zcfv5FvxsDv" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zDZyrmDggnc6" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities"&gt;(4,202&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zCcWCXm6WxE3" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--GainLossOnSaleOfDerivatives_pn3n3_d0_zReEvh8i047l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gain on sale of prepaid investment and derivative&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,845&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,845&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt"&gt;Net realized and unrealized gain on investment in LF Fund securities&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;25,041&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zQD40jp4UGU2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;99,415&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zJzaJkH3xEY2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">3403000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-07-012019-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">2334000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-01-012019-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesDerivativeMember"
      decimals="-3"
      unitRef="USD">10651000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-07-012019-09-30_custom_EquitySecuritiesDerivativeMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesDerivativeMember"
      decimals="-3"
      unitRef="USD">17542000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-01-012019-09-30_custom_EquitySecuritiesDerivativeMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember"
      decimals="-3"
      unitRef="USD">80896000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-07-012019-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember"
      decimals="-3"
      unitRef="USD">80896000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-01-012019-09-30_custom_EquitySecuritiesLFFundPrivateSecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_EquitySecuritiesForwardContractMember"
      decimals="-3"
      unitRef="USD">-74662000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-07-012019-09-30_custom_EquitySecuritiesForwardContractMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_EquitySecuritiesForwardContractMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2019-01-012019-09-30_custom_EquitySecuritiesForwardContractMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainLossOnSaleOfEquityInvestments
      contextRef="From2020-07-012020-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">1908000</us-gaap:GainLossOnSaleOfEquityInvestments>
    <us-gaap:GainLossOnSaleOfEquityInvestments
      contextRef="From2019-07-012019-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfEquityInvestments>
    <us-gaap:GainLossOnSaleOfEquityInvestments
      contextRef="From2020-01-012020-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">-4202000</us-gaap:GainLossOnSaleOfEquityInvestments>
    <us-gaap:GainLossOnSaleOfEquityInvestments
      contextRef="From2019-01-012019-09-30_custom_TradingSecuritiesLFFundPublicSecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfEquityInvestments>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2020-07-012020-09-30"
      decimals="-3"
      unitRef="USD">2845000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2019-07-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2020-01-01to2020-09-30"
      decimals="-3"
      unitRef="USD">2845000</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnSaleOfDerivatives
      contextRef="From2019-01-012019-09-30"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnSaleOfDerivatives>
    <us-gaap:GainLossOnInvestments
      contextRef="From2020-07-012020-09-30_custom_TradingSecuritesLfFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">25041000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2019-07-012019-09-30_custom_TradingSecuritesLfFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2020-01-012020-09-30_custom_TradingSecuritesLfFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">99415000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="From2019-01-012019-09-30_custom_TradingSecuritesLfFundSecuritiesMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:GainLossOnInvestments>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-09-30">&lt;p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zNn9TTHdhJok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;15. &lt;span&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;None.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232577608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 02, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-37721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Acacia Research Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000934549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4405754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4 Park Plaza<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irvine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">480-8300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACTG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,279,453<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112233053112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 162,564<span></span>
</td>
<td class="nump">$ 57,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Trading securities - debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">93,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent', window );">Trading securities - equity</a></td>
<td class="nump">24,471<span></span>
</td>
<td class="nump">17,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities - private</a></td>
<td class="nump">116,009<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Equity securities derivative</a></td>
<td class="nump">17,818<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCost', window );">Equity securities forward contract</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PrepaidInvestment', window );">Prepaid investment</a></td>
<td class="nump">42,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,685<span></span>
</td>
<td class="nump">2,912<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">366,050<span></span>
</td>
<td class="nump">171,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Long-term restricted cash</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investment at fair value (Note 5)</a></td>
<td class="nump">982<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Patents, net of accumulated amortization</a></td>
<td class="nump">18,071<span></span>
</td>
<td class="nump">7,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Leased right-of-use assets</a></td>
<td class="nump">1,101<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">5,311<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">426,515<span></span>
</td>
<td class="nump">218,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,707<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">4,849<span></span>
</td>
<td class="nump">7,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">2,595<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_RoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="nump">14,230<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebtCurrent', window );">Senior Secured Notes Payable - short-term</a></td>
<td class="nump">113,933<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">138,314<span></span>
</td>
<td class="nump">11,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Series A warrant liabilities</a></td>
<td class="nump">5,604<span></span>
</td>
<td class="nump">3,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Series A embedded derivative liabilities</a></td>
<td class="nump">25,682<span></span>
</td>
<td class="nump">17,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DerivativeLiabilitiesNoncurrent1', window );">Series B warrant liabilities</a></td>
<td class="nump">42,796<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">1,101<span></span>
</td>
<td class="nump">1,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">593<span></span>
</td>
<td class="nump">593<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">214,090<span></span>
</td>
<td class="nump">35,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionAmount', window );">Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of September 30, 2020 and December 31, 2019, respectively; aggregate liquidation preference of $35,000 as of September 30, 2020 and December 31, 2019, respectively</a></td>
<td class="nump">10,134<span></span>
</td>
<td class="nump">8,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share; 300,000,000 shares authorized; 49,279,453 and 50,370,987 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost, 4,604,365 and 2,919,828 shares as of September 30, 2020 and December 31, 2019, respectively</a></td>
<td class="num">(43,270)<span></span>
</td>
<td class="num">(39,272)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">650,130<span></span>
</td>
<td class="nump">652,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(406,451)<span></span>
</td>
<td class="num">(439,656)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Acacia Research Corporation stockholders' equity</a></td>
<td class="nump">200,458<span></span>
</td>
<td class="nump">173,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">202,291<span></span>
</td>
<td class="nump">174,958<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock, and stockholders' equity</a></td>
<td class="nump">$ 426,515<span></span>
</td>
<td class="nump">$ 218,161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DerivativeLiabilitiesNoncurrent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Series B warrant liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DerivativeLiabilitiesNoncurrent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PrepaidInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PrepaidInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_RoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties and contingent legal fees payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_RoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in equity securities and other forms of securities that provide ownership interests classified as available-for-sale, expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112152018456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">49,279,453<span></span>
</td>
<td class="nump">50,370,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">49,279,453<span></span>
</td>
<td class="nump">50,370,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">4,604,365<span></span>
</td>
<td class="nump">2,919,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series A redeemable convertible preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Series A redeemable convertible preferred stock, value per share</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Series A redeemable convertible preferred stock, shares authorized</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Series A redeemable convertible preferred stock, shares issued</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Series A redeemable convertible preferred stock, shares outstanding</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Series A redeemable convertible preferred stock, liquidation preference</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112233089208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 19,466<span></span>
</td>
<td class="nump">$ 1,711<span></span>
</td>
<td class="nump">$ 25,399<span></span>
</td>
<td class="nump">$ 10,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Portfolio operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Inventor royalties</a></td>
<td class="nump">5,772<span></span>
</td>
<td class="nump">776<span></span>
</td>
<td class="nump">6,843<span></span>
</td>
<td class="nump">4,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ContingentLegalFees', window );">Contingent legal fees</a></td>
<td class="nump">6,609<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">6,855<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_LitigationAndLicensingExpensesPatents', window );">Litigation and licensing expenses - patents</a></td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">987<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
<td class="nump">6,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of patents</a></td>
<td class="nump">1,174<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="nump">3,522<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other portfolio expenses (income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(475)<span></span>
</td>
<td class="num">(308)<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total portfolio operations</a></td>
<td class="nump">14,556<span></span>
</td>
<td class="nump">2,186<span></span>
</td>
<td class="nump">20,409<span></span>
</td>
<td class="nump">14,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NetPortfolioIncomeLoss', window );">Net portfolio income (loss)</a></td>
<td class="nump">4,910<span></span>
</td>
<td class="num">(475)<span></span>
</td>
<td class="nump">4,990<span></span>
</td>
<td class="num">(3,936)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses(1)</a></td>
<td class="nump">7,692<span></span>
</td>
<td class="nump">4,630<span></span>
</td>
<td class="nump">18,089<span></span>
</td>
<td class="nump">12,048<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(2,782)<span></span>
</td>
<td class="num">(5,105)<span></span>
</td>
<td class="num">(13,099)<span></span>
</td>
<td class="num">(15,984)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment, net (Note 5)</a></td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(4,266)<span></span>
</td>
<td class="nump">3,704<span></span>
</td>
<td class="nump">9,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Loss on sale of investment (Note 5)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(915)<span></span>
</td>
<td class="num">(2,762)<span></span>
</td>
<td class="num">(8,147)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of other investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of other investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Change in fair value of the Series A and B warrants and embedded derivatives</a></td>
<td class="nump">20,672<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(46,612)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Change in fair value of equity securities derivative and forward contract</a></td>
<td class="num">(64,011)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,542<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Gain on sale of prepaid investment and derivative</a></td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss', window );">Change in fair value of trading securities and equity securities - private</a></td>
<td class="nump">84,499<span></span>
</td>
<td class="num">(482)<span></span>
</td>
<td class="nump">81,907<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet', window );">Gain (loss) on sale of trading securities</a></td>
<td class="nump">2,737<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="num">(4,272)<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Loss on foreign currency exchange</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
<td class="num">(4,938)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense on Senior Secured Notes</a></td>
<td class="num">(2,410)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,178)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income and other</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">811<span></span>
</td>
<td class="nump">3,012<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">41,213<span></span>
</td>
<td class="num">(2,503)<span></span>
</td>
<td class="nump">45,047<span></span>
</td>
<td class="num">(1,456)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">38,431<span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
<td class="nump">31,948<span></span>
</td>
<td class="num">(17,440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="num">(83)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
<td class="num">(323)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income (loss) including noncontrolling interests in subsidiaries</a></td>
<td class="nump">38,348<span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
<td class="nump">33,205<span></span>
</td>
<td class="num">(17,763)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to noncontrolling interests in subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Acacia Research Corporation</a></td>
<td class="nump">38,348<span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
<td class="nump">33,205<span></span>
</td>
<td class="num">(17,749)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to common stockholders - basic</a></td>
<td class="nump">$ 30,529<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="nump">$ 24,838<span></span>
</td>
<td class="num">$ (17,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
<td class="num">$ (0.36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding - basic</a></td>
<td class="nump">48,467,885<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">48,949,706<span></span>
</td>
<td class="nump">49,727,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income (loss) attributable to common stockholders - diluted</a></td>
<td class="nump">$ 29,204<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="nump">$ 21,380<span></span>
</td>
<td class="num">$ (17,749)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="num">$ (0.36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted</a></td>
<td class="nump">90,624,702<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">60,153,773<span></span>
</td>
<td class="nump">49,727,385<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ContingentLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent legal fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ContingentLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_LitigationAndLicensingExpensesPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation and licensing expenses, patents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_LitigationAndLicensingExpensesPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NetPortfolioIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net portfolio income loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NetPortfolioIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232608936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 7,692<span></span>
</td>
<td class="nump">$ 4,630<span></span>
</td>
<td class="nump">$ 18,089<span></span>
</td>
<td class="nump">$ 12,048<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">7,204<span></span>
</td>
<td class="nump">4,330<span></span>
</td>
<td class="nump">16,846<span></span>
</td>
<td class="nump">11,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ACTG_NonCashStockCompensationExpenseMember', window );">Non Cash Stock Compensation Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NoncashStockBasedCompensationCredit', window );">Non-cash stock based compensation credit</a></td>
<td class="nump">$ 488<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 1,243<span></span>
</td>
<td class="nump">$ 753<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NoncashStockBasedCompensationCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash stock based compensation credit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NoncashStockBasedCompensationCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ACTG_NonCashStockCompensationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ACTG_NonCashStockCompensationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112228147320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Series A Redeemable Convertible Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">$ (39,272)<span></span>
</td>
<td class="nump">$ 651,156<span></span>
</td>
<td class="num">$ (422,541)<span></span>
</td>
<td class="nump">$ 1,847<span></span>
</td>
<td class="nump">$ 191,240<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">49,639,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Acacia Research Corporation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(17,749)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(17,749)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">753<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">678,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests in subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">(39,272)<span></span>
</td>
<td class="nump">651,988<span></span>
</td>
<td class="num">(440,290)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">174,309<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50,343,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">(39,272)<span></span>
</td>
<td class="nump">651,688<span></span>
</td>
<td class="num">(432,682)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">181,617<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50,132,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Acacia Research Corporation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">(39,272)<span></span>
</td>
<td class="nump">651,988<span></span>
</td>
<td class="num">(440,290)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">174,309<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50,343,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 8,089<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="num">(39,272)<span></span>
</td>
<td class="nump">652,003<span></span>
</td>
<td class="num">(439,656)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">174,958<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">50,370,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Acacia Research Corporation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,205<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue', window );">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</a></td>
<td class="nump">2,045<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,045)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,045)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Dividend on Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,119)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,243<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">593,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(3,998)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,999)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,684,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">$ 10,134<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
<td class="nump">650,130<span></span>
</td>
<td class="num">(406,451)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">202,291<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,279,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2020</a></td>
<td class="nump">$ 9,400<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="num">(43,270)<span></span>
</td>
<td class="nump">650,843<span></span>
</td>
<td class="num">(444,799)<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">164,656<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Jun. 30, 2020</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,306,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Acacia Research Corporation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">38,348<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">38,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue', window );">Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</a></td>
<td class="nump">734<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(734)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStockStock', window );">Dividend on Series A Redeemable Convertible Preferred Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(467)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(467)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense for share-based awards, net of forfeitures, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,684)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Sep. 30, 2020</a></td>
<td class="nump">$ 10,134<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="num">$ (43,270)<span></span>
</td>
<td class="nump">$ 650,130<span></span>
</td>
<td class="num">$ (406,451)<span></span>
</td>
<td class="nump">$ 1,833<span></span>
</td>
<td class="nump">$ 202,291<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Sep. 30, 2020</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">49,279,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of Series A Redeemable Convertible Preferred Stock to redemption value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStockStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStockStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232538088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income (loss) including noncontrolling interests in subsidiaries</a></td>
<td class="nump">$ 33,205<span></span>
</td>
<td class="num">$ (17,763)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment, net (Note 5)</a></td>
<td class="num">(3,704)<span></span>
</td>
<td class="num">(9,622)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment (Note 5)</a></td>
<td class="nump">2,762<span></span>
</td>
<td class="nump">8,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Impairment of other investment</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">8,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of other investment (Note 5)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,609<span></span>
</td>
<td class="nump">2,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">955<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative', window );">Change in fair value of Series A redeemable convertible preferred stock embedded derivative</a></td>
<td class="nump">7,708<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of Series A warrants</a></td>
<td class="nump">2,036<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_UnrealizedGainLossOnDerivatives1', window );">Change in fair value of Series B warrants</a></td>
<td class="nump">36,867<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash stock compensation</a></td>
<td class="nump">1,243<span></span>
</td>
<td class="nump">753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Loss on foreign currency exchange</a></td>
<td class="nump">4,938<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss', window );">Change in fair value of trading securities and equity securities - private</a></td>
<td class="num">(81,907)<span></span>
</td>
<td class="num">(914)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesRealizedGainLoss', window );">Loss on sale of trading securities</a></td>
<td class="nump">4,272<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Change in fair value of equity securities derivative and forward contract</a></td>
<td class="num">(17,542)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Gain on sale of prepaid investment and derivative</a></td>
<td class="num">(2,845)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">31,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="num">(983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">614<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable', window );">Royalties and contingent legal fees payable</a></td>
<td class="nump">12,052<span></span>
</td>
<td class="num">(20,414)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">5,549<span></span>
</td>
<td class="num">(846)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Patent acquisition costs</a></td>
<td class="num">(13,780)<span></span>
</td>
<td class="num">(4,420)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment', window );">Sale of investment at fair value (Note 5)</a></td>
<td class="nump">1,460<span></span>
</td>
<td class="nump">6,260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">(Purchase) Sale of other investments (Note 5)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of trading securities</a></td>
<td class="num">(33,800)<span></span>
</td>
<td class="num">(103,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Maturities and sales of trading securities</a></td>
<td class="nump">316,746<span></span>
</td>
<td class="nump">38,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of prepaid investment</a></td>
<td class="num">(276,275)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeInvestingActivities', window );">Equity securities derivative and forward contract acquisition cost</a></td>
<td class="num">(3,989)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(177)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(9,815)<span></span>
</td>
<td class="num">(61,181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(3,998)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Issuance of Senior Secured Notes, net of lender fee</a></td>
<td class="nump">110,437<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Senior Secured Notes issuance costs paid to other parties</a></td>
<td class="num">(496)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividend on Series A Redeemable Convertible Preferred Stock</a></td>
<td class="num">(1,120)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Issuance of Series B warrants</a></td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">109,471<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents and restricted cash</a></td>
<td class="nump">105,205<span></span>
</td>
<td class="num">(61,948)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning</a></td>
<td class="nump">92,359<span></span>
</td>
<td class="nump">128,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents and restricted cash, ending</a></td>
<td class="nump">197,564<span></span>
</td>
<td class="nump">66,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental schedule of noncash investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AcquisitionOfPrepaidInvestmentSecurities', window );">Acquisition of prepaid investment securities</a></td>
<td class="nump">$ 231,480<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AcquisitionOfPrepaidInvestmentSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AcquisitionOfPrepaidInvestmentSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Royalties And Contingent Legal Fees Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_UnrealizedGainLossOnDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of Series B warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_UnrealizedGainLossOnDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturities, repayments and calls of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized holding gain (loss) recognized in the income statement for investments in debt and equity securities and other forms of securities that provide ownership interests classified as trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229378872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_804_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zcOvkbxxmSQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. <span>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_z32GuCyYITk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
&#8220;Acacia&#8221; and the &#8220;Company&#8221; refer to Acacia Research Corporation and/or its wholly and majority-owned and
controlled operating subsidiaries, and/or where applicable, its management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia was incorporated on January 25, 1993 under the laws of
the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries invest in, license and
enforce patented technologies. Acacia&#8217;s operating subsidiaries partner with inventors and patent owners, applying their legal
and technology expertise to patent assets to unlock the financial value in their patented inventions. In recent years, Acacia has
also invested in technology companies. Acacia leverages its experience, expertise, data and relationships developed as a leader
in the intellectual property (&#8220;IP&#8221;) industry to pursue these opportunities. In some cases, these opportunities will
complement, and/or supplement Acacia&#8217;s primary licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries generate revenues and
related cash flows from the granting of IP rights (hereinafter &#8220;IP Rights&#8221;) for the use of patented technologies that
its operating subsidiaries control or own. Acacia&#8217;s operating subsidiaries assist patent owners with the prosecution and
development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing
revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their
patented technologies through the filing of patent infringement litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries are principals in the
licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.
Acacia&#8217;s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain
foreign counterparts, covering technologies used in a wide variety of industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP
through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#8217;s
operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be
able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended
September 30, 2020, Acacia obtained control of four <span id="xdx_90C_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20200101__20200930_zh7nbsdkupS5" style="display: none" title="Number of new patent portfolios acquired">4</span> new patent portfolios. During fiscal year 2019, Acacia obtained control
of five <span id="xdx_902_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20190101__20191231_zn2FWCeypwof" style="display: none" title="Number of new patent portfolios acquired">5</span> new patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAHYR1QGEwDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial
statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany
transactions and balances have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly,
certain information and footnotes required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance
with quarterly reporting requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;). These interim unaudited condensed
consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes
thereto for the year ended December 31, 2019, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March
16, 2020, as well as in our other public filings with the SEC. The condensed consolidated interim financial statements of Acacia
include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of
Acacia&#8217;s consolidated financial position as of September 30, 2020, and results of its operations and its cash flows for
the interim periods presented. The consolidated results of operations for the three and nine months ended September 30, 2020 are
not necessarily indicative of the results to be expected for the entire fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p id="xdx_847_eus-gaap--UseOfEstimates_zgNDy7D6wtaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S.
GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the
significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of
the equity instruments, the valuation of Series A redeemable convertible preferred stock (the &#8220;Series A Redeemable Convertible
Preferred Stock&#8221;) embedded derivatives, Series A warrants (the &#8220;Series A Warrants&#8221;), Series B warrants (the &#8220;Series
B Warrants&#8221;), equity securities derivative and forward contract, stock-based compensation expense, impairment of patent related
intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances
against net deferred tax assets, require its most difficult, subjective or complex judgments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_znVi8bw6TNse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassifications</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made to the prior fiscal
year financial information to conform with the current fiscal year presentation. Such reclassifications had no impact on net income
or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227287752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_z2cPuNtIBTPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2. <span>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zVTJGv8cLg5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue Recognition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue is recognized upon transfer of control of promised bundled
IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to
receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist
at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue
recognition criteria have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the periods presented, revenue contracts executed by the
Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the
grant of certain IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based
revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license
fees based on quarterly sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). Revenues may
also include court ordered settlements or awards related to our patent portfolio. IP Rights granted included the following, as
applicable: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented
technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any
pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents.
The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the
context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise
to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer
IP Rights in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the promised IP Rights are not individually distinct,
the Company combines each individual IP Right in the contract into a bundle of IP rights that is distinct and accounts for all
of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted generally are &#8220;functional
IP rights&#8221; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that
functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating
subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain
or upgrade the technology, or provide future support or services. The contracts provide for the grant (i.e., transfer of control)
of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally
obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized
upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have been met. Revenue
contracts generally provide for payment of contractual amounts within 30-90 days of execution of the contract, or the end of the
quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally
non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal
in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is
subsequently resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP
Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the
sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues from contracts with significant financing components
(either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee
had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the
promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust
the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception,
that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights
will be one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, the Company is required to make certain judgments
and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance
obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to
grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point
in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain
a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues were composed of the following for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zV3hnwRzqTli" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BA_zrRtoFE2jE6b" style="display: none">Disaggregation of revenue</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-size: 10pt; text-align: left">Paid-up Revenue Agreements</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">19,385</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">1,203</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">24,477</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">6,067</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Recurring Revenue Agreements</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">81</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">508</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">922</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">4,491</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">19,466</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">1,711</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">25,399</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">10,558</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A7_zIOa7M6K8RK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Refer to &#8220;<i>Inventor Royalties and Contingent Legal Expenses</i>&#8221;
below for information on related direct costs of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p id="xdx_845_ecustom--PortfolioOperationsPolicyTextBlock_z0PQej27meF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Portfolio Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues include the costs and expenses incurred in
connection with Acacia&#8217;s patent licensing and enforcement activities, including inventor royalties paid to patent owners,
contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing
and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment
costs. These costs are included under the caption &#8220;Portfolio operations&#8221; in the accompanying condensed consolidated
statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Inventor Royalties and Contingent Legal Expenses </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventor royalties are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of
the underlying inventor agreements, upfront advances paid to patent owners by Acacia&#8217;s operating subsidiaries are recoverable
from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic
useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense
is included in amortization expense in the condensed consolidated statements of operations. Any unamortized upfront advances recovered
from net revenues are expensed in the period recovered and included in amortization expense in the condensed consolidated statements
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Contingent legal fees are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from
potential infringers, no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for certain
out of pocket legal costs incurred pursuant to the underlying legal services agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventor royalty and contingent legal agreements typically provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee
payments are received from licensees by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentrations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, trading securities and accounts receivable. Acacia places its cash equivalents and trading
securities primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are
also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not
experienced any significant losses on its deposits of cash and cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One licensee accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z9PB9Iy8QFX5" title="Concentration risk percentage">98</span>% of revenues recognized during
the three months ended September 30, 2020, and four licensees accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zEIckxnT6oXa" title="Concentration risk percentage">75</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_z0flroiVykVf" title="Concentration risk percentage">9</span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zdPgccVRIOTd" title="Concentration risk percentage">8</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z10yUkRMa4B1" title="Concentration risk percentage">4</span>% of revenues recognized during the
nine months ended September 30, 2020. Three licensees individually accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z6lYye00U4Gb" title="Concentration risk percentage">52</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAu13o9juE95" title="Concentration risk percentage">21</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zfoUUzQGMiX3" title="Concentration risk percentage">12</span>% of revenues recognized during
the three months ended September 30, 2019, and three licensees individually accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zBDpPFZbq1Kj" title="Concentration risk percentage">46</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zQa3HNYTxCGj" title="Concentration risk percentage">23</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zqrHYPld61yh" title="Concentration risk percentage">14</span>% of revenues recognized
during the nine months ended September 30, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have any material foreign operations. Based
on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for
the three and nine months ended September 30, 2020, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zgKuW8Ya9Eya" title="Concentration risk percentage">0.1</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zioeaPVhaa6a" title="Concentration risk percentage">5</span>%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions. For the three and nine months ended September 30, 2019, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zdLNezg5HTF7" title="Concentration risk percentage">75</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_z3rdUQVsvQ3l" title="Concentration risk percentage">38</span>%, respectively, of revenues were attributable
to licensees domiciled in foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Four licensees individually represented approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zCMLLREbR1A5" title="Concentration risk percentage">57</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAwJRQASb4v8" title="Concentration risk percentage">25</span>%,
<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_z9kDn3aEUHvi" title="Concentration risk percentage">4</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z8dTWIWEruvc" title="Concentration risk percentage">3</span>% of accounts receivable at September 30, 2020. Two licensees individually represented approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zc6SME9mx9fk" title="Concentration risk percentage">70</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zepBPNtR6haa" title="Concentration risk percentage">17</span>% of accounts
receivable at December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zOwy2OfZDHf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Patents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patents include the cost of patents or patent rights (hereinafter,
collectively &#8220;patents&#8221;) acquired from third-parties or obtained in connection with business combinations. Patent costs
are amortized utilizing the straight-line method over their remaining economic useful lives. Refer to Note 4 for additional information
regarding our patents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zTc3XJcDJb0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impairment of Long-lived Assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset
may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than
the carrying amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#8217;s carrying
value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active
markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques,
including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources
to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 4 for additional
information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fair value is generally estimated using the &#8220;Income Approach,&#8221;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic
useful life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221; including
an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows
are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated
cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied
to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s
licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio
including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology
coverage and other pertinent information that could impact future net cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zi23fhAEv8r1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia considers all highly liquid, trading securities with
original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#8217;s cash
equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily
includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations,
and fully collateralized repurchase agreements. Acacia&#8217;s cash equivalents are measured at fair value using quoted prices
that represent Level 1 inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zdU7TBKEHj96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Long Term Restricted Cash </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-term restricted cash relates to the proceeds received from
the issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account. The amounts are to be released
to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii) the
conversion of Series A Redeemable Convertible Preferred Stock into common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p id="xdx_840_ecustom--PrepaidInvestmentPoliciesTextBlock_zyfejGKarNFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid Investment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid investment relates to the cash transferred to an escrow
account in connection with a Transaction Agreement with LF Equity Income Fund (&#8220;Seller&#8221;), pursuant to which the Company
will purchase from Seller certain equity securities. Refer to Note 14 for additional information on the Transaction Agreement.
The amounts are to be released to Seller upon transfer of the specified equity securities at set prices at various future dates
following various terms and conditions per the Transaction Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p id="xdx_84A_ecustom--EquitySecurityForwardContractPoliciesTextBlock_zydGaHPrZCN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Equity Securities Derivative and Forward Contract</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The equity security forward contract includes both private and
public equity securities not yet transferred, as of September 30, 2020, under the Company&#8217;s Transaction Agreement with Seller.
Refer to Note 14 for additional information on the agreement. The public company equity security forward contracts are accounted
for as derivatives and are carried at fair market value with changes in fair market value recorded in the condensed consolidated
statements of operations in other income (expense). The private company equity security forward contracts do not meet the definition
of a derivative as the underlying equity securities are not readily convertible to cash. Therefore, as the forward contracts do
not have readily determinable fair value, these forward contracts are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions involving securities similar to those underlying the forward
contract. Changes in fair market value are reported in the condensed consolidated statements of operations in other income (expense).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<p id="xdx_846_eus-gaap--AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_zJcyTLcbHe0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Trading Securities- Debt</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in debt securities are reported at fair value on
a recurring basis, with related realized and unrealized gains and losses recorded in the condensed consolidated statements of operations
in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest
is included in the condensed consolidated statements of operations in other income (expense). Accrued interest is included in the
trading securities balance on the condensed consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p id="xdx_840_eus-gaap--EquityMethodInvestmentsPolicy_z2TY0Mrhx7Oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Trading Securities - Equity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in equity securities are reported at fair value
on a recurring basis, with related realized and unrealized gains and losses in the value of such securities recorded in the condensed
consolidated statements of operations in other income (expense). Dividend income is included in the condensed consolidated statements
of operations in other income (expense).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trading securities for the periods presented were comprised
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--AvailableForSaleSecuritiesTextBlock_pn3n3_ze1v2CdeE3J2" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B8_zw6BmweOEiOa" style="display: none">Gain (loss) on trading securities</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross<br/> Unrealized<br/> Gain</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross<br/> Unrealized<br/> Loss</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left">Security&#160;Type</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">September 30, 2020:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; font-size: 10pt; text-align: left">Trading securities - equity</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermInvestments_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesrEquityMember_zeFIAbmCs501" style="width: 9%; font-size: 10pt; text-align: right" title="Short-term Investments">23,851</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_z6poe2yi2Vwa" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">4,218</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_znOLVRShnDbe" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(3,598</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_zAoUfUHKvcld" style="width: 9%; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">24,471</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Trading securities - debt</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Short-term Investments">93,712</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">143</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_ziLjQ8vjsE3f" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(12</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">93,843</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Trading securities - equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Short-term Investments">17,674</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">211</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_ztgOqQxKZgx3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(745</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">17,140</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortTermInvestments_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Short-term Investments">111,386</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">354</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231_zI2YltaXl7q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(757</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">110,983</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AF_zIxHhxktIfA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_846_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_ziVBDgH3Dorg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value Measurements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S. GAAP defines fair value as the price that would be received
for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly
transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an
entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established
to measure fair value is defined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(i) <b>Level 1 &#8211;
<i>Observable Inputs</i></b>: Quoted prices in active markets for identical investments;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(ii) <b>Level 2</b>
&#8211; <b><i>Pricing Models with Significant Observable Inputs</i></b>: Other significant observable inputs, including quoted
prices for similar investments, interest rates, credit risk, etc.; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(iii) <b>Level 3 </b>&#8211;
<b><i>Unobservable Inputs</i></b>: Significant unobservable inputs, including the entity&#8217;s own assumptions in determining
the fair value of investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whenever possible, the Company is required
to use observable market inputs (Level 1 &#8211; quoted market prices) when measuring fair value. In such cases, the level at which
the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement.
The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability
being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial
assets and liabilities measured at fair value on a recurring basis were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zy1ErhJzuWa9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B7_zwiVHwXkj41l" style="display: none">Schedule of fair value of financial assets and liabilities on a recurring basis</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal">Assets as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020:</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Trading securities - equity</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">24,471</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zdHQ3b5Ukm42" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zZyvFEAX6v67" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Equity securities derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativetMember_zCcuV3csw7Vb" style="font-size: 10pt; text-align: right" title="Assets">17,818</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_zFuktMcuGvBd" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_z1sLqYnzphdc" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - warrants (Note 5)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zXMUkDeMwDDe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">982</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zNL3fhQ4J0L4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Total recurring fair value measurements as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">42,289</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">982</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2gJaVBc0f14" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Assets as of December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Trading securities - debt</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zJWfNJyJfZ1h" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">93,843</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zGw6aHE3eMf9" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Trading securities - equity</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets">17,140</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zrjCAk54uysh" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zHHOgrXWj1kb" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Investment at fair value - warrants (Note 5)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z27SfLm2Rvvj" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets">757</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zZlq3yHytRWk" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - common stock (Note 5)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">743</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zH0sBseCWzr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zbcg9bq0MbWe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total recurring fair value measurements as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">17,883</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">94,600</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIZZjFqvhGPd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal">Liabilities as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020:</span></td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Series A warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6CELBHDVJSk" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">5,604</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z9P2RBRtgwxg" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zkRFn7cJUCnk" style="font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z8GfR69kkhB" style="font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Liabilities">42,796</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z0XfU5arLd1e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zBW0vcRi2x5f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">25,682</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Total liabilities as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zihAXRXdxwFb" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">5,604</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">68,478</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Liabilities as of December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Series A warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zI2UbZUHJRSc" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">3,568</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zIQGSEqHNMC5" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z2aoRdMWkFM" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zuVliFxeh6ke" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">17,974</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total liabilities as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxkw24lIyvD5" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">3,568</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">17,974</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A0_zQwtFdX4xap2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of the changes in the
estimated fair value of the Company&#8217;s Level 3 liabilities, which are measured at fair value as a on a recurring basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zeOiNDynHOg1" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span id="xdx_8B8_z9soetpk7fra" style="display: none">Summary of changes in financial liability Level 3</span></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Series A Preferred Stock Embedded Derivative Liability</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Series B Warrants Liability</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; font-size: 10pt">Opening balance as of December 31, 2019</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zqMdu5Eq6Xu1" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance">17,974</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zjxDzA0Rh557" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Issuance of Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_d0_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zNvn8DVtyFie" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants">4,600</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Remeasurement to fair value</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value">7,708</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value">38,196</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Balance as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrG5sEJsgE7c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance">25,682</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zof7bg0bcoQ1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance">42,796</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_8A9_zXcuuRk4sjVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>













<p id="xdx_84B_ecustom--SeriesAWarrantsPolicyTextBlock_zw5IVOoN786l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Series A Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series A Warrants is estimated using a
Black-Scholes option-pricing model. The fair value of the Series A Warrants as of September 30, 2020 was estimated based on the
following assumptions: volatility of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives">32 percent</span>, risk-free rate of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives">0.47 percent</span>, term of <span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives">7.04 years</span> and a dividend yield of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives">0 percent</span>.
Refer to Notes 10 and 11 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p id="xdx_84A_ecustom--SeriesBWarrantsPolicyTextBlock_z6Jin3VhDXle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Series B Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series B
Warrants is estimated using Monte Carlo valuation technique. The fair value of the Series B Warrants as of September 30, 2020
was estimated based on event probabilities of future exercise scenarios and the following weighted-average assumptions: (1)
volatility of <span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">32
percent</span>, risk-free rate of <span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">0.48
percent</span>, term of <span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">7.12
years</span>, a dividend yield of <span id="xdx_905_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">0
percent</span>, and a discount for lack of marketability of <span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">10
percent</span>, and (2) volatility of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">51
percent</span>, risk-free rate of <span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">0.13
percent</span>, term of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">1.9
years</span> and a dividend yield of <span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">0
percent</span>, and a discount for lack of marketability of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">10
percent</span>. Refer to Notes 10 and 12 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p id="xdx_843_eus-gaap--DerivativesEmbeddedDerivatives_zA3CZMcKCzI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Embedded derivatives</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Embedded derivatives that are required to be bifurcated from
their host contract are valued separately from host instrument. A binomial lattice framework is used to estimate the fair value
of the embedded derivative in the Series A Redeemable Convertible Preferred Stock. The binomial model utilizes the Tsiveriotis
and Fernandes implementation in which a convertible instrument is split into two separate components: a cash-only component which
is subject to the selected risk-adjusted discount rate and an equity component which is subject only to the risk-free rate. The
model considers the (i) implied volatility of the value of our common stock, (ii) appropriate risk-free interest rate, (iii) credit
spread, (iv) dividend yield, (v) dividend accrual (and a step-up in rates), and (vi) event probabilities of the various conversion
and redemption scenarios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The implied volatility of the Company&#8217;s common stock is
estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe a commonly
observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt is lower
than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining until
November 15, 2027, the maturity date. The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining term
equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&#8217;s
valuation of the embedded derivative at September 30, 2020 are as follows: volatility of <span id="xdx_90F_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives">32 percent</span>, risk-free rate of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives">0.47 percent</span>,
a credit spread of <span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives">21 percent</span> and a dividend yield of <span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives">0 percent</span>. The fair value measurement of the embedded derivative is sensitive
to these assumptions and changes in these assumptions could result in a materially different fair value measurement. Refer to Note
10 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_8A9_zXcuuRk4sxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>











<p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zS8cxDceF2if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investments at Fair Value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On an individual investment basis, Acacia may elect to account
for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies
of the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under
the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e.,
common stock and warrants). We elected the fair value method for our investment in Veritone upon acquisition of the investment.
As of September 30, 2020, our investment in Veritone warrants totaled $<span id="xdx_90A_eus-gaap--Investments_iI_pn3p0_c20200930__us-gaap--InvestmentsInAndAdvancesToAffiliatesCategorizationAxis__custom--VeritoneMember_zWWmSPR8uAD3" title="Investment in Veritone">982,000</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_844_eus-gaap--EquityAndCostMethodInvestmentsPolicy_zzu8Ha3HJ5rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity investments in common stock and in-substance common stock
without readily determinable fair values in companies over which the Company has the ability to exercise significant influence,
are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its
equity method investees in equity in earnings (losses) of investees in the condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in preferred stock with substantive liquidation
preferences are accounted for at cost (subject to impairment considerations, as described below, if any), as adjusted for the impact
of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.
In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar
to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is
not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference
is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation
to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a
fair value perspective is substantive because, in the event of liquidation, the investor will not participate in substantially
all of the investee's losses, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial determination of whether an investment is substantially
similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence
over the operating and financial policies of the investee. That determination is reconsidered if:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">contractual terms of the investment are changed,</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(iii)</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7IMkSefF09g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stock-Based Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation cost for all stock-based awards is measured
at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#8217;s
requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value
of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and
the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant
using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Restricted stock units granted in September 2019 with market-based
vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of
a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique.
Compensation cost is recognized with a market-based vesting condition provided that the requisite service is rendered, regardless
of when, if ever, the market condition is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique
included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected volatility of 38 percent; and expected
dividend yield of 0 percent. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon
issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on
expectations regarding dividend payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Profits Interest Units (&#8220;Units&#8221;) were accounted
for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock Compensation.&#8221;
The vesting conditions did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such,
the Units were classified as liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion
of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s
requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award,
which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized
in the period. The Company has a purchase option to purchase the vested Units that are not otherwise forfeited after termination
of continuous service. The exercise price of the purchase option is the fair market value of the Units on the date of termination
of continuous service. As of September 30, 2020, the Units totaled $591,000, which was their fair value as of December 31, 2018
after termination of service.</p>





<p id="xdx_849_eus-gaap--StockholdersEquityPolicyTextBlock_ztHNv9JfSzSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Treasury Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Repurchases of the Company&#8217;s outstanding common stock
are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the
formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to
additional paid-in capital, and reflected as treasury stock on the condensed consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p>

<p id="xdx_844_eus-gaap--CostMethodInvestmentsPolicy_zbcnh16MCdQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impairment of Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative
and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value,
Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than
cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee,
including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline
in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements
of operations and a new cost basis in the investment is established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i>&#160;</p>

<p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zxSGe5tiGsse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income taxes are accounted for using an asset and liability
approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events
that have been recognized in Acacia&#8217;s condensed consolidated financial statements or consolidated income tax returns. A valuation
allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized,
or if it is determined that there is uncertainty regarding future realization of such assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The provision for income taxes for interim periods is determined
using an estimate of Acacia&#8217;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account
in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate
changes, a cumulative adjustment is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s effective tax rates were <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200701__20200930_zsHjYk2Pbsx6" title="Effective tax rate">0</span>% and <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200101__20200930_ziGt7tz8vM53" title="Effective tax rate">(4%)</span> for
the three and nine months ended September 30, 2020, respectively and <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190701__20190930_z5M0RaWlYfZ2" title="Effective tax rate">0</span>% and <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190101__20190930_ziYsdARV37Pd" title="Effective tax rate">(2%)</span> for the three and nine months ended September
30, 2019, respectively. Tax benefit (expense) for the periods presented primarily reflects the impact of state taxes and foreign
taxes withholding or refund incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.
The Company has recorded full valuation allowance against our net deferred tax assets as of September 30, 2020 and 2019. These
assets primarily consist of foreign tax credits, capital loss carryforwards and net operating loss carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112230070712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. INCOME (LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">3. INCOME (LOSS) PER SHARE</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--EarningsPerShareTextBlock_z1W8kWwVCB2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. <span>INCOME (LOSS) PER SHARE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the shares of common stock outstanding
used in the calculation of basic and diluted net income (loss) per share:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zrMs58AlTb4h" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 3. INCOME (LOSS) PER SHARE (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8B8_zyt1E8bRR0wa" style="display: none">Calculation of basic and diluted net loss per share</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_491_20200701__20200930_z29qq7agZcq5" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49F_20190701__20190930_zIKWN8QuKJr9" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49D_20200101__20200930_zExwxzrYQcwl" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_498_20190101__20190930_zRSH2DotCJha" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><b>Three Months Ended</b></td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><b>Nine Months Ended</b></td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="text-align: center; font-size: 10pt">(In thousands, except share and per share information)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Numerator:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Net income (loss) attributable to Acacia Research Corporation</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">38,348</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">(7,608</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">33,205</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">(17,749</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di0_zxqOwbKWKiAd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Dividend on Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(467</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,118</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di0_zU9h3DvHXiAi" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Accretion of Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(733</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(2,045</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zv0jupxlZjH2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Undistributed earnings allocated to participating securities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(6,619</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(5,204</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net income (loss) attributable to common stockholders - basic</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">30,529</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(7,608</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">24,838</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(17,749</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DividendsPreferredStock_pn3n3_d0_zM3VNy1tOFwh" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Dividend on Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">467</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_pn3n3_d0_z9tIs3mLY24b" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Accretion of Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">733</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_pn3n3_d0_zjULQdByivRe" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(3,831</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ChangeInFairValueOfSeriesWarrants_pn3n3_d0_zsQ37QG9a9ni" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of Series A warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,348</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,348</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_pn3n3_d0_zsGmaSXRZ4Hi" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of dilutive Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(5,557</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(5,557</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--InterestExpenseOther_pn3n3_d0_zkHw9SievXb3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Interest expense associated with Starboard Notes, net of tax</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,889</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,889</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_pn3n3_d0_zZC20vagXWoj" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Undistributed earnings allocated to participating securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6,619</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">5,204</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_pn3n3_d0_z3W83rx7FVjb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Reallocation of undistributed earnings to participating securities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(296</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(3,645</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_zP5FDOoxTZQ6" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) attributable to common stockholders - diluted</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">29,204</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(7,608</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">21,380</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(17,749</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Denominator:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pip0_zK4sOlONYiu1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - basic</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">48,467,885</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">49,828,361</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">48,949,706</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">49,727,385</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Potentially dilutive common shares:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A Preferred Stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zVtgD3VH6oVl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">9,589,041</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKUOueVrvJe" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zMDPj1aStmSi" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zUhrrxgIp7Qk" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Restricted stock units</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zwGsQ2YBMcy" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">728,936</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zpLQyOdbF9k" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zz7SeVr6OoEe" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">598,328</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_z9ofT9abmOLd" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Employee stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_z6VL88jIbVa3" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">21,624</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zb6RDqbZ5ki5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zpJswYj5bsQ9" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zAOXioeMlmXl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A Warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1lhACTATp3i" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">310,367</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxn4k1MYdK7c" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zjcGTuf1R6p9" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">103,456</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0nMwksJ1qg7" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Series B Warrants</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zqmIiEXuNrD9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares">31,506,849</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z4zQrePeS6nh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zjcXXqjEYMw8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares">10,502,283</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z7dWJW1fxZl9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pip0_zEYLLRBoi9Fl" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - diluted</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">90,624,702</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">49,828,361</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">60,153,773</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">49,727,385</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareBasic_pip0_zrQ6VsuNV5jh" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Basic net income (loss) per common share</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.63</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.15</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.51</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.36</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pip0_zcs77cO8o7Cf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net income (loss) per common share</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.32</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.15</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.36</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.36</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left">Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Equity-based incentive awards</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">191,312</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">442,864</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">310,083</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">442,864</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zciNzaCD66le" style="font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zEoez9xVbfQ2" style="font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zIJ6U2DopC07" style="font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zQAW7w0xfhXg" style="font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Series B warrants</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares">68,493,151</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zvW7NH40Z111" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares">68,493,151</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zhJkZV7HMvK5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Total</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">68,684,463</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">442,864</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">68,803,234</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">442,864</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232739480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. PATENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">4. PATENTS</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVCypg06ecej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4. <span>PATENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s only identifiable intangible assets at September
30, 2020 and December 31, 2019 are patents and patent rights. Patent-related accumulated amortization totaled $<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3p0_c20200930_zCDVMi8l99n5" title="Accumulated amortization">326,296,000</span> and
$<span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pn3p0_c20191231_zLT8vH6m2iDh" title="Accumulated amortization">322,774,000</span> as of September 30, 2020 and December 31, 2019, respectively. Acacia&#8217;s patents have remaining estimated economic
useful lives ranging from three to fifty-five months. The weighted-average remaining estimated economic useful life of Acacia&#8217;s
patents is approximately four years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents the scheduled annual aggregate
amortization expense as of September 30, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zY2ENlAczsA8" style="border-collapse: collapse; width: 50%" summary="xdx: Disclosure - 4. PATENTS (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B4_zdkcEXwBHCEk" style="display: none">Schedule of intangible assets</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_497_20200930_zRGrGBAmH1W" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt">For&#160;the&#160;years&#160;ending&#160;December&#160;31,</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJ1C_zT4eK4C8Tby6" style="vertical-align: bottom; background-color: White">
    <td style="width: 33%; font-size: 10pt">Remainder of 2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">1,158</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJ1C_z9Tr7DvbAvMa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,451</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJ1C_zLTnG0LYCXEj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2022</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,451</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJ1C_zvawWHBTYQEe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,376</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJ1C_zJpG7y6MLKtc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,005</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJ1C_ztzRKw6jUsZc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">630</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJ1C_zYiMF6lKPArk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;&#160;<span style="color: White">Patents, net</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,071</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229298360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsTextBlock', window );">5. INVESTMENTS</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--InvestmentHoldingsTextBlock_zblEjhQBjTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>5. <span>INVESTMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Investment at Fair Value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2016 and 2017, Acacia made certain investments in Veritone,
Inc. (&#8220;Veritone&#8221;). As a result of these transactions, Acacia received an aggregate total of 4,119,521 shares of Veritone
common stock and warrants to purchase a total of <span id="xdx_905_ecustom--NumberOfWarrants_pip0_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z7fffCUVDXNj" title="Number of warrants">1,120,432</span> shares of Veritone common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Warrants price">13.61</span> per share
expiring between 2020 and 2027. During the year ended December 31, 2018, Acacia sold <span id="xdx_906_ecustom--InvestmentSharesSold_c20180101__20181231__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold">2,700,000</span> shares Veritone common stock and
recorded a realized loss of $<span id="xdx_90E_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20180101__20181231__srt--CounterpartyNameAxis__custom--VeritoneMember_zIUOBatk7hAh" title="Loss from sale of investment">19.1</span> million. During the year ended December 31, 2019, Acacia sold <span id="xdx_908_ecustom--InvestmentSharesSold_c20190101__20191231__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold">1,121,071</span> shares Veritone common
stock and recorded a realized loss of $<span id="xdx_903_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20190101__20191231__srt--CounterpartyNameAxis__custom--VeritoneMember_zwE38mgRIzP9" title="Loss from sale of investment">9.2</span> million. During the three months ended March 31, 2020, Acacia sold all remaining <span id="xdx_90B_ecustom--InvestmentSharesSold_c20200101__20200331__srt--CounterpartyNameAxis__custom--VeritoneMember_pii" title="Investment shares sold">298,450</span>
shares Veritone common stock and recorded a realized loss of $<span id="xdx_906_eus-gaap--LossOnSaleOfInvestments_pn3n3_dm_c20200101__20200331__srt--CounterpartyNameAxis__custom--VeritoneMember_zJR5Te0IE5Xa" title="Loss from sale of investment">3.3</span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended June 30, 2020, Acacia exercised
<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_c20200930_pii" title="Warrants exercised">154,312</span> warrants of the total <span id="xdx_90A_ecustom--NumberOfWarrants_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Number of warrants">1,120,432</span> Veritone common stock purchase warrants at a price of $13.61 per warrant, and then sold
the <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Number of stock sold">154,312</span> shares of Veritone stock received at $<span id="xdx_907_eus-gaap--SharePrice_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Share Price">17.23</span> per share, and recorded a realized gain of $<span id="xdx_904_eus-gaap--GainLossOnSaleOfInvestments_pn3p0_c20200701__20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zyQdLBJouoB8" title="Realized gain">554,000</span>. At September 30, 2020,
the fair value of the <span id="xdx_901_ecustom--InvestmentWarrants_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pii" title="Investment warrants">966,120</span> remaining warrants held by Acacia totaled $<span id="xdx_90D_eus-gaap--FinancialInstrumentsOwnedAtFairValue_iI_pn3p0_c20200930__srt--CounterpartyNameAxis__custom--VeritoneMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zQLuDbMEqiO3" title="Fair value of investment">982,000</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in the fair value of Acacia&#8217;s investment in Veritone
are recorded as unrealized gains or losses in the condensed consolidated statements of operations. For the three and nine months
ended September 30, 2020 and 2019, the accompanying condensed consolidated statements of operations reflected the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_z9s2dcLYaMj7" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 5. INVESTMENTS (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8BC_ziaOgnpgcot8" style="display: none">Schedule of gain (loss) on investments</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Change in fair value of investment, warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">(3,081</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">(3,216</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">225</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">(822</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of investment, common stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zCysRFZGlMU6" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">(1,050</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">3,479</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">10,444</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Gain on sale of investment, warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zsnPClIS32pl" style="font-size: 10pt; text-align: right" title="Gain on sale of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zxZNaTd6GJef" style="font-size: 10pt; text-align: right" title="Gain on sale of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zSNNy7Zj2KN7" style="font-size: 10pt; text-align: right" title="Gain on sale of investment">554</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zlfZtKRYwmif" style="font-size: 10pt; text-align: right" title="Gain on sale of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Loss on sale of investment, common stock</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zu5zqdgT9jn" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z6MTWm9O8X8d" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment">(915</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zifsbseloMIl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment">(3,316</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zEhIlcKgmQfe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment">(8,147</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net realized and unrealized gain (loss) on investment at fair value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--GainLossOnInvestments_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">(3,081</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">(5,181</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">942</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">1,475</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611322-123010<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611197-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=SL120429264-123010<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611133-123010<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611282-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229452296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">6. COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zGKCWkxrvCd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>6. <span>COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Patent Enforcement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain of Acacia&#8217;s operating subsidiaries are often required
to engage in litigation to enforce their patents and patent rights. In connection with any of Acacia&#8217;s operating subsidiaries&#8217;
patent enforcement actions, it is possible that a defendant may request and/or a court may rule that an operating subsidiary has
violated statutory authority, regulatory authority, federal rules, local court rules, or governing standards relating to the substantive
or procedural aspects of such enforcement actions. In such event, a court may issue monetary sanctions against Acacia or its operating
subsidiaries or award attorney&#8217;s fees and/or expenses to a defendant(s), which could be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Facility Leases</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company primarily leases office facilities under operating
lease arrangements that will end in various years through July 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 7, 2019, we entered into a building lease agreement
(the &#8220;New Lease&#8221;) with Jamboree Center 4 LLC (the &#8220;Landlord&#8221;). Pursuant to the New Lease, we have leased
approximately 8,293 square feet of office space for our corporate headquarters in Irvine, California. The New Lease commenced on
August 1, 2019. The term of the New Lease is 60 months from the commencement date, provides for annual rent increases, and does
not provide us the right to early terminate or extend our lease terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leased a facility under an operating lease agreement
(the &#8220;Old Lease&#8221;), the term of which ended on January 31, 2020. The Company ceased using the facility in December 2018
and the subleased the facility for the remainder of the Old Lease term. All sublease income under the Old Lease was received and
recorded in 2019. No sublease income on the Old Lease was recognized in 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 7, 2020, we entered into a building lease agreement
(the &#8220;New York Office Lease&#8221;) with Sage Realty Corporation (the &#8220;New York Office Landlord&#8221;). Pursuant to
the New York Office Lease, we have leased approximately 4,000 square feet of office space in New York, New York. The New York Office
Lease commenced on February 1, 2020. The term of the New York Office Lease is 24 months from the commencement date, provides for
annual rent increases, and does not provide us the right to early terminate or extend our lease terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating lease costs, net of sublease income, were $<span id="xdx_90D_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20200701__20200930_zQG3Ry3U6Bvl" title="Operating lease costs, net of sublease income">174,000</span>
and $<span id="xdx_90A_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20190701__20190930_zlNaqHwBZGmk" title="Operating lease costs, net of sublease income">96,000</span> for the three months ended September 30, 2020 and 2019, respectively. Operating lease costs, net of sublease income,
were $<span id="xdx_90B_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20200101__20200930_zHNDYfFJmTB9" title="Operating lease costs, net of sublease income">459,000</span> and $<span id="xdx_90A_eus-gaap--OperatingLeasesRentExpenseNet_pn3p0_c20190101__20190930_zgEOLGL6MPT7" title="Operating lease costs, net of sublease income">301,000</span> for the nine months ended September 30, 2020 and 2019, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The table below presents aggregate future minimum payments
due under the New Lease and the New York Office Lease discussed above, reconciled to lease liabilities included in the condensed
consolidated balance sheet as of September 30, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_pn3n3_zQy0J47soJT" style="border-collapse: collapse; width: 50%" summary="xdx: Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BD_zRqTouLlfun1" style="display: none">Schedule of future minimum operating lease payments</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49A_20200930_zqEvJuZNmSKa" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Operating Leases</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_pn3n3_maOLFMPzu8U_zZMc47WWRwp7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 33%; font-size: 10pt; text-align: left">2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">144</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pn3n3_maOLFMPzu8U_zBvGSiCMroX8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">589</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pn3n3_maOLFMPzu8U_z2wVp7aiANAk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2022</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">370</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pn3n3_maOLFMPzu8U_zENbv2ehdnWf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">364</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pn3n3_maOLFMPzu8U_zeMWQ9Lb0UP8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">2024</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">218</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_pn3n3_mtOLFMPzu8U_zkpxRETVod22" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Total minimum payments</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,685</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zta1dyCKj2ih" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Less: short-term lease liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(584</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Long-term lease liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,101</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Other Matters</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia is subject to claims, counterclaims and legal actions
that arise in the ordinary course of business. Management believes that the ultimate liability with respect to these claims and
legal actions, if any, will not have a material effect on Acacia&#8217;s condensed consolidated financial position, results of
operations or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 6, 2019, Slingshot Technologies, LLC (&#8220;Slingshot&#8221;)
filed a lawsuit in Delaware Chancery Court against the Company, Acacia Research Group, LLC, and Monarch Networking Solutions LLC
(collectively, the &#8220;Acacia Entities&#8221;), Acacia board member Katharine Wolanyk, and Transpacific IP Group, Ltd. (&#8220;Transpacific&#8221;).
Slingshot alleges that the Acacia Entities misappropriated its confidential and proprietary information, purportedly furnished
to the Acacia Entities by Ms. Wolanyk, in acquiring a patent portfolio from Transpacific after Slingshot&#8217;s exclusive option
to purchase the same patent portfolio from Transpacific had already expired. Slingshot seeks monetary damages, as well as equitable
and injunctive relief related to its alleged right to own the portfolio. The Acacia Entities maintain that Slingshot&#8217;s allegations
are baseless, that Ms. Wolanyk had no involvement in the acquisition, that the Acacia Entities neither had access to nor used Slingshot&#8217;s
information in acquiring the portfolio, that the Acacia Entities acquired the portfolio as a result of the independent efforts
of its IP licensing group, and that Slingshot suffered no damages given its exclusive option to purchase the portfolio had already
ended and it has proven itself incapable of closing on the portfolio purchase.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a separate case, on December 6, 2017, the Federal Court of
Canada allowed a counterclaim for invalidity of a patent asserted by Rapid Completions LLC and awarded costs payable by Rapid Completions
LLC in an amount to be determined.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended September 30, 2020, operating expenses
included a net income for settlement offset by contingency accruals totaling $<span id="xdx_90E_eus-gaap--OperatingLeasesIncomeStatementContingentRevenue_pn3p0_c20200101__20200930_zxDu3LEhThX2" title="Income from settlement">308,000</span>, net of prior accruals. During the nine months
ended September 30, 2019, operating expenses included expenses for settlement and contingency accruals totaling $<span id="xdx_904_eus-gaap--OperatingLeasesIncomeStatementContingentRevenue_pn3p0_c20190101__20190930_zbYWB3ht3D1l" title="Income from settlement">175,000</span>. At September
30, 2020, our contingency accruals totaled $<span id="xdx_904_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_pn3n3_dm_c20200930_zyF3T6ZoL0b2" title="Contingency accruals">1.4</span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227389992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. STOCKHOLDERS&#8217; EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">7. STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zF89CvvKk2ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>7. <span>STOCKHOLDERS&#8217; EQUITY</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Repurchases of Common Stock </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 5, 2019, Acacia&#8217;s Board of Directors approved
a stock repurchase program, which authorized the purchase of up to $<span id="xdx_90C_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_dm_c20190805__us-gaap--ShareRepurchaseProgramAxis__custom--StockRepurchaseProgramMember_z25cHR2BZ066" title="Value of shares authorized for repurchase">10.0</span> million of the Company's common stock through open market
purchases, through block trades, through 10b5-1 plans, or by means of private purchases, from time to time, through July 31, 2020.
Stock repurchases for the periods presented, all of which were purchased as part of a publicly announced plan or program, were
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_pn3n3_zyKsHg8pwXHb" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 7. STOCKHOLDERS' EQUITY (Details)">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: justify"><span id="xdx_8B9_z9FXUkUNJmBh" style="display: none">Schedule of repurchased shares</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total Number<br/> of Shares<br/> Purchased</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Average<br/> Price<br/> paid per<br/> Share</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Approximate Dollar<br/> Value of Shares that<br/> May Yet be Purchased<br/> under the Program</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Plan Expiration Date</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 32%; font-size: 10pt; text-align: center">March 20, 2020 - March 31, 2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="width: 15%; font-size: 10pt; text-align: right" title="Number of shares repurchased">576,898</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="width: 15%; font-size: 10pt; text-align: center" title="Average price paid per share">$2.28</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_989_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="width: 15%; font-size: 10pt; text-align: center" title="Approximate value of shares that may yet be purchased">$8,686,000</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_980_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3XFtIb7dl8i" style="width: 15%; font-size: 10pt; text-align: center" title="Plan expiration date">July 31, 2020</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt">April 1, 2020 - April 23, 2020</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares repurchased">1,107,639</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="padding-bottom: 1pt; font-size: 10pt; text-align: center" title="Average price paid per share">$2.42</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98B_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="padding-bottom: 1pt; font-size: 10pt; text-align: center" title="Approximate value of shares that may yet be purchased">$6,001,000</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_987_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkVK26nS2Xrf" style="font-size: 10pt; text-align: center; padding-bottom: 1pt" title="Plan expiration date">July 31, 2020</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt">Totals for 2020</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares repurchased">1,684,537</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: center" title="Average price paid per share">$2.37</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining whether or not to repurchase any shares of Acacia&#8217;s
common stock, Acacia&#8217;s Board of Directors consider such factors as the impact of the repurchase on Acacia&#8217;s cash position,
as well as Acacia&#8217;s capital needs and whether there is a better alternative use of Acacia&#8217;s capital. Acacia has no
obligation to repurchase any amount of its common stock under the Stock Repurchase Program. Repurchases to date were made in the
open market in compliance with applicable SEC rules. The authorization to repurchase shares presented an opportunity to reduce
the outstanding share count and enhance stockholder value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Tax Benefits Preservation Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 12, 2019, Acacia&#8217;s Board of Directors announced
that it had unanimously approved the adoption of a Tax Benefits Preservation Plan (the &#8220;Plan&#8221;). Our stockholders ratified
the adoption of the Plan in July 2019. The purpose of the Plan is to protect the Company&#8217;s ability to utilize potential tax
assets, such as net operating loss carryforwards and tax credits to offset potential future taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan is designed to reduce the likelihood that the Company
will experience an ownership change by discouraging (i) any person or group from acquiring beneficial ownership of 4.9% or more
of the Company&#8217;s outstanding common stock and (ii) any existing stockholders who, as of the time of the first public announcement
of the adoption of the Plan, beneficially own more than 4.9% of the Company&#8217;s then-outstanding shares of the Company&#8217;s
common stock from acquiring additional shares of the Company&#8217;s common stock (subject to certain exceptions). There is no
guarantee, however, that the Plan will prevent the Company from experiencing an ownership change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the adoption of the Plan, Acacia&#8217;s
Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of the Company&#8217;s
common stock to stockholders of record at the close of business on March 16, 2019. On or after the distribution date, each right
would initially entitle the holder to purchase one one-thousandth of a share of the Company&#8217;s Series B Junior Participating
Preferred Stock, $0.001 par value for a purchase price of $12.00.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also has a provision in its Amended and Restated
Certificate of Incorporation, as amended (the &#8220;Charter Provision&#8221;) which generally prohibits transfers of its common
stock that could result in an ownership change. Like the Plan, the purpose of the Charter Provision is to protect the Company&#8217;s
ability to utilize potential tax assets, such as net operating loss carryforwards and tax credits to offset potential future taxable
income. The Charter Provision was approved by the Company&#8217;s stockholders on July 15, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229503992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>8. RECENT ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">8. RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text"><p id="xdx_801_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_znyBcjVpxSId" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>8. <span>RECENT ACCOUNTING PRONOUNCEMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Recent Accounting Pronouncements - Not Yet Adopted</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;)
issued ASU No. 2019-12 Income Taxes (Topic 740) &#8212; Simplifying the Accounting for Income Taxes, to remove certain exceptions
and improve consistency of application, including, among other things, requiring that an entity reflect the effect of an enacted
change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date.
The amendments in this update will be effective for the Company beginning with fiscal year 2021, with early adoption permitted.
Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied
on a retrospective or modified retrospective basis. Management is currently evaluating the impact that the amendments in this update
will have on the Company&#8217;s condensed consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU No. 2016-13,Financial Instruments&#8212;Credit
Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, to replace the incurred loss methodology with an expected
credit loss model that requires consideration of a broader range of information to estimate credit losses over the lifetime of
the asset, including current conditions and reasonable and supportable forecasts in addition to historical loss information, to
determine expected credit losses. Pooling of assets with similar risk characteristics and the use of a loss model are also required.
Also, in April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments&#8212;Credit
Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments, to clarify the inclusion of recoveries of trade
receivables previously written off when estimating an allowance for credit losses. The amendments in this update will be effective
for the Company in fiscal year 2023, with early adoption permitted. Management is currently evaluating the impact that the amendments
in this update will have on the Company&#8217;s condensed consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=SL108384541-122693<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=d3e31137-122693<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229340952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>9. FAIR VALUE DISCLOSURES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">9. FAIR VALUE DISCLOSURES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--FairValueDisclosuresTextBlock_z8sPHQu1v2F" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>9. <span>FAIR VALUE DISCLOSURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia holds the following types of financial instruments at
September 30, 2020 and December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Trading securities - debt. </i>Debt securities include corporate
bonds with fair value that is determined by third party quotations from outside pricing services and/or computerized pricing models,
which may be based on transactions, bids or estimates. Acacia classifies the fair value of corporate bonds within Level 2 of the
valuation hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Trading securities - equity. </i>Equity securities include
investments in public companies&#8217; common stock and are recorded at fair value based on the quoted market price of each share
on the valuation date. The fair value of these securities are within Level 1 of the valuation hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity securities derivative.</i> Public company equity securities
derivative are recorded at fair value based on the quoted market price of the underlying shares on the valuation date and settlement
expectations. The fair value of these equity securities derivative are within Level 1 of the valuation hierarchy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investments at fair value - common stock</i>. Acacia&#8217;s
equity investment in Veritone common stock is recorded at fair value based on the quoted market price of Veritone&#8217;s common
stock on the applicable valuation date (Level 1).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investments at fair value - warrants. </i>Warrants are recorded
at fair value, as based on the Black-Scholes option-pricing model (Level 2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Series A Warrants. </i>Series A Warrants are recorded at
fair value, using Black-Scholes option-pricing model (Level 2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Series B Warrants. </i>Series B Warrants are recorded at
fair value, using Monte Carlo valuation technique (Level 3).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Embedded derivative liability. </i>Embedded derivatives that
are required to be bifurcated from their host contract are evaluated and valued separately from the host instrument. A binomial
lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred
Stock issued by the Company in 2019 (Level 3).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112230161544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--PreferredStockTextBlock_zC7XW9r0dRU6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>10. <span>SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 18, 2019, the Company entered into a Securities
Purchase Agreement (the &#8220;Securities Purchase Agreement&#8221;) with Starboard Value LP (&#8220;Starboard&#8221;) and the
investors set forth in the Securities Purchase Agreement (the &#8220;Buyers&#8221;) pursuant to which the Company issued (i) <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember_pii" title="Stock issued">350,000</span>
shares of Series A Redeemable Convertible Preferred Stock with a par value of $0.001 per share and a stated value of $100 per share,
and (ii) Series A Warrants to purchase up to <span id="xdx_908_ecustom--WarrantsIssued_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Warrants issued">5,000,000</span> shares of the Company&#8217;s common stock to the Buyers. The Securities
Purchase Agreement also established the terms of certain senior secured notes (the &#8220;Notes&#8221;) and Series B Warrants that
may be issued to the Buyers on a subsequent date. Refer to Notes 11 and 12 for additional information regarding the issuance of
the Series A and Series B Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Redeemable Convertible Preferred Stock can be converted
into a number of shares of common stock equal to (i) the stated value thereof plus accrued and unpaid dividends, divided by (ii)
the conversion price of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Conversion price">3.65</span> (subject to certain anti-dilution adjustments). Holders may elect to convert the Series A Redeemable
Convertible Preferred Stock into common stock at any time. The Company may elect to convert the Series A Redeemable Convertible
Preferred Stock into shares of Common Stock any time on or after November 15, 2025, provided that the closing price of the Company&#8217;s
common stock equals or exceeds 190% of the conversion price for 30 consecutive trading days and assuming certain other conditions
of the common stock have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders have the option to redeem all or a portion of the Series
A Redeemable Convertible Preferred Stock during the periods of May 15, 2021 through August 15, 2021 and May 15, 2022 through August
15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of Notes to the Buyers pursuant
to the Securities Purchase Agreement. Holders also have the option to redeem all or a portion of the Series A Redeemable Convertible
Preferred Stock during the period of November 15, 2024 through February 15, 2025. Additionally, holders have the option to redeem
all or a portion of the Series A Redeemable Convertible Preferred Stock upon the occurrence of (i) a change of control or (ii)
various other triggering events, such as the suspension from trading or delisting of the Company&#8217;s common stock. If the
Series A Redeemable Convertible Preferred Stock is redeemed at the option of the holders, the redemption price may include a make-whole
amount or a stated premium, depending on the redemption scenario.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may redeem all, and not less than all, of the Series
A Redeemable Convertible Preferred Stock (i) upon a change of control or (ii) during the period of May 15, 2022 through August
15, 2022, provided that the Company has not issued at least $50.0 million aggregate principal of the Notes, and assuming certain
conditions of the common stock have been met. If the Series A Redeemable Convertible Preferred Stock is redeemed at the option
of the Company, the redemption price would include a make-whole amount or a 15% premium depending on the circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any Series A Redeemable Convertible Preferred Stock remains
outstanding on November 15, 2027, the Company shall redeem such Series A Redeemable Convertible Preferred Stock in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In all redemption scenarios, the redemption price for the Series
A Redeemable Convertible Preferred Stock includes the stated value plus accrued and unpaid dividends. In addition, depending on
the redemption scenario, the redemption price may also include a make-whole amount or stated premium as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Company issues Notes, the Holder may exchange the Series
A Redeemable Convertible Preferred Stock for (i) Notes and (ii) Series B Warrants to purchase common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Redeemable Convertible Preferred Stock accrues
cumulative dividends quarterly at annual rate of 3.0% on the stated value. Upon consummation of an approved investment (an investment
to be identified and approved by each of the Company and Starboard), the dividend rate will increase to 8.0% on the stated value.
Upon certain triggering events, the dividend rate will increase to 7.0% if the triggering event occurs before an approved investment
or 10.0% on the stated value if the triggering event occurs after an approved investment. The Series A Redeemable Convertible Preferred
Stock also participates on an as-converted basis in any regular or special dividends paid to common stockholders. There are <span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pn3n3_do_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zCmWnix7w69l" title="Accrued and unpaid dividends">no</span>
accrued and unpaid dividends as of September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of the Series A Redeemable Convertible Preferred Stock
have the right to vote with common stockholders on an as-converted basis on all matters. Holders of Series A Redeemable Convertible
Preferred Stock will also be entitled to a separate class vote with respect to amendments to the Company&#8217;s organizational
documents that generally have an adverse effect on the Series A Redeemable Convertible Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon liquidation of the Company, holders of Series A Redeemable
Convertible Preferred Stock have a liquidation preference over holders of our common stock and will be entitled to receive, prior
to any distribution to holders of our common stock, an amount equal to the greater of (i) the stated value plus accrued and unpaid
dividends or (ii) the amount that would have been received if the Series A Redeemable Convertible Preferred Stock had been converted
into common stock immediately prior to the liquidation event at the then effective conversion price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determined that certain features of the Series A
Redeemable Convertible Preferred Stock should be bifurcated and accounted for as a derivative. Each of these features are bundled
together as a single, compound embedded derivative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total proceeds received and transaction costs incurred from
the issuance of the Series A Redeemable Convertible Preferred Stock amounted to $35 million and $1.2 million, respectively. Proceeds
received were allocated based on the fair value of the instrument without the Series A Warrants and of the Series A Warrants themselves
at the time of issuance. The proceeds allocated to the Series A Redeemable Convertible Preferred Stock were then further allocated
between the host preferred stock instrument and the embedded derivative, with the embedded derivative recorded at fair value and
the Series A Redeemable Convertible Preferred Stock recorded at the residual amount. The portion of the proceeds allocated to the
Series A Warrants, embedded derivative, and Series A Redeemable Convertible Preferred Stock was $4.8 million, $21.2 million, and
$8.9 million, respectively. Transaction costs were also allocated between the Series A Redeemable Convertible Preferred Stock and
the Series A Warrants on the same basis as the proceeds. The transaction costs allocated to the Series A Redeemable Convertible
Preferred Stock were treated as a discount to the Series A Redeemable Convertible Preferred Stock. The transaction costs allocated
to the Series A Warrants were expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company classifies the Series A Redeemable Convertible Preferred
Stock as mezzanine equity as the instrument will become redeemable at the option of the holder in various scenarios or otherwise
on November 15, 2027. As it is probable that the Series A Redeemable Convertible Preferred Stock will become redeemable, the Company
accretes the instrument to its redemption value using the effective interest method and recognizes any changes against additional
paid in capital in the absence of retained earnings. Accretion was $<span id="xdx_907_eus-gaap--AccretionExpense_pn3n3_dm_c20200701__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zBeYQReQQE7g" title="Accretion">0.7</span> million and $<span id="xdx_901_eus-gaap--AccretionExpense_pn3n3_dm_c20200101__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zbFObga2BzHg" title="Accretion">2.0</span> million, respectively, for the three and
nine months ended September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the issuance of the Series A Redeemable Convertible
Preferred Stock, the Company executed a Registration Rights Agreement with Starboard and the Buyers, and a Governance Agreement
with Starboard and certain affiliates of Starboard. Under the Registration Rights Agreement, the Company agreed to provide certain
registration rights with respect to the Series A Redeemable Convertible Preferred Stock and shares of Common Stock issued upon
conversion. In accordance with the Governance Agreement, the Company agreed to (i) increase the size of the Board of Directors
from six to seven members, (ii) appoint a director of the Company, (iii) grant Starboard and its affiliates the right to recommend
two additional directors for appointment to the board, (iv) form a Strategic Committee of the Board tasked with sourcing and performing
due diligence on potential acquisition targets, (v) appoint certain directors to the Strategic Committee, and (vi) appoint a director
to the Nominating and Corporate Governance Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following features of the Series A Redeemable Convertible
Preferred Stock are required to be bifurcated from the host preferred stock and accounted for separately as an embedded derivative:
(i) the right of the holders to redeem the shares (put option), (ii) the right of the holders to receive common stock upon conversion
of the shares (conversion option), (iii) the right of the Company to redeem the shares (call option), and (iv) the change in dividend
rate upon consummation of an approved investment or a triggering event (contingent dividend rate feature).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These features are required to be accounted for separately from
the Series A Redeemable Convertible Preferred Stock because the features were determined to be not clearly and closely related
to the debt-like host and also did not meet any other scope exceptions for derivative accounting. Therefore, these features are
bundled together and are accounted for as a single, compound embedded derivative liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, we have recorded an embedded derivative liability
representing the combined fair value of each of these features. The embedded derivative liability is adjusted to reflect fair value
at each period end with changes in fair value recorded in the &#8220;Change in fair value of redeemable preferred stock embedded
derivative&#8221; financial statement line item of the accompanying condensed consolidated statements of operations. As of September
30, 2020, the fair value of the Series A embedded derivative was $<span id="xdx_90E_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_iI_pn3n3_dm_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_z9fbr93dIQSe" title="Fair value of Series A embedded derivative">25.7</span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227059832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. SERIES A WARRANTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_SeriesWarrantsAbstract', window );"><strong>Series Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantDisclosureTextBlock', window );">11. SERIES A WARRANTS</a></td>
<td class="text"><p id="xdx_80A_ecustom--WarrantDisclosureTextBlock_z7M7a9RY9U78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>11. <span>SERIES A WARRANTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 18, 2019, in connection with the issuance of the
Series A Redeemable Convertible Preferred Stock, the Company issued detachable Series A Warrants to acquire up to <span id="xdx_907_ecustom--WarrantsIssuedShares_c20190101__20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_pii" title="Warrants issued, shares">5,000,000</span> shares
of common stock at a price of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pip0_c20191118__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zQz4wZWxGudk" title="Conversion price">3.65</span> per share (subject to certain antidilution adjustments) at any time during a period of eight
years beginning on the instrument&#8217;s issuance date of the Series A Warrants. As of September 30, 2020, the Series A Warrants
have <span id="xdx_907_ecustom--WarrantsExercised_pii_do_c20200101__20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zDICLBPCqs11" title="Warrants exercised">no</span>t been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Warrants will be recognized at fair value at each
reporting period until exercised, with changes in fair value recognized in the condensed consolidated statements of operations
in other income (expense) in the accompanying condensed consolidated statements of operations. As of December 31, 2019, the fair
value of the Series A Warrants was $<span id="xdx_903_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20191231__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zhOInMhEl6ta" title="Fair value of warrants">3.6</span> million. As of September 30, 2020, the fair value of the Series A Warrants was $<span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20200930__us-gaap--SecuritiesFinancingTransactionAxis__custom--SecuritiesPurchaseAgreementMember__srt--CounterpartyNameAxis__custom--StarboardValueMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember_zCeChSpd2WKl" title="Fair value of warrants">5.6</span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series A Warrants are classified as a liability in accordance
with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_SeriesWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_SeriesWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227229448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. SERIES B WARRANTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_SeriesBWarrantsAbstract', window );"><strong>Series B Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_SeriesBWarrantsTextBlock', window );">12. SERIES B WARRANTS</a></td>
<td class="text"><p id="xdx_809_ecustom--SeriesBWarrantsTextBlock_zfFravHjlkIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>12. <span>SERIES B WARRANTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 25, 2020, pursuant to the terms of the Securities
Purchase Agreement with Starboard and the Buyers, the Company issued Series B Warrants to purchase up to <span id="xdx_905_ecustom--WarrantsIssuedShares_pn3n3_dm_c20200101__20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zNJfwcB6Mzr1" title="Warrants issued, shares">100</span> million shares of
the Company&#8217;s common stock at an exercise price (subject to certain price-based anti-dilution adjustments) of either (i)
$<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_pii" title="Conversion price">5.25</span> per share, if exercising by cash payment, within 30 months from the issuance date (i.e., August 25, 2022); or (ii) $3.65
per share, if exercising by cancellation of a portion of Notes. The Company issued the Series B Warrants for an aggregate purchase
price of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfWarrants_pn3n3_dm_c20200101__20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_z5ltS97JhSA8" title="Proceeds from issuance of warrants">4.6</span> million. The Series B Warrants expire on <span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20200225__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zuujuKqSF0lb" title="Warrant expiration date">November 15, 2027</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the issuance of the Notes on June 4, 2020,
the terms of certain of the Series B Warrants were amended to permit the payment of the lower exercise price of $3.65 through the
payment of cash, rather than only through the cancellation of Notes outstanding, at any time until the expiration date of November
15, 2027. Only <span title="Warrants Description">31,506,849 of the Series B Warrants are subject to this adjustment with the remaining balance of 68,493,151 Series
B Warrants continuing under their original terms.</span> Refer to Note 13 for additional information on the modifications to Series A
Redeemable Convertible Preferred Stock and Series B Warrants. As of September 30, 2020, the Series B Warrants have <span id="xdx_90D_ecustom--WarrantsExercisedShares_pip0_do_c20200101__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zm6D0c8BbMfl" title="Warrants exercised">no</span>t been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series B Warrants will be recognized at fair value at each
reporting period until exercised, with changes in fair value recognized in the condensed consolidated statements of operations
in other income (expense). As of September 30, 2020, the fair value of the Series B Warrants was $<span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_pn3n3_dm_c20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zxyU4PExGay2" title="Fair value of warrants">42.8</span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Series B Warrants are classified as a liability in accordance
with ASC 480, Distinguishing Liabilities from Equity, as the agreement provides for net cash settlement upon a change in control,
which is outside the control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_SeriesBWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_SeriesBWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_SeriesBWarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Series B Warrants [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_SeriesBWarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227406888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. SENIOR SECURED NOTES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">13. SENIOR SECURED NOTES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zt9L64DPotwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>13. <span>SENIOR SECURED NOTES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Securities Purchase
Agreement dated November 18, 2019 with Starboard and the Buyers, on June 4, 2020, the Company issued $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zLqTn44DJEt" title="Proceeds from issuance of debt">115</span>
million in Notes to the Buyers. Also on June 4, 2020, in connection with the issuance of the Notes, the Company entered into
a Supplemental Agreement with Starboard (the &#8220;Supplemental Agreement&#8221;), pursuant to which the Company agreed to
redeem $<span id="xdx_90E_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zXZ4fIqPgVR6" title="Repayment of debt">80</span>
million aggregate principal amount of the Notes by September 30, 2020, and $<span id="xdx_901_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20201231__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zraSBrsG9ES2" title="Repayment of debt">35</span>
million aggregate principal amount of the Notes by December 31, 2020, resulting in the total principal outstanding being paid
by December 31, 2020. Per the Supplemental Agreement, interest is payable semiannually at a rate of 6.00% per annum, and in
an event of default, the interest rate is increased to <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zNkvbb2FTykc" title="Interest Rate">10</span>%
per annum. The Notes include certain financial and non-financial covenants. Additionally, all or any portion of the principal
amount outstanding under the Notes may, at the election of Starboard, be surrendered to the Company for cancellation in
payment of the exercise price upon the exercise of Series B Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 30, 2020, the Company entered into an Exchange Agreement
(the &#8220;Exchange Agreement&#8221;) with Merton Acquisition HoldCo LLC, a Delaware limited liability company and wholly-owned
subsidiary of the Company (&#8220;Merton&#8221;) and Starboard, on behalf of itself and on behalf of certain funds and accounts
under its management, including the holders of the Notes. Pursuant to the Exchange Agreement, the holders of the Notes exchanged
the entire outstanding principal amount for new senior notes (the &#8220;New Notes&#8221;) issued by Merton having an aggregate
outstanding original principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_dm_c20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zTG70nH9bU0h" title="Principal amount">115</span> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The New Notes bear interest at a rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pii_dp_c20200101__20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zgOtyG1Z2rbj" title="Interest Rate">6.00</span>% per annum and
will mature on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20200101__20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_z8vXz1EFOHyg" title="Maturity Date">December 31, 2020</span>. The New Notes are fully guaranteed by the Company and are secured by an all-assets pledge of
the Company and Merton and non-recourse equity pledges of each of the Company&#8217;s material subsidiaries. Pursuant to the Exchange
Agreement, the New Notes (i) are deemed to be &#8220;Notes&#8221; for purposes of the Securities Purchase Agreement, (ii) are deemed
to be &#8220;June 2020 Approved Investment Notes&#8221; for purposes of the Supplemental Agreement, and therefore the Company has
agreed to redeem $<span id="xdx_908_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zNVaVS80kWe2" title="Repayment of debt">80</span> million principal amount of the New Notes by September 30, 2020 (the &#8220;Initial Redemption Date&#8221;)
and $<span id="xdx_909_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotes1Member_z17L7mjnhE3i" title="Repayment of debt">35</span> million principal amount of the New Notes by December 31, 2020 (the &#8220;Final Redemption Date&#8221;), and (iii) are
deemed to be &#8220;Notes&#8221; for the purposes of the Series B Warrants, and therefore may be tendered pursuant to a Note Cancellation
under the Series B Warrants on the terms set forth in the Series B Warrants and the New Notes. Delivery of notes in the form of
the New Notes will satisfy the delivery of Exchange Notes pursuant to Section 16(i) of the Certificate of Designations of the Company&#8217;s
Series A Convertible Preferred Stock, par value $<span id="xdx_907_eus-gaap--TemporaryEquityParOrStatedValuePerShare_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_pii" title="Series A redeemable convertible preferred stock, par value">0.001</span> per share. The New Notes will not be deemed to be &#8220;Notes&#8221; for
the purposes of the Registration Rights Agreement, dated as of November 18, 2019, by and among the Company, Starboard and the Buyers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the New Notes will be settled within twelve months pursuant
to their terms, they are classified as current liabilities on the balance sheet. The Company capitalized $<span title="Payment of lender fees"><span id="xdx_909_eus-gaap--PaymentsOfFinancingCosts_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zkDuDsO3Y1ii" title="Payment of lenders fees">4.6</span></span> million in lender
fees and $<span title="Other issuance costs"><span id="xdx_903_eus-gaap--PaymentsOfDebtIssuanceCosts_pn3n3_dm_c20200101__20200930__us-gaap--TransactionTypeAxis__custom--ExchangeAgreementMember__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zrYUF2SWw826" title="Payment of other issuance costs">0.5</span></span> million in other issuance costs associated with the issuance of the Notes. The $4.6 million of lender fees are recognized
as long term deferred debt issuance cost and will be amortized to interest expense until November 15, 2027, the maturity date of
Series A Redeemable Convertible Preferred Stock. The $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember_zQuEXFGhLPVf" title="Discount">0.5</span> million issuance costs are recognized as a discount on the Notes and
will be amortized to interest expense over the contractual life of the Notes. There is $<span title="Accrued and unpaid dividends"><span id="xdx_90D_eus-gaap--DividendsPayableCurrent_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--SecuritiesFinancingTransactionAxis__custom--SeriesARedeemableConvertibleStockMember_zitnjNQ1RJ0e" title="Accrued and unpaid dividends">1.7</span></span> million accrued and unpaid interest on
the New Note as of September 30, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Initial Redemption Date was subsequently extended by the
parties to November 9, 2020 and the Final Redemption Date was extended to January 15, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Modifications to Series A Redeemable Convertible Preferred
Stock and Series B Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The June 4, 2020 Supplemental Agreement also provided for (i)
a waiver of increased dividends under the original terms of the Series A Preferred Stock that would have otherwise accrued due
to the Company&#8217;s use of the $35 million proceeds received from Starboard and the Buyers upon the issuance of the Series A
Redeemable Convertible Preferred Stock in November 2019, (ii) the replacement of original optional redemption rights for the Series
A Redeemable Convertible Preferred Stock provided to both the Company and the holders that otherwise would have been nullified
through the issuance of the Notes, and (iii) an amendment to the terms of the previously issued Series B Warrants to permit the
payment of the lower exercise price of $3.65 through the payment of cash, rather than only through the cancellation of Notes outstanding,
at any time until the expiration of the Series B Warrants on November 15, 2027. Only <span title="Warrants Description">31,506,849 of the Series B Warrants are subject
to this adjustment with the remaining balance of 68,493,151 Series B Warrants continuing under their original terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We analyzed the amendments to the Series A Redeemable Convertible
Preferred Stock and determined that the amendments were not significant. Therefore, the amendments are accounted for as a modification
on a prospective basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The incremental fair value of the Series B Warrants associated
with their modification in connection with the issuance of the Notes is $<span id="xdx_90F_ecustom--OriginalIssueDiscount_iI_pn3n3_dm_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_ztkOTNvawrmk" title="Original Issue Discount">1.3</span> million and is recognized as a discount on the Notes
and will be amortized to interest expense over the contractual life of the Notes. For the three and nine months ended September
30, 2020, respectively, $<span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_pn3p0_c20200701__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zREdr43vSJj9" title="Interest expense">532,000</span> and $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_pn3p0_c20200101__20200930__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_znRWuywov9Y4" title="Unamortized Discount">697,000</span> were amortized to interest expense. As of September 30, 2020, $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3p0_c20200930__srt--CounterpartyNameAxis__custom--MertonMember__us-gaap--LongtermDebtTypeAxis__custom--SeniorSecuredNotesMember__us-gaap--StatementClassOfStockAxis__custom--SeriesBWarrantsMember_zxjTHtVpuD3" title="Remaining discount">632,000</span> is remaining
to be amortized until the Final Redemption Date of January 15, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227229448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT</a></td>
<td class="text"><p id="xdx_801_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zCvvVUrnhmR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>14. <span>LF EQUITY INCOME FUND PORTFOLIO INVESTMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 3, 2020, the Company entered into
an Option Agreement with Seller, which included general terms through which the Company was provided the option to purchase life
sciences equity securities in a portfolio of public and private companies (&#8220;Portfolio Companies&#8221;) for an aggregate
purchase price of &#163;<span id="xdx_90E_eus-gaap--PaymentsToAcquireAvailableForSaleSecuritiesEquity_pn3n3_dm_c20200101__20200604__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_z3KWMMZn94fh" title="Payment to acquire equity securities">223.9</span> million, approximately $<span id="xdx_906_eus-gaap--PaymentsToAcquireAvailableForSaleSecuritiesEquity_pn3n3_dm_c20200101__20200403__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zo3AQdix0F9e" title="Payment to acquire equity securities">277.5</span> million at the exchange rate on April 3, 2020. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 4, 2020, the Company executed the
Transaction Agreement between Link Fund Solutions Limited, Seller, and the Company. Pursuant to the Transaction Agreement, the
Company will purchase from Seller and Seller will transfer to the Company the specified equity securities of all Portfolio Companies
at set prices at various future dates. The transfer dates will vary among the Portfolio Companies as the Transaction Agreement
gives the Company the exclusive right to determine when to call for transfer of each security, and because each Portfolio Company
(or its existing equity holders) may be required to approve the transfer due to rights of first refusals and other company-specific
terms and conditions. Thus, the execution of the Transaction Agreement resulted in forward contracts for the Company to purchase
equity securities in each public and private company at a specified price on a future date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the Transaction Agreement,
the Company transferred the total purchase price of &#163;223.9 million into an escrow account. As each of the equity securities
in the Portfolio are transferred to the Company, the associated funds will be released from the escrow account to Seller based
on the consideration amount assigned to the equity securities in the Transaction Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For accounting purposes, the total purchase price of the portfolio
was allocated to the individual equity securities based on their individual fair values as of April 3, 2020, in order to establish
an appropriate cost basis for each of the acquired securities. The fair values of the public company securities were based on their
quoted market price. The fair values of the private company securities were estimated based on recent financing transactions and
secondary market transactions and factoring in a discount for the illiquidity of these securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended September 30, 2020, Seller returned
a total of &#163;<span id="xdx_901_ecustom--ReturnOnPrepayment_pn3n3_dm_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_zAcUmHfRUNa" title="Return on prepayment">4.5</span> million of the Company&#8217;s prepaid investment upon the failure to obtain the approval of the existing
equity holders, pursuant to their rights of first refusals, of one of the Portfolio Companies in connection with the transfer of
its securities. In addition, due to an ownership restriction applicable to one of the Portfolio Companies, the Company sold a small
portion of an equity securities derivative for &#163;<span id="xdx_90B_eus-gaap--ProceedsFromSaleOfAvailableForSaleSecurities_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember__srt--CurrencyAxis__currency--GBP_pn3n3" title="Proceeds from sale of securities">33,000</span> before the remaining shares of such Portfolio Company could be transferred
to us. The Company recognized a net gain of $<span id="xdx_90A_eus-gaap--EquitySecuritiesFvNiRealizedGain_pn3n3_dm_c20200701__20200930__us-gaap--TransactionTypeAxis__custom--OptionAgreementMember__srt--CounterpartyNameAxis__custom--PortfolioCompaniesMember_zvCe6bFIjlU6" title="Gain on sale of deriviative">2.8</span> million related to the returned prepaid investments and sale of the derivative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in the fair value of Acacia&#8217;s investment in the
Portfolio Companies are recorded as unrealized gains or losses in the condensed consolidated statements of operations. For the
three and nine months ended September 30, 2020 and 2019, the accompanying condensed consolidated statements of operations reflected
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zepeP87rkN5k" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8BB_z58Oa7OcEZ0h" style="display: none">Changes in fair value of Acacias Investment</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49E_20200701__20200930_zW5j2zNiwn7h" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_494_20190701__20190930_zpiKyYHn3643" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_492_20200101__20200930_zva1bbiqQYVb" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_490_20190101__20190930_zDiQvy1w7Zfj" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Change in fair value of trading securities - LF Fund public securities</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">3,403</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zUZgIMo2uB87" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">2,334</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zm7I5B0PCRD7" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zwBJ36vuQ0M2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">10,651</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zrDGADWnIJeh" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zsFUZu7k857e" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">17,542</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_z1133gWw9bO6" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities - LF Fund private securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zVSFO2lNfWf2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">80,896</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z7ysG3TB4F44" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z3sk4jBRpnHk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">80,896</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zo8j4ONbD2Zg" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities forward contract</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zmmP3IofhU67" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">(74,662</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zVoFbxdBxw2l" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zruyd7HkfZBi" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_ziG4zeheCtwk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Gain (loss) on sale of trading securities - LF Fund public securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zoJ5KTT9TL6a" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities">1,908</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zcfv5FvxsDv" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zDZyrmDggnc6" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities">(4,202</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zCcWCXm6WxE3" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--GainLossOnSaleOfDerivatives_pn3n3_d0_zReEvh8i047l" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Gain on sale of prepaid investment and derivative</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,845</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,845</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net realized and unrealized gain on investment in LF Fund securities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">25,041</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zQD40jp4UGU2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">99,415</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zJzaJkH3xEY2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227874248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>15. SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">15. SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zNn9TTHdhJok" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>15. <span>SUBSEQUENT EVENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229332360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_DescriptionOfBusinessPolicyTextBlock', window );">Description of Business</a></td>
<td class="text"><p id="xdx_849_ecustom--DescriptionOfBusinessPolicyTextBlock_z32GuCyYITk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used herein, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
&#8220;Acacia&#8221; and the &#8220;Company&#8221; refer to Acacia Research Corporation and/or its wholly and majority-owned and
controlled operating subsidiaries, and/or where applicable, its management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia was incorporated on January 25, 1993 under the laws of
the State of California. In December 1999, Acacia changed its state of incorporation from California to Delaware.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries invest in, license and
enforce patented technologies. Acacia&#8217;s operating subsidiaries partner with inventors and patent owners, applying their legal
and technology expertise to patent assets to unlock the financial value in their patented inventions. In recent years, Acacia has
also invested in technology companies. Acacia leverages its experience, expertise, data and relationships developed as a leader
in the intellectual property (&#8220;IP&#8221;) industry to pursue these opportunities. In some cases, these opportunities will
complement, and/or supplement Acacia&#8217;s primary licensing and enforcement business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries generate revenues and
related cash flows from the granting of IP rights (hereinafter &#8220;IP Rights&#8221;) for the use of patented technologies that
its operating subsidiaries control or own. Acacia&#8217;s operating subsidiaries assist patent owners with the prosecution and
development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing
revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their
patented technologies through the filing of patent infringement litigation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia&#8217;s operating subsidiaries are principals in the
licensing and enforcement effort, obtaining control of the rights in the patent portfolio, or control of the patent portfolio outright.
Acacia&#8217;s operating subsidiaries own or control the rights to multiple patent portfolios, which include U.S. patents and certain
foreign counterparts, covering technologies used in a wide variety of industries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither Acacia nor its operating subsidiaries invent new technologies
or products; rather, Acacia depends upon the identification and investment in new patents, inventions and companies that own IP
through its relationships with inventors, universities, research institutions, technology companies and others. If Acacia&#8217;s
operating subsidiaries are unable to maintain those relationships and identify and grow new relationships, then they may not be
able to identify new technology-based opportunities for sustainable revenue and/or revenue growth.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the nine months ended
September 30, 2020, Acacia obtained control of four <span id="xdx_90C_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20200101__20200930_zh7nbsdkupS5" style="display: none" title="Number of new patent portfolios acquired">4</span> new patent portfolios. During fiscal year 2019, Acacia obtained control
of five <span id="xdx_902_ecustom--NumberOfPatentPortfoliosAcquired_pii_uInteger_c20190101__20191231_zn2FWCeypwof" style="display: none" title="Number of new patent portfolios acquired">5</span> new patent portfolios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zAHYR1QGEwDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis of Presentation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial
statements include the accounts of Acacia and its wholly and majority-owned and controlled subsidiaries. Material intercompany
transactions and balances have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying unaudited condensed consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly,
certain information and footnotes required by U.S. GAAP in annual financial statements have been omitted or condensed in accordance
with quarterly reporting requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;). These interim unaudited condensed
consolidated financial statements should be read in conjunction with the condensed consolidated financial statements and notes
thereto for the year ended December 31, 2019, as reported by Acacia in its Annual Report on Form 10-K filed with the SEC on March
16, 2020, as well as in our other public filings with the SEC. The condensed consolidated interim financial statements of Acacia
include all adjustments of a normal recurring nature which, in the opinion of management, are necessary for a fair statement of
Acacia&#8217;s consolidated financial position as of September 30, 2020, and results of its operations and its cash flows for
the interim periods presented. The consolidated results of operations for the three and nine months ended September 30, 2020 are
not necessarily indicative of the results to be expected for the entire fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_847_eus-gaap--UseOfEstimates_zgNDy7D6wtaj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S.
GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the
significant accounting policies described herein, the accounting policies associated with revenue recognition, the valuation of
the equity instruments, the valuation of Series A redeemable convertible preferred stock (the &#8220;Series A Redeemable Convertible
Preferred Stock&#8221;) embedded derivatives, Series A warrants (the &#8220;Series A Warrants&#8221;), Series B warrants (the &#8220;Series
B Warrants&#8221;), equity securities derivative and forward contract, stock-based compensation expense, impairment of patent related
intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances
against net deferred tax assets, require its most difficult, subjective or complex judgments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_znVi8bw6TNse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassifications</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made to the prior fiscal
year financial information to conform with the current fiscal year presentation. Such reclassifications had no impact on net income
or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_DescriptionOfBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of Business [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_DescriptionOfBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232510696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zVTJGv8cLg5f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue Recognition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue is recognized upon transfer of control of promised bundled
IP Rights and other contractual performance obligations to licensees in an amount that reflects the consideration we expect to
receive in exchange for those IP Rights. Revenue contracts that provide promises to grant the right to use IP Rights as they exist
at the point in time at which the IP Rights are granted, are accounted for as performance obligations satisfied at a point in time
and revenue is recognized at the point in time that the applicable performance obligations are satisfied and all other revenue
recognition criteria have been met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the periods presented, revenue contracts executed by the
Company primarily provided for the payment of contractually determined, one-time, paid-up license fees in consideration for the
grant of certain IP Rights for patented technologies owned or controlled by Acacia. Revenues also included license fees from sales-based
revenue contracts, the majority of which were originally executed in prior periods, that provide for the payment of quarterly license
fees based on quarterly sales of applicable product units by licensees (&#8220;Recurring Revenue Agreements&#8221;). Revenues may
also include court ordered settlements or awards related to our patent portfolio. IP Rights granted included the following, as
applicable: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented
technologies, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any
pending litigation. The IP Rights granted were perpetual in nature, extending until the legal expiration date of the related patents.
The individual IP Rights are not accounted for as separate performance obligations, as (i) the nature of the promise, within the
context of the contract, is to transfer combined items to which the promised IP Rights are inputs and (ii) the Company's promise
to transfer each individual IP right described above to the customer is not separately identifiable from other promises to transfer
IP Rights in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the promised IP Rights are not individually distinct,
the Company combines each individual IP Right in the contract into a bundle of IP rights that is distinct and accounts for all
of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted generally are &#8220;functional
IP rights&#8221; that have significant standalone functionality. Acacia's subsequent activities do not substantively change that
functionality and do not significantly affect the utility of the IP to which the licensee has rights. Acacia&#8217;s operating
subsidiaries have no further obligation with respect to the grant of IP Rights, including no express or implied obligation to maintain
or upgrade the technology, or provide future support or services. The contracts provide for the grant (i.e., transfer of control)
of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the contract. Licensees legally
obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized
upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have been met. Revenue
contracts generally provide for payment of contractual amounts within 30-90 days of execution of the contract, or the end of the
quarter in which the sale or usage occurs for Recurring Revenue Agreements. Contractual payments made by licensees are generally
non-refundable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For sales-based royalties, the Company includes in the transaction
price some or all of an amount of estimated variable consideration to the extent that it is probable that a significant reversal
in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is
subsequently resolved. Notwithstanding, revenue is recognized for a sales-based royalty promised in exchange for a license of IP
Rights when the later of (i) the subsequent sale or usage occurs, or (ii) the performance obligation to which some or all of the
sales-based royalty has been allocated has been satisfied. Estimates are generally based on historical levels of activity, if available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenues from contracts with significant financing components
(either explicit or implicit) are recognized at an amount that reflects the price that a licensee would have paid if the licensee
had paid cash for the IP Rights when they transfer to the licensee. In determining the transaction price, the Company adjusts the
promised amount of consideration for the effects of the time value of money. As a practical expedient, the Company does not adjust
the promised amount of consideration for the effects of a significant financing component if the Company expects, at contract inception,
that the period between when the entity transfers promised IP Rights to a customer and when the customer pays for the IP Rights
will be one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, the Company is required to make certain judgments
and estimates in connection with the accounting for revenue contracts with customers. Such areas may include identifying performance
obligations in the contract, estimating the timing of satisfaction of performance obligations, determining whether a promise to
grant a license is distinct from other promised goods or services, evaluating whether a license transfers to a customer at a point
in time or over time, allocating the transaction price to separate performance obligations, determining whether contracts contain
a significant financing component, and estimating revenues recognized at a point in time for sales-based royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Revenues were composed of the following for the periods presented:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zV3hnwRzqTli" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BA_zrRtoFE2jE6b" style="display: none">Disaggregation of revenue</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-size: 10pt; text-align: left">Paid-up Revenue Agreements</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">19,385</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">1,203</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">24,477</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">6,067</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Recurring Revenue Agreements</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">81</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">508</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">922</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">4,491</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">19,466</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">1,711</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">25,399</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">10,558</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A7_zIOa7M6K8RK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Refer to &#8220;<i>Inventor Royalties and Contingent Legal Expenses</i>&#8221;
below for information on related direct costs of revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PortfolioOperationsPolicyTextBlock', window );">Portfolio Operations</a></td>
<td class="text"><p id="xdx_845_ecustom--PortfolioOperationsPolicyTextBlock_z0PQej27meF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Portfolio Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues include the costs and expenses incurred in
connection with Acacia&#8217;s patent licensing and enforcement activities, including inventor royalties paid to patent owners,
contingent legal fees paid to external patent counsel, other patent-related legal expenses paid to external patent counsel, licensing
and enforcement related research, consulting and other expenses paid to third-parties and the amortization of patent-related investment
costs. These costs are included under the caption &#8220;Portfolio operations&#8221; in the accompanying condensed consolidated
statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Inventor Royalties and Contingent Legal Expenses </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventor royalties are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In certain instances, pursuant to the terms of
the underlying inventor agreements, upfront advances paid to patent owners by Acacia&#8217;s operating subsidiaries are recoverable
from future net revenues. Patent costs that are recoverable from future net revenues are amortized over the estimated economic
useful life of the related patents, or as the prepaid royalties are earned by the inventor, as appropriate, and the related expense
is included in amortization expense in the condensed consolidated statements of operations. Any unamortized upfront advances recovered
from net revenues are expensed in the period recovered and included in amortization expense in the condensed consolidated statements
of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Contingent legal fees are expensed in the condensed consolidated
statements of operations in the period that the related revenues are recognized. In instances where there are no recoveries from
potential infringers, no contingent legal fees are paid; however, Acacia&#8217;s operating subsidiaries may be liable for certain
out of pocket legal costs incurred pursuant to the underlying legal services agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventor royalty and contingent legal agreements typically provide
for payment by the Company of contractual amounts 30 days subsequent to the fiscal quarter end during which related license fee
payments are received from licensees by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Concentrations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject Acacia to concentrations
of credit risk are cash equivalents, trading securities and accounts receivable. Acacia places its cash equivalents and trading
securities primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are
also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. Acacia has not
experienced any significant losses on its deposits of cash and cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One licensee accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z9PB9Iy8QFX5" title="Concentration risk percentage">98</span>% of revenues recognized during
the three months ended September 30, 2020, and four licensees accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zEIckxnT6oXa" title="Concentration risk percentage">75</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_z0flroiVykVf" title="Concentration risk percentage">9</span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zdPgccVRIOTd" title="Concentration risk percentage">8</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z10yUkRMa4B1" title="Concentration risk percentage">4</span>% of revenues recognized during the
nine months ended September 30, 2020. Three licensees individually accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_z6lYye00U4Gb" title="Concentration risk percentage">52</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAu13o9juE95" title="Concentration risk percentage">21</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zfoUUzQGMiX3" title="Concentration risk percentage">12</span>% of revenues recognized during
the three months ended September 30, 2019, and three licensees individually accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zBDpPFZbq1Kj" title="Concentration risk percentage">46</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zQa3HNYTxCGj" title="Concentration risk percentage">23</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_zqrHYPld61yh" title="Concentration risk percentage">14</span>% of revenues recognized
during the nine months ended September 30, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have any material foreign operations. Based
on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement, for
the three and nine months ended September 30, 2020, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200701__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zgKuW8Ya9Eya" title="Concentration risk percentage">0.1</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zioeaPVhaa6a" title="Concentration risk percentage">5</span>%, respectively, of revenues were attributable to licensees domiciled
in foreign jurisdictions. For the three and nine months ended September 30, 2019, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190701__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_zdLNezg5HTF7" title="Concentration risk percentage">75</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20190930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__custom--ForeignLicenseeMember_z3rdUQVsvQ3l" title="Concentration risk percentage">38</span>%, respectively, of revenues were attributable
to licensees domiciled in foreign jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Four licensees individually represented approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zCMLLREbR1A5" title="Concentration risk percentage">57</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zAwJRQASb4v8" title="Concentration risk percentage">25</span>%,
<span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee3Member_z9kDn3aEUHvi" title="Concentration risk percentage">4</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20200101__20200930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee4Member_z8dTWIWEruvc" title="Concentration risk percentage">3</span>% of accounts receivable at September 30, 2020. Two licensees individually represented approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicenseeMember_zc6SME9mx9fk" title="Concentration risk percentage">70</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190101__20191231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--OneLicensee2Member_zepBPNtR6haa" title="Concentration risk percentage">17</span>% of accounts
receivable at December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Patents</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zOwy2OfZDHf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Patents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patents include the cost of patents or patent rights (hereinafter,
collectively &#8220;patents&#8221;) acquired from third-parties or obtained in connection with business combinations. Patent costs
are amortized utilizing the straight-line method over their remaining economic useful lives. Refer to Note 4 for additional information
regarding our patents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-lived Assets</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zTc3XJcDJb0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impairment of Long-lived Assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia reviews long-lived assets and intangible assets for potential
impairment annually (quarterly for patents) and when events or changes in circumstances indicate the carrying amount of an asset
may not be recoverable. In the event the expected undiscounted future cash flows resulting from the use of the asset is less than
the carrying amount of the asset, an impairment loss is recorded in an amount equal to the excess of the asset&#8217;s carrying
value over its fair value. If an asset is determined to be impaired, the loss is measured based on quoted market prices in active
markets, if available. If quoted market prices are not available, the estimate of fair value is based on various valuation techniques,
including a discounted value of estimated future cash flows. In the event that management decides to no longer allocate resources
to a patent portfolio, an impairment loss equal to the remaining carrying value of the asset is recorded. Refer to Note 4 for additional
information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fair value is generally estimated using the &#8220;Income Approach,&#8221;
focusing on the estimated future net income-producing capability of the patent portfolios over their estimated remaining economic
useful life. Estimates of future after-tax cash flows are converted to present value through &#8220;discounting,&#8221; including
an estimated rate of return that accounts for both the time value of money and investment risk factors. Estimated cash inflows
are typically based on estimates of reasonable royalty rates for the applicable technology, applied to estimated market data. Estimated
cash outflows are based on existing contractual obligations, such as contingent legal fee and inventor royalty obligations, applied
to estimated license fee revenues, in addition to other estimates of out-of-pocket expenses associated with a specific patent portfolio&#8217;s
licensing and enforcement program. The analysis also contemplates consideration of current information about the patent portfolio
including, status and stage of litigation, periodic results of the litigation process, strength of the patent portfolio, technology
coverage and other pertinent information that could impact future net cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zi23fhAEv8r1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Cash and Cash Equivalents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia considers all highly liquid, trading securities with
original maturities of three months or less when purchased to be cash equivalents. For the periods presented, Acacia&#8217;s cash
equivalents are comprised of investments in AAA rated money market funds that invest in first-tier only securities, which primarily
includes: domestic commercial paper, securities issued or guaranteed by the U.S. government or its agencies, U.S. bank obligations,
and fully collateralized repurchase agreements. Acacia&#8217;s cash equivalents are measured at fair value using quoted prices
that represent Level 1 inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Long Term Restricted Cash</a></td>
<td class="text"><p id="xdx_842_eus-gaap--CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_zdU7TBKEHj96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Long Term Restricted Cash </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-term restricted cash relates to the proceeds received from
the issuance of Series A Redeemable Convertible Preferred Stock which are held in an escrow account. The amounts are to be released
to the Company upon, among other things, (i) the consummation of a suitable investment or acquisition by the Company or (ii) the
conversion of Series A Redeemable Convertible Preferred Stock into common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_PrepaidInvestmentPoliciesTextBlock', window );">Prepaid Investment</a></td>
<td class="text"><p id="xdx_840_ecustom--PrepaidInvestmentPoliciesTextBlock_zyfejGKarNFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prepaid Investment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid investment relates to the cash transferred to an escrow
account in connection with a Transaction Agreement with LF Equity Income Fund (&#8220;Seller&#8221;), pursuant to which the Company
will purchase from Seller certain equity securities. Refer to Note 14 for additional information on the Transaction Agreement.
The amounts are to be released to Seller upon transfer of the specified equity securities at set prices at various future dates
following various terms and conditions per the Transaction Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EquitySecurityForwardContractPoliciesTextBlock', window );">Equity Securities Derivative and Forward Contract</a></td>
<td class="text"><p id="xdx_84A_ecustom--EquitySecurityForwardContractPoliciesTextBlock_zydGaHPrZCN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Equity Securities Derivative and Forward Contract</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The equity security forward contract includes both private and
public equity securities not yet transferred, as of September 30, 2020, under the Company&#8217;s Transaction Agreement with Seller.
Refer to Note 14 for additional information on the agreement. The public company equity security forward contracts are accounted
for as derivatives and are carried at fair market value with changes in fair market value recorded in the condensed consolidated
statements of operations in other income (expense). The private company equity security forward contracts do not meet the definition
of a derivative as the underlying equity securities are not readily convertible to cash. Therefore, as the forward contracts do
not have readily determinable fair value, these forward contracts are reported at cost minus impairment, if any, plus or minus
changes resulting from observable price changes in orderly transactions involving securities similar to those underlying the forward
contract. Changes in fair market value are reported in the condensed consolidated statements of operations in other income (expense).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy', window );">Trading Securities- Debt</a></td>
<td class="text"><p id="xdx_846_eus-gaap--AvailableForSaleSecuritiesPurchasedOptionsPricePolicy_zJcyTLcbHe0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Trading Securities- Debt</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in debt securities are reported at fair value on
a recurring basis, with related realized and unrealized gains and losses recorded in the condensed consolidated statements of operations
in other income (expense). Realized and unrealized gains and losses are recorded based on the specific identification method. Interest
is included in the condensed consolidated statements of operations in other income (expense). Accrued interest is included in the
trading securities balance on the condensed consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Trading Securities - Equity</a></td>
<td class="text"><p id="xdx_840_eus-gaap--EquityMethodInvestmentsPolicy_z2TY0Mrhx7Oc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Trading Securities - Equity</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in equity securities are reported at fair value
on a recurring basis, with related realized and unrealized gains and losses in the value of such securities recorded in the condensed
consolidated statements of operations in other income (expense). Dividend income is included in the condensed consolidated statements
of operations in other income (expense).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trading securities for the periods presented were comprised
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--AvailableForSaleSecuritiesTextBlock_pn3n3_ze1v2CdeE3J2" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B8_zw6BmweOEiOa" style="display: none">Gain (loss) on trading securities</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross<br/> Unrealized<br/> Gain</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross<br/> Unrealized<br/> Loss</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left">Security&#160;Type</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">September 30, 2020:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; font-size: 10pt; text-align: left">Trading securities - equity</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermInvestments_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesrEquityMember_zeFIAbmCs501" style="width: 9%; font-size: 10pt; text-align: right" title="Short-term Investments">23,851</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_z6poe2yi2Vwa" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">4,218</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_znOLVRShnDbe" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(3,598</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_zAoUfUHKvcld" style="width: 9%; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">24,471</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Trading securities - debt</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Short-term Investments">93,712</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">143</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_ziLjQ8vjsE3f" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(12</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">93,843</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Trading securities - equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Short-term Investments">17,674</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">211</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_ztgOqQxKZgx3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(745</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">17,140</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortTermInvestments_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Short-term Investments">111,386</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">354</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231_zI2YltaXl7q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(757</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">110,983</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8AF_zIxHhxktIfA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_846_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_ziVBDgH3Dorg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fair Value Measurements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S. GAAP defines fair value as the price that would be received
for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly
transaction between market participants on the measurement date, and also establishes a fair value hierarchy which requires an
entity to maximize the use of observable inputs, where available. The three-level hierarchy of valuation techniques established
to measure fair value is defined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(i) <b>Level 1 &#8211;
<i>Observable Inputs</i></b>: Quoted prices in active markets for identical investments;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(ii) <b>Level 2</b>
&#8211; <b><i>Pricing Models with Significant Observable Inputs</i></b>: Other significant observable inputs, including quoted
prices for similar investments, interest rates, credit risk, etc.; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">(iii) <b>Level 3 </b>&#8211;
<b><i>Unobservable Inputs</i></b>: Significant unobservable inputs, including the entity&#8217;s own assumptions in determining
the fair value of investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whenever possible, the Company is required
to use observable market inputs (Level 1 &#8211; quoted market prices) when measuring fair value. In such cases, the level at which
the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement.
The assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability
being measured. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. Financial
assets and liabilities measured at fair value on a recurring basis were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zy1ErhJzuWa9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B7_zwiVHwXkj41l" style="display: none">Schedule of fair value of financial assets and liabilities on a recurring basis</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal">Assets as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020:</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Trading securities - equity</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">24,471</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zdHQ3b5Ukm42" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zZyvFEAX6v67" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Equity securities derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativetMember_zCcuV3csw7Vb" style="font-size: 10pt; text-align: right" title="Assets">17,818</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_zFuktMcuGvBd" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_z1sLqYnzphdc" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - warrants (Note 5)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zXMUkDeMwDDe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">982</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zNL3fhQ4J0L4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Total recurring fair value measurements as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">42,289</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">982</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2gJaVBc0f14" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Assets as of December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Trading securities - debt</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zJWfNJyJfZ1h" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">93,843</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zGw6aHE3eMf9" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Trading securities - equity</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets">17,140</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zrjCAk54uysh" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zHHOgrXWj1kb" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Investment at fair value - warrants (Note 5)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z27SfLm2Rvvj" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets">757</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zZlq3yHytRWk" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - common stock (Note 5)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">743</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zH0sBseCWzr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zbcg9bq0MbWe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total recurring fair value measurements as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">17,883</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">94,600</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIZZjFqvhGPd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal">Liabilities as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020:</span></td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Series A warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6CELBHDVJSk" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">5,604</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z9P2RBRtgwxg" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zkRFn7cJUCnk" style="font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z8GfR69kkhB" style="font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Liabilities">42,796</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z0XfU5arLd1e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zBW0vcRi2x5f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">25,682</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Total liabilities as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zihAXRXdxwFb" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">5,604</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">68,478</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Liabilities as of December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Series A warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zI2UbZUHJRSc" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">3,568</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zIQGSEqHNMC5" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z2aoRdMWkFM" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zuVliFxeh6ke" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">17,974</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total liabilities as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxkw24lIyvD5" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">3,568</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">17,974</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A0_zQwtFdX4xap2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of the changes in the
estimated fair value of the Company&#8217;s Level 3 liabilities, which are measured at fair value as a on a recurring basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zeOiNDynHOg1" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span id="xdx_8B8_z9soetpk7fra" style="display: none">Summary of changes in financial liability Level 3</span></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Series A Preferred Stock Embedded Derivative Liability</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Series B Warrants Liability</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; font-size: 10pt">Opening balance as of December 31, 2019</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zqMdu5Eq6Xu1" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance">17,974</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zjxDzA0Rh557" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Issuance of Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_d0_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zNvn8DVtyFie" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants">4,600</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Remeasurement to fair value</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value">7,708</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value">38,196</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Balance as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrG5sEJsgE7c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance">25,682</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zof7bg0bcoQ1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance">42,796</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_8A9_zXcuuRk4sjVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>













<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_SeriesAWarrantsPolicyTextBlock', window );">Series A Warrants</a></td>
<td class="text"><p id="xdx_84B_ecustom--SeriesAWarrantsPolicyTextBlock_zw5IVOoN786l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Series A Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series A Warrants is estimated using a
Black-Scholes option-pricing model. The fair value of the Series A Warrants as of September 30, 2020 was estimated based on the
following assumptions: volatility of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives">32 percent</span>, risk-free rate of <span id="xdx_903_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives">0.47 percent</span>, term of <span id="xdx_90D_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives">7.04 years</span> and a dividend yield of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesModelMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesAWarrantsMember" title="Assumptions used for derivatives">0 percent</span>.
Refer to Notes 10 and 11 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_SeriesBWarrantsPolicyTextBlock', window );">Series B Warrants</a></td>
<td class="text"><p id="xdx_84A_ecustom--SeriesBWarrantsPolicyTextBlock_z6Jin3VhDXle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Series B Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series B
Warrants is estimated using Monte Carlo valuation technique. The fair value of the Series B Warrants as of September 30, 2020
was estimated based on event probabilities of future exercise scenarios and the following weighted-average assumptions: (1)
volatility of <span id="xdx_90A_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">32
percent</span>, risk-free rate of <span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">0.48
percent</span>, term of <span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">7.12
years</span>, a dividend yield of <span id="xdx_905_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">0
percent</span>, and a discount for lack of marketability of <span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice525Member" title="Assumptions used for derivatives">10
percent</span>, and (2) volatility of <span id="xdx_904_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">51
percent</span>, risk-free rate of <span id="xdx_908_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">0.13
percent</span>, term of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">1.9
years</span> and a dividend yield of <span id="xdx_90B_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">0
percent</span>, and a discount for lack of marketability of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloMethodMember__us-gaap--DerivativeInstrumentRiskAxis__custom--SeriesBWarrantsMember__us-gaap--AwardTypeAxis__custom--WarrantPrice365Member" title="Assumptions used for derivatives">10
percent</span>. Refer to Notes 10 and 12 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesEmbeddedDerivatives', window );">Embedded derivatives</a></td>
<td class="text"><p id="xdx_843_eus-gaap--DerivativesEmbeddedDerivatives_zA3CZMcKCzI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Embedded derivatives</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Embedded derivatives that are required to be bifurcated from
their host contract are valued separately from host instrument. A binomial lattice framework is used to estimate the fair value
of the embedded derivative in the Series A Redeemable Convertible Preferred Stock. The binomial model utilizes the Tsiveriotis
and Fernandes implementation in which a convertible instrument is split into two separate components: a cash-only component which
is subject to the selected risk-adjusted discount rate and an equity component which is subject only to the risk-free rate. The
model considers the (i) implied volatility of the value of our common stock, (ii) appropriate risk-free interest rate, (iii) credit
spread, (iv) dividend yield, (v) dividend accrual (and a step-up in rates), and (vi) event probabilities of the various conversion
and redemption scenarios.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The implied volatility of the Company&#8217;s common stock is
estimated based on a haircut applied to the historical volatility. A volatility haircut is a concept used to describe a commonly
observed occurrence in which the volatility implied by market prices involving options, warrants, and convertible debt is lower
than historical actual realized volatility. The assumed base case term used in the valuation model is the period remaining until
November 15, 2027, the maturity date. The risk-free interest rate is based on the yield on the U.S. Treasury with a remaining term
equal to the expected term of the conversion and early redemption options. The significant assumptions utilized in the Company&#8217;s
valuation of the embedded derivative at September 30, 2020 are as follows: volatility of <span id="xdx_90F_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives">32 percent</span>, risk-free rate of <span id="xdx_909_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives">0.47 percent</span>,
a credit spread of <span id="xdx_906_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputCreditSpreadMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives">21 percent</span> and a dividend yield of <span id="xdx_907_eus-gaap--DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue_c20200101__20200930__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EmbeddedDerivativeMember" title="Assumptions used for derivatives">0 percent</span>. The fair value measurement of the embedded derivative is sensitive
to these assumptions and changes in these assumptions could result in a materially different fair value measurement. Refer to Note
10 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p id="xdx_8A9_zXcuuRk4sxxx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 9pt Sans-Serif; color: Red">&#160;</span></p>











<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments at Fair Value</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--InvestmentPolicyTextBlock_zS8cxDceF2if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investments at Fair Value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On an individual investment basis, Acacia may elect to account
for investments in companies where the Company has the ability to exercise significant influence over operating and financial policies
of the investee, at fair value. If the fair value method is applied to an investment that would otherwise be accounted for under
the equity method of accounting, it is applied to all of the financial interests in the same entity that are eligible items (i.e.,
common stock and warrants). We elected the fair value method for our investment in Veritone upon acquisition of the investment.
As of September 30, 2020, our investment in Veritone warrants totaled $<span id="xdx_90A_eus-gaap--Investments_iI_pn3p0_c20200930__us-gaap--InvestmentsInAndAdvancesToAffiliatesCategorizationAxis__custom--VeritoneMember_zWWmSPR8uAD3" title="Investment in Veritone">982,000</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAndCostMethodInvestmentsPolicy', window );">Other Investments</a></td>
<td class="text"><p id="xdx_844_eus-gaap--EquityAndCostMethodInvestmentsPolicy_zzu8Ha3HJ5rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Other Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Equity investments in common stock and in-substance common stock
without readily determinable fair values in companies over which the Company has the ability to exercise significant influence,
are accounted for using the equity method of accounting. Acacia includes its proportionate share of earnings and/or losses of its
equity method investees in equity in earnings (losses) of investees in the condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments in preferred stock with substantive liquidation
preferences are accounted for at cost (subject to impairment considerations, as described below, if any), as adjusted for the impact
of changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer.
In-substance common stock is an investment in an entity that has risk and reward characteristics that are substantially similar
to that entity's common stock. An investment in preferred stock with substantive liquidation preferences over common stock, is
not substantially similar to common stock, and therefore is not considered in-substance common stock. A liquidation preference
is substantive if the investment has a stated liquidation preference that is significant, from a fair value perspective, in relation
to the purchase price of the investment. A liquidation preference in an investee that has sufficient subordinated equity from a
fair value perspective is substantive because, in the event of liquidation, the investor will not participate in substantially
all of the investee's losses, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial determination of whether an investment is substantially
similar to common stock is made on the initial date of investment if the Company has the ability to exercise significant influence
over the operating and financial policies of the investee. That determination is reconsidered if:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">contractual terms of the investment are changed,</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">there is a significant change in the capital structure of the investee, including the investee's receipt of additional subordinated financing, or</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Times New Roman, Times, Serif">(iii)</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the Company obtains an additional interest in an investment, resulting in the method of accounting for the cumulative interest being based on the characteristics of the investment at the date at which the Company obtains the additional interest.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Refer to Note 5 for additional information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_841_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z7IMkSefF09g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stock-Based Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation cost for all stock-based awards is measured
at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the employee&#8217;s
requisite service period (generally the vesting period of the equity award) which is generally two to four years. The fair value
of restricted stock and restricted stock unit awards is determined by the product of the number of shares or units granted and
the grant date market price of the underlying common stock. The fair value of each option award is estimated on the date of grant
using a Black-Scholes option-pricing model. Forfeitures are accounted for as they occur.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Restricted stock units granted in September 2019 with market-based
vesting conditions vest based upon the Company achieving specified stock price targets over a three-year period. The effect of
a market condition is reflected in the estimate of the grant-date fair value of the options utilizing a Monte Carlo valuation technique.
Compensation cost is recognized with a market-based vesting condition provided that the requisite service is rendered, regardless
of when, if ever, the market condition is satisfied. Assumptions utilized in connection with the Monte Carlo valuation technique
included: estimated risk-free interest rate of 1.38 percent; term of 3.00 years; expected volatility of 38 percent; and expected
dividend yield of 0 percent. The risk-free interest rate was determined based on the yields available on U.S. Treasury zero-coupon
issues. The expected stock price volatility was determined using historical volatility. The expected dividend yield was based on
expectations regarding dividend payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Profits Interest Units (&#8220;Units&#8221;) were accounted
for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 718-10, &#8220;Compensation - Stock Compensation.&#8221;
The vesting conditions did not meet the definition of service, market or performance conditions, as defined in ASC 718. As such,
the Units were classified as liability awards. Compensation expense was adjusted for changes in fair value prorated for the portion
of the requisite service period rendered. Initially, compensation expense was recognized on a straight-line basis over the employee&#8217;s
requisite service period (generally the vesting period of the equity award) which was five years. Upon full vesting of the award,
which occurred during the three months ended September 30, 2017, previously unrecognized compensation expense was immediately recognized
in the period. The Company has a purchase option to purchase the vested Units that are not otherwise forfeited after termination
of continuous service. The exercise price of the purchase option is the fair market value of the Units on the date of termination
of continuous service. As of September 30, 2020, the Units totaled $591,000, which was their fair value as of December 31, 2018
after termination of service.</p>





<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text"><p id="xdx_849_eus-gaap--StockholdersEquityPolicyTextBlock_ztHNv9JfSzSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Treasury Stock</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Repurchases of the Company&#8217;s outstanding common stock
are accounted for using the cost method. The applicable par value is deducted from the appropriate capital stock account on the
formal or constructive retirement of treasury stock. Any excess of the cost of treasury stock over its par value is charged to
additional paid-in capital, and reflected as treasury stock on the condensed consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostMethodInvestmentsPolicy', window );">Impairment of Investments</a></td>
<td class="text"><p id="xdx_844_eus-gaap--CostMethodInvestmentsPolicy_zbcnh16MCdQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Impairment of Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acacia reviews its investments quarterly for indicators of other-than-temporary
impairment. This determination requires significant judgment. In making this judgment, Acacia considers available quantitative
and qualitative evidence in evaluating potential impairment of its investments. If the cost of an investment exceeds its fair value,
Acacia evaluates, among other factors, general market conditions and the duration and extent to which the fair value is less than
cost. Acacia also considers specific adverse conditions related to the financial health of and business outlook for the investee,
including industry and sector performance, changes in technology, and operational and financing cash flow factors. Once a decline
in fair value is determined to be other-than-temporary, an impairment charge is recorded in the condensed consolidated statements
of operations and a new cost basis in the investment is established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i>&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zxSGe5tiGsse" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income taxes are accounted for using an asset and liability
approach that requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events
that have been recognized in Acacia&#8217;s condensed consolidated financial statements or consolidated income tax returns. A valuation
allowance is established to reduce deferred tax assets if all, or some portion, of such assets will more than likely not be realized,
or if it is determined that there is uncertainty regarding future realization of such assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The provision for income taxes for interim periods is determined
using an estimate of Acacia&#8217;s annual effective tax rate, adjusted for discrete items, if any, that are taken into account
in the relevant period. Each quarter, Acacia updates the estimate of the annual effective tax rate, and if the estimated tax rate
changes, a cumulative adjustment is recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s effective tax rates were <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200701__20200930_zsHjYk2Pbsx6" title="Effective tax rate">0</span>% and <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20200101__20200930_ziGt7tz8vM53" title="Effective tax rate">(4%)</span> for
the three and nine months ended September 30, 2020, respectively and <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190701__20190930_z5M0RaWlYfZ2" title="Effective tax rate">0</span>% and <span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_c20190101__20190930_ziYsdARV37Pd" title="Effective tax rate">(2%)</span> for the three and nine months ended September
30, 2019, respectively. Tax benefit (expense) for the periods presented primarily reflects the impact of state taxes and foreign
taxes withholding or refund incurred on revenue agreements executed with third-party licensees domiciled in foreign jurisdictions.
The Company has recorded full valuation allowance against our net deferred tax assets as of September 30, 2020 and 2019. These
assets primarily consist of foreign tax credits, capital loss carryforwards and net operating loss carryforwards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EquitySecurityForwardContractPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Security Forward Contract [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EquitySecurityForwardContractPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PortfolioOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portfolio Operations [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PortfolioOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_PrepaidInvestmentPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Investment [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_PrepaidInvestmentPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_SeriesAWarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Series A Warrants [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_SeriesAWarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_SeriesBWarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Series B Warrants [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_SeriesBWarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for premium paid to acquire option for investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6435544&amp;loc=d3e41834-113960<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the cost method of accounting for investments in common stock or other interests including unconsolidated subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. An entity also may describe how such investments are assessed for impairment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75025870&amp;loc=d3e40691-111596<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesEmbeddedDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=107671284&amp;loc=SL5844817-113951<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77984636&amp;loc=d3e40733-113955<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56949186&amp;loc=d3e50579-113967<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121596415&amp;loc=d3e48542-113965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesEmbeddedDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAndCostMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the equity method of accounting for investments in common stock or other interests including unconsolidated domestic subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. Additionally, this element describes the entity's application of the cost method to equity investments or other interests that are not consolidated or accounted for under the equity method of accounting. The disclosure provided may include how equity method or cost investments are assessed for impairment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAndCostMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21459-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112225934056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--DisaggregationOfRevenueTableTextBlock_pn3n3_zV3hnwRzqTli" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BA_zrRtoFE2jE6b" style="display: none">Disaggregation of revenue</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-size: 10pt; text-align: left">Paid-up Revenue Agreements</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">19,385</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">1,203</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">24,477</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--PaidUpRevenueAgreementsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Revenues">6,067</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Recurring Revenue Agreements</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">81</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">508</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">922</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930__srt--ProductOrServiceAxis__custom--RecurringRevenueAgreementsMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Revenues">4,491</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">19,466</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">1,711</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">25,399</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Revenues">10,558</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Gain (loss) on trading securities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--AvailableForSaleSecuritiesTextBlock_pn3n3_ze1v2CdeE3J2" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B8_zw6BmweOEiOa" style="display: none">Gain (loss) on trading securities</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross<br/> Unrealized<br/> Gain</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Gross<br/> Unrealized<br/> Loss</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; font-size: 10pt; font-weight: bold; text-align: left">Security&#160;Type</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">September 30, 2020:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; font-size: 10pt; text-align: left">Trading securities - equity</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--ShortTermInvestments_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesrEquityMember_zeFIAbmCs501" style="width: 9%; font-size: 10pt; text-align: right" title="Short-term Investments">23,851</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_z6poe2yi2Vwa" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">4,218</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_znOLVRShnDbe" style="width: 9%; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(3,598</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--InvestmentOwnedAtFairValue_iI_pn3n3_c20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_zAoUfUHKvcld" style="width: 9%; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">24,471</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Trading securities - debt</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Short-term Investments">93,712</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">143</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_ziLjQ8vjsE3f" style="font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(12</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesDebtMember_pn3n3" style="font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">93,843</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Trading securities - equity</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShortTermInvestments_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Short-term Investments">17,674</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">211</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_ztgOqQxKZgx3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(745</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--InvestmentOwnedAtFairValue_c20191231__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesEquityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">17,140</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShortTermInvestments_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Short-term Investments">111,386</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190101__20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Gain">354</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pn3n3_di_c20190101__20191231_zI2YltaXl7q6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Available-for-sale Securities, Gross Unrealized Loss">(757</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--InvestmentOwnedAtFairValue_c20191231_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Investment Owned, at Fair Value">110,983</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of fair value of financial assets and liabilities on a recurring basis</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_pn3n3_zy1ErhJzuWa9" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B7_zwiVHwXkj41l" style="display: none">Schedule of fair value of financial assets and liabilities on a recurring basis</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal">Assets as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020:</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Trading securities - equity</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">24,471</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zdHQ3b5Ukm42" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zZyvFEAX6v67" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Equity securities derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativetMember_zCcuV3csw7Vb" style="font-size: 10pt; text-align: right" title="Assets">17,818</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_zFuktMcuGvBd" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EquitySecuritiesDerivativeMember_z1sLqYnzphdc" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - warrants (Note 5)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zXMUkDeMwDDe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">982</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zNL3fhQ4J0L4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Total recurring fair value measurements as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">42,289</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">982</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z2gJaVBc0f14" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Assets as of December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Trading securities - debt</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zJWfNJyJfZ1h" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">93,843</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesDebtMember_zGw6aHE3eMf9" style="width: 11%; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Trading securities - equity</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets">17,140</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zrjCAk54uysh" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--TradingSecuritiesEquityMember_zHHOgrXWj1kb" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Investment at fair value - warrants (Note 5)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_z27SfLm2Rvvj" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Assets">757</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--WarrantInvestmentMember_zZlq3yHytRWk" style="font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Investment at fair value - common stock (Note 5)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">743</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zH0sBseCWzr6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--CommonStockInvestmentMember_zbcg9bq0MbWe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total recurring fair value measurements as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">17,883</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">94,600</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--AssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zIZZjFqvhGPd" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Assets">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal">Liabilities as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020:</span></td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Series A warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z6CELBHDVJSk" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">5,604</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z9P2RBRtgwxg" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zkRFn7cJUCnk" style="font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z8GfR69kkhB" style="font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_pn3n3" style="font-size: 10pt; text-align: right" title="Liabilities">42,796</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z0XfU5arLd1e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zBW0vcRi2x5f" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">25,682</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Total liabilities as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zihAXRXdxwFb" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">5,604</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">68,478</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt">Liabilities as of December 31, 2019:</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; font-size: 10pt; text-align: left">Series A warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zI2UbZUHJRSc" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_pn3n3" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">3,568</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zIQGSEqHNMC5" style="width: 11%; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Embedded derivative liability</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_z2aoRdMWkFM" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_zuVliFxeh6ke" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--EmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Liabilities">17,974</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">Total liabilities as of December 31, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxkw24lIyvD5" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">3,568</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--LiabilitiesFairValueDisclosure_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Liabilities">17,974</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Summary of changes in financial liability Level 3</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zeOiNDynHOg1" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"><span id="xdx_8B8_z9soetpk7fra" style="display: none">Summary of changes in financial liability Level 3</span></td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Series A Preferred Stock Embedded Derivative Liability</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Series B Warrants Liability</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">(In thousands)</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; font-size: 10pt">Opening balance as of December 31, 2019</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zqMdu5Eq6Xu1" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance">17,974</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_d0_c20191231__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zjxDzA0Rh557" style="width: 13%; font-size: 10pt; text-align: right" title="Fair value ending balance">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">Issuance of Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_d0_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zNvn8DVtyFie" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="font-size: 10pt; text-align: right" title="Issuance of Series B warrants">4,600</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Remeasurement to fair value</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value">7,708</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20200101__20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Remeasurement to fair value">38,196</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; font-weight: 400; font-style: normal; padding-bottom: 2.5pt">Balance as of <span style="font: normal 400 10pt Times New Roman, Times, Serif">September 30, 2020</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesAEmbeddedDerivativeLiabilityMember_zrG5sEJsgE7c" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance">25,682</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20200930__us-gaap--BalanceSheetLocationAxis__us-gaap--LiabilityMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsLiabilityMember_zof7bg0bcoQ1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Fair value ending balance">42,796</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227751736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. INCOME (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Calculation of basic and diluted net loss per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_zrMs58AlTb4h" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 3. INCOME (LOSS) PER SHARE (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8B8_zyt1E8bRR0wa" style="display: none">Calculation of basic and diluted net loss per share</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_491_20200701__20200930_z29qq7agZcq5" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49F_20190701__20190930_zIKWN8QuKJr9" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49D_20200101__20200930_zExwxzrYQcwl" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_498_20190101__20190930_zRSH2DotCJha" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><b>Three Months Ended</b></td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="6" style="text-align: center; font-size: 10pt"><b>Nine Months Ended</b></td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="text-align: center; font-size: 10pt">(In thousands, except share and per share information)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Numerator:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--NetIncomeLoss_i01_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Net income (loss) attributable to Acacia Research Corporation</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">38,348</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">(7,608</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">33,205</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 9%; font-size: 10pt; text-align: right">(17,749</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--PreferredStockDividendsIncomeStatementImpact_i01N_pn3n3_di0_zxqOwbKWKiAd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Dividend on Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(467</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,118</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PreferredStockAccretionOfRedemptionDiscount_i01N_pn3n3_di0_zU9h3DvHXiAi" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Accretion of Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(733</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(2,045</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic_i01_pn3n3_d0_zv0jupxlZjH2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Undistributed earnings allocated to participating securities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(6,619</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(5,204</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Net income (loss) attributable to common stockholders - basic</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">30,529</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(7,608</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">24,838</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(17,749</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--DividendsPreferredStock_pn3n3_d0_zM3VNy1tOFwh" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Dividend on Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">467</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--AccretionOfSeriesRedeemableConvertiblePreferredStock_pn3n3_d0_z9tIs3mLY24b" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Accretion of Series A redeemable convertible preferred stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">733</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives_pn3n3_d0_zjULQdByivRe" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(3,831</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--ChangeInFairValueOfSeriesWarrants_pn3n3_d0_zsQ37QG9a9ni" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of Series A warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,348</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(1,348</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--ChangeInFairValueOfDilutiveSeriesBWarrants_pn3n3_d0_zsGmaSXRZ4Hi" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Less: Change in fair value of dilutive Series B warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(5,557</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">(5,557</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--InterestExpenseOther_pn3n3_d0_zkHw9SievXb3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Interest expense associated with Starboard Notes, net of tax</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,889</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,889</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_pn3n3_d0_zZC20vagXWoj" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Add: Undistributed earnings allocated to participating securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">6,619</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">5,204</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_pn3n3_d0_z3W83rx7FVjb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Reallocation of undistributed earnings to participating securities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(296</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(3,645</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_pn3n3_zP5FDOoxTZQ6" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net income (loss) attributable to common stockholders - diluted</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">29,204</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(7,608</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">21,380</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(17,749</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_ecustom--EarningsPerShareBasicAndDilutedDeniminatorAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Denominator:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pip0_zK4sOlONYiu1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - basic</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">48,467,885</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">49,828,361</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">48,949,706</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">49,727,385</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Potentially dilutive common shares:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A Preferred Stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zVtgD3VH6oVl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">9,589,041</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zvKUOueVrvJe" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zMDPj1aStmSi" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__us-gaap--SeriesAPreferredStockMember_zUhrrxgIp7Qk" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Restricted stock units</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zwGsQ2YBMcy" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">728,936</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zpLQyOdbF9k" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_zz7SeVr6OoEe" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">598,328</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--RestrictedStockUnitsMember_z9ofT9abmOLd" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Employee stock options</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_z6VL88jIbVa3" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">21,624</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zb6RDqbZ5ki5" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zpJswYj5bsQ9" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--EmployeeStockOptionsMember_zAOXioeMlmXl" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A Warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z1lhACTATp3i" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">310,367</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zxn4k1MYdK7c" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_zjcGTuf1R6p9" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">103,456</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesAWarrantsMember_z0nMwksJ1qg7" style="font-size: 10pt; text-align: right" title="Potentially dilutive common shares:">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Series B Warrants</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200701__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zqmIiEXuNrD9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares">31,506,849</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190701__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z4zQrePeS6nh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_c20200101__20200930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_zjcXXqjEYMw8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares">10,502,283</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_i01_pip0_d0_c20190101__20190930__us-gaap--FinancialInstrumentAxis__custom--SeriesBWarrantsMember_z7dWJW1fxZl9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Potentially dilutive common shares">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pip0_zEYLLRBoi9Fl" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - diluted</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">90,624,702</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">49,828,361</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">60,153,773</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">49,727,385</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; padding-bottom: 1pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--EarningsPerShareBasic_pip0_zrQ6VsuNV5jh" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Basic net income (loss) per common share</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.63</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.15</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">0.51</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(0.36</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--EarningsPerShareDiluted_pip0_zcs77cO8o7Cf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Diluted net income (loss) per common share</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.32</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.15</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">0.36</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">(0.36</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold; text-align: left">Anti-dilutive potential common shares excluded from the computation of diluted net income (loss) per common share:</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Equity-based incentive awards</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">191,312</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">442,864</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">310,083</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--EquityBasedIncentiveAwardsMember_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">442,864</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left">Series A warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zciNzaCD66le" style="font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zEoez9xVbfQ2" style="font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zIJ6U2DopC07" style="font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAWarrantsMember_zQAW7w0xfhXg" style="font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Series B warrants</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares">68,493,151</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190701__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zvW7NH40Z111" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares">68,493,151</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_d0_c20190101__20190930__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesBWarrantsMember_zhJkZV7HMvK5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Antidilutive shares">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; font-weight: bold">Total</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200701__20200930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">68,684,463</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190701__20190930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">442,864</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20200930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">68,803,234</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20190101__20190930_pii" style="font-size: 10pt; text-align: right" title="Antidilutive shares">442,864</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227808936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>4. PATENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_pn3n3_zY2ENlAczsA8" style="border-collapse: collapse; width: 50%" summary="xdx: Disclosure - 4. PATENTS (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8B4_zdkcEXwBHCEk" style="display: none">Schedule of intangible assets</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_497_20200930_zRGrGBAmH1W" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt">For&#160;the&#160;years&#160;ending&#160;December&#160;31,</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_pn3n3_maFLIANzJ1C_zT4eK4C8Tby6" style="vertical-align: bottom; background-color: White">
    <td style="width: 33%; font-size: 10pt">Remainder of 2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">1,158</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pn3n3_maFLIANzJ1C_z9Tr7DvbAvMa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,451</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pn3n3_maFLIANzJ1C_zLTnG0LYCXEj" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2022</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,451</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pn3n3_maFLIANzJ1C_zvawWHBTYQEe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,376</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pn3n3_maFLIANzJ1C_zJpG7y6MLKtc" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2024</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,005</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pn3n3_maFLIANzJ1C_ztzRKw6jUsZc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; padding-bottom: 1pt">Thereafter</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">630</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pn3n3_mtFLIANzJ1C_zYiMF6lKPArk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;&#160;<span style="color: White">Patents, net</span></td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">18,071</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227211464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsAbstract', window );"><strong>Schedule of Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of gain (loss) on investments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--GainLossOnInvestmentsTextBlock_pn3n3_z9s2dcLYaMj7" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 5. INVESTMENTS (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8BC_ziaOgnpgcot8" style="display: none">Schedule of gain (loss) on investments</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Change in fair value of investment, warrants</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">(3,081</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">(3,216</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">225</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">(822</td><td style="width: 1%; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of investment, common stock</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zCysRFZGlMU6" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">(1,050</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">3,479</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_pn3n3" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">10,444</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Gain on sale of investment, warrants</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zsnPClIS32pl" style="font-size: 10pt; text-align: right" title="Gain on sale of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zxZNaTd6GJef" style="font-size: 10pt; text-align: right" title="Gain on sale of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zSNNy7Zj2KN7" style="font-size: 10pt; text-align: right" title="Gain on sale of investment">554</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--GainOnSaleOfInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--WarrantInvestmentMember_zlfZtKRYwmif" style="font-size: 10pt; text-align: right" title="Gain on sale of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Loss on sale of investment, common stock</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di0_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zu5zqdgT9jn" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_z6MTWm9O8X8d" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment">(915</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zifsbseloMIl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment">(3,316</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--LossOnSaleOfInvestments_iN_pn3n3_di_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--CommonStockInvestmentMember_zEhIlcKgmQfe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Loss on sale of investment">(8,147</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net realized and unrealized gain (loss) on investment at fair value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--GainLossOnInvestments_c20200701__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">(3,081</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20190701__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">(5,181</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--GainLossOnInvestments_c20200101__20200930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">942</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20190101__20190930_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">1,475</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227808936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of future minimum operating lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_pn3n3_zQy0J47soJT" style="border-collapse: collapse; width: 50%" summary="xdx: Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span id="xdx_8BD_zRqTouLlfun1" style="display: none">Schedule of future minimum operating lease payments</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49A_20200930_zqEvJuZNmSKa" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center">Operating Leases</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="2" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_iI_pn3n3_maOLFMPzu8U_zZMc47WWRwp7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 33%; font-size: 10pt; text-align: left">2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 13%; font-size: 10pt; text-align: right">144</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pn3n3_maOLFMPzu8U_zBvGSiCMroX8" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2021</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">589</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pn3n3_maOLFMPzu8U_z2wVp7aiANAk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left">2022</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">370</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pn3n3_maOLFMPzu8U_zENbv2ehdnWf" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">2023</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">364</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pn3n3_maOLFMPzu8U_zeMWQ9Lb0UP8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">2024</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">218</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iTI_pn3n3_mtOLFMPzu8U_zkpxRETVod22" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Total minimum payments</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">1,685</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pn3n3_di_zta1dyCKj2ih" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt">Less: short-term lease liabilities</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">(584</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Long-term lease liabilities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">1,101</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227870568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. STOCKHOLDERS&#8217; EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesTextBlock', window );">Schedule of repurchased shares</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--AcceleratedShareRepurchasesTextBlock_pn3n3_zyKsHg8pwXHb" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 7. STOCKHOLDERS' EQUITY (Details)">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: justify"><span id="xdx_8B9_z9FXUkUNJmBh" style="display: none">Schedule of repurchased shares</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total Number<br/> of Shares<br/> Purchased</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Average<br/> Price<br/> paid per<br/> Share</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Approximate Dollar<br/> Value of Shares that<br/> May Yet be Purchased<br/> under the Program</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Plan Expiration Date</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 32%; font-size: 10pt; text-align: center">March 20, 2020 - March 31, 2020</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockSharesAcquired_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="width: 15%; font-size: 10pt; text-align: right" title="Number of shares repurchased">576,898</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="width: 15%; font-size: 10pt; text-align: center" title="Average price paid per share">$2.28</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_989_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="width: 15%; font-size: 10pt; text-align: center" title="Approximate value of shares that may yet be purchased">$8,686,000</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td id="xdx_980_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200320__20200331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3XFtIb7dl8i" style="width: 15%; font-size: 10pt; text-align: center" title="Plan expiration date">July 31, 2020</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt">April 1, 2020 - April 23, 2020</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Number of shares repurchased">1,107,639</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="padding-bottom: 1pt; font-size: 10pt; text-align: center" title="Average price paid per share">$2.42</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98B_ecustom--ApproximateValueOfSharesThatMayYetBePurchased_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="padding-bottom: 1pt; font-size: 10pt; text-align: center" title="Approximate value of shares that may yet be purchased">$6,001,000</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td id="xdx_987_eus-gaap--StockRepurchaseProgramExpirationDate_dd_c20200401__20200423__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkVK26nS2Xrf" style="font-size: 10pt; text-align: center; padding-bottom: 1pt" title="Plan expiration date">July 31, 2020</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-size: 10pt; text-align: center; padding-bottom: 2.5pt">Totals for 2020</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td id="xdx_985_eus-gaap--TreasuryStockSharesAcquired_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Number of shares repurchased">1,684,537</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td id="xdx_987_eus-gaap--TreasuryStockAcquiredAverageCostPerShare_c20200101__20200930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pii" style="padding-bottom: 2.5pt; font-size: 10pt; text-align: center" title="Average price paid per share">$2.37</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112224829608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Changes in fair value of Acacias Investment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--UnrealizedGainLossOnInvestmentsTableTextBlock_pn3n3_zepeP87rkN5k" style="border-collapse: collapse; width: 100%" summary="xdx: Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"><span id="xdx_8BB_z58Oa7OcEZ0h" style="display: none">Changes in fair value of Acacias Investment</span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_49E_20200701__20200930_zW5j2zNiwn7h" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_494_20190701__20190930_zpiKyYHn3643" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_492_20200101__20200930_zva1bbiqQYVb" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_490_20190101__20190930_zDiQvy1w7Zfj" style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Three Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center">Nine Months Ended</td><td style="font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">September 30,</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="14" style="font-size: 10pt; text-align: center">(In thousands)</td><td style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; width: 48%; font-size: 10pt; text-align: left">Change in fair value of trading securities - LF Fund public securities</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">3,403</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zUZgIMo2uB87" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--UnrealizedGainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_pn3n3" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">2,334</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundPublicSecuritiesMember_zm7I5B0PCRD7" style="width: 9%; font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities derivative</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zwBJ36vuQ0M2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">10,651</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zrDGADWnIJeh" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_zsFUZu7k857e" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">17,542</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesDerivativeMember_z1133gWw9bO6" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities - LF Fund private securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zVSFO2lNfWf2" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">80,896</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z7ysG3TB4F44" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_z3sk4jBRpnHk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">80,896</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesLFFundPrivateSecuritiesMember_zo8j4ONbD2Zg" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Change in fair value of equity securities forward contract</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zmmP3IofhU67" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">(74,662</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zVoFbxdBxw2l" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_zruyd7HkfZBi" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--UnrealizedGainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--EquitySecuritiesForwardContractMember_ziG4zeheCtwk" style="font-size: 10pt; text-align: right" title="Change in fair value of investment">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left">Gain (loss) on sale of trading securities - LF Fund public securities</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zoJ5KTT9TL6a" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities">1,908</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zcfv5FvxsDv" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zDZyrmDggnc6" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities">(4,202</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GainLossOnSaleOfEquityInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritiesLFFundPublicSecuritiesMember_zCcWCXm6WxE3" style="font-size: 10pt; text-align: right" title="Gain (loss) on sale of trading securities">&#8211;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--GainLossOnSaleOfDerivatives_pn3n3_d0_zReEvh8i047l" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left; padding-bottom: 1pt">Gain on sale of prepaid investment and derivative</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,845</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,845</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Net realized and unrealized gain on investment in LF Fund securities</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--GainLossOnInvestments_c20200701__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">25,041</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190701__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zQD40jp4UGU2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--GainLossOnInvestments_c20200101__20200930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_pn3n3" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">99,415</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td id="xdx_984_eus-gaap--GainLossOnInvestments_pn3n3_d0_c20190101__20190930__us-gaap--InvestmentTypeAxis__custom--TradingSecuritesLfFundSecuritiesMember_zJzaJkH3xEY2" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Net realized and unrealized gain (loss) on investment">&#8211;</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227289976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - Integer<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NumberOfPatentPortfoliosAcquired', window );">Number of new patent portfolios acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NumberOfPatentPortfoliosAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of patent portfolios acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NumberOfPatentPortfoliosAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112236606776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 19,466<span></span>
</td>
<td class="nump">$ 1,711<span></span>
</td>
<td class="nump">$ 25,399<span></span>
</td>
<td class="nump">$ 10,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember', window );">Paid Up Revenue Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">19,385<span></span>
</td>
<td class="nump">1,203<span></span>
</td>
<td class="nump">24,477<span></span>
</td>
<td class="nump">6,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember', window );">Recurring Revenue Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">$ 922<span></span>
</td>
<td class="nump">$ 4,491<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ACTG_PaidUpRevenueAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ACTG_RecurringRevenueAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229040296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains', window );">Available-for-sale Securities, Gross Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Available-for-sale Securities, Gross Unrealized Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(757)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Owned, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,983<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesrEquityMember', window );">Trading Securitesr Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term Investments</a></td>
<td class="nump">$ 23,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesEquityMember', window );">Trading Securites Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains', window );">Available-for-sale Securities, Gross Unrealized Gain</a></td>
<td class="nump">4,218<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Available-for-sale Securities, Gross Unrealized Loss</a></td>
<td class="num">(3,598)<span></span>
</td>
<td class="num">(745)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Owned, at Fair Value</a></td>
<td class="nump">$ 24,471<span></span>
</td>
<td class="nump">17,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesDebtMember', window );">Trading Securites Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains', window );">Available-for-sale Securities, Gross Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Available-for-sale Securities, Gross Unrealized Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment Owned, at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesrEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesrEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112228189192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">$ 42,289<span></span>
</td>
<td class="nump">$ 17,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Trading Securities Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">24,471<span></span>
</td>
<td class="nump">17,140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Equity Securities Derivativet [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">17,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Trading Securities Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 1 [Member] | Common Stock Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">982<span></span>
</td>
<td class="nump">94,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Trading Securities Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Equity Securities Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">982<span></span>
</td>
<td class="nump">757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Trading Securities Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Common Stock Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Trading Securities Equity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Equity Securities Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Trading Securities Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Fair Value, Inputs, Level 3 [Member] | Common Stock Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 1 [Member] | Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">5,604<span></span>
</td>
<td class="nump">3,568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">5,604<span></span>
</td>
<td class="nump">3,568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 2 [Member] | Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">68,478<span></span>
</td>
<td class="nump">17,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">42,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Liability [Member] | Fair Value, Inputs, Level 3 [Member] | Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">$ 25,682<span></span>
</td>
<td class="nump">$ 17,974<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_TradingSecuritiesEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_TradingSecuritiesEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesDerivativetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesDerivativetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_TradingSecuritiesDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_TradingSecuritiesDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_CommonStockInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_CommonStockInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesDerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EquitySecuritiesDerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EmbeddedDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EmbeddedDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112228508216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details) - Liability [Member] - Fair Value, Inputs, Level 3 [Member] - Fair Value, Recurring [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Series A Embedded Derivative Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value ending balance</a></td>
<td class="nump">$ 17,974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Issuance of Series B warrants</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Remeasurement to fair value</a></td>
<td class="nump">7,708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value ending balance</a></td>
<td class="nump">25,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember', window );">Series B Warrants Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems', window );"><strong>Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value ending balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Issuance of Series B warrants</a></td>
<td class="nump">4,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Remeasurement to fair value</a></td>
<td class="nump">38,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value ending balance</a></td>
<td class="nump">$ 42,796<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAEmbeddedDerivativeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAEmbeddedDerivativeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112231384008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=ACTG_VeritoneMember', window );">Veritone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investment in Veritone</a></td>
<td class="nump">$ 982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Embedded Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">32 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Black Scholes Model [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">32 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">32
percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">51
percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Embedded Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0.47 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Black Scholes Model [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0.47 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0.48
percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0.13
percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Black Scholes Model [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7.04 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7.12
years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1.9
years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Embedded Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Black Scholes Model [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0
percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0
percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 525 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10
percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Monte Carlo Method [Member] | Series B Warrants [Member] | Warrant Price 365 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10
percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember', window );">Measurement Input, Credit Spread [Member] | Embedded Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue', window );">Assumptions used for derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">21 percent<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | One Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | One Licensee 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | One Licensee 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | One Licensee 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Foreign Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | One Licensee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | One Licensee 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | One Licensee 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | One Licensee 4 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes how an entity determines the fair values of its derivatives, including its valuation methodology and significant assumptions used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=ACTG_VeritoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis=ACTG_VeritoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ACTG_EmbeddedDerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ACTG_EmbeddedDerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=ACTG_BlackScholesModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=ACTG_BlackScholesModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=ACTG_MonteCarloMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=ACTG_MonteCarloMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ACTG_WarrantPrice525Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ACTG_WarrantPrice525Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ACTG_WarrantPrice365Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ACTG_WarrantPrice365Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCreditSpreadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicenseeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicenseeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ACTG_OneLicensee4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=ACTG_ForeignLicenseeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=ACTG_ForeignLicenseeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112239287176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>3. INCOME (LOSS) PER SHARE (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Acacia Research Corporation</a></td>
<td class="nump">$ 38,348<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="nump">$ 33,205<span></span>
</td>
<td class="num">$ (17,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Dividend on Series A redeemable convertible preferred stock</a></td>
<td class="num">(467)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,118)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount', window );">Accretion of Series A redeemable convertible preferred stock</a></td>
<td class="num">(733)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,045)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic', window );">Undistributed earnings allocated to participating securities</a></td>
<td class="num">(6,619)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,204)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to common stockholders - basic</a></td>
<td class="nump">30,529<span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
<td class="nump">24,838<span></span>
</td>
<td class="num">(17,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Add: Dividend on Series A redeemable convertible preferred stock</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock', window );">Add: Accretion of Series A redeemable convertible preferred stock</a></td>
<td class="nump">733<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives', window );">Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative</a></td>
<td class="num">(3,831)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfSeriesWarrants', window );">Less: Change in fair value of Series A warrants</a></td>
<td class="num">(1,348)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,348)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants', window );">Less: Change in fair value of dilutive Series B warrants</a></td>
<td class="num">(5,557)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,557)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Add: Interest expense associated with Starboard Notes, net of tax</a></td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,889<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Add: Undistributed earnings allocated to participating securities</a></td>
<td class="nump">6,619<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,204<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Reallocation of undistributed earnings to participating securities</a></td>
<td class="num">(296)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,645)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income (loss) attributable to common stockholders - diluted</a></td>
<td class="nump">$ 29,204<span></span>
</td>
<td class="num">$ (7,608)<span></span>
</td>
<td class="nump">$ 21,380<span></span>
</td>
<td class="num">$ (17,749)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - basic</a></td>
<td class="nump">48,467,885<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">48,949,706<span></span>
</td>
<td class="nump">49,727,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - diluted</a></td>
<td class="nump">90,624,702<span></span>
</td>
<td class="nump">49,828,361<span></span>
</td>
<td class="nump">60,153,773<span></span>
</td>
<td class="nump">49,727,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per common share</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="nump">$ 0.51<span></span>
</td>
<td class="num">$ (0.36)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per common share</a></td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="num">$ (0.36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">68,684,463<span></span>
</td>
<td class="nump">442,864<span></span>
</td>
<td class="nump">68,803,234<span></span>
</td>
<td class="nump">442,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_EquityBasedIncentiveAwardsMember', window );">Equity Based Incentive Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">191,312<span></span>
</td>
<td class="nump">442,864<span></span>
</td>
<td class="nump">310,083<span></span>
</td>
<td class="nump">442,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesAWarrantsMember', window );">Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesBWarrantsMember', window );">Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">68,493,151<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">68,493,151<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">9,589,041<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">728,936<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">598,328<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_EmployeeStockOptionsMember', window );">Employee Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">21,624<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember', window );">Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">310,367<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">103,456<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember', window );">Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive common shares</a></td>
<td class="nump">31,506,849<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,502,283<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of Series A redeemable convertible preferred stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of dilutive Series B warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of Series A redeemable convertible preferred stock embedded derivative</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ChangeInFairValueOfSeriesWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of Series A warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ChangeInFairValueOfSeriesWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockAccretionOfRedemptionDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accretion of the preferred stock redemption discount during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockAccretionOfRedemptionDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) from continuing operations allocated to participating securities for basic earnings (loss) per share or per unit calculation under two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_EquityBasedIncentiveAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_EquityBasedIncentiveAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_EmployeeStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_EmployeeStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229803368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>4. PATENTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2020</a></td>
<td class="nump">$ 1,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">4,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">4,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">4,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">3,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">&#160;&#160;Patents, net</a></td>
<td class="nump">$ 18,071<span></span>
</td>
<td class="nump">$ 7,814<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112227340696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>4. PATENTS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">$ 326,296<span></span>
</td>
<td class="nump">$ 322,774<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112233031000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. INVESTMENTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="num">$ (3,081)<span></span>
</td>
<td class="num">$ (4,266)<span></span>
</td>
<td class="nump">$ 3,704<span></span>
</td>
<td class="nump">$ 9,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,762)<span></span>
</td>
<td class="num">(8,147)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net realized and unrealized gain (loss) on investment</a></td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(5,181)<span></span>
</td>
<td class="nump">942<span></span>
</td>
<td class="nump">1,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember', window );">Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(3,216)<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="num">(822)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on sale of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember', window );">Common Stock Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
<td class="nump">3,479<span></span>
</td>
<td class="nump">10,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on sale of investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (915)<span></span>
</td>
<td class="num">$ (3,316)<span></span>
</td>
<td class="num">$ (8,147)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_WarrantInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_CommonStockInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232916936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>5. INVESTMENTS (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepurchaseAgreementCounterpartyLineItems', window );"><strong>Repurchase Agreement Counterparty [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss from sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,762<span></span>
</td>
<td class="nump">$ 8,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants exercised</a></td>
<td class="nump">154,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Realized gain</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (915)<span></span>
</td>
<td class="num">$ (2,762)<span></span>
</td>
<td class="num">$ (8,147)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_VeritoneMember', window );">Veritone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepurchaseAgreementCounterpartyLineItems', window );"><strong>Repurchase Agreement Counterparty [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_InvestmentSharesSold', window );">Investment shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,121,071<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss from sale of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="nump">$ 19,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ACTG_VeritoneMember', window );">Veritone [Member] | Warrant Investment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepurchaseAgreementCounterpartyLineItems', window );"><strong>Repurchase Agreement Counterparty [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_NumberOfWarrants', window );">Number of warrants</a></td>
<td class="nump">1,120,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants price</a></td>
<td class="nump">$ 13.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of stock sold</a></td>
<td class="nump">154,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="nump">$ 17.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Realized gain</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_InvestmentWarrants', window );">Investment warrants</a></td>
<td class="nump">966,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Fair value of investment</a></td>
<td class="nump">$ 982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_InvestmentSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment shares sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_InvestmentSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_InvestmentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_InvestmentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_NumberOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_NumberOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42546-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepurchaseAgreementCounterpartyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepurchaseAgreementCounterpartyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_VeritoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_VeritoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ACTG_WarrantInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229515736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>6. COMMITMENTS AND CONTINGENCIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">2020</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2021</a></td>
<td class="nump">589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2022</a></td>
<td class="nump">370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2023</a></td>
<td class="nump">364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2024</a></td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total minimum payments</a></td>
<td class="nump">1,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: short-term lease liabilities</a></td>
<td class="num">(584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">$ 1,101<span></span>
</td>
<td class="nump">$ 1,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232602456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>6. COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Operating lease costs, net of sublease income</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 459<span></span>
</td>
<td class="nump">$ 301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesIncomeStatementContingentRevenue', window );">Income from settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Contingency accruals</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesIncomeStatementContingentRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent rental revenue recognized for the period under lease, based on the occurrences of an event or condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121578510&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesIncomeStatementContingentRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229647400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>7. STOCKHOLDERS' EQUITY (Details) - Common Stock [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Apr. 23, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares repurchased</a></td>
<td class="nump">576,898<span></span>
</td>
<td class="nump">1,107,639<span></span>
</td>
<td class="nump">1,684,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price paid per share</a></td>
<td class="nump">$ 2.28<span></span>
</td>
<td class="nump">$ 2.42<span></span>
</td>
<td class="nump">$ 2.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ApproximateValueOfSharesThatMayYetBePurchased', window );">Approximate value of shares that may yet be purchased</a></td>
<td class="nump">$ 8,686,000<span></span>
</td>
<td class="nump">$ 6,001,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramExpirationDate', window );">Plan expiration date</a></td>
<td class="text">Jul. 31,  2020<span></span>
</td>
<td class="text">Jul. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ApproximateValueOfSharesThatMayYetBePurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Approximate value of shares that may yet be purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ApproximateValueOfSharesThatMayYetBePurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112229694712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>7. STOCKHOLDERS&#8217; EQUITY (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Aug. 05, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember', window );">Stock Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Value of shares authorized for repurchase</a></td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=ACTG_StockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232407048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 18, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionLineItems', window );"><strong>Securities Financing Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair value of Series A embedded derivative</a></td>
<td class="nump">$ 25,682<span></span>
</td>
<td class="nump">$ 25,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Starboard Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionLineItems', window );"><strong>Securities Financing Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Starboard Value [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionLineItems', window );"><strong>Securities Financing Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsIssued', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember', window );">Series A Redeemable Convertible Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionLineItems', window );"><strong>Securities Financing Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Accrued and unpaid dividends</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair value of Series A embedded derivative</a></td>
<td class="nump">$ 25,700<span></span>
</td>
<td class="nump">$ 25,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6394232&amp;loc=d3e17558-110866<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_StarboardValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232440312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>11. SERIES A WARRANTS (Details Narrative) - Securities Purchase Agreement [Member] - Starboard Value [Member] - Series A Warrants [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">11 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 18, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionLineItems', window );"><strong>Securities Financing Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsIssuedShares', window );">Warrants issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsExercised', window );">Warrants exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants</a></td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_StarboardValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_StarboardValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=ACTG_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112232814888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>12. SERIES B WARRANTS (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 25, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember', window );">Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationEquityLineItems', window );"><strong>Schedule of Capitalization, Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsIssuedShares', window );">Warrants issued, shares</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="nump">$ 5.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrant expiration date</a></td>
<td class="text">Nov. 15,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_WarrantsExercisedShares', window );">Warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsExercisedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsExercisedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_WarrantsIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued, shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_WarrantsIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112233637640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>13. SENIOR SECURED NOTES (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 04, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496<span></span>
</td>
<td class="nump">$ (0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember', window );">Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Unamortized Discount</a></td>
<td class="nump">$ 532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember', window );">Series A Redeemable Convertible Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Accrued and unpaid dividends</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotesMember', window );">Senior Secured Notes [Member] | Merton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Series A redeemable convertible preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Discount</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotesMember', window );">Senior Secured Notes [Member] | Merton [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_OriginalIssueDiscount', window );">Original Issue Discount</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Remaining discount</a></td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotesMember', window );">Senior Secured Notes [Member] | Merton [Member] | Series A Redeemable Convertible Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Accrued and unpaid dividends</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=ACTG_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Senior Secured Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=ACTG_ExchangeAgreementMember', window );">Exchange Agreement [Member] | Senior Secured Notes [Member] | Merton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payment of lenders fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of other issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=ACTG_ExchangeAgreementMember', window );">Exchange Agreement [Member] | Senior Secured Notes 1 [Member] | Merton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_OriginalIssueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_OriginalIssueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ACTG_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=ACTG_SeriesARedeemableConvertibleStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_MertonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_MertonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=ACTG_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=ACTG_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=ACTG_ExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=ACTG_ExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotes1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=ACTG_SeniorSecuredNotes1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112228055000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="num">$ (3,081)<span></span>
</td>
<td class="num">$ (4,266)<span></span>
</td>
<td class="nump">$ 3,704<span></span>
</td>
<td class="nump">$ 9,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfDerivatives', window );">Gain on sale of prepaid investment and derivative</a></td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,845<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net realized and unrealized gain (loss) on investment</a></td>
<td class="num">(3,081)<span></span>
</td>
<td class="num">(5,181)<span></span>
</td>
<td class="nump">942<span></span>
</td>
<td class="nump">1,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesLfFundPublicSecuritiesMember', window );">Trading Securites Lf Fund Public Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">3,403<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,334<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesDerivativeMember', window );">Equity Securities Derivative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">10,651<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,542<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember', window );">Equity Securities L F Fund Private Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="nump">80,896<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">80,896<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesForwardContractMember', window );">Equity Securities Forward Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Change in fair value of investment</a></td>
<td class="num">(74,662)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritiesLFFundPublicSecuritiesMember', window );">Trading Securities L F Fund Public Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfEquityInvestments', window );">Gain (loss) on sale of trading securities</a></td>
<td class="nump">1,908<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,202)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesLfFundSecuritiesMember', window );">Trading Securites Lf Fund Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems', window );"><strong>SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net realized and unrealized gain (loss) on investment</a></td>
<td class="nump">$ 25,041<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 99,415<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesLfFundPublicSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesLfFundPublicSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesDerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesDerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesForwardContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_EquitySecuritiesForwardContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritiesLFFundPublicSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritiesLFFundPublicSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesLfFundSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=ACTG_TradingSecuritesLfFundSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140112236402360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative) - Option Agreement [Member] - Portfolio Companies [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Apr. 03, 2020</div></th>
<th class="th"><div>Jun. 04, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity', window );">Payment to acquire equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGain', window );">Gain on sale of deriviative</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=ACTG_OptionAgreementMember', window );">United Kingdom, Pounds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingLiabilitiesLineItems', window );"><strong>Offsetting Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity', window );">Payment to acquire equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ACTG_ReturnOnPrepayment', window );">Return on prepayment</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sale of securities</a></td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ACTG_ReturnOnPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Return on prepayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ACTG_ReturnOnPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ACTG_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire equity securities classified as available-for-sale securities, because they are not classified as trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=ACTG_OptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=ACTG_OptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ACTG_PortfolioCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ACTG_PortfolioCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>64
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M W!_)80ZGN@7E/NYX_\ 4$L#!!0    ( ,^#:5%J@7XCPP<  ,T@   8
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M@/$(PP,IPF<%D/\ DU+#5.OD*=2&2U#"P^QLY8W-!1K&P9"XB2())B/,>^W
MQ)V=A&+%.22)N3##T N&TV_!06:*PF"$:"])V*U)GT2UOE!<EK *:B7S5/&=
M/EG94I-MX!EK]23LF&NO2M@M2Q^[?8280BN62P0"VG#TZYU0' 6_63E;U"<F
M0\8F" >CA'N)PFZ-NH<4#QMLBBJPWV(%%C5MRJ9@.L:L%%+E_S#M7:V\+5H4
M>X9B66"0A?T1YKUD8;=F?>+@A#,DM>>]$*N+IN:N56S3+,^@:D&1<(QJ+UO8
MK5N?VWQ0B>KBC.UFRE% L4'41!T*VS'/7K>P6[AV*<'!S=0?GX0!-C*6B2,X
MQN%8MNW5"B=G&=XB9X]YT6JKR_627FC(F4*S92]C*D,L*A-YT6#L%M1X$B2]
MSA"WS@!!V7"GSAP$Q4K?E!$_]H>>S8**R"C]@T+%+3:O]%-1:OZC*868(D*"
M9+B^+*C@8"*..?8Z0]PZ\T6\L**U:VT!!%8-S'L;6+Z&;;'BW+T\3$G!/J%#
MY;' "+C2$?*]\!"W\"QYE0N)EMIS0IRUVM3H?L<6S'R]@53>BJB5ND5;,$WH
MT$)9<","1'H!(B>*I",;<FH-6Q2'QA0/2TX;#LS(V#+N-8>X-6<)Y0;$=8[
MS4MV!E]33X+0,]B:*!J$8TNB5QWB5IV.+"\?>9;!JNBKI9/$37V!RMXP)188
MCI)H1#!)+T3$+41[ZA_.CK--F*(D'-(]NWXBO201=P75N]-"&Y*33,TJR>)#
M;*A1'T)[E:-NE=OYD*)G[.9*+153,LP))T#'3'NYHVZYVV6%4_PLA1'VO628
M<BTX"J7?6#A[4:-N4>LV&&1<SLLVU8)L/'%PS?IZ*_F*2YV.:R72;U-0C]=R
MX(WWUO,PVL)TU!LF^7N M)Y[_S/VO,,?H3:90G6RNP5]:A3D\_P?GDU17M=:
M6%L[T"CHI6K/G%BMW?R2;Y7>_;([M&R!-U!-[Y[NSR*GNK3:\O9XNGAYC]AZ
M+4'TE%[.WYL\:_5Z/QY>I5SW_88&+:?_\B;KK%KJ2 ]3XU31A,5>/'*J2 _.
M/ZG382[U3&U$ :FR_F5_6.<\6.T5FKH5^OYG5@-NY]L^Y^^ADGA]NI]]4/Z#
MR;=&]?09J!-R/.A>W:E;W1>B+&'EG#%BZCF'["=32.A3/Z#MNH+]0"-OFL31
M(!+_YSZPQM%T%H:'MF""L4CVUH.ZK<>#!'EIY,MK+)F"7%.K*?*GX"BF- S:
M(9%I L.(2=P%\?\.@&E6+GP*A= P"!8<34@T<FY%>UM#W;9FGF6Y3D>@#_KD
M[2*O4,JV.>B%E:[I4,( THE!UX8CGC>F9+V5H6XK,S\X4,GX*D]SZQ$K-:W)
MA>^%?C"T!E8@3<(@'&':.QGJ=C([S9VG+,T9^L)KSF2Z00LAMT+N!*"V)$?K
M8$S[ J'T@^')NP6'(XK)B$_W>Z/CNXW.G:C:HW91%#H)Y!78'5[;#S5\2\$>
M&Z7/*=0QT=[G^.?XG'/CZEL,CT=(,EPC%AR._"08*2G\WO'XYYP9']BRZ=G>
M1Z>;L\=)C$^&UG,F"\YZSC0[^-:L/_3_R>0ZKVIP["MHZ+V-(%)R]^U\=Z/$
MMOW\_"B4$F5[N>$,:&L _+X24%_O;_07[>Y_,%S_"U!+ P04    " #/@VE1
M1X(:V:@#   ##P  &    'AL+W=O<FMS:&5E=',O<VAE970S+GAM;)V7T9*B
M.!2&7R5%S<5,U6Q#0$6GU"I;W9JNFNFQFN[=BZV]B'"45 -ADJ S^_2;@(VB
M"-A]T29PSLGWAY"?C/>,OXH00*)?<92(B1%*F7XQ3>&'$!-QQU)(U)T-XS&1
MJLNWID@YD"!/BB/3MJR!&1.:&--Q?FW%IV.6R8@FL.)(9'%,^.][B-A^8F#C
M[<(3W8927S"GXY1LP0/YDJZXZIEEE8#&D C*$L1A,S%F^,L<NSHAC_B+PEZ<
MM)&6LF;L57<>@HEA:2*(P)>Z!%$_.YA#%.E*BN/GH:A1CJD33]MOU?_,Q2LQ
M:R)@SJ*_:2##B3$T4  ;DD7RB>V_PD%07]?S623R_VA_B+4,Y&="LOB0K AB
MFA2_Y-=A(DX2<.]*@GU(L+LF.(<$)Q=:D.6R%D22Z9BS/>(Z6E73C7QN\FRE
MAB;Z,7J2J[M4Y<GIR^/L9?'PO%R@^8_'Q?+1*UK>CV\/BYF^?#_[-GN<+Y'W
M=;E\]M#'%>&0R! D]4GT"?V!7KP%^OCA$_J :(*>0Y8)D@1B;$I%I\<P_0/)
M?4%B7R'Q(+U#CO49V99MU:3/F],7X*MTK-/QJ)INJCDI)\8N)\;.Z_6NU%NI
MY02<0X#4,_!?/Z.4<+0C409UTHI:;EY+OSF[J75G67AL[DX5M$550)T2U+D-
M5(3J$0E$,ADR3O^#H ZXJ-D_0<%6\7?&W"&P@MTKL7OOPJ9"9/7(O0N2<]:F
MB IDOX3LOPM2[8="JF5.DVT=:;^5M"FB0CHH20>-I',6QVI7[+)6!YW6:EM4
MA=(M*=T;*#LM5/=BIARK?J5VB:Q0#TOJX>W4U]?I\(*C-[+=4:_OG %?!O8M
MQ[5&0[>>=U3RCF[G;5FRHZ[0EX'-T-@Z.I'5B/VL/D-$QG]7P6N-Q+JD'5@]
M9] _@ZT)M$=X-+2'5V!/;!,WPCY! .J#:AT!.FX2G@9'_WR'> W\WP83PD<7
MPLTVY &GZNG-U"=3.:#/DAUP274[O<FF<#>?:@VKBCDZ%6ZVJIO%Y$)0"KQ8
M#+62BB$'58,Z%]0<5)5S=##<;&$WR^FTX>%+%W/Z-=M=>UQ5UM'S<+/IO5?6
M]1T17]I=O:36N*JDHSGB9G=\KZ263?,P:KNNUKBJKJ.=XF8_O5E71']F-"#Y
M":JX"8E?_UZY%Z],SGPNK2VL4&:>G%#T\? [X5N:"!3!1N59=ZZ:&UZ<N(J.
M9&E^:%DSJ8Y >3-4IU3@.D#=WS FWSKZ'%2>>Z?_ U!+ P04    " #/@VE1
M+_Q&M1,)  !!*0  &    'AL+W=O<FMS:&5E=',O<VAE970T+GAM;*5:76_C
MMA+]*T30ARS0Q"*ISR )D-AJ;X#=)(BSMP_%?9!MVA96%EV)3G;[Z^]0LBV;
M'-'I]B6VE,,1S^%P>$CK^EU6W^JE$(I\7Q5E?7.V5&I]-1C4TZ589?6E7(L2
M_C.7U2I3<%DM!O6Z$MFL:;0J!LSSPL$JR\NSV^OFWG-U>RTWJLA+\5R1>K-:
M9=6/>U'(]YLS>K:[\9(OEDK?&-Q>K[.%& OU=?U<P=5@'V66KT19Y[(DE9C?
MG-W1JY0GND&#^&\NWNN#[T13F4CY35\\S&[./-TC48BITB$R^'@30U$4.A+T
MXZ]MT+/],W7#P^^[Z+\UY(',)*O%4!9_Y#.UO#F+S\A,S+--H5[D^W_$EE"@
MXTUE43=_R?L6ZYV1Z:96<K5M##U8Y67[F7W?"G'0 .+@#=BV 3,;^#T-^+8!
M_^@3_&T#_Z-/"+8-&NJ#EGLCW"A3V>UU)=])I=$037]IU&]:@UYYJ1-EK"KX
M;P[MU.W7Q[NOHX?7=$2&3X^C]''<?AL_?7X8W>G;XU?X^)(^OH[)TV_DZ3E]
MN7M]  "Y(%_'(W+^RR?R"\E+\KJ4FSHK9_7U0$&_=/3!=-N'^[8/K*</G'R1
MI5K6)"UG8H:T'[G;)X[V ]!C+PK;B7+/G ''8GU)N/<K81[SD/X,/]R<)AB=
M?_?T]*>??B0&WV<(;^+QGG@/Y52N!!FK3 FH$(K\>3>I504S_'^.Z/X^NM]$
M]WNBOX@W46X$FC5MR[!IJ0O>VRU-_#"\'KP=C@6"BB@]!HUL$ MXDARC4B24
M%P3Q'G7$,-@S#)SZ/<M*S6612P+5O<IT>:RO',J%^[BA4[F'$I13LB*5_)$5
M*L<U;&,$!Y2"*&*&A#8HB@R91S8FC'UN"&B#_"A@N'[1GF?DY#F$N9V7"YUY
MA5AD!9D+G&ID]S#TC"$>VB >&$R1.'%@@%(;%,013C3>$XV=1#_G*E]D[?)9
MSDB13_5Z7"Z(^ ZVH!8UE-PU3,)2H?1CJT?4\XQY,+1!R4&W6_XVAON) 4IM
M4!@>I,.1 ,E>@,0IP-T*IDK^=RN!G+O()C99&OD&61L4AT;&CFP,#Y@Q/U(;
MQ#CO&6WJ=2NOYZ3[I):B(NM]>=@/\WG>E-Q/Z$KJ67WQ#-H(Y *FH4$<0W$O
M-I@C*'H0ZICY@>>@3N:O4L$\7B.%$:5,[3[X06"N PB,T=@L8QC*\\TRD:+/
M]!._ASGKF#,G\T>P_AWO=IS)>2'K&A]M9A?4A%H#;J.P <=B)9Y)'(G%$Q[V
M$.],!.5.XK^+$L:X:"I;-@,CFVL/H3<)^[P_I[@&W%Z=PL1<PA"4'W+/U,!&
MT=B+K=%'8) E/4: =EZ'NLW.4YOG4-+UB*-D?5M^%L466P06@%<QZ2(PRCW+
M]Z"X((G[TKVS/M3M?=H2MTOS[4!_<KD?VMD?ZO8_PV4&KD!O/>997I&WK-@(
MO6KDX(MJI9WJKZ2$Z7;^*)4@ 9Y;MF'11=!<-3&8STPG.D)@//)\4VP;E82L
MQR31SB51MTWZ#!E%8-VLL\*0P:V ;62L\F)#+A)JY1J"8E%H+J48+*9^WV+:
M>2?J-D\/JS5D04,7R,MMWNTD0)G;%L9B?A(R.@U)$0A03OI6T<XM4;==^CV#
MW(<1G^7U6L*P?YBX;6<LXHCC\3R+^\E Z:E Q]OSSCHQMW7JF_O GHQ%!7LA
M<M<L-??D/:NJ#%QD<RE6$S&;B1F9 >BM67[0,LQLV\.\T-HW(3!3(P1R 7M8
M:LX+9ZACE3J;Q=PVJT\E\=<F5S](+::;*M<;QP,Y&IGFL@+99F0*6R^]T4<E
MLAW21>A[YLY[B. LC1"S%06^)9$KTK%$G1]C;C^VFT.[JKFN!-21V6'UU()T
M^J!2V)Z)Q7Y@"F&C+"$^$BAU!CK6H;-GS&W/>B=4E<VT7SG(E68>61D$6]-&
M(EP@VT_%X*;-O3D"N_!-[S/"@M'$,S>H"(SRGE66=0Z.N1U<DR^M7S],&ULF
M5 ;;9K&(1Z8*"(K'I@B(8_.96:!2+!;K\?*L<W4L^)#5@#(A\D5)@',ERND/
M</+3)H]0\@$VN"9W!$0]TV>AH1)3H_14L&/VG>]DI\[=E*B@..SV+5J)L2AS
M6<$'2 &KB_9;> 8@1I+YUH8.@5FE G.N-+(T<$4Z%J!SFLSM-/<";'V]+@B-
M[T 9VW[/IHMAF)7R-BHV5YL4 7&/]DW[SETRM[ML#RPDNIM!6=N6SZ>,<I,X
MX@Q9X)EG5%BTP/.MBH=$HW[0E_"=SV1NG_EP>$I!)D)/^YT**OO>D^G(P5KL
M<\L=V+"+*#2/H498-)J8Y2/%HM'(]WM2GG=^D[O]YL.>+? OQ3Q7[O'GB.N+
MS=%'0.8L1R"4!>; 8T_CK.<PEG?VD;OMHSZK.CJATE?%IEGH2EDVYE 6A;[,
MMR6AU@ZBWDSJ?)9G5<\RR&T?QV-NK04(#$L-+!IGYE%(BD6C413VJ=0Y2'[Z
M1$^K0S*EJGRR4=D$/(&2_TZBDUYQ>!HR.@U)$0CM.?7A!S\8NLVDG3BF-G?3
M;)IGY$74(JNF2S*4U5JV1\"H'+:70S,&\8]8QB#1L(Q!HD'&^$F//)V'Y&X/
M>5H>^-]*NTLEI]^6LH#=AS;8DZS.IZ@\]N^6W N8::\1&"H/\ENI'UON"HOF
MDJ=SE]SM+N\US>;D[EBD-:R].V&6686:S&WH^##C+\W??(8(ZL*[M$ZTT&"!
MZ3CP8'T'YKRSF=QM,_]H7G$!,YF]B2J#O5FY64U  MAM-/3!@6]4K<!\Z>KB
MR@[D1]G8#Z,X-G>H&#*)6<Q#\^=T-&;B)Y'IU5,T9@3;GKCG_(MW/I2[?>C/
MSJ-97FP4^I[)_?:)1[F?,/,(=XC T)F$1*,\MFHP$LTUDSK7RMVN==02_=FY
M%"/IS\TC, 2%SB4TF)4L:+#>N=0Y6.YVL/]T+KDRQ+:8B1<R/_(L96QDWVRR
MD:%' QY%YOL5:$QT-@T.7@E;B6K1O(M7PZ!O2M6^^[._NW_?[ZYYR\VX?T^O
MAA2Y/Z)7:?LV7Q>^?;GP2U8M\K(FA9C#H[S+"+I;M>_KM1=*KIL7TB92*;EJ
MOBY%!K-3 ^#_<PG[Y^V%?L#^K<G;_P-02P,$%     @ SX-I4>VW(%(- P
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MM# 0WS\F2?[U3?&#]]U_=3C_/U!+ P04    " #/@VE1N/3NY9T(  !/)0
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M7=&\]*^.8?&J)6KWRR3F&% 4&'/&8I=@5RS5:,5^M@YS =,IJV@3GXQ$PUS
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M?/TMHU%UV$*95;7),!PD+,)#Y::=4[F&'?/#[J;*:JYBXDG.NR/UTK!SIBT
MU8'B'N38;9ZJ+JH7AW61-;S[W>J4I0Z$,M!\0VKA88@3YD@"F28B>^5EXGL\
M^("6_*&H*A@LJS,F_1)"I\-DQ&*&21P'KD'2D&2O;)6^SQ>(6"Y'S-U.G$33
M<+BU8+$+PSATT)YI!K/82_O%;KLMN<J@TA*ISV_R75</J;?3RK?WEKI,4Y7Y
MJ3KK)9WV?4!_6;!OOO\NGU#,C/+78C<,B9/>IRD;7C^T7^Q(U.X5=1]T'*\>
MOPJ:M=_"#*Y?XD_S[ML>W4SWJ='7M(;Y+"%%6$&3P<<(AK+NOM[I3AJQ;3^
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M-+,AV(8_+OE&DA;@=^*G^0L=T+^-//\O4$L#!!0    ( ,^#:5%%O2E3D"8
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MNE^:Q_\TLI]+G&_95);^JQ_YW8MG3_2RMUVSD<$ P::L^=_\D^ A&G!]=F#
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M%/RRWO:B5T_< 8HD_+MU@U2\B,EAQA0=K,(*8T$P+U""+X!""#*$EBQ/& C
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M1KIDZ>^V+%ER<9050SE U8#%81[W7WR&M\MEV]/,O)S>7TZ-N!Z+O&)S[RA
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MJL.P50_J7)6: 6/-C\8(>-BKA]EUV*WIBW(/@^M$7+E0FT>F)C8)RCK"FXL
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M4)\Z[]3L1"H7/K:6D?I9^M\9[04/PL)GD6MX$$4MX5.M\VJ#?+$3$%5&@TD
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M(9&3*D_I7<7MK3'F> &'^A002UU@N\E9:6U-04?-VN:>J='GW%0X%3+K8CM
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MI"YU9T%TLRYMW#G2NYE/1>.SB,U[4!CJDMO2_T'';8RCX6E3,)*&#@SQ#[K
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M>KO_SO))Z#E7G!QG)!KUCR<]?SE<#:RJW/>"J;)6%>XQ0T$X\09:GREJ,LV
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M!<;5\0(M^[[YG=[?OCMF#EQ9(F#OI/'DPX(2TW=T'Z!N0A?M-+J>#-/:_03
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M* VIL!2/![R:XS-RQ\X"S*$5?7RP$3E 4YYO^W!"8;2U8WN- -EF*?O%S]F
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M6[&M6]^755'=H5RH'F%-6]7*/@7OYW:=KO/4$R1@N&@J6'I==+B?'D ;H$K
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MNKY/1/:#9;WF9S4E/T0I.GHY#9YQ,1OO:J=)>:VL&N"HB85XF/10G,>>=9P
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M;T-)_08<,@:1G?I)QL(#"$3P^C _.,('Q(7F-Q>;%J D(XQ=)5=GU_;\.ED
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M_MM95</C>,"=H *,M@\0_ L8J<767E2'%Y>(]A#.4>O;HQ5;$Q-[W[C%2 B
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ME/G8( CO7ALV#DJR([B]'L?^#M$3M:^_/1)3&^NH_0D<Z!7I['G<F^)(G!&
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M[DN87 #_KRCTN^I%.JAOTQ?_ 5!+ P04    " #/@VE1 ]](;(T%  #U#@
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MNS=1.0=KWTIICHI+4&_BT1]02P,$%     @ SX-I4?_L4?J? @  =@4  !D
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M"$U]:J<)/8PH30"MKX30.\-LT#RUHS]02P,$%     @ SX-I47MRI0=. P
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M*Z%I$I3+F$8O2G. ]M="Z(-@".IA/OX/4$L#!!0    ( ,^#:5$D_"^*? (
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M_BMV^5Q;OE0PY;ZP[V(##])&:5%U8*.@HKS]D_>N#D< PW,:$': \%_ S1G
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M#D"U,]\&1E9^;+;2V"'TR\+^)E"Y!'N^D](< S>)_8\G_0M02P,$%     @
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MG?W 8[!<"36@#?MKLH09B.?U Y-O6NYE'D00\X#&B,%BT+G$%S?84X#$XB6
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MWU:JV*K,)7P>^_U^ZCZWH/H-JG\.Y;>A*E5T@(J283LJ:E#1.530AHJ.4.'
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M%N9;@-(FF/.E$'H;V/[LOB[)7U!+ P04    " #/@VE1+P/2(LT#   T#0
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M'N 5 .^M@&X!Z+X$^ V 7@'HO03T&@#] F!"M_/8#7$+)-%TS-D1N)96VO3
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MI]+^P[Z,]1R(<JEX5H)U!AEEQ9-\E'6H 31/,R H <%70'@$T"T!W:^ WA%
MKP3T;&4**[8.,Z+(>"CX'H2)UFQF8(MIT=H^9>:U+Y70NU3CU-CW.["\6=S=
M+&$"+Y/%8O+PN(33&2I"4PD/1 ABWLP9_( E1KF@BJ*$>2ZB1)<;)AN!J-M
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ SX-I49E<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " #/@VE13F0N3"@%  #;%0  &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ SX-I46J!?B/#!P
MS2   !@              ("!:PT  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( ,^#:5%'@AK9J ,   ,/   8              " @605
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #/@VE1+_Q&
MM1,)  !!*0  &               @(%"&0  >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ SX-I4>VW(%(- P  / D  !@
M ("!BR(  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ,^#
M:5'JQ?+@*PD  .%!   8              " @<XE  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " #/@VE1N/3NY9T(  !/)0  &
M        @($O+P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ SX-I4<J9=%T&"P  F1P  !@              ("! C@  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( ,^#:5%%O2E3D"8  (QZ   8
M              " @3Y#  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " #/@VE1_(HQ"ZP%  !\#P  &0              @($$:@  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( ,^#:5&P$#A?"@,
M %8&   9              " @>=O  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ SX-I44<GS<8W!   @@D  !D              ("!
M*',  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #/@VE1
M[!11TQ<*  !>&   &0              @(&6=P  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( ,^#:5'+_(Q$*0<  &(1   9
M      " @>2!  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ SX-I44M ,\*U!0  4 T  !D              ("!1(D  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " #/@VE1J.QVU)L"  #4!0
M&0              @($PCP  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( ,^#:5&TKHK-V P  (TH   9              " @0*2  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ SX-I40>B%"AR
M P  @P<  !D              ("!$9\  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " #/@VE1\]D';$,$   ^"0  &0
M@(&ZH@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( ,^#
M:5&;[[=5J08  $@/   9              " @32G  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ SX-I44(- P,D!P  3!(  !D
M         ("!%*X  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " #/@VE1+5[Q*.P!  !B!   &0              @(%OM0  >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( ,^#:5$1QQ9#2@L  "8>
M   9              " @9*W  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ SX-I40L:@WHN*   1H8  !D              ("!$\,
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #/@VE1LU7E
M 38%  !9#P  &0              @(%XZP  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( ,^#:5$#WTALC04  /4.   9
M  " @>7P  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
MSX-I48V49$A^ @  - 4  !D              ("!J?8  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " #/@VE1=!S6BN "  "2!@  &0
M            @(%>^0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( ,^#:5&1N1 &H0(  )4%   9              " @77\  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ SX-I4?_L4?J? @
M=@4  !D              ("!3?\  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " #/@VE1>W*E!TX#  #8!P  &0              @($C
M @$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ,^#:5$D
M_"^*? (  (T%   9              " @:@% 0!X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ SX-I4:2997(C P  $0H  !D
M     ("!6P@! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,^#:5&ECT04UP<  %$H   9              "
M@7(B 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ SX-I
M4=_PM&"@ @  )@<  !D              ("!@"H! 'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " #/@VE1E&8SDB@"  "$!   &0
M        @(%7+0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( ,^#:5'0G+I8H ,  +4-   9              " @;8O 0!X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ SX-I44CI1)5(!   ^1
M !D              ("!C3,! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " #/@VE1!H;C&[X"  "R!P  &0              @($,. $
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( ,^#:5&X#K@0
MZ0(   T(   9              " @0$[ 0!X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ SX-I42/])X3E @  IP<  !D
M ("!(3X! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #/
M@VE1ZC[!93P"  !I!   &0              @($]00$ >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( ,^#:5$O ](BS0,  #0-   9
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M970U,2YX;6Q02P$"% ,4    " #/@VE1N7!T$C,#  #D"   &0
M    @('J6 $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M ,^#:5&*ACY/,P(  -L)   -              "  51< 0!X;"]S='EL97,N
M>&UL4$L! A0#%     @ SX-I49>*NQS     $P(   L              ( !
MLEX! %]R96QS+RYR96QS4$L! A0#%     @ SX-I47BRLPI8!   TB(   \
M             ( !FU\! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,^#
M:5&*,79?SP$  #,?   :              "  2!D 0!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,^#:5$RX8'AQP$  !(?   3
M          "  2=F 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     \ #P
*6Q   !]H 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>292</ContextCount>
  <ElementCount>360</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>81</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - 3. INCOME (LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeLossPerShare</Role>
      <ShortName>3. INCOME (LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - 4. PATENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Patents</Role>
      <ShortName>4. PATENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - 5. INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/Investments</Role>
      <ShortName>5. INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingencies</Role>
      <ShortName>6. COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - 7. STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquity</Role>
      <ShortName>7. STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - 8. RECENT ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/RecentAccountingPronouncements</Role>
      <ShortName>8. RECENT ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - 9. FAIR VALUE DISCLOSURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/FairValueDisclosures</Role>
      <ShortName>9. FAIR VALUE DISCLOSURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock</Role>
      <ShortName>10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - 11. SERIES A WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesWarrants</Role>
      <ShortName>11. SERIES A WARRANTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - 12. SERIES B WARRANTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesBWarrants</Role>
      <ShortName>12. SERIES B WARRANTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - 13. SENIOR SECURED NOTES</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://acaciaresearch.com/role/SeniorSecuredNotes</Role>
      <ShortName>13. SENIOR SECURED NOTES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment</Role>
      <ShortName>14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - 15. SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SubsequentEvents</Role>
      <ShortName>15. SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies</Role>
      <ShortName>1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - 3. INCOME (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeLossPerShareTables</Role>
      <ShortName>3. INCOME (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomeLossPerShare</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - 4. PATENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsTables</Role>
      <ShortName>4. PATENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Patents</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - 5. INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentsTables</Role>
      <ShortName>5. INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/Investments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>6. COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - 7. STOCKHOLDERS??? EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityTables</Role>
      <ShortName>7. STOCKHOLDERS??? EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/StockholdersEquity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables</Role>
      <ShortName>14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails</Role>
      <ShortName>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails</Role>
      <ShortName>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails</Role>
      <ShortName>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details</Role>
      <ShortName>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - 3. INCOME (LOSS) PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/IncomeLossPerShareDetails</Role>
      <ShortName>3. INCOME (LOSS) PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/IncomeLossPerShareTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - 4. PATENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsDetails</Role>
      <ShortName>4. PATENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/PatentsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - 4. PATENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/PatentsDetailsNarrative</Role>
      <ShortName>4. PATENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/PatentsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - 5. INVESTMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentsDetails</Role>
      <ShortName>5. INVESTMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/InvestmentsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - 5. INVESTMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/InvestmentsDetailsNarrative</Role>
      <ShortName>5. INVESTMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/InvestmentsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>6. COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>6. COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - 7. STOCKHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityDetails</Role>
      <ShortName>7. STOCKHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - 7. STOCKHOLDERS??? EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>7. STOCKHOLDERS??? EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/StockholdersEquityTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative</Role>
      <ShortName>10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - 11. SERIES A WARRANTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative</Role>
      <ShortName>11. SERIES A WARRANTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SeriesWarrants</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - 12. SERIES B WARRANTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative</Role>
      <ShortName>12. SERIES B WARRANTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SeriesBWarrants</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - 13. SENIOR SECURED NOTES (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative</Role>
      <ShortName>13. SENIOR SECURED NOTES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/SeniorSecuredNotes</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails</Role>
      <ShortName>14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="acacia_i10q-093020.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative</Role>
      <ShortName>14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="acacia_i10q-093020.htm">acacia_i10q-093020.htm</File>
    <File>acacia_ex3101.htm</File>
    <File>acacia_ex3102.htm</File>
    <File>acacia_ex3201.htm</File>
    <File>acacia_ex3202.htm</File>
    <File>actg-20200930.xsd</File>
    <File>actg-20200930_cal.xml</File>
    <File>actg-20200930_def.xml</File>
    <File>actg-20200930_lab.xml</File>
    <File>actg-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>69
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "acacia_i10q-093020.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "contextCount": 292,
   "dts": {
    "calculationLink": {
     "local": [
      "actg-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "actg-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "acacia_i10q-093020.htm"
     ]
    },
    "labelLink": {
     "local": [
      "actg-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "actg-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "actg-20200930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 496,
   "entityCount": 1,
   "hidden": {
    "http://acaciaresearch.com/20200930": 8,
    "http://fasb.org/us-gaap/2020-01-31": 75,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 88
   },
   "keyCustom": 35,
   "keyStandard": 325,
   "memberCustom": 47,
   "memberStandard": 23,
   "nsprefix": "ACTG",
   "nsuri": "http://acaciaresearch.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://acaciaresearch.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - 3. INCOME (LOSS) PER SHARE",
     "role": "http://acaciaresearch.com/role/IncomeLossPerShare",
     "shortName": "3. INCOME (LOSS) PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - 4. PATENTS",
     "role": "http://acaciaresearch.com/role/Patents",
     "shortName": "4. PATENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - 5. INVESTMENTS",
     "role": "http://acaciaresearch.com/role/Investments",
     "shortName": "5. INVESTMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentHoldingsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES",
     "role": "http://acaciaresearch.com/role/CommitmentsAndContingencies",
     "shortName": "6. COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - 7. STOCKHOLDERS\u2019 EQUITY",
     "role": "http://acaciaresearch.com/role/StockholdersEquity",
     "shortName": "7. STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - 8. RECENT ACCOUNTING PRONOUNCEMENTS",
     "role": "http://acaciaresearch.com/role/RecentAccountingPronouncements",
     "shortName": "8. RECENT ACCOUNTING PRONOUNCEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - 9. FAIR VALUE DISCLOSURES",
     "role": "http://acaciaresearch.com/role/FairValueDisclosures",
     "shortName": "9. FAIR VALUE DISCLOSURES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK",
     "role": "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock",
     "shortName": "10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:WarrantDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - 11. SERIES A WARRANTS",
     "role": "http://acaciaresearch.com/role/SeriesWarrants",
     "shortName": "11. SERIES A WARRANTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:WarrantDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:SeriesBWarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - 12. SERIES B WARRANTS",
     "role": "http://acaciaresearch.com/role/SeriesBWarrants",
     "shortName": "12. SERIES B WARRANTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:SeriesBWarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - 13. SENIOR SECURED NOTES",
     "role": "http://acaciaresearch.com/role/SeniorSecuredNotes",
     "shortName": "13. SENIOR SECURED NOTES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT",
     "role": "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment",
     "shortName": "14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - 15. SUBSEQUENT EVENTS",
     "role": "http://acaciaresearch.com/role/SubsequentEvents",
     "shortName": "15. SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:DescriptionOfBusinessPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)",
     "role": "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies",
     "shortName": "1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ACTG:DescriptionOfBusinessPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRecognitionPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - 3. INCOME (LOSS) PER SHARE (Tables)",
     "role": "http://acaciaresearch.com/role/IncomeLossPerShareTables",
     "shortName": "3. INCOME (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - 4. PATENTS (Tables)",
     "role": "http://acaciaresearch.com/role/PatentsTables",
     "shortName": "4. PATENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InvestmentHoldingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - 5. INVESTMENTS (Tables)",
     "role": "http://acaciaresearch.com/role/InvestmentsTables",
     "shortName": "5. INVESTMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InvestmentHoldingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://acaciaresearch.com/role/CommitmentsAndContingenciesTables",
     "shortName": "6. COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - 7. STOCKHOLDERS\u2019 EQUITY (Tables)",
     "role": "http://acaciaresearch.com/role/StockholdersEquityTables",
     "shortName": "7. STOCKHOLDERS\u2019 EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AcceleratedShareRepurchasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)",
     "role": "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables",
     "shortName": "14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:DescriptionOfBusinessPolicyTextBlock",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ACTG:NumberOfPatentPortfoliosAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Integer",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "role": "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
     "shortName": "1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:DescriptionOfBusinessPolicyTextBlock",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ACTG:NumberOfPatentPortfoliosAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Integer",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails",
     "shortName": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30_custom_PaidUpRevenueAgreementsMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AvailableForSaleSecuritiesTextBlock",
       "us-gaap:EquityMethodInvestmentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails",
     "shortName": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Trading Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AvailableForSaleSecuritiesTextBlock",
       "us-gaap:EquityMethodInvestmentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails",
     "shortName": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30_us-gaap_AssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
     "shortName": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES : Changes to fair value measurement Level 3 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2019-12-31_us-gaap_LiabilityMember_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_SeriesAEmbeddedDerivativeLiabilityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - 3. INCOME (LOSS) PER SHARE (Details)",
     "role": "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
     "shortName": "3. INCOME (LOSS) PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:PreferredStockDividendsIncomeStatementImpact",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - 4. PATENTS (Details)",
     "role": "http://acaciaresearch.com/role/PatentsDetails",
     "shortName": "4. PATENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RoyaltyExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - 4. PATENTS (Details Narrative)",
     "role": "http://acaciaresearch.com/role/PatentsDetailsNarrative",
     "shortName": "4. PATENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - 5. INVESTMENTS (Details)",
     "role": "http://acaciaresearch.com/role/InvestmentsDetails",
     "shortName": "5. INVESTMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "us-gaap:InvestmentHoldingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30_custom_WarrantInvestmentMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossOnSaleOfInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - 5. INVESTMENTS (Details Narrative)",
     "role": "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
     "shortName": "5. INVESTMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentHoldingsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-012020-03-31_custom_VeritoneMember",
      "decimals": "INF",
      "lang": null,
      "name": "ACTG:InvestmentSharesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails",
     "shortName": "6. COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - 6. COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "6. COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-03-202020-03-31_us-gaap_CommonStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - 7. STOCKHOLDERS' EQUITY (Details)",
     "role": "http://acaciaresearch.com/role/StockholdersEquityDetails",
     "shortName": "7. STOCKHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:AcceleratedShareRepurchasesTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-03-202020-03-31_us-gaap_CommonStockMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2019-08-05_custom_StockRepurchaseProgramMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - 7. STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "role": "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative",
     "shortName": "7. STOCKHOLDERS\u2019 EQUITY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2019-08-05_custom_StockRepurchaseProgramMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - 10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative)",
     "role": "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
     "shortName": "10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PreferredStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:WarrantDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ACTG:WarrantsIssuedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - 11. SERIES A WARRANTS (Details Narrative)",
     "role": "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative",
     "shortName": "11. SERIES A WARRANTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:WarrantDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2019-01-012019-11-18_custom_SecuritiesPurchaseAgreementMember_custom_StarboardValueMember_custom_SeriesAWarrantsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ACTG:WarrantsIssuedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfWarrants",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - 12. SERIES B WARRANTS (Details Narrative)",
     "role": "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
     "shortName": "12. SERIES B WARRANTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ACTG:SeriesBWarrantsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-012020-02-25_custom_SeriesBWarrantsMember",
      "decimals": "-3",
      "lang": null,
      "name": "ACTG:WarrantsIssuedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30_us-gaap_GeneralAndAdministrativeExpenseMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RepaymentsOfSecuredDebt",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - 13. SENIOR SECURED NOTES (Details Narrative)",
     "role": "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
     "shortName": "13. SENIOR SECURED NOTES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30_custom_SeriesBWarrantsMember132395046",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)",
     "role": "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails",
     "shortName": "14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-07-012020-09-30_custom_TradingSecuritesLfFundPublicSecuritiesMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrealizedGainLossOnInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - 14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative)",
     "role": "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative",
     "shortName": "14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-012020-04-03_custom_OptionAgreementMember_custom_PortfolioCompaniesMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2018-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "AsOf2018-12-31_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "shortName": "1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "acacia_i10q-093020.htm",
      "contextRef": "From2020-01-01to2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 81,
   "tag": {
    "ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accretion of Series A redeemable convertible preferred stock",
        "label": "Add: Accretion of Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "AccretionOfSeriesRedeemableConvertiblePreferredStock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accretion of Series A Redeemable Convertible Preferred Stock to redemption value",
        "label": "Accretion of Series A Redeemable Convertible Preferred Stock to redemption value"
       }
      }
     },
     "localname": "AccretionOfSeriesRedeemableConvertiblePreferredStockToRedemptionValue",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_AcquisitionOfPrepaidInvestmentSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Acquisition of prepaid investment securities"
       }
      }
     },
     "localname": "AcquisitionOfPrepaidInvestmentSecurities",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ApproximateValueOfSharesThatMayYetBePurchased": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Approximate value of shares that may yet be purchased",
        "label": "Approximate value of shares that may yet be purchased"
       }
      }
     },
     "localname": "ApproximateValueOfSharesThatMayYetBePurchased",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_BlackScholesModelMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Black Scholes Model [Member]"
       }
      }
     },
     "localname": "BlackScholesModelMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_ChangeInFairValueOfDilutiveSeriesBWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in fair value of dilutive Series B warrants",
        "label": "Less: Change in fair value of dilutive Series B warrants"
       }
      }
     },
     "localname": "ChangeInFairValueOfDilutiveSeriesBWarrants",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative",
        "label": "ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative",
        "negatedLabel": "Change in fair value of Series A redeemable convertible preferred stock embedded derivative"
       }
      }
     },
     "localname": "ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in fair value of Series A redeemable convertible preferred stock embedded derivative",
        "label": "Less: Change in fair value of Series A redeemable convertible preferred stock embedded derivative"
       }
      }
     },
     "localname": "ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivatives",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_ChangeInFairValueOfSeriesWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in fair value of Series A warrants",
        "label": "Less: Change in fair value of Series A warrants"
       }
      }
     },
     "localname": "ChangeInFairValueOfSeriesWarrants",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_CommonStockInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Common Stock Investment [Member]"
       }
      }
     },
     "localname": "CommonStockInvestmentMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_ContingentLegalFees": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent legal fees",
        "label": "Contingent legal fees"
       }
      }
     },
     "localname": "ContingentLegalFees",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_DerivativeLiabilitiesNoncurrent1": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series B warrant liabilities",
        "label": "Series B warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent1",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_DescriptionOfBusinessPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of Business [Policy Text Block]",
        "label": "Description of Business"
       }
      }
     },
     "localname": "DescriptionOfBusinessPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_EarningsPerShareBasicAndDilutedDeniminatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Denominator [Abstract]",
        "label": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedDeniminatorAbstract",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ACTG_EmbeddedDerivativeLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Embedded Derivative Liability [Member]"
       }
      }
     },
     "localname": "EmbeddedDerivativeLiabilityMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EmbeddedDerivativeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Embedded Derivative [Member]"
       }
      }
     },
     "localname": "EmbeddedDerivativeMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EmployeeStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Employee Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionsMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquityBasedIncentiveAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Based Incentive Awards [Member]"
       }
      }
     },
     "localname": "EquityBasedIncentiveAwardsMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritiesDerivativeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Securities Derivative [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesDerivativeMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritiesDerivativetMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Securities Derivativet [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesDerivativetMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritiesForwardContractMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Securities Forward Contract [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesForwardContractMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecuritiesLFFundPrivateSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity Securities L F Fund Private Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesLFFundPrivateSecuritiesMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_EquitySecurityForwardContractPoliciesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Security Forward Contract [Policy Text Block]",
        "label": "Equity Securities Derivative and Forward Contract"
       }
      }
     },
     "localname": "EquitySecurityForwardContractPoliciesTextBlock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_ExchangeAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Exchange Agreement [Member]"
       }
      }
     },
     "localname": "ExchangeAgreementMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_ForeignLicenseeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Foreign Licensee [Member]"
       }
      }
     },
     "localname": "ForeignLicenseeMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase Decrease In Royalties And Contingent Legal Fees Payable",
        "label": "IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable",
        "verboseLabel": "Royalties and contingent legal fees payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_InvestmentSharesSold": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment shares sold",
        "label": "Investment shares sold"
       }
      }
     },
     "localname": "InvestmentSharesSold",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ACTG_InvestmentWarrants": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment warrants",
        "label": "Investment warrants"
       }
      }
     },
     "localname": "InvestmentWarrants",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ACTG_LitigationAndLicensingExpensesPatents": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation and licensing expenses, patents",
        "label": "Litigation and licensing expenses - patents"
       }
      }
     },
     "localname": "LitigationAndLicensingExpensesPatents",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_MertonMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Merton [Member]"
       }
      }
     },
     "localname": "MertonMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_MonteCarloMethodMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Monte Carlo Method [Member]"
       }
      }
     },
     "localname": "MonteCarloMethodMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_NetPortfolioIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net portfolio income loss",
        "label": "Net portfolio income (loss)"
       }
      }
     },
     "localname": "NetPortfolioIncomeLoss",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_NonCashStockCompensationExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-cash stock compensation expense",
        "label": "Non Cash Stock Compensation Expense [Member]"
       }
      }
     },
     "localname": "NonCashStockCompensationExpenseMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_NoncashStockBasedCompensationCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-cash stock based compensation credit",
        "label": "Non-cash stock based compensation credit"
       }
      }
     },
     "localname": "NoncashStockBasedCompensationCredit",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_NumberOfPatentPortfoliosAcquired": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of patent portfolios acquired",
        "label": "Number of new patent portfolios acquired"
       }
      }
     },
     "localname": "NumberOfPatentPortfoliosAcquired",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "ACTG_NumberOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of warrants",
        "label": "Number of warrants"
       }
      }
     },
     "localname": "NumberOfWarrants",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ACTG_OneLicensee2Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "One Licensee 2 [Member]"
       }
      }
     },
     "localname": "OneLicensee2Member",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_OneLicensee3Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "One Licensee 3 [Member]"
       }
      }
     },
     "localname": "OneLicensee3Member",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_OneLicensee4Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "One Licensee 4 [Member]"
       }
      }
     },
     "localname": "OneLicensee4Member",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_OneLicenseeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "One Licensee [Member]"
       }
      }
     },
     "localname": "OneLicenseeMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_OptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Option Agreement [Member]"
       }
      }
     },
     "localname": "OptionAgreementMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_OriginalIssueDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Original Issue Discount"
       }
      }
     },
     "localname": "OriginalIssueDiscount",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_PaidUpRevenueAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Paid Up Revenue Agreements [Member]"
       }
      }
     },
     "localname": "PaidUpRevenueAgreementsMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_PortfolioCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Portfolio Companies [Member]"
       }
      }
     },
     "localname": "PortfolioCompaniesMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_PortfolioOperationsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Portfolio Operations [Policy Text Block]",
        "label": "Portfolio Operations"
       }
      }
     },
     "localname": "PortfolioOperationsPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_PrepaidInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Prepaid Investment",
        "label": "Prepaid investment"
       }
      }
     },
     "localname": "PrepaidInvestment",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_PrepaidInvestmentPoliciesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Prepaid Investment [Policy Text Block]",
        "label": "Prepaid Investment"
       }
      }
     },
     "localname": "PrepaidInvestmentPoliciesTextBlock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_RecurringRevenueAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Recurring Revenue Agreements [Member]"
       }
      }
     },
     "localname": "RecurringRevenueAgreementsMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_RestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restricted Stock Units [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_ReturnOnPrepayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Return on prepayment",
        "label": "Return on prepayment"
       }
      }
     },
     "localname": "ReturnOnPrepayment",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_RoyaltiesAndContingentLegalFeesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Royalties and contingent legal fees payable",
        "label": "Royalties and contingent legal fees payable"
       }
      }
     },
     "localname": "RoyaltiesAndContingentLegalFeesPayable",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_SecuritiesPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "localname": "SecuritiesPurchaseAgreementMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeniorSecuredNotes1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Senior Secured Notes 1 [Member]"
       }
      }
     },
     "localname": "SeniorSecuredNotes1Member",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeniorSecuredNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Senior Secured Notes [Member]"
       }
      }
     },
     "localname": "SeniorSecuredNotesMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesAEmbeddedDerivativeLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Series A Embedded Derivative Liability [Member]"
       }
      }
     },
     "localname": "SeriesAEmbeddedDerivativeLiabilityMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesARedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series A Redeemable Convertible Preferred Stock [Member]",
        "label": "Series A Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesARedeemableConvertiblePreferredStockMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesARedeemableConvertibleStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Series A Redeemable Convertible Stock [Member]"
       }
      }
     },
     "localname": "SeriesARedeemableConvertibleStockMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesAWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Series A Warrants [Member]"
       }
      }
     },
     "localname": "SeriesAWarrantsMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesAWarrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series A Warrants [Policy Text Block]",
        "label": "Series A Warrants"
       }
      }
     },
     "localname": "SeriesAWarrantsPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_SeriesBWarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Series B Warrants"
       }
      }
     },
     "localname": "SeriesBWarrantsAbstract",
     "nsuri": "http://acaciaresearch.com/20200930",
     "xbrltype": "stringItemType"
    },
    "ACTG_SeriesBWarrantsLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Series B Warrants Liability [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantsLiabilityMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesBWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Series B Warrants [Member]"
       }
      }
     },
     "localname": "SeriesBWarrantsMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_SeriesBWarrantsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series B Warrants [Policy Text Block]",
        "label": "SeriesBWarrantsPolicyTextBlock",
        "verboseLabel": "Series B Warrants"
       }
      }
     },
     "localname": "SeriesBWarrantsPolicyTextBlock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_SeriesBWarrantsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series B Warrants [Text Block]",
        "label": "12. SERIES B WARRANTS"
       }
      }
     },
     "localname": "SeriesBWarrantsTextBlock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_SeriesWarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Series Warrants"
       }
      }
     },
     "localname": "SeriesWarrantsAbstract",
     "nsuri": "http://acaciaresearch.com/20200930",
     "xbrltype": "stringItemType"
    },
    "ACTG_StarboardValueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Starboard Value [Member]"
       }
      }
     },
     "localname": "StarboardValueMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_StockRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stock Repurchase Program [Member]"
       }
      }
     },
     "localname": "StockRepurchaseProgramMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradingSecuritesDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trading Securites Debt [Member]"
       }
      }
     },
     "localname": "TradingSecuritesDebtMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradingSecuritesEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trading Securites Equity [Member]"
       }
      }
     },
     "localname": "TradingSecuritesEquityMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradingSecuritesLfFundPublicSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trading Securites Lf Fund Public Securities [Member]"
       }
      }
     },
     "localname": "TradingSecuritesLfFundPublicSecuritiesMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradingSecuritesLfFundSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trading Securites Lf Fund Securities [Member]"
       }
      }
     },
     "localname": "TradingSecuritesLfFundSecuritiesMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradingSecuritesrEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trading Securitesr Equity [Member]"
       }
      }
     },
     "localname": "TradingSecuritesrEquityMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradingSecuritiesDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trading Securities Debt [Member]"
       }
      }
     },
     "localname": "TradingSecuritiesDebtMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradingSecuritiesEquityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trading Securities Equity [Member]"
       }
      }
     },
     "localname": "TradingSecuritiesEquityMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_TradingSecuritiesLFFundPublicSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Trading Securities L F Fund Public Securities [Member]"
       }
      }
     },
     "localname": "TradingSecuritiesLFFundPublicSecuritiesMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_UnrealizedGainLossOnDerivatives1": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in fair value of Series B warrants",
        "label": "UnrealizedGainLossOnDerivatives1",
        "negatedLabel": "Change in fair value of Series B warrants"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives1",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ACTG_VeritoneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Veritone [Member]"
       }
      }
     },
     "localname": "VeritoneMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_WarrantDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrant disclosure [Text Block]",
        "label": "11. SERIES A WARRANTS"
       }
      }
     },
     "localname": "WarrantDisclosureTextBlock",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesWarrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ACTG_WarrantInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Warrant Investment [Member]"
       }
      }
     },
     "localname": "WarrantInvestmentMember",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails",
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_WarrantPrice365Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Warrant Price 365 [Member]"
       }
      }
     },
     "localname": "WarrantPrice365Member",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_WarrantPrice525Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Warrant Price 525 [Member]"
       }
      }
     },
     "localname": "WarrantPrice525Member",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ACTG_WarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants exercised, shares",
        "label": "WarrantsExercised",
        "verboseLabel": "Warrants exercised"
       }
      }
     },
     "localname": "WarrantsExercised",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ACTG_WarrantsExercisedShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants exercised",
        "label": "WarrantsExercisedShares",
        "verboseLabel": "Warrants exercised"
       }
      }
     },
     "localname": "WarrantsExercisedShares",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ACTG_WarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants issued",
        "label": "Warrants issued"
       }
      }
     },
     "localname": "WarrantsIssued",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ACTG_WarrantsIssuedShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Warrants issued, shares",
        "label": "Warrants issued, shares"
       }
      }
     },
     "localname": "WarrantsIssuedShares",
     "nsuri": "http://acaciaresearch.com/20200930",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_GBP": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "United Kingdom, Pounds"
       }
      }
     },
     "localname": "GBP",
     "nsuri": "http://xbrl.sec.gov/currency/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r468",
      "r470",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r462"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r47",
      "r96"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r168",
      "r245",
      "r246",
      "r383",
      "r422",
      "r423"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r168",
      "r245",
      "r246",
      "r383",
      "r422",
      "r423"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]"
       }
      }
     },
     "localname": "SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesReportableDataLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of accelerated share repurchase (ASR) programs.  An ASR is a combination of transactions that permits an entity to purchase a targeted number of shares immediately with the final purchase price of those shares determined by an average market price over a fixed period of time. An accelerated share repurchase program is intended to combine the immediate share retirement benefits of a tender offer with the market impact and pricing benefits of a disciplined daily open market stock repurchase program.  ASRs can be disclosed as part of stockholders' equity.",
        "label": "Schedule of repurchased shares"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r16",
      "r171",
      "r172"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionExpense": {
     "auth_ref": [
      "r213",
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.",
        "label": "Accretion"
       }
      }
     },
     "localname": "AccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r17",
      "r272"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to reconcile net income (loss) including noncontrolling interests in subsidiaries to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r63",
      "r83",
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Unamortized Discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r83",
      "r341"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of debt discount and issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r83",
      "r201",
      "r206"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of patents"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r94",
      "r157",
      "r160",
      "r166",
      "r186",
      "r292",
      "r295",
      "r327",
      "r392",
      "r408"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Default Label]",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r42",
      "r94",
      "r186",
      "r292",
      "r295",
      "r327"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r175",
      "r196"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Trading securities - debt"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesEquitySecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments in equity securities and other forms of securities that provide ownership interests classified as available-for-sale, expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.",
        "label": "Trading securities - equity"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesEquitySecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossRealizedGainLossNet": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 9.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.",
        "label": "Gain (loss) on sale of trading securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossRealizedGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains": {
     "auth_ref": [
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.",
        "label": "Available-for-sale Securities, Gross Unrealized Gain"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossUnrealizedGains",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss": {
     "auth_ref": [
      "r179"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.",
        "label": "Available-for-sale Securities, Gross Unrealized Loss",
        "negatedLabel": "Available-for-sale Securities, Gross Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesPurchasedOptionsPricePolicy": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for premium paid to acquire option for investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Trading Securities- Debt"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesPurchasedOptionsPricePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Gain (loss) on trading securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r261",
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r301",
      "r306"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r2",
      "r98",
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r24",
      "r85"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r86",
      "r89"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r9",
      "r86",
      "r89",
      "r391"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Long Term Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r79",
      "r85",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r79",
      "r332"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental schedule of noncash investing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r92",
      "r94",
      "r122",
      "r123",
      "r124",
      "r129",
      "r133",
      "r141",
      "r142",
      "r143",
      "r186",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/StockholdersEquityDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Warrants price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Warrants exercised"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r36",
      "r218",
      "r398",
      "r413"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and contingencies (Note 6)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "6. COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r99",
      "r100"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, par value $0.001 per share; 300,000,000 shares authorized; 49,279,453 and 50,370,987 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r148",
      "r149",
      "r170",
      "r325",
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r170",
      "r325",
      "r326",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r170",
      "r325",
      "r326",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r148",
      "r149",
      "r170",
      "r325",
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r148",
      "r149",
      "r170",
      "r325",
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostMethodInvestmentsPolicy": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the cost method of accounting for investments in common stock or other interests including unconsolidated subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. An entity also may describe how such investments are assessed for impairment.",
        "label": "Impairment of Investments"
       }
      }
     },
     "localname": "CostMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r57",
      "r383"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "ACTG_NetPortfolioIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "totalLabel": "Total portfolio operations"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Portfolio operations:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Customer Securities for which Entity has Right to Sell or Repledge (Including Securities Sold or Repledged) [Line Items]"
       }
      }
     },
     "localname": "CustomerSecuritiesForWhichEntityHasRightToSellOrRepledgeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "13. SENIOR SECURED NOTES"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Conversion price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r340",
      "r342"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r32",
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Interest Rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r33",
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r339",
      "r342"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Remaining discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r339",
      "r342"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesRealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Realized Gain (Loss)",
        "negatedLabel": "Loss on sale of trading securities"
       }
      }
     },
     "localname": "DebtSecuritiesRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesTradingUnrealizedGainLoss": {
     "auth_ref": [
      "r182"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 8.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Change in fair value of trading securities and equity securities - private"
       }
      }
     },
     "localname": "DebtSecuritiesTradingUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r83",
      "r210"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Equity securities derivative"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Change in fair value of the Series A and B warrants and embedded derivatives"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r302",
      "r305",
      "r309",
      "r310"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Series A warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue": {
     "auth_ref": [
      "r89",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes how an entity determines the fair values of its derivatives, including its valuation methodology and significant assumptions used.",
        "label": "Assumptions used for derivatives"
       }
      }
     },
     "localname": "DerivativesBasisAndUseOfDerivativesBasisDeterminationOfFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesEmbeddedDerivatives": {
     "auth_ref": [
      "r89",
      "r299",
      "r300",
      "r312",
      "r313"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts.",
        "label": "Embedded derivatives"
       }
      }
     },
     "localname": "DerivativesEmbeddedDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r7",
      "r30"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued and unpaid dividends"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStock": {
     "auth_ref": [
      "r237",
      "r406"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Add: Dividend on Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "DividendsPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPreferredStockStock": {
     "auth_ref": [
      "r237",
      "r406"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.",
        "label": "Dividends, Preferred Stock, Stock",
        "negatedLabel": "Dividend on Series A Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "DividendsPreferredStockStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r53",
      "r108",
      "r109",
      "r110",
      "r111",
      "r112",
      "r119",
      "r122",
      "r129",
      "r132",
      "r133",
      "r137",
      "r138",
      "r402",
      "r416"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic net income (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r53",
      "r108",
      "r109",
      "r110",
      "r111",
      "r112",
      "r122",
      "r129",
      "r132",
      "r133",
      "r137",
      "r138",
      "r402",
      "r416"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted net income (loss) per common share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r139"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "3. INCOME (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.",
        "label": "Series A embedded derivative liabilities",
        "verboseLabel": "Fair value of Series A embedded derivative"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAndCostMethodInvestmentsPolicy": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the equity method of accounting for investments in common stock or other interests including unconsolidated domestic subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. Additionally, this element describes the entity's application of the cost method to equity investments or other interests that are not consolidated or accounted for under the equity method of accounting. The disclosure provided may include how equity method or cost investments are assessed for impairment.",
        "label": "Other Investments"
       }
      }
     },
     "localname": "EquityAndCostMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r105",
      "r113",
      "r115",
      "r140",
      "r188",
      "r230",
      "r237",
      "r268",
      "r269",
      "r270",
      "r281",
      "r282",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r424",
      "r425",
      "r426"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r55",
      "r56",
      "r83"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Gain on disposal of other investment",
        "negatedLabel": "Gain on disposal of other investment (Note 5)"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r25",
      "r78",
      "r89",
      "r185",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Trading Securities - Equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r324"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity securities - private"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCost": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value.",
        "label": "Equity securities forward contract"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGain": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Gain on sale of deriviative"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r314",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of fair value of financial assets and liabilities on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r319",
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Summary of changes in financial liability Level 3"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r315",
      "r355",
      "r356",
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r314",
      "r315",
      "r317",
      "r318",
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "9. FAIR VALUE DISCLOSURES"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/FairValueDisclosures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r251",
      "r252",
      "r257",
      "r258",
      "r315",
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r251",
      "r252",
      "r257",
      "r258",
      "r315",
      "r356"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r315",
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Remeasurement to fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements": {
     "auth_ref": [
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)",
        "verboseLabel": "Issuance of Series B warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value ending balance",
        "periodStartLabel": "Fair value ending balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r355",
      "r356",
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r321",
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r180",
      "r181",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r197",
      "r198",
      "r199",
      "r200",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsOwnedAtFairValue": {
     "auth_ref": [
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.",
        "label": "Fair value of investment"
       }
      }
     },
     "localname": "FinancialInstrumentsOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r205"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r207"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Remainder of 2020"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r207"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r207"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r207"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r205",
      "r384"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/PatentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Patents, net of accumulated amortization",
        "totalLabel": "Patents, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r328",
      "r329",
      "r330",
      "r331"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 10.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Loss on foreign currency exchange"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r61",
      "r83",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Net realized and unrealized gain (loss) on investment"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails",
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Schedule of gain (loss) on investments"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfDerivatives": {
     "auth_ref": [
      "r83",
      "r403"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the book value and the sale price of options, swaps, futures, forward contracts, and other derivative instruments. This element refers to the gain (loss) included in earnings.",
        "label": "Gain on sale of prepaid investment and derivative",
        "negatedLabel": "Gain on sale of prepaid investment and derivative"
       }
      }
     },
     "localname": "GainLossOnSaleOfDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfEquityInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.",
        "label": "Gain (Loss) on Sale of Equity Investments",
        "verboseLabel": "Gain (loss) on sale of trading securities"
       }
      }
     },
     "localname": "GainLossOnSaleOfEquityInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Loss on sale of investment (Note 5)",
        "verboseLabel": "Realized gain"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "auth_ref": [
      "r55",
      "r56",
      "r83",
      "r399",
      "r417"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.",
        "label": "Gain on sale of investment"
       }
      }
     },
     "localname": "GainOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and administrative expenses(1)",
        "verboseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r89",
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Patents"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r176"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Impairment of other investment",
        "negatedLabel": "Impairment of other investment"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r209",
      "r212"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment of Long-lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r51",
      "r157",
      "r159",
      "r162",
      "r165",
      "r167",
      "r388",
      "r400",
      "r404",
      "r419"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r94",
      "r104",
      "r157",
      "r159",
      "r162",
      "r165",
      "r167",
      "r186",
      "r291",
      "r327"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Net income (loss) including noncontrolling interests in subsidiaries",
        "totalLabel": "Net income (loss) including noncontrolling interests in subsidiaries"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r114",
      "r115",
      "r156",
      "r275",
      "r286",
      "r287",
      "r420"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r50",
      "r89",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Change in fair value of equity securities derivative and forward contract",
        "negatedLabel": "Change in fair value of equity securities derivative and forward contract"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "4. PATENTS"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Patents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 12.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest income and other"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r63",
      "r222"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 11.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedLabel": "Interest expense on Senior Secured Notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of interest expense classified as other.",
        "label": "Add: Interest expense associated with Starboard Notes, net of tax"
       }
      }
     },
     "localname": "InterestExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r434",
      "r445",
      "r450",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTextBlock": {
     "auth_ref": [
      "r434",
      "r445",
      "r446",
      "r450",
      "r452"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for investment holdings. This includes the long positions of investments for the entity. It contains investments in affiliated and unaffiliated issuers. The investments include securities and non securities (i.e. commodities and futures contracts).",
        "label": "5. INVESTMENTS"
       }
      }
     },
     "localname": "InvestmentHoldingsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r433",
      "r441",
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r185",
      "r418"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investments at Fair Value"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r447",
      "r448",
      "r453",
      "r454",
      "r455",
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails",
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r442",
      "r443",
      "r444",
      "r447",
      "r448",
      "r453",
      "r454",
      "r455",
      "r456"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails",
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investment in Veritone"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r314"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investment at fair value (Note 5)"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by category of investments used to group investments in and advances to affiliates.",
        "label": "Investments in and Advances to Affiliates Categorization [Axis]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesCategorizationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationDomain": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Used to categorize investments in and advances of affiliate. Lists the categories for (1) Investments in majority owned subsidiaries, segregating subsidiaries consolidated; (2) other controlled companies; and (3) other affiliates."
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesCategorizationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r183",
      "r390",
      "r405",
      "r457"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "14. LF EQUITY INCOME FUND PORTFOLIO INVESTMENT"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r29",
      "r94",
      "r161",
      "r186",
      "r293",
      "r295",
      "r296",
      "r327"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities [Default Label]",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r21",
      "r94",
      "r186",
      "r327",
      "r395",
      "r412"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable convertible preferred stock, and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r31",
      "r94",
      "r186",
      "r293",
      "r295",
      "r296",
      "r327"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r34",
      "r220"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Contingency accruals"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossOnSaleOfInvestments": {
     "auth_ref": [
      "r55",
      "r56",
      "r83",
      "r399",
      "r417"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.",
        "label": "Loss from sale of investment",
        "negatedLabel": "Loss on sale of investment",
        "verboseLabel": "Loss on sale of investment (Note 5)"
       }
      }
     },
     "localname": "LossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails",
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputCreditSpreadMember": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using amount above (below) yield between two debt instruments similar in maturity, but different in credit quality.",
        "label": "Measurement Input, Credit Spread [Member]"
       }
      }
     },
     "localname": "MeasurementInputCreditSpreadMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r41",
      "r94",
      "r186",
      "r327",
      "r394",
      "r411"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r79",
      "r80",
      "r84"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r48",
      "r49",
      "r52",
      "r84",
      "r94",
      "r104",
      "r108",
      "r109",
      "r110",
      "r111",
      "r114",
      "r115",
      "r126",
      "r157",
      "r159",
      "r162",
      "r165",
      "r167",
      "r186",
      "r327",
      "r401",
      "r415"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income (loss) attributable to Acacia Research Corporation",
        "totalLabel": "Net income (loss) attributable to Acacia Research Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r48",
      "r49",
      "r114",
      "r115",
      "r294",
      "r298"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net income attributable to noncontrolling interests in subsidiaries",
        "negatedLabel": "Net loss attributable to noncontrolling interests in subsidiaries"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r111",
      "r119",
      "r120",
      "r128",
      "r133",
      "r157",
      "r159",
      "r162",
      "r165",
      "r167"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net income (loss) attributable to common stockholders - basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r121",
      "r128",
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net income (loss) attributable to common stockholders - diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r102",
      "r103",
      "r106",
      "r107",
      "r116",
      "r117",
      "r118",
      "r189",
      "r190",
      "r247",
      "r248",
      "r249",
      "r250",
      "r271",
      "r283",
      "r284",
      "r285",
      "r385",
      "r386",
      "r387",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "8. RECENT ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/RecentAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r237",
      "r289"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r45",
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingLiabilitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Liabilities [Line Items]"
       }
      }
     },
     "localname": "OffsettingLiabilitiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r157",
      "r159",
      "r162",
      "r165",
      "r167"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: short-term lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Long-term lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r348"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Leased right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r343",
      "r345"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "totalLabel": "Total minimum payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r343",
      "r345"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "verboseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r343",
      "r345"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r343",
      "r345"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r343",
      "r345"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "2020"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesIncomeStatementContingentRevenue": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contingent rental revenue recognized for the period under lease, based on the occurrences of an event or condition.",
        "label": "Income from settlement"
       }
      }
     },
     "localname": "OperatingLeasesIncomeStatementContingentRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating lease costs, net of sublease income"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedLabel": "Other portfolio expenses (income)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeInvestingActivities": {
     "auth_ref": [
      "r70",
      "r81"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.",
        "label": "Payments for Hedge, Investing Activities",
        "negatedLabel": "Equity securities derivative and forward contract acquisition cost"
       }
      }
     },
     "localname": "PaymentsForHedgeInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payment of other issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividend on Series A Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payment of lenders fees"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesEquity": {
     "auth_ref": [
      "r68",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire equity securities classified as available-for-sale securities, because they are not classified as trading securities.",
        "label": "Payment to acquire equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Patent acquisition costs"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of prepaid investment"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedLabel": "Purchases of trading securities"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockAccretionOfRedemptionDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of accretion of the preferred stock redemption discount during the period.",
        "label": "Preferred Stock, Accretion of Redemption Discount",
        "negatedLabel": "Accretion of Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "PreferredStockAccretionOfRedemptionDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "negatedLabel": "Dividend on Series A redeemable convertible preferred stock"
       }
      }
     },
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockRedemptionAmount": {
     "auth_ref": [
      "r37",
      "r229"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, par value $0.001 per share; stated value $100 per share; 350,000 shares authorized, issued and outstanding as of September 30, 2020 and December 31, 2019, respectively; aggregate liquidation preference of $35,000 as of September 30, 2020 and December 31, 2019, respectively"
       }
      }
     },
     "localname": "PreferredStockRedemptionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "10. SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r22",
      "r23"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Issuance of Senior Secured Notes, net of lender fee"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Issuance of Series B warrants",
        "verboseLabel": "Proceeds from issuance of warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r64",
      "r65",
      "r174"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Maturities and sales of trading securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.",
        "label": "(Purchase) Sale of other investments (Note 5)"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturities, repayments and calls of securities classified as trading securities and held for investment purposes. Excludes proceeds from trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).",
        "label": "Sale of investment at fair value (Note 5)"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r66",
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.",
        "label": "Proceeds from sale of securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r71",
      "r267"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r8",
      "r94",
      "r186",
      "r225",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayment of debt",
        "negatedLabel": "Senior Secured Notes issuance costs paid to other parties"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepurchaseAgreementCounterpartyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Repurchase Agreement Counterparty [Line Items]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r9",
      "r85",
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, ending"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.",
        "label": "Long-term restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r237",
      "r272",
      "r410",
      "r427",
      "r431"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r105",
      "r113",
      "r115",
      "r188",
      "r268",
      "r269",
      "r270",
      "r281",
      "r282",
      "r424",
      "r426"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r154",
      "r155",
      "r158",
      "r163",
      "r164",
      "r168",
      "r169",
      "r170",
      "r244",
      "r245",
      "r383"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "ACTG_NetPortfolioIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r90",
      "r91"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostOfGoodsAndServicesSold",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Inventor royalties"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Number of stock sold"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r148",
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Capitalization, Equity [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Calculation of basic and diluted net loss per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r202",
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/PatentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of future minimum operating lease payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r60",
      "r63",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Schedule of Investments [Abstract]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r38",
      "r92",
      "r141",
      "r142",
      "r224",
      "r226",
      "r228",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredDebtCurrent": {
     "auth_ref": [
      "r10",
      "r393",
      "r409"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, collateralized debt obligations due within one year or the operating cycle, if longer. Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Senior Secured Notes Payable - short-term"
       }
      }
     },
     "localname": "SecuredDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r43",
      "r97",
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Securities Financing Transaction [Line Items]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTable": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule, as of the balance sheet date, of security financing transactions by type, the aggregate value of securities financing transactions by type and aggregate acquisition price by type of security financing transaction.",
        "label": "Securities Financing Transaction [Table]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement of financing transaction securities held."
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Non-cash stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r259",
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r89",
      "r261",
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the share repurchase program."
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r11",
      "r396",
      "r397",
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesTradingSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r92",
      "r94",
      "r122",
      "r123",
      "r124",
      "r129",
      "r133",
      "r141",
      "r142",
      "r143",
      "r186",
      "r230",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/StockholdersEquityDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r40",
      "r99",
      "r100",
      "r101",
      "r105",
      "r113",
      "r115",
      "r140",
      "r188",
      "r230",
      "r237",
      "r268",
      "r269",
      "r270",
      "r281",
      "r282",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r424",
      "r425",
      "r426"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r140",
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperationsParenthetical",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r14",
      "r15",
      "r230",
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesRedeemableConvertiblePreferredStockDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r230",
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Compensation expense for share-based awards, net of forfeitures, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r14",
      "r15",
      "r230",
      "r237",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock options exercised, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r14",
      "r15",
      "r237",
      "r260",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Compensation expense for share-based awards, net of forfeitures"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r40",
      "r230",
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the CCYY-MM-DD format.",
        "label": "Plan expiration date"
       }
      }
     },
     "localname": "StockRepurchaseProgramExpirationDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Value of shares authorized for repurchase"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r14",
      "r15",
      "r230",
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Repurchase of common stock, shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r14",
      "r15",
      "r230",
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r19",
      "r20",
      "r94",
      "r173",
      "r186",
      "r327"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Acacia Research Corporation stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r94",
      "r99",
      "r100",
      "r101",
      "r105",
      "r113",
      "r186",
      "r188",
      "r237",
      "r268",
      "r269",
      "r270",
      "r281",
      "r282",
      "r289",
      "r290",
      "r297",
      "r327",
      "r333",
      "r334",
      "r338",
      "r425",
      "r426"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r237",
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "7. STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r88",
      "r89",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Treasury Stock"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "15. SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r8",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Series A redeemable convertible preferred stock, par value"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "auth_ref": [
      "r8",
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, value per share"
       }
      }
     },
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, shares authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, shares issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Series A redeemable convertible preferred stock, shares outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized holding gain (loss) recognized in the income statement for investments in debt and equity securities and other forms of securities that provide ownership interests classified as trading.",
        "label": "Trading Securities, Change in Unrealized Holding Gain (Loss)",
        "negatedLabel": "Change in fair value of trading securities and equity securities - private"
       }
      }
     },
     "localname": "TradingSecuritiesUnrealizedHoldingGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetailsNarrative",
      "http://acaciaresearch.com/role/SeniorSecuredNotesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r180",
      "r181",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/InvestmentsDetailsNarrative",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesChangesToFairValueMeasurementLevel3Details",
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Average price paid per share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r39",
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfSeriesRedeemableConvertiblePreferredStockAndStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r39",
      "r239"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r15",
      "r230",
      "r237"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Number of shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r39",
      "r239",
      "r242"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost, 4,604,365 and 2,919,828 shares as of September 30, 2020 and December 31, 2019, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r127",
      "r130",
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) from continuing operations allocated to participating securities for basic earnings (loss) per share or per unit calculation under two-class method.",
        "label": "Undistributed earnings allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r127",
      "r130",
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Add: Undistributed earnings allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "auth_ref": [
      "r125",
      "r127",
      "r130",
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Reallocation of undistributed earnings to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedLabel": "Change in fair value of Series A warrants"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax": {
     "auth_ref": [
      "r308"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.",
        "label": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax",
        "negatedLabel": "Loss on foreign currency exchange"
       }
      }
     },
     "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Change in fair value of investment, net (Note 5)",
        "negatedLabel": "Change in fair value of investment, net (Note 5)",
        "verboseLabel": "Change in fair value of investment"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/InvestmentsDetails",
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Changes in fair value of Acacias Investment"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/LfEquityIncomeFundPortfolioInvestmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r152"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/DescriptionOfBusinessAndBasisOfPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Fair value of warrants"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative",
      "http://acaciaresearch.com/role/SeriesWarrantsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in CCYY-MM-DD format.",
        "label": "Warrant expiration date"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/SeriesBWarrantsDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Potentially dilutive common shares"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r121",
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted average number of shares outstanding - diluted",
        "verboseLabel": "Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r119",
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average number of shares outstanding - basic",
        "verboseLabel": "Weighted-average shares used in computing net income (loss) per share attributable to common stockholders - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://acaciaresearch.com/role/IncomeLossPerShareDetails",
      "http://acaciaresearch.com/role/UnauditedCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2740-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27405-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "325",
   "URI": "http://asc.fasb.org/extlink&oid=75025870&loc=d3e40691-111596"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21459-112644"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21564-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=107671284&loc=SL5844817-113951"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=77984636&loc=d3e40733-113955"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=6435544&loc=d3e41834-113960"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121596415&loc=d3e48542-113965"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=56949186&loc=d3e50579-113967"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121578510&loc=d3e41551-112718"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35711157&loc=d3e42546-110969"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.13(h))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=49176635&loc=d3e9760-107771"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611133-123010"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(1)(a))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611322-123010"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611322-123010"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r459": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r460": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r461": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r462": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r463": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r464": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r465": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r466": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r467": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r468": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r469": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r470": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r471": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r472": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r473": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r474": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r475": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r476": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r477": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3444-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(m))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>70
<FILENAME>0001683168-20-003785-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-20-003785-xbrl.zip
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M>K>U TL6@;X4U;KEH]9N3AWM6F>*O^\SK/6&UND4UQWKTNGOOU!+ P04
M" #/@VE1AR5*4AD'   :'@  $0   &%C86-I85]E>#,Q,#(N:'1MW5G?;]I(
M$'Y'XG]8(5V52$X@R>7A$HI$@%R0.)(21VH?%WL->[&]=->&<G_]?;-K?B1
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MW/%LN-DG7H8;>/E!J2VF! 3 8\]@\_(J?3%Z@+BI# D3W*@4' 3.X :(HE&
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M=C#?6+G56TI(DLV!I;*\5DE+.Q@^\=5M?<*C;#3%4W.'C7I,4I8\G/\?'\^
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MCOI9P*9^?U:^4-/OW7X 4$L#!!0    ( ,^#:5$4\_DSW\(! .1D%0 6
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MR$IVH-D8V!ETA'>#]LU%N_?V39'.4>C9R9D?68E9RW=L/FK.(Z V/&YJ/BP
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M"DSUHPHO%<$,C922\%!SJ([ B7.4-%,P6V(A^6'C./GJ=KK*<.ME@49Q!RB
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M1CP"]L=OWVQ%ZC@\AX9#DG%T/5?UL ,*"T@\"FM7*][-2!A%R.AEX@*]_46
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MN[$B+A6U &=\RZ!OF3H!3$H!0T<'F+6Y0$BYG0%]6ZI*F6O/!G 4 ..E*TC
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MD68(TGSGX3,9G:X,<;OS@P@5>NL[9-8Y5M74[1_&\OH!ZX$ \+1]H0[O798
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M])%'+<>=V"6\9=F;O(]Z07RN2E>S4YM+E.VAUN,B71&V5F[&6;FA=X??*'/
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MY-BMF"0>51Q"1]>Q^-1D'H62AQ#J.!AZ)D)MWQ<&-786<U[),H_[B +E6>"
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M[+A2(.G;L^V;\\P6S\W6E!M0&BX7-W'U+]WGL)EU-JSW]+8FQ;O^.JL8]B_
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M5[]M:[9LW^^W&TSAD6%*9C>8UO<?S]KBX8&1:B%V@SD46O_+SF1HD71\)=U
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MW?@W-'977_<#QN9PW6W[$<E[]W0=>/MF->-B=AS8&2$5;,&"5[[[9YS_:9+
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M!"RV^\&A@G?(I[,QG_*7L.(8(5_!&5MKHL:G_';5[Y,%K8WPQJ!K":.QR@T
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MBJB1G=+H*\K98QK<479:A4DAVBKS(8;2Q#@3,LX$PK8SZ;TFAR\Q@A@YOXO
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M8OW,1C4DWA.'^F@  8NM&0;]EFGW-9A0^5D5B*7#LO2;$!NR4S-7A1B5$8<
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MB4E0C(/  9-5#:X/NBIK0FX\Q#&I[\(\OL]P] 9:(_!VC#&$?C!'EZG1 6Z
MN6 /$JWANGA1(^R;7#LXOA1)\.\03-=0='@;WUO88.-N^"6A@HOG,'5<Q@ZK
M.6N:;##?/SVA7,G<#%@F,&,U; >VF]&-;C#5F6J]^_UNW7!SITTB;5S6#Y<?
MYB<0[<!A<)I?F9;J[U8$F9/H+,O>  DQ"@0Y2[C:BT1L>^2"1U>3B/YX9T4I
M!,KT)GN&X RB5EF+-6,\M1-(WVAX@*\:)#7AMDY?:0(]$@K ]:J;4@'Z_ W#
MW^F26.7O(:1/:=.4>"8X9@O?)6#?AM.Q2T2G)^!6Q[\0_SEE]];5.C&SQ4T)
M@7((8PQ<2<<PJ1O!9#:N1%;F9&(DV%<CR&H2EHUIN-G<H2 %WBZ]I+!/AM0W
M@NA?!-0IONI9-"-,S1%KH<"+."38/C^O",2H119"1/]MUL&N.V4#XL;,Q L'
MDI)N5QT@K0""UF EAN\)V^(1?>H3(%&3FX#I3;>.0W/3=+ F8AKP<#Z!\;KY
M[0@N_X4#APA]Q$AZ GA&2'B& N6H J]7%-8UBY"5,K6Y>]66_F $AAJ&;S.
MB[@,K7A1(I3*PEQ.@"UDL6\KA##''XR3T&C,"PL-V'%1!L.%811CH$&9QC4
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M\C&)!U$3X@T\L7JLS@-@EGSJW^=8]89/"2L94_ AM@<D\*^%Z^$$W!X*G]A
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M%.1P-\3,'@1B5ND^8J:Y'C"10M3D&H[Y_?2D!2GZ$*'14'0DU*:2&'=3*0Q
ML%# H*S$B#(QWJ*_O@>N18BF%B'^7&JQ#$39._>F[)7GE;UE[W5G^6M1SCP,
MJD^2$+BR=_Y)E;WSTY-5VMXMX 93855)P:]C+$;34'ZU1L\[7Z_GG9XL4?2$
M=XA_&JE*SZIPBT;HCW4H-R1\(.H4-8'1$(VRJJAHF/AT1^$K$H@B\&?LNZ""
M'<>A+7Y-?3L]6:TREB-]Q^RJ,N*SQ4=[*^@#A=_I=CF?ZPADC5*>L"IO;<=X
MC3Z/-Y%+YZ*K:"X!D[O?SOGCDCWZKX2>GNRNA>8CC>R^:*$QQGO77:./]DBO
M+:Y'_&6*[7FDT7TGQ39&\_7J</31N_ ]A?CZ*ETYX4E1SAT$HN^D*,<([UV]
MCC[B)]<S=<-(I''*&&D) %(<4X#0'VE$KX)N5,9TH8="I.FA2O<4T\%.=. "
MQH/!_Y1' OB:_K;&Y1EM&^GQZ*^9_/'KK[8]^HWPN90?^FLQTLA^9/KKOC$^
M-/TU0+1/?D]EMM=?2Y%&]R/17_>-YH'KKP&B=^I[:;7ZZMG5>QBFFB/18*."
M\H%KL$%R]F UV&BS_B/18/=-!X%KL$&R_K4$\)U9$CV1WFOTA*M;/KCH"1>(
M+Z8K:W,!%$NB15U>[,[*F<I_M]RORJR>"2Z"PIC93@NA!%&XQKH$-)G;)AE]
MP.JXRQ5D\(K0K0/A<T]@>F)_K'*D@19"B=,3?2"(*C-0-!WC"R1?XO=PT 3/
M:,*(!;56FN+GR8.BR=^^,V4TI*P,<=<?5M<1]:('$0I-%/45PC8P.T)S&W$4
M)!#"#,LX/:%Q&<+B+FC3+RLTOR7P@C#$N5851<:93O!YKB,)B?PP5X6C_IDQ
MV!]F&# "T]'0Z*JHZ*)V>@*T?2&H,OH7VA@-1Z1J( DG02N@#<, .N:,_Y^]
M+VU.6]D6_>XJ_P>]U#[UDBKLPSSL?=ZNPA@/B6<[=I(OE$ -R!82T6 ,O_ZM
MU8/4 HG)"+#CNO><$P-J=:]>\Q@  (_H]$$<PF=P2G=@^2"#)WI]R\3*VK_Q
M>=7I[EDF -+_G*V]NX-K>,U'4"X04KA#AQA4U6#.!57#RT;8"*%,UZ>"VE3P
M@MV)515I4?I6OG+86T%AM;O#8 0G=$"QL1F0/NM?*#1T>&_8EX??^CDUEF?C
MJWL6%@(!]%/P(#RI]ONVU;=UW&?P2IW;Q/3=])?PTQ;<G.[N[CA]FZ@:?OK\
M94SUA@_ES]16R_;@:C\S505 T]_S^GA9N*[SA3LAGV'QF%P==@1  <_A%^O
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MRPDMALFM@M'X[C<^C!0?02+D81@JHVB^M$.;V&%V-LVH)J;LH$"G#.614A/
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M5;?O<2[F E"I]YI$TXAV" \\T\%=CB3F'[^?76L'0_WYAFRG^7Q&'.=OA0%
M"<\&75S.*X0# VY;0&-[R2/&DTSI8\48L?Y4LURJG,O\D?FZZ[J_#\7AC5[<
MAT[Q9J_N#:L;U3G4C0?5ME73E14(YSI7NCZNJ!5SF<JV]?H)YM0E!OR4VXOD
M2VD&XO+6+^LS<S6@^?-D_;0;^9#>VT4=2:9%?]#'<O3Q1B5M;:JDI;TC0;]@
M(#B($KG'/?7VQ\VO_,F6%I-/E[,:/Z 0N ?O3^#&W.'Z)6\A52C\F1U@5G U
M'R)X2^DEV1*E#XIY%<6\4:%<E[+.3G$, ''<.AO.?>EVB2W)WZ>30>56)\\_
MFLO4^6P@-"[.H_!IXSA%VVKIJC_?^]95[::EVIIR8;DX89).N6[C8.RWAL4B
MWR/J#M<6_<ZDRN79*=3O@,^OY@X^!.T6$$$B/=0^R&!!,GBCTK,8UW@EHLJ8
M:#.:K 22]E<MFWY6.S\>K,?MM'2I>$VPB\K6XO1K+WEMHGB^EB;OG@<E<5\?
M8OL-759"(GZ^CAX?-[8D>;U1=2"[&G6 CU&2%(+<0SEGOY2.[A^W/2L]IJSY
MAJA^KQ6TL+UHW>&C[]HRG9&6PJ[U.^6SE>)'YX45H<<FL..CH]H;0(R-\8TD
M@Q.Y5'&.)K<?O&.[><=[ZI:67:I;6EBQ&UT5C@XOK9>[7]?%;73S3.)]=K_P
MFM9I&CO^PN3&7[LPP='G%,WR8%>KIKD%UEYQLZ3D];=QM6VI[I440$G*Z?>!
M%2MKF_0*Q6T3+=7F1X_%Q?/[P(PU\8LDVJME4KER^H-CO&V.L76MUA9F&1_-
MUCY:=WT<[(\_V(Q<=&'C7A'[MJO:A 8FJJ;&V>,A,?6>;JJN95>;8!C3&:4'
MVV"OT0\&!"&%[S6T3__"9BV^V;_?^:U^'.SC8%MRL%DCF1XHC1*M"LQ"[9 +
MK]<D]F6;<AOGTG,=5S61W*5F^GH_W1A]RSN7QN7%3]W+;'G4[]._XHQ[*CND
MXM#3*9Y#-*R% 8VT[]&0GCGA/>H3F_U\A2WXMS9DOA RK-3)<WIQY"OG:4DG
M9Z_^]&^^G,H72ZER>27SY+:=\A.^I:5]+C-OJ9(J9\NI7'$E743^\%MZA0-D
M#FJJP%V5TK.#WA_W- \U+>6/F(.:2ME2*K=ZGO<*Y\,:$GBO+!=6T57#& :%
MJ4+:4MA\V \?!_LXV)KMA\TH^=EYN8;?*L9O$J3<;J"/K+"R*N7R+"N+.W$F
M)$U5>_0<MT?8S'IF;[50!TB7X,\&_5<EEVXT_.6/=%,U6\ Q3TW'M3U\M/JB
M.](O&'2JX09*Y]AZSVZ,[MW.8>[^I&C=@WQR=1=//IL)?TI8!L\&SWP6B !"
M8PH,5B2Q*ZE"N9)*Y]^N^AN@;VZ5Z*M1#,Y4! ;#OU:*P<_?OE]ZY-Y^_DK>
M/ 9/6F>+8W!4RM(LY'WKI1X!ZL[T;RV.NL!R,\DPW_/#J\>,>NOV;O4WC[K"
M9'T-\_VS4;>0"-?-),-UOW=M^Z5SVB]=/[UYU)VTXM\TZF[$PI];5[\AF,7;
M<OT>T B6==?=!D17VP)-741\ ]!0-/N.@!'T-CAVKK,_#\Y;PS=/;A%J.H-
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M*G=ZCSC*!1DH-U9/-5/L@Y2"RFS['Z6GVAT=WH@_30>O[-,E\49X^=6_L+A
MKFRNUA@YQ]_2=\VAWKW-?EKA:^G)Q#NG[J'0&/W^-K#O?O8KSG-[,WLX!,OH
M\?K.37<UX_KQ]7N8_?;_L[>G'.G$T/Y6KM0.^0<6^NT1LT4P4J/L[0DFHNG/
MX7V>DI?KYP.[GLZUYK;2V.[V7*O_MU)$'.4?B >*R,#^Q[KEMXAA<+V?-D7
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MQ0GMP=>C-N)^RE=*@:MQ='-L'Q]4>R>9AX7\0>OL0Q%Q;PN&,#_]>V39[,W
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M0) HJ.UK5 *![!O!/W&Z3231RUF:9_"C2_-6Q7R; "H.-]FTWJHN;'3Z_?)
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M$HQJWW*$7%RJ!!5#FDO7H+XV>2R0,6,5J97&J'+TX_O3]XNOO8,@K6U*16I
M !KG=8D7GRY2(/J*UX@P[WM^SQ;4QZXCV7#.0EJ6P@O<#J3?_YJV\M]_:>,
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M%]I"DP#JL" 5*L)M.JA0P9P13)K(I-C'\"<Z/H2&W,?(E@L0@ V<6V"F23O
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MRDI8:T>3!;;>LO4F;K%I/2?=4VI="/" !943H5Y'Z*3X#;.;F1OKA2O72V%
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MZY*HFYUDQBSV,5P#O6:6B\J9%*KL"XS'R/)(. (-8(H"JS9H*&4WP;$[*3]
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M&_8J[\V85),DC!+!!B-P KS'&.-;J_*X42OM-?%/%R#]D2>%'["]]B_W^3M
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MK27;W;AML-/>K#OLK[IFWR7WQN RTD!0S,UR8K2R8^X1A7_FMG+# !B^)7.
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MV,PMP5J(P_]^U'HT#YQ98EV#>'HS3Q$U)[*IUMZ]Y?J?YMJRVZ31I0'<."0
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ML,16K:;VAX__9/EH@7AY6_SH>%1:930WSO3QSM'V>#'\R$+*X[^B9 2D!+#
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ME B,JHG/$'<]ER#04=_>VP2]5XE=6SCXX?G"!H[V _Y%IBM0JUT$ /'LO9&
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M,M[62V)_2+2G19.3:__^-W95_A]02P,$%     @ SX-I47 GI[@\#P  TZ@
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M*:F[KP52'Q>6+G5R*#DUC%9']H_0ELUH3.+$W=+E7,"*!8"W_33EBI)D!DU
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MN#CH"3O1L+\G[5+-+M4Q3.MBJ',#/ZBY/R,G<G?"#ECT&[@[4<19+(@@>5K
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MC.%0??\&YM#S-K5Y&/O^5-=)-V0,A\I[Y[;0GH?8CV3*?U=!*1VE.E5=9]V
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MPR_63^S_'IQ/L5AWH] *5\&VK_>O[]?_B\G_Y3K>[U_I_SU9 3+(8'G!U]?
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M<H+?;]YND#>=DR7^.]M)RZ?4X)%C'D8XITAZ:A%IOC=<\QQL?$HU'E=A)'@
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M+*">^TDMCC1T,S::T73N.7^L.*X J'WM' %LP77+3DUSRS,N80HU+@#.>//
MT=S\EX>/SJ:_% PKO06\<:WI[V2+(.,0/& ;N4Q/--!:F:'.7098D'?8*I?L
M]W^@,ZIC^2Y^0.$<PZH ;9W=>'*I*% HSVBS6 <'^UJMWW^7(KM+T:3F/OO
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MQ\H)WZ*@T6X49D"8BB)&.2H[ATQ9L2;AU8?S"@.N6MF6KH0T1T4&;I'!9T@
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MM5@[>+&T/-[U -2\ZL/GV$I^+#GTV1+C=(OI&^,LVFNA_QF4(9#<C.5@(U*
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MO_79Z-^:&_U;H(W^K7VC?WON1K]-"8XVB;E#5P@Z:WHMT+KUI5(P"*"#UN=
M*7OZ3OY$.]BK5;I/<CH+6N'HA27WZ#>OE>).]ZT-H#M;U@I9[TRR!"AL5)?B
MJ)$'1JE9\H*SG*WS&2:@,D&WQSQ40+NG._I28*BCA":>Y:@$'4PJ'TG RADL
MV?IOE..,%-FLZO[(H."L7[("7O=/6FGO%+&&*.9;<1W4**$R&_G,PY<^V*&L
M 4*:09R!3YDQC/%$F!O\)%\X-TI[(XL(64F51A0F401\9IHP%6!CEZL@9I5;
MEL\8VYQ858N[',>80+=',RI9[Z2R!-AG52F.N#S,(ZJ3+,.*# :YB-.IE 1<
M9_K4^AX,1R2@A&D2%P$676Z#B/#"5U>'^L^?(DSH8WP^W.$7VLKJ6&.K[)(]
MPQQJ\\I.$PSC!L$5EH"H1E'P#-4Z/!GO?O(SJ$A5NS9+=OL\XWZ]U08NK887
M)JJA2^DGBL/CG!*CFF@7J%"Z0%P-O84;"3_P\ST\+^R6X#_V.%D=[,*@6M-3
M##2YH@B *C5X3#1B[3.R)8YJ>9@QKP4UJW,7[8*?5M4+%RV<D9)1HP>/C6:P
MN@#9Y*<""XU10F<T41#/DBPG>^:=+ARJI)W23@^YPS2Y*!QR:?$)?*JD42/N
M<G$]&KI,*BAX6OI2 %>L?D7P5TKE$ UK8-'IUTK/-Q&0IXQ9:?B>"$A2R2S$
MO=/,'J/]1.!T^6;G8YH\3\U*PS?3)/EK%N*@F:;/:U,S[>Q);D7D;$+I#2;1
M"R\$I]D&LE!RUB5:.U!WBT8-[TP:!%-1]JK5.[8T_=%I#)L D6DPEUX'E48S
MZ=Q$^B4@)$CR)N=&S1^EJ#/:&,#6;%'(P2")'ER?&Z4T:B5%.<U4B(:E*D0@
M<A6DH-73-=C9"C* %E.UD^8K**C2JJ1F$T"TXLZH8@&ZIHI&%@95S "U5>W.
M$%5.,].ZBX*G*%:M%2FE7,ZH%!#;LZB>B'?*Z''UF5)+G3N,E+4_RZY.4SY#
M(>BZ-JL<:+\ :U?*>]L;H2E+J5;2;FAP94L#0= Q#11 >S2X@DL#.30%#:Z<
MT6!*C8<A#ILYD+XSL%5R-[FU=:"9W9HT8-#&%J8PORWUVM-:UYW+*%;9Z[KN
M@H9SS%81!M4&HE7V70"H5X=9:\*I-7QU<7;D4HE#HI0!H[GW.SU[3C-C:N67
M\*T-PW%&M;C+.90)='LRI9+USBY+@+IL,RY_RM..Y^'4 XE6^.<TIG'4.#>W
MU/7)-JT[.NI)%<'R4(?62,H+Q-51HP\L[K'M7'Z,YA&OGI/HC[TNZJF$7;)0
M#[A-.[DD&)YIX?6)50NCR6Y'TF#US \5U*KG342[BH/5[\O5,W4I^Y"&6'[I
M@5[4V=C+ +8>="GDO//# IQP,(Y)HU(<<7E@8::9/S3)DZSNG2;8Z%5<AAP;
M\.W HY/W3J\!(/LT:TT"3YX">YX1%W/HEF!<5<M?!+F^YLT0 S['7F;'= ,P
MM388>@Z&;#$4XX4VF9'F]@1F!EBH['O.[I]<Y3A\Q&0[B+LR19^<53NBXZJH
M!9:C2J@6W*QT$5-^)8R\B5ZB$"?AX*BJ,P"!H6K';)@J:H-GK!+R$.961DX;
M5!53D@\I#>'7 8G3#SA_3D/UC$0EZ6Q"HH=:ST?D8MZI8\8F<(0)(RZ-"G%@
M\6SR*2"A88&W)^.T3(<,7J=.1UO .T%TJ(1*'4S&05FZ<KN!K[U]]^X[8U)N
M7]!U2JX<:#\AMROEO>&-T%3)N,62*)4&%A?ZO>--E/'ZFX/'-S)%G^,:M2.Z
M\8RHY9UR@Z%:C%\J72?#EO;K\OY/EH&I)>@E, E I8&IEO+.$B,T?6"BTNZ3
MM(;D9@%(R;+.Q()$"0,ZF[PKV!W6-<%AE"]W! ?R"=$019\=EMH178<E:GGG
MW6"H%AU6H8L*96",;$Y$9+-DDH23\(65;,P>T\EZ'<41[6*S:_H_FY1$_S15
MW!QKS$]=\3$.RVN/#[$$AN%'P5?7,,]0E/"M[LH>RE/46$1=D^>=5?Y,^X$\
M331]=5_"60\MAU;WR]VOO7-&C4G(>RB%@(6Y,K_V@9K$A(9C?AQ,V^-J-9Q>
MYVB&WKG442WNG4;V&)4)SK5.>:+O[)<>9SF=8^0EQH])I+_N6"WM\*)C$^36
M%<<J4>]4L<,GW@-:*93TX"KGGQSNXO2 ,?_)^8[U:QJ2Z*0=3A!-D%M31)4H
M#)(8\8G3Q$*AI$BI JS#FB1Y%$;QGDUB6U7,/J_B/9WAWM*6O$ZW=';!1U'S
M]30@291LL@=,EL\!P5<'N0'=!LHY?]'I=LSY'UUG<^=\/^?]!7/GH[#QU%)H
MEWDXZWRA*$QS%60XG/$+?^F/\QTP73@WZCBN,F2&WZLRI%;PSK\A*!55AK@>
MJA51H7G>:)^1O!7IZ;_Z49Y^]-LUV\/ 9!>0_' ?;&5[VVHQ%YPR@60T4LEX
M9XX!F%@EI!%%3!94EBP/H@N\HP_FF=+Y@:0;$FPU?;E.P>G<U0B\,W552GNG
MDS5$8>+*%%"C@4J5\W9D?&0KP-2<P]7*NSN%:P&[.8.K$?;.%UN$ EWXE$1&
M%U"SDV9 5A;93C:/)$@R2D?]#H&-HMO%-5M'NFML)BWO!!P,55QQJ\?<M29J
MJ9XY@-6__E"^"9,-P5A?;\U"R6%! 4L'6C4%#!K>.34(IH9/E2*J-<]>F2(/
MR%-*!_[EU13J?E FY[#_4\-L]7NB$!!JJ)&)_5PI6EZ]Y:8HS@*'E&_L5N[K
M-'G!)(_HG^JMH&&JKDOBV#K3KXACT@/"I4%@E=M%C3YJ&3CQWM%IQE2MOM60
MZBZ5=#EJTD!M#Y,D8M[)9<8FJ35;CWG 52RY2Y--CLF65;\UL$8NZK2"J 9L
MIXRH1 X,<33@A(*B5/22R?+BQ!<.CE$L<1*EA ^U<'B?YEA;55(EZ[ GT\-M
M=5UR0>^LL$$G=DY,')7RB"N<?8OZ,QUQ)QN;6912U-T^AAYLLWTAEX-!"CTX
M8;.BE'8W)?I QT)IHCF%V?G>W=E+":SFQ&7K2QBM+$$D)@0SD?//</HQ2'XW
ML$G88^R7W BLEX1! 1,\J_!_NBN %?PHLEPLPK]"T!DOM$!K3DBE8/!!!ZW/
MA4+67=!_2$F^3N,H9>D:01+IQH=J66=<,,&MZ: 2A,$( [H^*6IQ5,M#2%?8
M$Z*X_5O\VEEZ@@14G9;0^LX[#Q2 A#2$4N2$:PQ9U=P97GV]25^^696_431Y
M]:]^DU>?__;CU4//E^Y7+II:!H8U<_MS[TTL =-O7I:-3+O\OT?))DRW%^@A
MW2=AYN1>*YS=K6_IKSWLG^)HU6S&J./_,'U/-U_9N:6X"DNO[)U08Q$;+LNB
MO<G=&C$KJ##32:\\\S)$[\+ NUON#3^MBVU(.=" MPL>K1Q3WO:HU8;!RS&0
MS?= WJ';DIF%(8_4O$T)RQ2]3I.<4!5[2BH4O5%1ZXB2@E(MF-330353KM1&
ME;KSZR;+-V=DOVPTX.]*2AO'U)=4ZK1A\' ,9(N++)L8Z+IWEH\UQH\5P9#1
MY(IA?/@:Z&? :C\F/ /=I-/0$$?%#)3^T9]\TH]^NTY?,)D\93PH]_R7?.^"
M64I8C#_"E]Y9HD(DGGV@,NC72LI/<]^D*UZ=G.V12_SH?NVJL66@JK9N?P>B
MJ26 A'KPI0C/1/#2S!/Z\R&#<!L'&XD3O>]=-;045M72G2]!-+4,D7" LI)!
M3,AO8]_@;$4BOM>A\Z8CYKSI)2 %!K1D8!%!!*;F0TO6:ZA?X$W$NAP&9)G3
MV3[[4!/8%/*N.P,M['[O(!4&01T;A,K^HZV$:BVO;)HDR3Z(%WB7$AV)NF*N
MN2,#V:=,6P844R3 E 0I9%$A[)47_[D/2(Y)?#!20Y!TS0X%U#Y!>F*@."+'
MIJ1)+0Z!*3S1.V(AS4@54=3YE$0!5IB>].1 L44!3CUMJ>4A\&7YC..X2-$P
M!Q>9L&O.J 'W62-*@N*-$IZ2.5RCS*<!$6S:+DQ?V B>#J(L76[)^Z20 %O'
MHEH8+)'Z""VYQ-40T_/*IP=,HC1DQRI-3!(D77-( ;7/GIX8*-[(L2D94X@C
M+@^%*M,DM")*+>>')CV8<I*40@ ITD5F(@B5]D^/VRA;!7&!Z)9^UL_V-,BZ
MIHD2;I\J@B HNJC0*2E3*%3,X2H :/,/'! [TK0D_5!&@"HG3"T&D"Y];":R
M,'F/5"FRFUO8U7V06M391J\!;+WGJY #01<#.'GZ>9<N7OND:9)'^>$VBO']
M7I)[(A=QQ1 5N(H9_>]!,$(!2LB3XV*(R:%"T&/[5[L-2<XJ,RJ=ZHNYY8$<
M9)<+71E ?) "4W"BD>6%,CWRXAJSE,UXEH3X\]_Q0>F=(.>6&0J876KTA !Q
M0XY,08Y2&'%I1,4]TN.!1-N ');1RM!YB()N":("VF5(7PH01130%!PII=%R
M=NV_;WD,/L]"2MIH':WX=K:!*TIYMY0QP.XR1R$,B$!ZA H>4274U?)/IUFR
M2LDN;:53\,K2Y'"=ANJ1BT'++;6L7.@23*L"B&8V.!5DZZA>%#DO*"6H-("8
M!8^\FX0A?5Q9^9^[*,%OE4]!*NN68QJX769)! 'Q28U.P:)2\J+Z S$=-$]@
M4>?= (??^:?..UOJO --G7=CJ//X*05%G?<#''[OGSKO;:GS'C1UWH^B#FU^
M ''GFOXY)X_I)UEJN%+2"W%$J%+:-&+P2"-@,U&&*;!Q#E/Q3Q8^[)J3!Y*^
M1,E*/:!6B7NAC0*TE#L]67@$D@,TL:@>+E=Z_JE4#MR-+TPEYB?B=$'*PTTA
M X\J76#&0%-(^R?&0YKE0?S_13OME%TN[(4D4L!2JG0DX1%&!L]$FT('425_
M4_"2NFQC1'K K?>]NZ/*$EC-4>76ER"H($,DO::-%'M0GDZOL0'1A.! $1VZ
M7SMK:@FHNJ5;W\%H:!&0T,[\':<R_E[JNY3E8SVGB3KU0!1QU=XJ<%6;][\'
MT>X*4&+5?)[7QN2\KN=_SG&2R0-ZZSMG/7X?3MW!5U^ :.,^&K'.>?F]ES;]
MA40Y_?WK=+O=)^6>D2Q342'GJJVU,*MVEPJ!X( .69\/I2SJ"GLAQS*-HU64
M1\GF YVLDBB0^283<D4+-<"*$Z($"$(H80FET6M!5$EZH<(#P8R0F#8'/Z:(
MDQ"3^7HM'07HA%U1PPRXHHA:$@15C/"$8MD$7ZY:&JA005P' GEF6;;'9!"%
M)"J>B*0$KZ"3( ^15"J01FH5BOX95I9H.[Q]]_08Y;%L&BJ*..NE%.#J/JKW
M/0B&*$ )5?/8=RA=H[?OOGSZJBJ5YV?-\CZM"@ >MD]IK*BG)95R104-Q(H-
M$A$0A%#CZG/B/D5U,44NZZ_>5@>RQ*G>]ZYH((55$:#S)8BFER%2EL_D0EX[
M@>KF,,71"+F8Z\Y !K+?(;1E0!!! TQQN?4!U?>X>3L:T71E&_/@8.-M<+ Q
M# XV$ <'&]O!P<;SX*#Z\:+0"8U4\Z<XV@2* HQ::=?4T$#NLT0B"HHP:GS*
M^%&KH$;'3^U.7L!MEJQ3LN4H;ND?$E\5<LZJ=^I@UN4[94(@F*)#)A3P+$KJ
MM839W05;/^S8A^PFHP+2;90$R2H*XKH0I&Q-W:SBC#.6X&OZ&.1A,,D.I$"J
M0JVJUU@K-D4]_2S&%VD>O^ X_GN2?DJ6.,C2!(?%"HQLWTDO[S8OQP"[FYJC
M$ 9!*AN$B@0=IG3Y.]-"E5JY?N:13S^G\3[) \+/OQ-9E%+(N>6/ F:7-STA
M0'R1(U/PI!9&A;3/X^1%]8MZ",9"H+20C5[<\>%R+>C>&7.I+"#F: &J3IR7
M-4N:D7.AY?40:([931K1"[X)\J!$J/1:)>[ZV*<.=/^\ITP6$)&T )4G/&L=
M5O FJ)CEN? -N:8#L4VJR53O2;DO?R- %"O@U"* 2"+#I:F#0U EZY$1RVT0
MQU?[+$IPINZ:>E)N&2&%V&5$1P00(V2X%(S@HJB2]<B(Z1:3#>WV?B3II_RY
MK$JK]% A[98A6LA=IDA% 3%&AT_!G$H%%3I5(6&?%/K<%%8OZDFJ_96(.B:/
M$FR/.8(<)-JHP F<B?&*K<_<ISEZ3-''#*/\&2.>1AO2SUL5\0L[?N]@6:W8
M 8UBY)Z$ 9$122?L_#X6)6#A5A9!$@2=C/#4-[34&JA2\<*=.>4S:<_X.)19
MCK?*<Q=F%5<\L@5?L<DD#X)3EB#[S.)JW6DX5T1,TW]EIG:I?_4 L"/D>-PL
M =@;-K<D0#!%"4LU:&[?G."S,B"_6?DV3@/UJDQ'QG$]0!%>KQ1@(P"(!R(J
M50' XF)K+NF1!5=!\CO9[_+5X8&D*XQ91E=6QR_3JIVEMEOF#'*IRRDK54!L
M&X)7P</&!&K9N&CU8?Z7 %GB.JM5EZY^7SX']#'.]WG&>E8*3[V.KE5RO$%A
MX4!OFT*C 8B %C!56Q9<$W'5"U0HHY:VUSE<UE0ZQ.'588'7F+ 3$(_X<WY%
M?^YWS2S$0M?U#,_:G?Z$SZ@(@HI#T:JF@QEJ&T!/+!.M-(%^9480MW*2N^$K
M9JZ#[(F[N<\N-T&P*^B)XSRK/NGSM/SXMSHY9;ZN,U8>TF(=I+K&OO>PAJFZ
M8.D89QA)A^AYY^@(L$)N9*7*<FN;!*5*&_U:Z0,AYR3+<)X9:-@7<DDX.< V
MM;H28$@DA25DM"V7T\<E)"J4@T@K1@BR[HFA@"ORHR<(C"9R=*H;;P*N\P,,
MVEP'V?,D"=E_IG_LHY<@9CWT)+\."#G0\>'/0;SOG^L8J.N25H/<:=/,2A$,
M[8:@%6A(E1 =_*,5^P,WZC (.7D)(@HAQK<I65)@Y7&%"&<W^"EO_B5?,QEM
MQ6GL&^=B)RH.,P&&N.-PJXY$9K4\ND0A-0"=PNQES0_'DUAI!P:-#6[:$5EA
MY!5068_<BLR8FX!!Y[X[MR_WD>*9R$5=DE('MLT[F1P8:FG "<M\7+1+GAVA
M7?II;E$\GCTWF*.)7G!GK*SP7"GMDD,&R&T:*43!,$F/STRFL-:'P2;9FW&=
M9BHZJ<5]QZ0V:%-<8K)@&&4 :*;4.B6?6*H&?7!\MGPLL:B)#:?+F^_?O^%D
MF5P__L@*,>V"*)PE+SC+MV+$40FY((8>(*.#7,([";2P)#6MF!R*:D$8,:3,
M1LL6>(5I<*,CN'N<&T;B6A6G@VX+\)WQM4;>.YT&@!267DL51&H=&.PJ63_]
MO,-)AB=)R'/5;,8^5IHNN3; E3;E+-3 ,,\>JRJZX4(UXTMJ*<]+7'46>F'0
MTH: 'JEF))4_^N1I'L1WMGL JDD^,P*2& O:-Y.()?Z7B\I-OY[=TX;3,L96
MV265ACG4YIB=)IC8-0BN6/D^V5SFF&QI!UJ9X3L",%C9<N4VB C?S[B)LE6<
M9GNBVH\R*;EDH9T#;?;I-<"PS@IFGVV-$@IRM*9ZZ(4IHB_OTQRC[[Z"P;K;
M*(ER?!>]8/HNY=2!B XKB_!.!Z2*!V)2<LDZ.P?:K--K@&&=%4QAB!;DC*87
M*,$\H2=8K?;;?<RSSH(M2[O]Y\F*GAU/OOD.LQN?D\T=#C*\B#;/^7S],2N\
M5#P6@XY+ZEG!;S-/JP"&>#8HA;Z5B8:(,.'+='VYSS"H(5]KCF,<X2EDG3)+
M![?#*)D@'"9IT,G/MR5I<@EQRE XH9T-^9@]JJ>-$.>+VHDBI-:^BX*G*.9K
M]W2.P0\2/*=QB$FYSVW(-;17=\F8H4ZU.66K"R;R# 0L=&>SR=7L;O8XFRXO
MT&)Z,YU^F%S=3='U_/[GZ>)QQOY^6$QOIPOZ)5H^SJ__?H$F]^6?/\WO;J:+
MY;^CZ7]^G#W^ QRG[3)F=0J>>&N1.ZN6ALC-85FT<:,())6VVI)X" YL.\)N
M1ZDO[&,O20Y8MHO4E01#(BT\Y<[1KI &21X:I^DG9(]#\06Q>PAZ"QYI9N.:
MAGLZ=:B$M, L82F3UVTOM2(@# Y/M[LX/6"\P'R-Q9JY%GI.TW5LW>CD[9B4
MP'#3%JF*D:MTRRAYDI4S1>[.(CT$<3E<O4YYX2"*ZPYO@O@6X^JMDN6FV&HZ
MR_(9YDJ=^F.GYIU3P['V654K%T=2:G44,WVTI@9@==0\\PV'[+B"/JK)!)V>
M]54"[9SL%:2\D\H(3;S1)(E2@DIY5K^.DJ:D';I$V7-*<K[7"8-!UOVB[X[0
MKN?SW-49E]NL.[ANC@:XT563RMWRR+A^;]3RDUBO=4&>8"]5 1.L['"*D8NP
MKF^"/@6$!!!9-]T^X3!D4;CRK][UGZ_%+ROG^V7OCC?G=@9PG-/=B<$X6V"8
M?:0#2LKC4K5UQN24]%=,+0SOZ5O9 ->LXVPZ80N_GDB8%+S3; A*!9>NX(;/
M;OI _6Z8M]W->OZ2.S1NJ!,\)$K>N3<4J3J),F:* .G'%@R'#!=U"LYS/JP'
MB6II.!0S092G@,0-PZ!QJ^6,>>;E;>)JF+&"G:IJYZC@N,"J3$9%4G![$7"E
MYH96PVG%(#/T3IT@M3B86&/&*&RJ-QK==5BF4R9I_PE(DO8#8=4B"2X2618X
MQ-L=+^VW95MNBD=B4G)\K,["@=Z).HT&&-Y9P53.!ZD>QEN^9DL?X@LF.<OQ
M1KO**,J*&K:[H#H\\#_>?/WFS5M$!V\H8X5M_TI%>')W^?7;-V_:7[[_[LW%
M&_I15A3!#?;Y<TJB?^+P D7LMM"PV&-M:N.B(&-IXTO:GFRR2M#[-Q>(L9(+
MWN!5^>E;]NG;[R_849H=YK>ZQ8>_HF"S(7A# =%X_<<^"HM[E M_>+%3:OM_
MO/^.8SKFEV"\EH,3 Z&D @Y+_GL%Z7Z#$_S:"O]>EAX"DE/5#2FZ8H1227]A
M75EH4"(&ACEJ;)+3S_91^2V/N_+8^U>4I-6G911.23L(P^!AJP"[MB*F(.9Z
M*"L#V1^_MF7 <$\!3#92I;VH!>O>O]'2[MOO+][]^?N+;[][S_M8.C9X_^<W
M%]__Y<\]-IYR3 "#RX\$!]F>'(QLE@FZY+,::)O1HI0;3G]?<#KA0[Q0-ZU7
M(A1+ 1:"%;V#G Z%L_P"?7OQIS??7KS_TW><9>\NOJ?,^LN[O]2\?O6<G(0A
MK[ >Q ^\M-!UL(OR0)E>J9)VFM:JA]Q)896+@HF]>GQ"(F MC5@%E,LH0:M"
M 0:7%C@/H@2'TX D[)*=27/L]P:OHU6DKF9A5G1;R<+6D6X5"Y,6&-Y90Y7D
MHM8GN<-"$@;WQ+F7]23-]ZS7;K8+:\%<B4^^;CY9!:LH0 N<88J:78=<W$(3
M52/*WB08!J<^1 D=M.:'69)C5JQ%\2Q$,9=\4H%LLZDO R8.*8#U2<3V[%C1
MRC2.V4P@*J6![,&([\(L6<5[-FEY8+4NTF22YR1ZVN=LC?4Q[7IC(->IC/L-
M<<<\$'U8'&,9>B@]PB=Y^(4;8DTGI,W[M0HU2&?:#5OA4AU8'+5$:]PTO[#>
M;&(3:+BTK:\K>Y2<AU()>;EO[K%_RDDN 69$((6EOBWN5RX&Y%*X&M8=G5NQ
M"]%5.1@R02_L$(!*&5)+P6-)'YJ&*4R47U.? :'+(]ZR21 Y%#'T(2!SPO&&
M?*GR 1-^:ZQJ;=-6V^G"\3"7.JO)=JI@*#@,[^F2+T!RMTDY>2#1:B!UE<H>
MF6MP2$-<A294WNKA'DW;8H^PWAP$2=[B;NY)O45I]^!$+8]T5;F@X6E?!2I!
M%3B/9J:P,PV8FS.^(S[D>54:WCG9A6[D8R$.FXL=C*?B89'T )B#\R858\C#
MZJAY9Z/$"2,E6SJP>2D"/14YP66%]?R_:])\'^HL7[M'IU#UR%2M,QJV2O6@
M,E8']FC6RK.^83"WF^DY<,YOJ^PO^W;(C-].$PR#!\&U3]N%2$O+&9%)R1\-
M;>9#>@V@M+.<#0ET SK;D3FGG>SH%'S333W544N#IIEVHJ.B&*2)C,PI\SS&
MJ.6;:(99C$$%-.7,<Q@5[\#-45KG*@8.\ZPT/9UO&3+ LU #0T9[K)8'8\"1
MT')0I]7P1#J;X9Q&'"+)+ =R77(!'<4);FF'<$IIK^12#]X4HG!)I1VV20D%
M:<PFN&,>L.E5O-+*,%33R<,EF'F0)F49N!%:YWA@X9IJ]5(FZ>U$9A>J\DAF
M(0:&1FILIM.8!7]@<&:6K-(MKM/*#*4VE-)N;\350NY>A2L5!<,A/3[Q\ELF
MC5HY@)4"D S !7[!R1[?TN9BQ:(8LE^B_/EZ3XF_Q63ZN3P'P"ZNH_\O? P^
M*Q[,*$MNCU2.=K5[QG*P&3#D'8]=N+NAL 0D)%ZG63Y?EY@, 5$AZW:,IH';
M'9Q)!,&P28=.6#-+2;Y.XRA%:5%P-4V@W-U67$-RF!:W+:G>G)Z0T\ E!=B)
M21T), 21PI+=#Y_0ID6DN@[F3.6_)??3]'"KQ9P5^=: K.MZ2V2\-[D!F#@[
MDUSV<Z9VOXOR:,,CSB0)[Z(5Y2+]Z9*467E1O,P=2T5GW!CD2,T6*RT8_!D"
M5:C'7>OR@WMQI=W<HG>)=H4%&-W.9,N.UOZ30YZO9TE.O6')1/H;M@U*3HO@
M6#G0J86CU?#.P4$PA;(D+256D0D4UWA!\;K2?3$I+5^K>ZRM!Z]1<EX3WNB
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M=CEH12\X=X3^@J/-,QVK3%[HV'R#[_?;)TSF:Z$ KHYG VVXY-\H]]J\'&0
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M/7]8@U8Z4BHN"+@.LN?;./V4&>Y(TJNX'2.8P7<CB%H>3"=B 5)<J"U5V("
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M=+D!^HZO?QOFECXB*93!S%*'(I8'(YX\%G!YSM4X"IZBV)P/YI.MDU6Q<;3
M*TQ?K*=8?6>WC:I?CJJ=T=-3U(,640=@EM1<XX(L,;*4A$K&AR+FWY1[)F5=
MYNIB\^)-M'Y =L;\$G:(PWH*VUB"3^H!7O1I7JK6%;F;J^W+D R5]-7[^1 <
MV+O)DDY6*[*GCZ[I/@9'!;TQ&%':QF&[N*VS!'B,,0"^,JCO"MTB\:C0/G=1
M>M&117H(8IZIGX3%J9P-':_?T0@0WV)<^2?;?AIOR]G^W['NUON"8PU!288^
MA1-"E8I*F1-X5:NCF.FC-35041Q&_+8_LJ@( T,,P#R,*HO-]MK@KH(=AEMV
M1G#@V2#01"ZRKT]PREIK" "Q+1RU(+C&"IB!QVCHIE/6467!]N";.W;37J<\
M>SA9_;&/".VG<NH*R\G33B,M]%QRU]J--E6-2M#F@;: A2D?-<R6A9E2%A57
MYIPB>_E$%"3I"N.0'U5GR^!T>/0AR-FFQ&&^%K9;?\)QN$Y)L]JM>E;'6G5*
MW],\@@ZYCS,))BB?Q@^AQ(MXXC#(VQMDL(X^:1\"7_(QGW@=: ,,_57N69.]
M;^!U4%N!ND_D+Q_*XH5?H8K3_6-\&30R]WNQY7-*\D=,MA8DMM/U.O30N:,=
M?L@4P0]!-*"%84A)U6QX0@F04%M?%7V;$O9ET_&,><5UUL"$7[/+UH%8;>IU
MA&0C_C[A2]5JU8YE;,#FOCB_&!R0X<3AH>'W-47=@<%6S!&"13CZ0OV$PPV6
M++48GHA6TP?]+%R1L5"C!I6,9LA"Y=:A*8?"D@4LVM:O(^TV=ICDAP?J;D[[
M#.;H3K<X,<" UQAJ=$P;497:4"EMC=P0;0OE.G]_!R?BVJ]Q'[U(#G7WXKA=
MBU>Q+6<?DNMMN7(G3KI7 9JZ=8V/8S?BM(8 4-G"40M*:ZR F86-AF[:B%M7
M%N!NQ-%157,CR7Q]S>\CT5V_:*/H:2!L<$0Q#E9H01TS&!&_MCN/VFL@L[+:
M$3N:\F2SU=97\+6.)0>N6JKJ2H.)@T:(0N7&JC@5KS"11"E!?)&*=NUL"Z"Y
M]2W&"9UZL;0Q&)RC[T3Y.K&B1!RQAG!*:9=L,T!N4TTA"BVBZ6$*6Z@2?O6J
MHR&^Z)2GY9;4+B!P1I,/M:OUS;J&0-^1]-&C2J#*NM"6&#2&J2'^R]U=+(_=
MOY35?@8%_$;)?V_:=\#<HU8:P'O5'DQ]SPJR=E-G[TIV+[W-GI=<S]MNI,X-
MY;ZC3 DD^W1(Q6-;A5XQD<6E-*-C40,J+<S H*+]!/[H%0"H2S/'+<F\BE5&
M-6ZKY'_98@P,^C)GV?]GJ_XO08SYZ>$L)]&*CF_8%Y,D['[0DBRNG.T?_YE^
M+B]4F9;EJ19TK#1=K[%RE=(U")>OD9\'W'X5W2* ]3I[\5T84)46T)=A:8/=
M.E1$"7[$C?V!F]_E'Y(:%?_^7R!:G*.)7M&[?/)7T\/%MLL\(/G9WC?=SH;M
M>W*!GO F2A+Z?L)X903W>TY/Z'B#D /%RPN5*]>K!EIQNSPXRL7NLN$@$_#N
M=![GP)%4Q_QZ:!@\KVX<9O=ITC^;;?DDE R>V>44<9KM"39L8!]OUG4'<8J'
MT.\CCK$)9CG@1(X(B_/[W2[F=U@',<I6SSC<%X=#DN)WSG,D55$'8](D\<W7
M9?F9)H%5F4,_4-=9G8NA[M1U+6P5O9-S#%JQ\$J3N2FO4@@M^WU.-D%2WOUS
MG299&D=A=;T5]3]C+U/G6J$@KF^*-Z4<G<BVR[!]TL?1CMTG,>S]'3F'-_UW
MJ&W[ G6L\[%/VSY[R>I?0,U/H%^K'_DO&*_9U3Z+$IQE-SA;D6A7/JJK((LR
M'F=JCQ[QY_PJ5B<^C3'D\@4:[VC[;1EN!<RK,1IZ_SUX^S6ZF2ZO%[.'Q]G\
M'LUOT=7'Y>Q^NERBR?T-NIHL9TOVZ<-BNIS>/TZ8% RRE^7'Z#CK@;ZZ*XM;
MX34*3B\-- +O7!.HE 9#1B-$1>4X-D2N-,#%TF6T2:)UM&*'% 3_3/'35MGI
M=3Z#'.I<[V.E"8:.@^#VJ?GN:[3\^.'#9/$/%O66LQ_O9[>SZ\G](YI<7\\_
MWC_.[G]$#_.[V?5LNH3!U&E V/(CVS[@-QT9PJ!:W"4;3: [=TLK9,$PS@!0
M.*M7BB,JC[@"N.C7]\@4\#3R/EFE#6M*8;"\,@6O]U^CV?WU_,,4?7DW7RZ_
M0@_3!5K^-%E,8;#JQS0-/T5Q3(>J_?):U@NT VVX9-\H]SH7; PQ (:E8U +
M-V^4-OC<N[&""C.HL0,N4JI=-L5,*TVW9;*M7>G6Q#:J@>&J/=8^0[_]&CU,
M'ND4&,BH;UGN/,S7K8(5AMAIT'$Z&[&!WYF$Z!3 \,L&I;"AU-I#:FD!C'05
MMO(V/N,T6*OA-K(9H7<CFE(<#-/,&/L\^XZ-#G^>+A\_P(EB[$AG5+XEK=+M
MJT%;]L-L.-V?'^->9S-^B $PW!R#6DA-:6SP06''"N0!H97SIL@YU @X4FOC
MZS +KXO6IBC\IZ\1G:%_F!51F&^R7,_YLN+T'M":(B\G95I)[ DY7>F1 NPL
M[W0DP)!("DM1S0M::..'JI[I< .3K(#(CB;;1[4!^D[G(D/=ZLQ+;)7!,' H
MXCXY__PU6C[.K__^T_SN9KI8_L]_^\N[MW_^*YK^Y\?9XS]@$+79]REOQ61U
MQ@A)R75*"%[QXWS6N\4V)OSL']L[)]]1-NN#(>T(T)I=Y^JN5#:PY%90RPRX
ML'N//[4V,DF:T#]7N!Z'%+[45[EQF8B.2G:Q>:/Z-*;='A,]W</H'B ]WBZ8
MM^6$SO3?HK]\C1;3ZVEO0WPQOZ=_7T\!+2W<!A'A9Q^:GLT4\_4J+EEN [[-
M7IT\&%9:@.RSC:D@KM.:\L.+T#+/3*'7H..;;=I@J54 S3=3>/O^:W0[F2W0
MSY.[CU-T,UM>W\V7'Q=0YN5U/1X^B#=13"GMMNB(%G*WU(A4% RA]/B$U-HW
M=*(T7<RF2U9?:7HSG7Z87-U-V7+/S]/%XXS]_;"8WDX7],MB2G6F4T)%59VJ
M#(^B$]1*.CL!I(=:G_>1BWDGBAF;6.J-%SSZY43ECA0$*,V;5VJ,TLZ(8(9<
MDT$M"H,01GQ"Y'C;BAR_3!:+R0E&U=K8<&4?'"2BCJ.#$FPO/ AR,.B@!Z<(
M$%?G#A$]5-H H9;UQ01U<% )@N2",3"\JP/#U<D"PVE&IJR<J?66O4K8Y;A4
M#[@]+)5+>B>0%3RA^"<5AKQ[WG7&-,%12OLCDG:"HQ %2B5C-'K/HM'];+Z@
M_[G^R&8Q]_-'*%/E5BH=<ZN\:28_-,?K#4%JB $_R6RVCLESVTS:8%@Y&+)8
M$*TV<(%X!.0;/\4F>V,%7#!LX9XEI>L? O([SEFA9N$A).$U)GD0)8_%)8C#
M$]+/]7.>7H^S/#3%RW32WX+XZIW#0:%'^?9K='=;IA)49YEN/][?H(?YXO%V
M?C>;MW)88;RDR_U3AO_8TT<T?;')P5>*.TUY,8#N9+@H9,&0U !0+.!4B:-"
M'ES<[SMDS*M2R_LDE3YO2B4,EE;&X/4=.SM^M:31BVV/3W\^Q5ZX8K6F5?=C
MOJZ*@? S[@?MRHV=GK-5G"%NU"LZ-DK>2304J3A/KU79N:!*&49\*NO,]*HK
M'/3\&ZKLM)[0((<Z-82L-+W3<13</B>Y,F-CN\ 0#$9^9/?#3;,\V@:Y\N:#
MOI!+ALD!MIG4E0##&"FL/C,^%M=EU&(P2/% HI041=47>!4'6<;+PO!B6>%_
M[XMY32O0*G?]AYIQFUXQSLENWL4P&V#(.1*X>&UD5Q<(?Q>8CCOWF*)+-PDO
M]VG7PUKHN2W7;>E&MT"W00D,!VV1BJ3C>JBE>*;)PD-*\C7%E,YWF!0$MY@J
MV&@YFRC8NU!/$\PJWBDT#*=P;56EB!I-&(%+4Q&F_^_"5<6K-<(.D'H_>C<M
M:_[(C7AG[;'(!1[3$2.8F_YFVUT0$39LF).;*-NE61#/UW=ILKF+7G#8=L>X
MG3+*E-.MDB.<[6R#C+ #AL9'@!?V&6M3;#;$3%S&S$99Q@H&P^7WA=A1VE+7
M]148UN[T[[DP*H)AZ1"TREM>^!\M=<B$-%UPHQTX'&?2/WV'.6]FM9T]X&0?
MY$3_'6#!&#UBLD6-&?X^G&O.U;_5PU0ZVEK+W9S+VH5FSF54\<ZQ83C%JX*+
MNU8:S3/QIY-:<;A-R:> \)(S;)O:BDM#+3CCU3C7:HX-4X?!MU&8%45A6OEJ
M-YC0X)?3(2;OWDN[J#(,HWN?O 11S+*%*+PEC=0-_@?Z?)^##(?E/=T/-"QC
M;;\^TI;3ZAS'N-LITS'&D'>ZGP)]G_AE,EF+^9<\BQ,&OXO7\@/.G]-6AZ(?
MGQITW!?2,L 7ZVHI%,#PSP:EF6?HLLP2AD&U^D#[!QRP=,IZY&*9>C% WTOY
M 5NWI*4(3,I@J#D4L:8F1LO"><\%3JH3:A8;1R8-QV<$3=![)P55XM[I8X]1
M<81TXO@(J355U!J^CI/:444E[I0J+Y@\I1F^TS/& /7LAXY/=3BPFN]DT^T3
M#D,<MCY2A%N3DMNC@C8.=$\,ZC2\!Z5!,(4);2F)PD84!M%Z"T/FK3ZUO)^C
M3S:;=BIA,*0R(=0<\T-!CIIQ$@Q2E95_6>7H+!\S7S2I>JB_;.6,I"JS5@\,
M 0> %>X7SI\Q:5_G 8.#_!JQ*[;Z<IUN=SC)B@N4JPMD9[3=$Q:''Z@S>DJ.
MLN3T--)X5SOGE(:; </?\=B% 2$K>';)3:&V+2"L%BI:VW7;%GI^ZY!;=.-&
M)3ALM$0J+LOQ58X#X@9@,&YX%PZFYQ[88;^&?GIX]]S-U +73=/(G&[Q8_#9
M=OJA$G<[^]"#[DX^Y+)@*&4 *$X]F#BB\E"FL#=1%FPV!&^*/G]='C=X9'MR
MQK)*=KI.5TZ&N--90+%1!$.[(6B%(\,=71;72*$-@Y#J'6$3':TT8>SQ:ZEH
MH0:&B/98A:M\@RA!7\9IEGV%* WS<E,UJPW H&.]"U?D9I<[:>$\63"@A$+F
MQYVMMU2MS7C961WHI'2#U=(&& J/!*Z[GG7-EA1?^-8K^U>4!,DJ"F(4%-=4
MLR2L. J>HKC('J#T#V@0+G\-/;&?>U7L_YBD3QDF+RP0S)+=/F>'%:G+U$G6
MQYSHY;#_%8#OSM!'-.+5LOV)U_;F#?1+K..TW0;DP-[$57F?$^UYFI>R>A,/
MZ(Z.@V+T'L:KUUP1/0U(PB[N?<"D6JF+5I,DO(GB?8Y#JZ'Z:&M^+OL>Y;+\
M&O!!IL"\&L?A%T_VQ*M]7(_W60>SXKU06!A!"<X1&XJA'28H8S\#[26XC9(H
MQ_RH7?_4Z, 78( E/^0?[*J<^-9F ))^*';=8"RJ#93C+QC49O.?._K*S9/6
MLJ*)Q28EI\?:K1SHG&'7:H"AH15,'>,VW:EM!&W9N/6>[7,ZXOI W[;M?KM@
MM;KBA^# H=()?5DO(MG<T9$9'AQGC['M*?(>_S@4L7B\83"OQ2F]T4Z>N76T
M+<RCM#*'8F8/[<I?@O$J358K'#. ..2CLP7>E>=6S,N55JJ.;PRV=J9W4[!1
M#PR-!X#5L934:F$Q8 9"R(\)P4$<_1.'\F[,)H8/M.&T/N(8]SKE$X<8 $/:
M,:B%26!K\:.S/CE9!:LHR,Y_6/E^OWW"9+XN*OG4=:FRR>J/?41PV'/>4L=9
M\K\M_#K]WZ3@G5Y#4/;I5*@Q_B3X$^V5F3+:U=HH*-5AA,5F\/) TG"_RF?)
M.B7;8@&1O3W&08]2S\]0U>"&?!BJ4/+.PZ%(=1USJ8E:JNA7K@RD:K_HVEV4
MX%F.MZJC*5H-MT5DC="[]6*5XF H9\8HUO:0$(PI(:X%A&7-J]1TZT7V$1WP
MTBB-P\F6U?;.K@[7-'9O4G*PBX-#S?D)C^.<ED?-8;; ,/M(!]2G9E"9Q7;.
MJ)J1O,5U^J\^S^E'OY4[>VT',WZ@XI$.=3M7$BUPS"9\#P%A&^Z%_PS\39 '
MJNA[EE]P\3:<\=&P%^0,YKV_,^?S21BJ3*]1]69>H+?O+M]^=T%?J&Q/ MJ@
M_-!$D%"K%ZBU;]VYF*XX,I134.W/V;2NQ(5*8!![I6?ZJ%AYM19R5?B2BKH]
M&:0&VSWZ(\IY9[0%.(&:3/0R9\7OP&6ZJ_,,?R1IEG771U24&FH$1JZHSD&[
MM%&9!3 $'06[3]W:R"4=DU]FU$RK.L\%XI908PHQ6Z^,V&S1[]A'6-@ 2>NV
M>Z-8S0RX(?7W!:D3ED%/?_<4W&Z!/Y;:S!0,:C>=R/Q30F<;>9WOIWA<.@4_
M]1%4P.4%$OK28&*L$:)FLL<U+B 62KC>9SF=AY+F=:"OV2_/T>IYFN11?O@I
MR!;1YCE_3)<XCN>$#M1C'&ZP:;GM!':='M0\U6/H'.<\UB@8[I_*$V$[K;3;
M+@-((S3ZQ$RCPC9Z#C+$K:,\1<P^HA+5+Z O9\DJWO=K"2[3.&R+A5\!G,@5
MN7AU&&FN;E;UA&IYI\,1$^S.T$,E#(;;)H3"6 )0_N-=<P#&GD8F)9=<LG.@
M32B]!AA66<$4"N<W2C#X)2N?^4N4/PNG2;+N<9*L>_BD\NN@&[B>Z;=\%U<]
MV>,R%6(]^H><OCL[?I'D,@](KIO\G=-1::W7(J$')V%QB#!F"\JO^UU4/(FJ
M-'C&YM39+,OVS-5LB?,\QKHU90\X7L,[?/1C/L7[/1H$E#*JOA^ ,(<O1=D&
M4EVH]1.H0JVG?E0\,--)%:L$A6]P\5]'S:3X[=?\_FL?YSG?>>D/@QD?N_16
MO UXV_PH6U1H4GEUKS1 T@$9.+[S,'2<)MI=@_,Z^LJ&CM<IKSY9W%N\B++?
MZ>O"/@@V^*UJQ4^KXK:&GAE\MXB>6AY,^+, *:R5ME40H3KLH'FI!(-GK3+D
M_.V9).''#,_7_<]O,$N0B)*R\)9I2^MXLY[JSA_U$!25Z4?9!,/[$SDB69/=
M;XLKKM">G29CFPB *]VKYM;>TK0,V5D0D[+,N5BM#=@H03]3.N1I B143M=K
MO&+<K(M?+H(<L]L$HV1/!Q#E >!4F8<UQ(#38O6#'>N4K+?6!L/#P9"%JSDJ
M R@//B-VJ!8&19O<]PGUA5>YH2";3=;I9[;QBL-;VOXLY7:?E]&Z7VW'[DS$
M:7[$STF)4SX@^?F)4_P"F%?F+&[ISK.U?Z:=)E#]$&(-BUH_Q92J'T,/+$&!
M_1RL,W!'/KL[0P;/Z<P[34XX\4/IY#*<R#:8]_#$#@FC\E.]=7?0,G<,]>0F
M3QF_%%HU8K#5=CIN&^929]!FIPJ&]L/P2L[LLP%=2GZ P<4':@L3@D-^9<=-
M]!*%. FS8C2ZI"\67_MDES H"3G,A-O#TL.=ZYZ>MM>'EO@^ KM8IKY08A74
MZIM)J46,MVP@@V@+O&"2\[I^N^KG4 ;G[I?N,YBL5@17Q?I#7*SXL*PJ=@37
MZBD:+/BCMI5K:F9KU6$3VP:Z,+*H=%K[\J^+V!^3,*+=3/3$>AS)8D'51[&3
M*).8 V'U.U)^+'45[7@UMV9,Q;LPQ>,^ST^Y+5AUOH?5K6MU^M\!,^HYHW/]
MU[/S4PA7(_J@L$H_RE.T:YL%=V-%W=MV8Y5J5T,E[?;6'BWD[CT]4E$P5-7C
M$SJ#,/P!>1SI* JUM?JU M"B1G/=@-'RZP@[S@JZ'>-F7>1MC!'O;#T6N93'
M/D<V"B(7-0]G2;T).\!5\]7QY_D)9_0_T\.IWXP3VX?QTIS'*>$T#<ZR'U#Q
M6V+!SH'O%L+E[[;2"ER_;[^4><>#'FFCY/^=Z#M@9GFE 9RW/9@CF7BJO')[
M7MW4B_\,PM5 @BFU?3+-X)*.<@I5L-S3XQU&PM8^#<A3#K,DQ_1YYM//[#YT
MS.MW*1.#9*)NLZG48+MI5:*<=[99@)..7"MYA L%=E%,NHKX?/]3E#\C=MCO
M*0U(B.[3G)5=81<F4>KEP6<8'.LL6TB60W!X_/K;*+/>UMJ.> C*=;41-L&\
M$R=R1/K^O/Y%LR.>3KGU>OK'7AM^)>]0[T&<Z"TJK?XKO$==5\2C74&]=,WZ
MEKW\I3KCJZ08?!MR#FYP$O%T]Y0HDD=&6W$V&!_O8CTH'V[".Z6/PRULV.,D
M+26UZ25G#%Z_8%9K"8>3%TR"#:YNMN!^9?-]GN4!/^*F[.T'&7!\=M#BZ/DX
M^/V&K*Q<!H69\GZCXG0*G7VM>-8;"SUL%!P5Q<#+Z^[J^T-1D!>QBZ].T:!%
MI;8TL/$5J><T#C')T&5Q%2F,(8#TX95O@? $)^%_[XOS&4.:PL::R\[^2)>-
M;X[9E/<8>!K\PAT1*;L.)Z(=^J%9GJC> .-M8>XCI,K1 3%29>+51$FC S[C
M9'E1,XQ(>63N=7'MQ'GRNBO;KRAOO_LX3IBT7Q@&$V%/Z8TV71_2=8R:BZRI
M0W0:]\\B@:E8=US@;1 E(8M&MU&V"N)_T&F?XG&>Q++3ZC2G>Q2=LB#'FP7S
MBIS.%TG=F$*6K2PPKK[&U^,>?\X?/^'X!7](D_Q96>7M2*-P7PK5 QC_/O0M
MOM)70>%&_RV@+'S[&HG/7NS'3^E)'E5M"R[->^Z.9W=IZ)62NHM>PN5WKY;+
M].>5=?G&6@/.Y[;+1S*:F7K-G&[AE[#Z_6ME]2U]KB=[2(4QV)QN.WP<I9FE
M5\SH%GP)H;]]C82>K'-,N&]4X20/JF<1+K6EKH_G=\?<*R6YS(<^TQ^?,<$!
M$_15B53MTCV6+K#I-1RO7.=I'L2Z=6M+M/UV^9__]O9/;_Y:_.]#D!>7B"8X
MAQ^55JO]=L^O-&U3<@2A58:@Q""]H[:A1V[E540<+73)">I*&@4M<1B$;BKW
M_93&;/\HT]404TK[J: HA2ROIM@1!4,R/3Y-E<5*'%:=+-&=.T/I*ZV&7U()
MT/7$N@-7<\J,T8I@=W8EH<Z:Y-F^5)<E+\X30QE5@\IO[Z'M\ML"%FI5*TZ9
M1+4NC-# O)HG[%*0SHWUBJ>AE'89$@R0VW13B(()!7I\?4XQ:7:ZG]_>:\VE
M,[9$\3I8M81"U-7DR+XTCPFH<*B,79P\N%'<ON#*T"RAHT36]<MMU9/(PS&D
M%UN%3BBGAW-4W[L=)"':-]=P;]@K7R9[49)!(U=3QO8ZC2F6E/!CX1-V;G)3
M7"LU2<)[VNR*KQ_I7UFPXL6A[8HDG^Z'_!1*/O6#DA=+/M6O@'FASN::>,E(
M2Q^U#/!7L_UO?AX4Y72@A[I*H.9^"[PKKWZ;; CFR*]9"APF[/S/P301M%=W
M^3H-=:K]DMCJ@J'^0,!BSE:ECFI]U#9PTNK"BL-?57:TKKZ"*./LX)8*7GTL
MJR_@G1PZ5))ZO4]%RAZLB@;7<4!'2!7Z.>%7W$\_8[**,OQ HA5N7"N_S92W
M=8VSY?0:KV/<[=SO-<:0=\:> KUP=J*40SNF=Z;8U8S@BT,=RS3N']/6R#F+
M83J8=1R3"7EGA@F99CFT/"N34>'7NP;B=M%3]VZ:$$H7/_@=!E"7/Z31IC[1
M6I\?N0[B&(=7AVFP>N[*#HEBP^QZ[WO&/ 9C/S3$*!C>G\H39?^$R_X-R-&[
MX@WGU02[I[O9;=]L8[TU6U9-R >9<+K6,L*YSBK* 'TP#!X!6CU-*.H]FCI5
MAW1EGO"AH<K[EH!3J@G .D2JOX5#DSXDX<XP?IKXP32<=K(#8+W%YWESR7XW
MV0:LK*!/O1=P]BF.;H%&)N5A>J-<I!%%O+]W>ER:B0VLE9K;* F2513$LR3+
MR9X3=OXIP>$D-UU=;:?J.(72VIE>TJ11SSOA1H#ML_ 6=,)*>5M'LKG#08:S
MVWV^)_A#E$3;_?8A.'!'AQR /\*>2](>[7:;R:.-@:'WL1Y(SM< .<MNX]G-
M'E_O"5&7C1IJ!!J310>'TK>Q &T,. H]W"/HEN[0">BGE+V JHWF$78 LE9T
M<P1Q&R.OE+N" W!/G=M[Q(X;GX; +4LP*2RX.H[$M9G72^.^"W /FEO[Q$X9
MGX3'+4,@:2PX.HK%M9572^*^!W#/EENZ=-P# <G6(R@*ZW3Q,-#"X6]F'FT+
M<;0KY2&2\RX*GJ(XR@]#)F*BDC\JJAQ0,["O >WDAA5:^9U V7-*\LL<DRV*
MF3**2VTP-TOTWJL%]:@N6F:Y"M#7\1@&Y? UP:^K '492HJRS[A:IZ3:*LWR
MYBJ@;/]4?%P4^@5)OAF'MLSI"UDD([.;E#?TKP5^P8EM_VRVXI&@MBYJ*&LR
M 97$EKC%O2M>F+I(!L-Y'F,X>P9LR[7V8W5@-\SN@WB27P>$'.B'NOTK2UV7
M7!WD3C\!T:@(AI=#T(JG>&H]%!2*0#KRYB 33]:Y.O#<,[NS;Q(-/X?8E-#E
MI]$$<3 <,V,4$F1*#7YO*<^3>CH@K@7KW%>9TL@AWAD.>2ED/22HRN%*DDZ[
M@F#XI$,GQ"A.FII&ISR%=1H*/1(Z(-B3 \=79!-.5G_L(Z*\IDZKX9).%M#;
MI-*(@Z&6&:,FH;,X)D'JHX! $CL[/E7>E!>J7--Y475K@\TCT:I[XYZ%4THB
M:G1ALM(,6"C"5MYYP\]OH5T0A<V=-F?*=9SL=B3]'&WI_*:ZP9R_'8_/0?XA
M./P#YU?XH7I-9.E\ PTXRY <Y5B=/#E(VSO]1D,6"-C8:'+>RG"94SMH&QS0
M >?HB=(35O#DKUQSNON!I!L2;*>?=Q'AA0QOJ$^J8:^5JM.YQ0!G.I,,"SWO
M;!T!5K@*COZ+W2M>2J*0BL*@83GD[70$NNFL1M[#A$,-6S+I$(7!4,N$4#GY
MJ#2J60BD.>R4#B?R@\PUTXS62M,EW0:XTB:>A1H8"MIC[9.QT+Q 2E*"FQK+
M(WF1<<QN]MSGSREAIW9:Q5OXS7.J^A7'&/3?3P]QW-Q[VU@#P_JC7>B_##_W
M1J%!;0&M4]*:PP-Y$^K3T>61DV33.FJJ7=>VT73*;7M7.B0VJ\%AJS568=V[
MUD2U*FKIPAHYZ/TTC1ZLM>&P4SN*L%1])2PUC2;,3(4YG"A.ZM]0[,GF 9,H
M+2^1OL>?^%=*MEHJ.Q\F6#LD# F,FG"H.@2NP%0^NHVX]IE6.ZL3QP5$V2I:
M7\+9>J4<6KT@V?W:>X.K,2F+OIRF84\386[P4]X<!;Y.DQ=,<G9U2O%G1N,B
M+_J@FI\,T'<99P:[U0XUULK>R3<6L20MIA0[3<6\$W$S>HE"G(390W!@8TA]
M2K52VBGO]) [+).+PN&4%I_DUB2RK^N4\PV[L#( @TT,(6Y=.J=P6Q1SR1\5
MR#9Q^C)@&*, )J,*-MVH=<XEU^T3#D,Z+J,CLA=>F;NN?#%?BU_6!P:DZ[ C
M;<$K072T)_IR(4NJ22=>$X1+4RBL;3D9XA8C;_/@K9+S--SMPE0,>@LA[^^]
M"9EA 'Q1KF2>N?FK$L+:24Y+R'G#"P"%5J\EH 0-+;K74NRRPC5)PJ*:]'R?
M9SD=P-#9NB)(ZE5<#A1LP+<[*IV\]T R *2^EX%5':UU-TFPBW)6KJ^X]9AO
M:]Z9%IMMM3W=5V/CDN(2&ITJ&#(.PZL[#M#5OT"%!0@W-3Z0=(5QF-W23UD'
M'B3M*ONR5M1KP!O66N(5TJI*M>+<6E0JP@LQNHCY(<C9?L=!D^]GKPZE;Y,Y
M9=O/M77!A)F!@!6#JU.G -J.J<VS*D'4W_C:,+?JR4&)9!887\N(>[Y>LR/
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MK&@)9'1]-'X5"88:]+5U@G-6"/Z!I&QI+KPZ?,QP.$OJW;7)B@X,E:F ]MJ
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MKVD3%3IV1KY,[- U5DL,8.O(T"F;@S[_6AI68+R-DB!9C0V,$FU 334"],#
M6)OR'Q@92O;_60?\$L28KSYG.8E6.0[9%[2?[W[0DBR2<_I+4=//Y1$>^@??
M%EH$.9ZNUW@E'1NY10"(9YX<%Y)HJ.&+@JTM^VQ#J/KIXDLV3.M_UE$H("')
M\O0%JH&A"AEBT%"![35R_^14_E=AYKF)YHDLP@/HN3VAG08A!TIQ92KG0!.
M"#$6N5BR1&QJD1!^RA*<H1(_D,TG2Y3R*OPJ-5]%4%Z"*&8;672:LZ2$:5(8
M?B1IULIF425V##( Z!4<AUNHO%)9N:13O<N,VNDD@7!3[12>._>7FU<.UTF]
M'W@U!\R+"$?Y\\<D?<HPX;D-LV2WY^D2U%P41\7E2 OF$$L>9\7NL^H@\D$9
MEL_R0P#>?3?^]1G67)UZ@5H_B#[17T3MGT3%;Z+NC[+A0/FKB/_L!:I_V&LA
MC[%/4?$0JUK*&7N7>7E9.B.D_\)Y'F/EOHUS$( "H#_?'5*<SJ(J7!?H2PZ-
MSIYJ=.RS!J"O_+SN08IZA:HXBKC,Z;R.P9MM=X%\QC]$'Q !1\&6W K7N2VZ
M=5:M/,I96T*%*1"-W+IMI+FOG=WARK(-S6VL50?;Q':H#2U\@3K7JS2&4&7)
M=RF'.[9&D]WN<QK'/D1)M-UOJQ7HFSW6U,0;9@%0,X\$KJX-4=BY0(4E5)I"
M]4+^#>LJ[MG=98^?</Q")=(D?_8ULK9T?Y8\?DK_@0.B+_%A:^3UM;\$^V@*
M7# .L#1=:A)QF^ ;_YE@?(+FK\V\2@*(Z$]  6;T=9#@EC[VXSE06WF-%!#!
M'\\ 9O,U$."(5G]]37V:?AY$@];S2>O16U\#;/,I@1I:K3/)]KC#,.9N'O]K
MB09@JNM@ICYO@SGV.AZH3[T'S_CLESXN1*I>WN:D.5O,FJ^K0K+:]'2C$J#H
M9(^UWU"] _-,G:T0E%63]2GK[8_NZ%_TX^HC^C]/--[13_Y_4$L#!!0    (
M ,^#:5$%:K8B0$4  %Z>!  5    86-T9RTR,#(P,#DS,%]P<F4N>&UL[7WM
M<^,VTN?WJ[K_09>M>FKWP\S$,Y.7R>[>E2Q+$]7*DE:2D\M]V:)%6.83BG1
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M],A[.=WJ/9O(HP*88$*"<SBY*KA%-HU*#VV.YDHYS.8J-U=^[<YFW;HG44%
MV/&H)&K.6XL:MQFAEO4.L\4XA8S EO[*A'6LQ"H.4"KQM5R+2Q$?5^_W6GQM
M4(NOM=2XHG6;>ESXB$J+Q<WMZ[!0KGDE5O&+2(4#+Z39,V?NY*C6XO>EX(FK
M#UR+Q\/)C/W3N^.'D_%D8=4^X*^T=?SCHO:6ZZEI.=Z$!)8/*W(L*BJ@G<-Z
M/WI(SV!IQ-%@$[C3D,8/H>^%A[NSZOE3"J:X^OBV,QID_NI='-+@;GS3F4YF
MB\%D-)SD+GLMSJK<_2''*<M_E2\Q!BFH!.\#Q2UP- RR@=XZ]'<2<TNO-.3
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MG=@.JVE32T#R.G\EN0M<CWN8[[F *L*)=B+ERV#73P;"P^O#J4-C;^D].;P
MSF&C3"0NUB8S7[.="KB9VIE$ ,>&=;27=I\=S^=.FT7(3E+K,$AFVV/H,XQ4
MZJ/=D>U[O!;/('"YX0!]O\L>+ZMB<(4$0!"-/1 T;!(H!&7(WLYM;ZD!RC<Y
MLN8*QM:@9\+6%O:C$CO>5[VN@*@:NW0RA6I]B1C%N_?(GTL.@WWTO<;0RND"
MJJQ _IG6OP+4$F/I\4QJB2%(3JU .\>5KDH<Z&S'<%@!N2BVT\%VLV?UR/$(
MQT_8 =CE\TJ05$@2QT%LE\":)\T-(C*)'V5A<=6MH< :<^89/H/)9(0#Q2,K
ML<(D)&XK-GFMGJV7,C&L'6W)_NPU*3-;C>C2OF_KL8)XM:D@?QSZ!/=2*-6G
M1E=0;3'F_#.L+;6E:RHL6.[1NB&!ESSU#JGD3CB)[ZC1$13L$P>RM'.^K"]9
M'.O K\1;/7*G)K-8G149;W@< [-V."_19!-'L<-6OF"E.(YH=@-5B?:]@PTQ
M"YMP7??VZ4-Z^\0^<A]&Q/[M4R7;F?!*O'?=_]ZDV0LTM0?2H;T@>/-Z!!<H
MZI5$Q(;V6B+N"*H%[?L;3[&:J 1X_NM)I00U@]+@6G!V#DDYVYB6@.(0E::#
MD  <N?1*P$1I(S:407<M#U)JJ7OK#ZX,JTJK**!)+S1UXN29F2RGT*=B3J&/
M;SO3[J(_7LQ1Y!#Z'(;N%\_WV68_9,()5OS&KQM%A/&U'[8ZR%JS&[L9/+R8
M*>PS*8V4J1F-LZR0F3]^1GCPO,O/, /&A^/_QG1 +(96.K<<AUY+(\H9/]H2
M,HYM1(^A,5M.%E^(_TQX4:)'>7J81OW:#G4_O;*(9'N.>L+U?/$E;$L]]MW9
MCID_O584)'FVRL ^+\E@5[M#V^'QEA0B+\US58E!N&GMP''HSW;@NAV%R,OR
M'/6A^Q 3FC#""-I2BD*GM@/73Z\9E5)%KQYC(C''5'2V ]L-@YR336W/<AS&
MCE_P*V-P,XQYJ%^<U]2\O^'CMP!_0V??Q\7S@&,R=Y?+S7KC\Q"<_ )5;XD7
M]?7*_0IR$:)Q&N8RX<L<AQ^OBA/Y.YZ,_)?^?'&+QGEXR*64XTH]915D*$HQ
M_!SZ_((R4N04%Q+@2&$$ DA8JJ' $I)4W^7QE6X?(#B-L"7D5NB>$J41NF39
MAS$FI?" !>$.;<\;EP,?.-)<'X_LN :6*F4QA!8;6D6=DP)5S9+1TJ6' 4"*
M8Y9;VW;]P_6IHM:EB'E3;]$.,<M L4LI;/M(ZHD>( 0<7H^[@!+']_XD[F?'
M"WCX^20 %<E2$EHV@0!'E]*3#9 HSC]^CK,W">9.X:PJL?M%!'C612C("MYQ
M3,I4]S0 $A+8OIW4!TC!^_GG8M)<9YNMKL9N&>O-/,BBBLUEI' "OP?ZCG X
M@E^=%^DPLE[HLX&'J8SSA>.[@3L.@Z7@STGZ>\8%K^4 +FK7WK=P6')U?%<F
MI('$[34C3QNV*C@1Z:XH20;;XU&QA#)IQEN #PS> S8%:'L:%;0&+A@SCK6(
MQCD]8/]5U 'VJ__D1\33.@O<::QI=<NO!5.A (QXX4#0*?1+6C.!T6N06P99
M*/L21!H\F7'"_4*H%X<!D3J!BHVLF99Z$BN[?JJYQ6%8OMZ2FH:W+5593<L%
M8BYE-;_"LIJO^\K#=%DR.Y<CNT?:BG1\Y6:6O>FZ%E%>TB*><6R)/=^)HOW@
M)G3&']7W7PA=>A&94F])#B//_AI=B=?(FMW9GFUU\6W&M=&I=IC9:2J$>7C@
MOS#=JIO:]ITWF7,RYG',NY/?<1ASA3><._ +#VRKY#Y_T?Z5><_Q?>)>;_O.
M\O&XK>:*J=>U[1<V)E;/.L+%H2NI*B>Q#\<9KH91M.'!Q#FC2^)LU^K%=I1(
M0PVH(S(D8/-A)CN\!,I<&]NO89H"56(7!PR'RU7-L(ZFNZJQR@T-@0((Q&8@
MC_+,JC 0JQK:KJ+0SGD5IY58Y5N8? F(VXWWF>*UO*@5U+8+)#2<<3HB0A/N
MP>,TO7CG*$[K<JT(8X/(7PQ]*$9]?/^VTYO<W@ZSJ(_N^(;]]W@Q''_NCWO#
M/HXW1#)N-9X!:G9C<=IFY=6"U8@PM8X&FYB-[-8+O/5F/76V"0N::8<:=&G9
MAU<+_<(D;RQ0',LYA(V;#>EM*)=K,V7(]V/;S7<J%2C+[ORCIH%\,UOM2\@U
M7G+PKM&5;6?D"36G+,&O27EX'IW6U"?7F6TOZ6D5J"3%KTB%>.:=MC0HUY=M
M)^M)%:@DPZ]&?QHKC7UG[ DUI;%Z5*6^L:X<(\^Y]WPOWFH>@,MTMMV][:N"
M2#;G_S!)P">/GJNI!GE2V_YD@YI0EM 9^;<4SYL^UG9TX7CP]+6[O&9LR/ML
MOG!/1I'L];FNJ@6#TCV5EH:;,VEG3OF,_7A&GDF@<613=_0*'510Z>& GM]9
M'MC>\AKS&\?OQCVVF&[9+Q4W34#RU^!-TI(4F@TY7\NQ_\>&G1ZD]TS?%;??
M']YVYHM)[U\_3T8W_=G\OYRG,/I[I__ON^'B-Q1W3"E3ZAVUV [%&^($G>MM
M$I %?@Q<083C;4,U%,)GO!5\('F/FP7()0,<J1_?"IKC  6@;-7A@45VD"2>
M.VRLN6'*'Y5)2,X5(PE+.#+2Y<>E>N=5U18),"IEDTR=EEY=M6>69OG!5/D
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MX-)G!Q[79;OF_N"T3] Z>2C_<9_G0G)A6KM'V[F"FN'<5)(M9Y6R&7>P.QC
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M[./ Z#AH=<@M0!+%,[9 YW-5RX,Y(/2VHT%K(:@G'(R #IQE5@<4"F&>PG;
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M:6%?97@S,3 Q+FAT;5!+ 0(4 Q0    ( ,^#:5&')4I2&0<  !H>   1
M          "  5H'  !A8V%C:6%?97@S,3 R+FAT;5!+ 0(4 Q0    ( ,^#
M:5%"3\2^8@0  ,\2   1              "  :(.  !A8V%C:6%?97@S,C Q
M+FAT;5!+ 0(4 Q0    ( ,^#:5%JSVB : 0  'X3   1              "
M 3,3  !A8V%C:6%?97@S,C R+FAT;5!+ 0(4 Q0    ( ,^#:5$4\_DSW\(!
M .1D%0 6              "  <H7  !A8V%C:6%?:3$P<2TP.3,P,C N:'1M
M4$L! A0#%     @ SX-I47 GI[@\#P  TZ@  !$              ( !W=H!
M &%C=&<M,C R,# Y,S N>'-D4$L! A0#%     @ SX-I47$H,K22%0  6B<!
M !4              ( !2.H! &%C=&<M,C R,# Y,S!?8V%L+GAM;%!+ 0(4
M Q0    ( ,^#:5&&O#%[\BH  &#I @ 5              "  0T  @!A8W1G
M+3(P,C P.3,P7V1E9BYX;6Q02P$"% ,4    " #/@VE1*T*.Y5Y@  #*: 4
M%0              @ $R*P( 86-T9RTR,#(P,#DS,%]L86(N>&UL4$L! A0#
M%     @ SX-I405JMB) 10  7IX$ !4              ( !PXL" &%C=&<M
F,C R,# Y,S!?<')E+GAM;%!+!08     "@ * (L"   VT0(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
